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Abstract: 
 
In the present day, the fetus is a well-studied entity, with both physical appearance and 
genetic constitution able to be determined prior to birth. However, this is a relatively 
new phenomenon, that has been made possible due to developments which have 
occurred in the field of prenatal testing in the last fifty or so years. Prior to the 
implementation of antenatal testing technologies, the fetus was surrounded by mystery, 
accessed through information passed on by the pregnant woman. This thesis examines 
the developments that have occurred in the prenatal testing field within the time period 
1950 to 1990, which have made it possible to characterise the physical and genetic 
structure of the fetus prior to birth. An analysis is made of the development of relevant 
prenatal testing technologies, including amniocentesis, chorionic villus sampling, and 
ultrasound, with a consideration of their role in making the fetus an accessible entity 
during pregnancy.  
 
To examine how these technologies have been implemented into clinical care, this 
thesis focuses on the development of prenatal testing and screening programmes in the 
West of Scotland. Within this region, the city of Glasgow presents an interesting case 
study for analysis. Work in this city was led by Malcolm Ferguson-Smith, who is 
widely regarded as one of the most eminent British medical geneticists of recent 
decades. This thesis studies the role which Ferguson-Smith and his colleagues played in 
the development and implementation of prenatal testing and screening programmes in 
the West of Scotland, particularly for chromosome disorders and neural tube defects. It 
will be shown that the group played a central role in bringing prenatal testing to 
residents of Glasgow, with the majority of screening programmes proving to be popular 
with pregnant women in the region. 
 
Whilst prenatal testing became technically feasible due to advances in technology and 
science, the field presents a particularly interesting area for analysis, due to the ethical 
questions which prenatal diagnosis raises. There are no medical treatments available for 
the majority of conditions which can be detected, and after a positive prenatal diagnosis, 
many women choose to terminate their pregnancies. The importance of the development 
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of permissive abortion legislation is therefore important to consider within the context 
of this thesis. With prenatal testing being linked to termination of pregnancy, it can be 
seen that it has the potential to cause conflict between those who manage and participate 
in the prenatal testing programmes, and those who oppose abortion, such as certain 
religious groups. This thesis examines how the two largest religious organisations that 
were present in Glasgow during the time period of this study, the Church of Scotland 
and the Roman Catholic Church, responded to permissive abortion legislation in the 
form of the Abortion Act 1967. The views of both the Church of Scotland and the 
Roman Catholic Church on abortion following prenatal diagnosis will also be 
considered, and it will be argued that remarkably few discussions were taking place on 
this subject. This has created a complex situation whereby the expected conflict 
between prenatal testing and religion did not seem to be overly prominent during the 
time period of this study; this is reflected in a lack of direct correlation between prenatal 
decision making and religious affiliation. 
 
Glasgow presents a particularly interesting area for examining the interplay of the 
technical and social aspects of prenatal diagnosis. In the city there was a focus on 
prenatal testing amongst the group led by Ferguson-Smith, whilst concurrently the 
Roman Catholic population in the region were openly voicing their opposition to 
abortion. This thesis provides a detailed picture of the interaction of the technical and 
social influences in this geographical region. To achieve this, a wide variety of sources 
have been examined, including archival material, published scientific papers, and 
newspapers and magazines. A number of oral history interviews have also been carried 
out. As a result of the analysis of these sources, what emerges is an in-depth account of 
the development of prenatal testing in the West of Scotland.   
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Introduction 
 
Prenatal diagnosis is a highly atypical diagnostic approach. Usually the 
aim of diagnosis of a pathological condition is to treat it, prevent it, or 
both. The main consequence – at least, for now – of the prenatal diagnosis 
of a major fetal anomaly is to allow the pregnant woman to choose to end 
the pregnancy. In that case, the “prevention” of an impairment is the 
prevention of the birth of a human being with that impairment, a unique 
and, for many, a highly problematic solution.1 – Ilana Lӧwy 
 
I. Introduction 
Prenatal testing has contributed to the study of the fetus in utero, and has made it 
possible to detect fetal anomalies prior to birth, providing women with the option to 
terminate an affected pregnancy if they choose to do so. Prenatal diagnosis enables the 
detection of a number of conditions in the fetus, including chromosome disorders such 
as Down’s syndrome,2 and a variety of neural tube defects, including anencephaly and 
spina bifida.3 As highlighted in the quote above by Lӧwy, the nature of research into the 
detection of these and other genetic anomalies, enabling elective termination of affected 
pregnancies, has raised ethical issues which challenge the views of a number of groups 
and individuals who oppose abortion, including religious organisations. Prenatal testing 
involves the use of invasive diagnostic techniques including amniocentesis and 
chorionic villus sampling, alongside visual technologies such as obstetric ultrasound, to 
gain information about both the genetic constitution and physical structure of the fetus.4  
                                                          
1 Ilana Lӧwy, Imperfect Pregnancies: A History of Birth Defects and Prenatal Diagnosis, (Baltimore: Johns 
Hopkins University Press, 2017), p. vii. 
2 Down’s syndrome is caused by an extra copy of chromosome 21 inside the cells of the body. The 
condition is characterised by Down’s Syndrome Scotland as being ‘the most frequently recognised form 
of learning disability’. For more information on the condition see ‘What is Down’s Syndrome?’, Down’s 
Syndrome Scotland <https://www.dsscotland.org.uk/new-parents/what-is-downs-syndrome/> 
[accessed 18th July 2018]. 
3 In spina bifida the spinal column does not develop properly, resulting in a gap in its formation. The 
condition can be on a spectrum from mild to severe, and symptoms can range from leg weakness to 
paralysis. Many babies with the condition will also develop hydrocephaly, a condition caused by excess 
fluid on the brain. Anencephaly is a more severe condition in which babies are born missing part of the 
brain or skull. It results in ante- or neo-natal death. 
4 Detailed descriptions of the development of these technologies and their uses will be given in chapter 
one. Briefly, amniocentesis involves the insertion of a needle into the amniotic sac, to remove a small 
volume of amniotic fluid for analysis. Chorionic villus sampling involves removing a small number of cells 
from the placenta for analysis, and ultrasound is a visual technology which uses high-frequency sound 
waves to create an image of the fetus for visual examination. 
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For the majority of pregnant women today, prenatal screening programmes and 
diagnostic testing are both accepted and expected aspects of antenatal care.5 However, 
the ability to examine the fetus has only been possible since the 1950s. As Nicolson and 
Fleming have noted in Imaging and Imagining the Fetus: The Development of Obstetric 
Ultrasound, ‘Fifty years ago, the unborn human being was hidden, enveloped within the 
female abdomen, away from the medical gaze. The fetus made its presence known 
largely by its effects on the pregnant woman’s body, and many of its activities and 
characteristics were understood by doctors only through the medium of her verbal 
testimony.’6 Prior to the advent of prenatal testing, the pregnant woman was the main 
source of information about the developing fetus, and doctors and midwives required 
close physical contact with the pregnant woman to gain access to the fetus. As described 
by Rothman, midwives and doctors had to use their hands to palpate the abdomen of the 
woman, which enabled them to ‘feel the recognizable shape of the baby’ and ‘feel its 
movements against their own hands through the mother’.7 This is a contrast to the 
current situation, whereby the fetus is accessed as a separate entity by clinicians, both 
through the visual use of ultrasound where it can be seen as an individual, and in the 
characterising of genetic information of the fetus, which differs from that of the 
pregnant woman. Lӧwy argues that the generalisation of prenatal diagnosis ‘has 
transformed the understanding of pregnancy, childbirth, and human reproduction’ and 
has produced ‘a technoscientific entity; “the scrutinized fetus”’.8  
 
The technical developments which made prenatal diagnosis clinically feasible were also 
affected by the social and cultural context of the time and place in which they occurred. 
The aim of this thesis is to examine the scientific and technical developments which 
were occurring in prenatal diagnosis in the West of Scotland between 1950 and 1990, 
                                                          
5 Prenatal screening involves large-scale programmes which are targeted at all pregnant women. They 
aim to detect women who have an increased chance of having a fetus affected by the screened-for 
condition, to refer them on for further diagnostic testing. Termination of pregnancy would not be 
offered based on an increased chance result at the screening stage, and would require confirmation of 
the diagnosis using an invasive diagnostic test, such as amniocentesis or chorionic villus sampling. 
6 Malcolm Nicolson and John E.E. Fleming, Imaging and Imagining the Fetus: The Development of 
Obstetric Ultrasound (Baltimore: The Johns Hopkins University Press, 2013), p. 1. 
7 Barbara Katz Rothman, The Tentative Pregnancy: Amniocentesis and the Sexual Politics of Motherhood, 
2nd Edition, (London: Pandora, 1994), p. 113. 
8 Lӧwy, Imperfect Pregnancies, p. 4. 
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and to place these alongside wider national developments. To analyse the developments 
in prenatal diagnosis in detail, this thesis will utilise the case study of an individual who 
was centrally involved in the field, Malcolm Ferguson-Smith, who helped to develop 
and implement prenatal testing in the West of Scotland from the 1960s to the late 1980s.  
 
Malcolm Ferguson-Smith was the key figure involved in bringing medical genetics to 
the West of Scotland, and was the driving force for approximately 30 years behind the 
scientific and clinical work which led to prenatal testing and screening programmes in 
the region. Ferguson-Smith graduated with his medical degree in 1955, which was 
immediately before many of the crucial discoveries were made which would enable the 
creation of the field of prenatal testing, and only a few years after the structure of DNA 
had been identified. In the space of only a few decades, the field of medical genetics 
was created and expanded a great deal – it moved from a scenario where the correct 
chromosome number in humans was not known, to being able to map genes on specific 
chromosomes. Peter Harper has commented that the field expanded ‘so rapidly and 
extensively over a period of little more than 50 years’, and that the changes happened so 
quickly that ‘there has been little time for those directly involved to reflect on this 
process of development’.9 To provide a sense of the huge expansion of medical genetics 
in the few years after Ferguson-Smith graduated, some key events which were occurring 
in the prenatal field can be highlighted here.10 In 1956 the correct chromosome number 
in humans was identified by Tjio and Levan, and in the same year Fuchs and Riis would 
use amniocentesis to determine fetal sex. In 1959, the year that Ferguson-Smith 
travelled out to the United States to begin his own medical genetics training, the 
previously unknown chromosome constitutions were determined in Down’s syndrome, 
Turner’s syndrome, and Klinefelter’s syndrome. 1960 led to the identification of both 
trisomy 13 and trisomy 18,11 and 1966 was the year where Steele and Breg announced 
that the cells in amniotic fluid could be cultured and their chromosome constitution 
analysed, thus opening up the possibility of the entire field of prenatal testing. 
Ferguson-Smith was beginning his career in the midst of all of these developments, and 
                                                          
9 Peter S. Harper, A Short History of Medical Genetics, (Oxford: Oxford University Press, 2008), p. 3. 
10 All of these events will be discussed in detail in chapter one, with references provided for each in that 
chapter. 
11 Trisomic conditions are characterised by an extra copy of a chromosome, for example, in cases of 
trisomy 13, the individual would have three copies of chromosome 13, as opposed to two copies. 
4 
 
his early training was with Victor McKusick, a senior clinician and researcher whose 
contributions and influence in medical genetics have been described by Harper as 
‘probably greater than those of any other single individual’, partly due to his role in 
training others who would go on to set up their own medical genetics units throughout 
the world.12 Ferguson-Smith would be one of these individuals. 
 
Thus, Ferguson-Smith was starting out on his career at a time when the entire field of 
medical genetics was showing promise, with discoveries following closely one after 
another over a period of a few short years. Ferguson-Smith himself would go on to 
implement huge change in this area in Glasgow, becoming the first Lecturer in Medical 
Genetics at the University of Glasgow.13 He was responsible for bringing medical 
genetics, particularly clinical services, to Glasgow and the West of Scotland, where no 
provision had previously been available. When he began his role as lecturer, the region 
had no chromosome diagnostic testing programmes in place, and Ferguson-Smith 
campaigned to rectify this situation. He became responsible for establishing a 
chromosome diagnostic service which would become available to many families 
through genetic clinics, and to thousands of pregnant women through prenatal testing. 
For the first time in the city it became possible, through the work of Ferguson-Smith 
and his colleagues, to test pregnant women for conditions such as Down’s syndrome in 
the fetus, and offer a termination of pregnancy. The work led by Ferguson-Smith on 
chromosomes also examined, to name but a few areas, the role of maternal age effect on 
chromosome disorders in the fetus, mapping genes to specific chromosomes, and 
campaigning for better understanding of sex chromosome disorders. 
 
Ferguson-Smith also led a huge campaign of screening for neural tube defects, with the 
aim of detecting these conditions in pregnancy. The scale of the screening programme 
was in the thousands, and completely changed the way in which pregnant women in the 
region could receive information on their fetus during pregnancy. The department run 
by Ferguson-Smith were also centrally involved in the clinical trials looking at the use 
of folic acid supplements to prevent the formation of neural tube defects, hence 
                                                          
12 Harper, A Short History of Medical Genetics, p. 285. 
13 Full details of this will be provided in chapter two. 
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obviating the need to offer termination of affected pregnancies. Additionally, Ferguson-
Smith was responsible for sourcing the funding and creating the Duncan Guthrie 
Institute of Medical Genetics, which would bring together scientists, clinicians, nurses 
and various other staff members under the one roof. This Institute was at the helm of 
modern medical genetics practice, enabling close work and collaboration between all 
these different staffing groups. The Institute made it possible for thousands of families 
in the West of Scotland to seek genetic advice, and greatly expanded medical genetics 
services, including prenatal testing, to the wider public in the region.  
 
Ferguson-Smith contributed a great deal to medical genetics. Under his leadership, 
prenatal testing and then prenatal screening programmes became implemented in the 
West of Scotland for a number of different conditions. Ferguson-Smith himself has 
described how his department’s publication on prenatal chromosome analysis in 1971 
was the first in the United Kingdom to report on a prospective study of prenatal 
diagnosis, and that his department also made the first prenatal diagnosis of spina bifida 
from amniotic fluid alpha-fetoprotein in 1972.14 In addition to providing diagnostic 
services, the staff working in his team were involved in key research projects, including 
work on sex chromosome anomalies, and gene mapping projects, to name only a few. 
The formation of the Duncan Guthrie Institute meant that more patients could access 
genetics services, and that these services were located in one building – a system that 
would go on to be seen as an example of best practice, and central in fostering the 
development and collaboration of staff members, and improving the care of patients. In 
the thirty-two years between Ferguson-Smith’s graduation, and his departure from 
medical genetics in Glasgow, he developed a department from one which had no 
                                                          
14 These comments were made by Ferguson-Smith in the following article: Malcolm A. Ferguson-Smith, 
‘Putting Medical Genetics into Practice’, Annual Review of Genomics and Human Genetics, 12:1 (2011), 
pp. 9-10. It should be noted that the original work linking alpha-fetoprotein and neural tube defects was 
carried out by Brock and Sutcliffe, based in Edinburgh. Further information will be provided on this in 
chapter one. 
For the 1971 publication, see M.E. Ferguson-Smith, M.A. Ferguson-Smith, N.C. Nevin and M. Stone, 
‘Chromosome Analysis Before Birth and its Value in Genetic Counselling’, British Medical Journal, 4:5779 
(1971), pp. 69-74. 
For the 1972 work which resulted in a 1973 publication, see Lindsey D. Allan, M.A. Ferguson-Smith, Ian 
Donald, Elizabeth M. Sweet and A.A.M. Gibson, ‘Amniotic-fluid Alpha-fetoprotein in the Antenatal 
Diagnosis of Spina Bifida’, The Lancet, 302:7828 (1973), pp. 522-525. 
6 
 
diagnostic capabilities, to one which contributed a significant amount to clinical 
practice and research in the medical genetics field.  
 
Having such a department ensured that the West of Scotland was not left behind in 
providing a medical genetics service to patients, and contributing important research 
data. Many of the other centres which were established that provided such services were 
based in England, particularly in the London region.15 For example, one of the most 
renowned figures in genetics, Lionel Penrose, headed up the Galton Laboratory in 
London. The Galton has been described by Harper as playing a ‘pivotal role in the 
development of human genetics worldwide’, with ‘almost all students and visiting 
workers’ at the Galton finding that it had ‘a profound and lasting influence on their later 
careers and on their thinking’.16 Those based in London benefitted from the close 
proximity to one another, and several key figures were located here. These included 
Paul Polani (who had studied genetics with Penrose) who in 1960 opened up the first 
full medical genetics institute in the UK, the Paediatric Research Unit at Guy’s 
Hospital, which was ‘clearly established from the outset as a specific medical genetics 
institute, with a focus on research into developmental genetic disorders’.17 Polani was 
also able to develop the service aspects of a medical genetics department, and received 
NHS funding to ‘support diagnostic cytogenetics and biochemical genetics’, creating an 
‘integrated institute, unique in the world at that time’.18 A third centre was located at 
London’s Great Ormond Street Hospital for Sick Children, where John Fraser Roberts 
established a genetic counselling clinic in 1946, and where Cedric Carter would go on 
to become the director, from 1964 until 1982, of the MRC-funded Clinical Genetics 
Research Unit.19  
 
                                                          
15 Details of Lionel Penrose, John Fraser Roberts, Cedric Carter, and Paul Polani can all be found in the 
Witness Seminar on Clinical Genetics. Further information will be given on this Witness Seminar in the 
literature review. See L A Reynolds and E M Tansey, (eds) (2010) Clinical Genetics in Britain: Origins and 
Development. Wellcome Witnesses to Twentieth Century Medicine, vol. 39. (London: Wellcome Trust 
Centre for the History of Medicine at UCL). 
16 Harper, A Short History of Medical Genetics, p. 235. 
17 Ibid., p. 294. 
18 Ibid., p. 295. 
19 Ibid., p. 296. 
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The result of the proximity of these sites to each other has led Harper to comment that 
‘medical genetics was well developed in the three centers described by the mid-1960s’, 
but that ‘it was largely absent from the rest of the country’.20 Whilst other geneticists 
were based throughout the United Kingdom, such as Alan Stevenson in Oxford, Cyril 
Clarke in Liverpool, Rodney Harris in Manchester, Alan Emery in Edinburgh, and John 
Edwards in Birmingham,21 there was no comparable figure in the West of Scotland until 
Ferguson-Smith became involved in expanding medical genetics in that region. As can 
be seen from the above descriptions, in London there was a genetic counselling clinic 
established as early as the 1940s, with a genetics institute following in 1960. Thus, the 
lack of medical genetics services out with the London area cannot purely be linked to 
time-sensitive developments in the field, such as the expansion of cytogenetics. The role 
that Ferguson-Smith played in developing and implementing medical genetics services 
becomes more crucial in light of the above information, as it can be seen that other 
patients throughout the United Kingdom were able to access genetics services when 
these were not yet available in Glasgow. Key individuals built up services around them 
in London, as did Ferguson-Smith for the West of Scotland, the specific details of 
which will be explored in chapters two to four of this thesis.  
 
In addition to examining the technical developments which were occurring within the 
department led by Ferguson-Smith, it will be argued that key social changes were 
essential for the establishment of prenatal diagnosis as a routine part of antenatal care. 
This thesis will emphasise the importance of the implementation of the Abortion Act 
1967, which made termination of pregnancy legal for a number of reasons, including 
following a diagnosis of fetal anomaly. Without the development of permissive 
legislation, prenatal testing would have been able to provide information only. Whilst 
that is the aim of some women accessing prenatal testing, in Scotland, between 2000 
and 2011, 85.2% of women terminated pregnancies after a diagnosis of a trisomy 
                                                          
20 Ibid., p. 297. 
21 Details of Alan Stevenson, Cyril Clarke, Rodney Harris, and Alan Emery can all be found in the Clinical 
Genetics Witness Seminar. See Reynolds and Tansey, Clinical Genetics in Britain: Origins and 
Development. 
Further details on John Edwards can be found in D A Christie and E M Tansey, (eds) (2003) Genetic 
Testing. Wellcome Witnesses to Twentieth Century Medicine, vol. 17. (London: Wellcome Trust Centre 
for the History of Medicine at UCL), p. 19. 
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condition.22 This highlights that the majority of women are not using prenatal services 
solely as an information gathering exercise, and are instead making use of abortion 
legislation to end their pregnancies should they be given a diagnosis of fetal anomaly.  
 
That a specific fetal anomaly clause was included in the Abortion Act 1967 is therefore 
of importance, and will be considered within this thesis. This will be examined in 
several ways, including by looking at the ways in which fetal anomaly was discussed 
within the debates surrounding the legislation. It will be argued that abortion for fetal 
anomaly was often viewed as acceptable by the wider public, even when terminations 
for other reasons were not. In addition, campaigns against more liberal abortion 
legislation did not often focus on the fetal anomaly clause. Whilst there were attempts to 
alter or remove this clause, they generally seemed to be put forward by small groups of 
individuals who were opposed to more liberal abortion legislation in a broader sense. 
 
The thesis will also examine the ways in which medical professionals viewed 
termination for fetal anomaly, as it was they who would be responsible for carrying out 
abortion procedures. In addition to considering the viewpoints of some of the key 
professional medical bodies and figures, the specific views of Ian Donald towards 
abortion for fetal anomaly are investigated. Donald was often seen as a key figure in the 
anti-abortion movement, and played a central role in restricting access to abortion 
services in the West of Scotland. By way of contrast to liberal medical figures such as 
Dugald Baird, who was based in Aberdeen, and who was centrally involved in ensuring 
women could safely access abortion services in that region, Donald was proud of the 
low numbers of abortions which took place in the Glasgow region. One area, however, 
where Donald was willing to carry out terminations in very specific circumstances, was 
in cases of fetal anomaly. This thesis adds a contribution to the literature by examining 
in more detail this facet of Donald’s personality, and also looks at the role that 
Ferguson-Smith may have had in influencing the development of these views. 
                                                          
22 Myrthe Jacobs, Sally-Ann Cooper, Ruth McGowan, Scott M. Nelson and Jill P. Pell, ‘Pregnancy 
Outcome Following Prenatal Diagnosis of Chromosomal Anomaly: A Record Linkage Study of 26,261 
Pregnancies’, PLOS ONE, 11:12 (2016), p. 7. 
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What becomes apparent when considering the roles that individuals such as Baird and 
Donald had on the availability of abortion services within their regions, is that 
inequality was prevalent. Such variances in access to abortions dependent upon 
postcode were apparent not only in Scotland, but more broadly throughout the United 
Kingdom, and were noted as an area of concern amongst the medical profession. This 
thesis will look at the responses of various medical professional bodies to the Report 
published by the Lane Committee, which was set up to examine the working of the 
Abortion Act. Examining responses by Scottish medical professionals and religious 
groups based within the region, provides an insight into the ongoing debates which 
surrounded abortion legislation after it had been implemented. 
 
As the majority of positive prenatal diagnoses result in a termination of pregnancy, it is 
possible to see that a conflict could exist between those who provide prenatal testing 
and those who oppose abortion. Some of the key groups in this category are a variety of 
religious organisations. Within this thesis, this potential conflict between religious 
organisations and prenatal testing will be examined, focusing on the viewpoints of two 
of the main religious groups that were prominent in the West of Scotland during the 
time period of the study, the Roman Catholic Church and the Church of Scotland. Their 
specific views on termination after a diagnosis of fetal anomaly will be considered, in 
the context of a wider examination of their broader views towards abortion. The 
complex interactions of faith and prenatal testing will also be considered by looking at 
the ways in which women correlate religious views with termination decisions. 
Considering the views of religious organisations and the impact religion can have on 
decision making helps to place the medical developments occurring in prenatal 
diagnosis in a wider social context. By specifically examining these views for the West 
of Scotland, a more nuanced analysis can be achieved. 
 
The examination of a smaller regional area can provide a detailed insight into the 
development of new technologies and the reaction to their implementation, but as will 
be shown throughout the literature review in a later section of this introduction, the 
majority of studies which have considered the history of prenatal testing have 
10 
 
concentrated more on a national context, with perhaps a few local case studies 
interspersed into the narrative. With the exception of Nicolson and Fleming’s book 
Imaging and Imagining the Fetus, which charts the development of obstetric ultrasound, 
with a focus on Glasgow where the technology was pioneered, very few studies have 
considered the wider Scottish perspective on the development of prenatal testing. This 
creates a gap in the literature, which is particularly important to examine, given the 
central role that a number of scientists and clinicians who were based in Scotland 
played in developing and implementing prenatal testing. Thus, a great deal of the 
significance of this research is aligned with its configuration; the particular groups and 
their views have never before been analysed with regards to prenatal testing in this 
geographical area. By examining this variety of scientific developments and the 
responses to them, it is envisaged that a detailed picture will emerge of the medical and 
social factors involved in the development of the field of prenatal testing. 
 
II. Literature Review – Published Texts on Prenatal Diagnosis 
There were a number of scientific and technical developments which led to the 
formation of prenatal diagnosis as a clinical service, which will be examined in detail 
throughout the chapters of this thesis. Although it is clear that there is a lack of 
published data on these developments in the West of Scotland, there are a number of 
publications which discuss the evolution of the field of prenatal testing more widely. It 
is important to give consideration to published works which discuss these technological 
developments, and those which discuss the wider social issues associated with them. 
One of the first texts to examine the development of prenatal technologies was The 
Captured Womb: A History of the Medical Care of Pregnant Women by Ann Oakley, 
published in 1984. The book set out to ‘write the history of the care pregnant women 
receive in preparation for childbirth and motherhood’,23 which included a chapter titled 
‘Getting to Know the Fetus’, incorporating a detailed study of the development of 
ultrasound technology. Oakley argued that the new technology was ‘revolutionary’, as it 
enabled obstetricians to ‘make direct contact with the fetus, and to acquire a quite 
detailed knowledge of her or his physiology and personality before the moment of the 
                                                          
23 Ann Oakley, The Captured Womb: A History of the Medical Care of Pregnant Women, (Oxford: Basil 
Blackwell Publisher Ltd, 1984), p. 1. 
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official transition to personhood – the time of birth’.24 It is unclear why Oakley 
commented that ultrasound could gain an insight into the personality of the fetus, as this 
is not possible from the testing; perhaps it stemmed from the visual accessibility of the 
fetus, which would have showed the fetus moving around, thus potentially giving an 
impression of how active the fetus was. Oakley’s account of the development of 
ultrasound is particularly interesting, as she interviewed Ian Donald, the clinical pioneer 
for ultrasound. The contributions of Ian Donald will be discussed in detail throughout 
this thesis, both from a technological and a social point of view. Oakley’s descriptions 
of the development of ultrasound are interspersed with direct quotations from Donald, 
and also of photographs showing Donald working early ultrasound machines, which 
provide a more personal insight into the development of this technology. As will be 
described later in the introduction, a similar approach is taken within this thesis through 
the examination of a local case study, which incorporates these personal insights.  
 
Such an approach is also taken by Malcolm Nicolson and John Fleming in their book 
Imaging and Imagining the Fetus. Whilst Oakley dedicated only part of a chapter to the 
development of ultrasound, Nicolson and Fleming chart the story in detail throughout 
the entirety of their publication. The use of the Ian Donald archive throughout the book 
adds a much greater level of detail than prior publications on the history of ultrasound; 
the use of archival documents to create such a detailed analysis will also be used 
throughout this thesis. Although a great deal of the book focuses on describing the 
development of ultrasound in Glasgow by Donald, this work is placed into context by 
considering others who played important roles in the story of ultrasound. Developments 
which were occurring in Glasgow are also placed in a wider geographical context, and 
both technological and social factors are considered throughout the text. Nicolson and 
Fleming have described their historiographical approach to the book as posthumanist, 
which ‘with its symmetrical handling of the natural, the social, and the technological, 
allows us to provide a more precise and convincing account of the origins of human 
actions, by placing them in their fullest context’.25 Indeed, consideration is given to the 
impact that Donald’s religious views had on his willingness to terminate pregnancies; 
this subject is examined in detail throughout chapter five of this thesis. Building on 
                                                          
24 Ibid., p. 155. 
25 Nicolson and Fleming, Imaging and Imagining, p. 11. 
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Nicolson and Fleming’s work, this thesis considers Donald’s views in an in-depth 
manner, and adds original material to the subject by specifically examining Donald’s 
views with regards to termination for fetal anomaly. Whilst Nicolson and Fleming 
consider Donald’s views on this subject, this thesis provides original archival material 
which gives a more detailed insight into this area, and specifically considers how 
Donald’s friendship with Ferguson-Smith could have further impacted his views. Thus, 
it could be said that a similar ‘posthumanist’ approach as taken by Nicolson and 
Fleming has been shown throughout this thesis, whereby an examination of both the 
technical and social developments which have impacted prenatal diagnosis are 
considered in detail. 
 
Whilst ultrasound is a central component of antenatal care today, invasive testing in the 
form of amniocentesis is also commonly used to diagnose chromosome conditions and 
neural tube defects. As amniocentesis gives a definitive diagnosis and is an invasive 
procedure, it is perhaps not surprising that it has been the focus of a number of studies 
into its uses. Two of the most detailed are Testing Women, Testing the Fetus: The Social 
Impact of Amniocentesis in America by Rayna Rapp, and The Tentative Pregnancy: 
Amniocentesis and the Sexual Politics of Motherhood by Barbara Katz Rothman. Both 
of these publications explore the impact that amniocentesis has had on the women who 
underwent the procedure, and both authors have carried out interviews to gain this 
insight, resulting in an authoritative analysis of the development and implementation 
effects of amniocentesis. The inspiration for Rapp’s book Testing Women, Testing the 
Fetus came from her own experience of prenatal testing in 1983, where she had an 
amniocentesis test at the age of 36, and her fetus was diagnosed with Down’s syndrome. 
After terminating the pregnancy, Rapp sought out information in medical libraries to try 
and help her recover from the experience, only to discover that the voices of medical 
experts ‘dominated the discourse on prenatal diagnosis’, with most of these experts 
being male, ‘highly educated, and overwhelmingly white’.26 She became convinced that 
‘the complex topic of prenatal testing and abortion begged for a woman-centered 
                                                          
26 Rayna Rapp, Testing Women, Testing the Fetus: The Social Impact of Amniocentesis in America, (New 
York: Routledge, 2000), pp. 3-4. 
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analysis’, and thus began interviewing other women about their experiences in late 
1983.27  
 
Rapp’s research methodology was multi-faceted, involving interviews with women who 
underwent and who turned down amniocentesis, observation of medical genetics 
departments in a variety of healthcare settings, and interviews with families who had 
children with Down’s syndrome, amongst other approaches.28 Rapp’s book covers a 
whole host of factors involved with prenatal testing, including how the technical 
processes are carried out within a laboratory (she spent time observing the technicians at 
work), the reactions of women to being offered testing, the reasoning behind those 
women who turn it down, and the decision to terminate or continue a pregnancy after a 
diagnosis of fetal anomaly. Running throughout all of these chapters are the women’s 
voices themselves, which frequently highlight the complex nature of prenatal diagnosis. 
Rapp describes these women as ‘moral pioneers’, none of whom entered the ‘decision 
to undergo amniocentesis trivially’ or ‘aborted for superficial reasons’.29 She concluded 
that ‘Women are both constrained and empowered through technologies like 
amniocentesis … At once held accountable at the individual level for a cascade of 
broadly social factors which shape the health outcome of each pregnancy, and 
individually empowered to decide whether and when there are limits on voluntary 
parenthood.’30 
 
Whilst Rapp argues that the complexities of prenatal testing can be both limiting and 
empowering for women, throughout The Tentative Pregnancy, Rothman seems to be 
more critical of the testing. Rothman interviewed over 120 women to gather their 
thoughts on how prenatal testing impacted their pregnancy experiences, and also spent 
time observing and interviewing genetic counsellors, who guide women through the 
process of prenatal testing. Describing amniocentesis as ‘the fulcrum on which the 
reproductive revolution turns’, Rothman argues consistently that the procedure is 
changing how many women experience pregnancy, and is causing society ‘to confront 
                                                          
27 Ibid., p. 4. 
28 Ibid., pp. 6-8. 
29 Ibid., pp. 306-307. 
30 Ibid., pp. 317-318. 
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the very meaning of motherhood’.31 For Rothman, the use of amniocentesis is leading to 
what she terms ‘tentative pregnancies’, whereby a ‘woman’s commitment to her 
pregnancy under the conditions imposed by amniocentesis can only be tentative. She 
cannot ignore it, but neither can she wholeheartedly embrace it.’32  
 
Rothman believes that women are waiting on the results of amniocentesis tests before 
being able to fully commit to their pregnancy. For this theory she presents several 
arguments, including that women who are undergoing amniocentesis choose to begin 
wearing maternity clothes later in their pregnancy. This was confirmed by one of her 
interviewees, who stated that ‘“There was a definite feeling of resisting buying 
maternity clothes until the results came back.”’33 Rothman also hypothesised that 
women undergoing amniocentesis do not feel movement of the fetus until later in the 
pregnancy than those women who opt not to have the testing done, which she argues is 
a ‘response to a “tentative pregnancy”’.34 For women who have undergone prenatal 
testing, the feeling of fetal movement does not provide reassurance that all is well with 
their pregnancy, in the way that it did for women who have not had the testing. Instead, 
Rothman argues, the reassurance comes from the amniocentesis test results, resulting in 
two very different experiences, as for ‘women who had amniocentesis, reassurance 
came from medical science and authoritative reports. For the women who refused 
amniocentesis, reassurance came from the experience of their own bodies and from their 
developing relationship with their babies.’35 This parallels both Lӧwy’s ideas of the 
changing experience of pregnancy as a result of prenatal testing, whereby the fetus is 
seen as a separate ‘technoscientific’ entity from the pregnant woman, and Nicolson and 
Fleming’s comments that the advent of prenatal testing has changed the role that 
pregnant women play in providing information about the fetus. Throughout the book, 
Rothman argues against the proclaimed benefits of prenatal testing, instead contesting 
that the technology is ‘being used to give the illusion of choice’.36 This choice, she 
argues, only really benefits those ‘who want what the society wants them to want’, 
                                                          
31 Rothman, The Tentative Pregnancy, p. 3. 
32 Ibid., p. 101. 
33 Ibid., p. 99. 
34 Ibid., p. 105. 
35 Ibid., p. 108. 
36 Ibid., p. 14. 
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which, she puts forward, is prenatal testing followed by selective termination of 
pregnancy.37 
 
However, not all of those who have examined the impact of prenatal testing have come 
to such conclusions. In Heredity and Hope: The Case for Genetic Screening, Ruth 
Schwartz Cowan argues that ‘Genetic screening increases reproductive choice, and it 
also provides hope … of having, not a perfect child, but a child who, at least at the start 
of life, is free of devastating disease or overwhelming disability.’38 In the introduction, 
Cowan details how she struggled with many of the ethical and moral dilemmas 
surrounding prenatal testing. Questioning whether prenatal diagnosis discriminated 
against the disabled, and whether medical geneticists were ‘inherently evil’ and their 
patients ‘inherently deluded’ as some of her feminist friends believed, she turned to 
history to ‘resolve such dilemmas, because the discipline of history teaches us to 
examine the particular, not the universal; we try, in other words, to uncover the very 
particular interests of very different people who are interacting in very particular 
situations’. She further described how ‘Once that is understood, we can begin thinking 
not only about the moral content of those interests but also about how they can be 
balanced so that no set of interests is allowed to dominate over the others.’39 This 
approach has also been taken throughout this thesis, whereby the interests of specific 
people working in defined situations can provide an insight into the development of 
prenatal testing, which can then be expanded to comment on the wider moral questions 
which surround the field.  
 
Throughout the text Cowan examines prenatal diagnosis as a socio-technical system, an 
approach which she argues ‘allows me to explain that, for example, changes in abortion 
law were as important in the diffusion of amniocentesis as changes in laboratory 
techniques and discoveries in classical genetics’.40 The examination of these 
developments as part of a socio-technical system is reflective of the approach which is 
                                                          
37 Ibid. 
38 Ruth Schwartz Cowan, Heredity and Hope: The Case for Genetic Screening, (Massachusetts: Harvard 
University Press, 2008), p. 245. 
39 Ibid., pp. 8-9. 
40 Ibid., p. 10. 
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taken throughout this thesis, whereby social and technical influences are both 
considered in detail, with their importance highlighted in the relevant descriptive 
chapters. In Heredity and Hope, Cowan covers a number of key themes which are also 
reflected in this thesis, including the development of genetic techniques which made 
prenatal testing possible, the uses of amniocentesis and ultrasound, and the importance 
of the Thalidomide crisis and the rubella epidemic for impacting abortion legislation.41 
However, one area of difference is that Cowan is arguing in favour of prenatal testing, 
whilst this thesis retains a neutral view on whether the testing is inherently ‘right’ or 
‘wrong’. For Cowan, those who choose to undergo prenatal testing should not be made 
to feel ‘unnecessarily guilty about their fundamentally wise and moral behaviour’, 
highlighting her approval of the prenatal diagnosis technologies which are available.42 
 
Other authors, such as Andrew Hogan, have also charted the detailed development and 
implementation of invasive testing, with Hogan writing an informative piece on the 
history of chorionic villus sampling. Similar to the approach taken by Nicolson and 
Fleming in Imaging and Imagining the Fetus, Hogan has written a detailed description 
of the development of the technology, including information on the different prototypes 
which existed, and how researchers worked to improve these. Hogan also undertook a 
detailed analysis of the social circumstances which surrounded the development and 
implementation of prenatal testing using chorionic villus sampling, some of which are 
specific to the United States of America, such as the impact that the Food and Drug 
Association had on limiting access to the devices used to carry out the testing.43 
However, Hogan also covers wider social issues including those associated with uptake 
of new prenatal testing methods, highlighting the problems created by 
devising/designing these new tests without the input of the women who will use them, 
                                                          
41 Thalidomide was a drug given to pregnant women to help with morning sickness. However, it resulted 
in a number of babies being born with limbs which were shortened, or incompletely formed. Rubella can 
affect the fetus in several ways, including causing problems with the developing brain. Both Thalidomide 
and rubella will be discussed in detail in chapter five of this thesis. 
42 Cowan, Heredity and Hope, p. 245. 
43 Andrew J. Hogan, ‘Set Adrift in the Prenatal Diagnostic Marketplace: Analyzing the Role of Users and 
Mediators in the History of a Medical Technology’, Technology and Culture, 54:1 (2013), pp. 71-74. 
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and also the impact that the ‘fetal limb defect’ controversy had on uptake, which will 
also be discussed in this thesis.44  
 
The above information highlights the importance of both technical and social factors for 
the development of prenatal testing which involved scientific and technological 
changes, mediated by a variety of scientific researchers and clinicians, all of which were 
situated amongst the wider social and cultural context of the 1960s onwards. One of the 
key publications which ties all of these issues together for prenatal diagnosis is Ilana 
Lӧwy’s 2017 publication, Imperfect Pregnancies: A History of Birth Defects and 
Prenatal Diagnosis. This book has many parallels to this thesis, and discusses in detail 
the technical developments of invasive and non-invasive prenatal testing methods, and 
the stories of some of the individuals who were involved.45 Whilst the thesis does have 
similarities to Lӧwy’s work, there are several areas where the texts differ from one 
another, and a discussion of the distinctions of Lӧwy’s work and this thesis will follow. 
 
Chapter one of Lӧwy’s publication follows the origins of the concept of ‘birth defects’, 
before the development of prenatal diagnosis. Much of the chapter considers a time 
period prior to the primary focus of this thesis, charting the histories of individuals who 
worked in areas surrounding birth defects, which provides useful background of the 
early work on fetal anomaly. For some of these individuals, but not all, the aim of 
preventing birth defects had a eugenic focus. 46 Throughout Imperfect Pregnancies, 
Lӧwy discusses what some see as the linked history between prenatal testing and the 
eugenics movement. This is one of the key differences between Lӧwy’s book and this 
thesis, which does not examine these eugenic links. Whilst there is some brief 
discussion in chapters five and six about the views of some individuals who associate 
eugenics and prenatal testing, this is not a focus of this thesis. One of the reasons for 
                                                          
44 Ibid., pp. 76-78 discusses the fetal limb defect controversy, and pp. 81-83 considers some of the issues 
associated with lower than expected uptake rates.  
45 Lӧwy’s work was not available to view when the research for this thesis was being planned and 
undertaken. The book was published when much of the analysis and writing for this thesis was already 
concluded. 
46 For example, Lӧwy spends much time in this chapter discussing the history of Lionel Penrose, who was 
a strong opponent of eugenics, but also presents information about Alfred Frank Tredgold, who she 
describes as ‘an enthusiastic advocate of eugenic measures’ (Lӧwy, Imperfect Pregnancies, p. 26). 
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this is that Ferguson-Smith himself has specifically distanced himself from any eugenic 
agenda. Throughout the years he has maintained that it was always his aim, and that of 
his colleagues, to provide women with the opportunity to have healthy children. In 
many cases, Ferguson-Smith has argued, the provision of prenatal testing led to women 
having children who had previously refused to do so, due to their concerns of the child 
being born with certain genetic conditions. These points by Ferguson-Smith will be 
highlighted later in this thesis, but it is important to mention here that Lӧwy’s 
discussion of the eugenic implications of prenatal testing is not replicated in this thesis. 
 
Chapter two of Lӧwy’s book is titled ‘Karyotypes’, and focuses on the study of human 
chromosomes and prenatal diagnosis. As would perhaps be expected, there is crossover 
between the material in that chapter and the work contained within this thesis, 
particularly chapter one of this thesis. However, although the early history of the 
development of the field of cytogenetics is covered in both, there are also marked 
differences. Lӧwy looks at the study of dermatoglyphs, metabolic studies (including the 
work on the discovery of phenylketonuria) and also the development of genetic 
counselling, three areas which this thesis does not cover at all.  
 
Chapter three of Lӧwy’s book examines the link between rubella and Thalidomide 
changing attitudes towards abortion, which is a key theme discussed particularly in 
chapter five of this thesis. However, Lӧwy also focuses on areas such as the 
development of the field of teratology, dysmorphology and fetal pathology, in addition 
to a discussion of the use of birth defect registries. Whilst these areas are of interest, 
they are not considered within the scope of this thesis, which has a more specific focus. 
Interestingly, in this chapter Lӧwy does discuss the history and use of ultrasound, but 
only briefly over the course of a few pages. She does, however, highlight that there is a 
lack of literature on the diagnostic uses of this technology by social scientists, who tend 
to focus on ‘the transformation of the intimate experience of pregnancy by the 
production of fetal images, and on the social, political, economic, and cultural roles of 
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such images’.47 It is hoped that this thesis can help to address this issue, as the 
diagnostic uses of ultrasound are discussed throughout this work. 
 
By way of contrast, chapter four of Lӧwy’s book shares a focus with this thesis, as it 
looks at the movement from diagnostic prenatal testing towards wide-scale prenatal 
screening programmes. Lӧwy considers particularly the development of prenatal 
screening programmes for Down’s syndrome, and the discussions which were taking 
place at the time around the cost-effectiveness of implementing such policies. Malcolm 
Ferguson-Smith is mentioned by name twice in this chapter – once to highlight his role 
as the head of the Working Party of the Clinical Genetic Society when they published 
their report recommending the introduction of alpha-fetoprotein screening for the 
detection of neural tube defects,48 and again when she discusses Ferguson-Smith’s 
views that an abnormal alpha-fetoprotein result should be relied upon more closely than 
an ultrasound scan for the detection of neural tube defects during pregnancy.49 Whilst 
no more details are given of the work which was taking place in the department led by 
Ferguson-Smith, that his views are highlighted in Lӧwy’s book lends support to the 
view that he was seen as a central figure within the development of the prenatal testing 
field.  
 
Chapters five and six of Imperfect Pregnancies contain far fewer direct links with this 
thesis, as they focus on the history of sex chromosome anomalies and the new 
developments in fetal DNA, including non-invasive prenatal testing (NIPT), 
respectively. Whilst this thesis briefly considers conditions such as Turner’s and 
Klinefelter’s syndromes, Lӧwy charts a far more detailed history of the discovery of 
these conditions. Whilst NIPT is highlighted in chapter three of this thesis, a discussion 
of its developing impact was unable to be covered within the scope of this thesis.  
 
                                                          
47 Lӧwy, Imperfect Pregnancies, p. 89. 
48 Ibid., p. 107. 
49 Ibid., p. 109. 
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Thus, it can be seen from the above discussion, that whilst there is crossover between 
the material that Lӧwy covers within Imperfect Pregnancies and the material covered 
within this thesis, there are also distinct differences. Lӧwy’s text is far-ranging and 
covers a wide range of topics, whilst this thesis has a more specific temporal and 
geographic focus. However, both texts are written from a similar standpoint, whereby 
the interaction between scientific and social factors are both seen as being of central 
importance to gain an insight into the development of the prenatal testing field.  
 
Lӧwy discusses the interaction of technical and social factors, which have led to the 
development of what she terms the ‘“prenatal diagnosis dispositif”’.50 The term 
“dispositif”, Lӧwy explains, was ‘coined by the philosopher Michel Foucault to 
describe an entity that combines a certain “regime of truth” with the practices and 
institutional forms that make it a bona fide site of knowledge/power’.51 For Lӧwy, the 
“prenatal diagnosis dispositif" emphasises that prenatal diagnosis was ‘developed 
thanks to a partly fortuitous combination of several medical technologies: 
amniocentesis, the culture of fetal cells, the study of human chromosomes, and 
obstetrical ultrasound’, which along with the ‘professional practices, and institutional 
and legal arrangements’ formed the ‘“prenatal diagnosis dispositif”’.52 That the 
development of medical technologies and the social elements linked to prenatal testing 
are both of central importance is a key concept running throughout this thesis.  
 
The quote below by Rayna Rapp about her approach in her book Testing Women, 
Testing the Fetus further highlights these complexities, where she argues that both 
social and technological aspects need to be given consideration when examining the 
development of prenatal diagnosis: 
 
At the center of this account lies my conviction that the technologies of 
prenatal diagnosis, like all technologies, are produced at multiple 
intersections where the work of particular scientists, research clinicians, 
and health service providers engages social relations far beyond the 
                                                          
50 Ibid., p. 2. 
51 Ibid. 
52 Ibid. 
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purview of their laboratories, clinics and consulting rooms. What come to 
count as the technologies of prenatal diagnosis, now and in the past, are 
shaped by large-scale transformations of biomedical knowledge, our legal 
structure, widely shared and sometimes contested cultural values, and the 
social identities within which service providers and patients encounter one 
another. In other words, I will argue that an understanding of the history 
and ongoing evolution of this biomedical technology requires us to see 
how its developers, because of and despite their individual expertise and 
achievements, became enrolled in larger social projects to which their 
scientific accomplishments were conscripted.53 
 
To provide an example of the intersection of scientific and social factors in the 
development of amniocentesis, Rapp considers the differences that having a national 
health service can have on the availability of, and access to, amniocentesis. 
Emphasising that ‘larger, more complex social transformations are also at work’ in the 
development of prenatal diagnostic technology than just the medical progress which is 
simultaneously occurring, Rapp compares the ‘experience’ of prenatal diagnosis in 
Great Britain, with that of the United States.54 She discusses her view that the impact of 
a commitment to providing some form of national health service has led to a higher 
minimum age for amniocentesis being implemented in Britain, as opposed to the United 
States, where a ‘free market economy in health care’ has led to a much lower age 
limit.55 Without an understanding of the different social contexts in which 
amniocentesis was developing in these countries, the slightly different trajectories that 
the testing followed may not be known. However, by considering the social aspects 
alongside the scientific and clinical developments which were occurring, a fuller and 
more complex picture emerges, which implicitly links funding to the resources and 
choices available to the women undergoing the testing.  
 
This thesis is written from a similar standpoint to Rapp’s work, whereby the scientific, 
technical, social and cultural changes which were occurring throughout the decades in 
which prenatal diagnosis was being developed and implemented, are all viewed as being 
of equal importance. This approach is particularly important for understanding the 
history of prenatal diagnosis, where a mere description of the technologies and scientific 
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techniques not placed alongside a relevant social context, could result in what Pickstone 
has described as ‘mere chronicles of progress, or scientific biographies which do little to 
illuminate either the science or the society in which it as produced, let alone their subtle 
interactions’.56 In a similar manner to Rapp, this thesis therefore aims to examine the 
technical and scientific aspects of prenatal diagnosis, including the development of 
amniocentesis, chorionic villus sampling and ultrasound, and will later place these 
developments alongside the social circumstances in which they were being devised. The 
specific impact of the Abortion Act 1967 will be considered, alongside religious 
responses to the more permissive abortion legislation, and prenatal testing more 
specifically. These will provide an insight into the cultural context amongst which the 
developments were occurring. 
 
III. Literature on Abortion 
It can be seen that work has been undertaken by scholars to chart the development of 
the prenatal testing field. However, as described above, inextricably linked to prenatal 
testing is abortion, with many women choosing to terminate a pregnancy upon receiving 
a diagnosis of an anomaly in their fetus. It is therefore important to consider the 
literature on abortion, as this will be the subject of chapters five and six.  
 
One of the key texts on the subject is Abortion Law Reformed, published in 1971 by 
Keith Hindell and Madeleine Simms.57 The book considers a wide range of issues 
regarding abortion. There is also a foreword by David Steel, who introduced the private 
member’s Bill which became the Abortion Act 1967. The authors of the text were in 
favour of abortion law reform, with Madeline Simms one of the most prominent 
members of the Abortion Law Reform Association (ALRA). This should be kept in 
mind when analysing the text.  
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Some of the key material within Abortion Law Reformed examines the links between 
religious organisations and opposition to legislative change. The chapter titled ‘Religion 
and Reform’ discusses the many ways in which religious groups attempted to prevent 
more permissive abortion legislation being passed prior to Steel’s Bill, and also 
provides an in-depth look at the formation and role of the Society for the Protection of 
Unborn Children (SPUC), which campaigned strongly against abortion. The role that 
groups such as SPUC played will be considered in chapter six, and the detailed 
overview provided by Hindell and Simms is of use in understanding the workings of 
this group, and its contributions to the abortion debate. Hindell and Simms also examine 
the role of the Roman Catholic Church more broadly, which is again useful for the 
discussion which takes place on this organisation in chapter six. 
 
Fetal anomaly is also an important theme within Abortion Law Reformed, and is of 
particular interest for this thesis. Hindell and Simms place it as a central reason by 
which the ALRA was ‘reinvigorated’ to campaign strongly for abortion law reform, 
after a time of being less active.58 They specifically link the Thalidomide scandal to the 
increase in the membership of the ALRA in the early 1960s. The importance of factors 
such as rubella and Thalidomide in impacting the perception of abortion for reasons of 
fetal anomaly will be considered within chapter five. This discussion will form part of a 
larger narrative of fetal anomaly terminations being viewed as different to terminations 
for other reasons by many people, and Hindell and Simms provide useful background 
information on this subject.  
 
Fetal anomaly is also considered by others, notably Kate Gleeson. In her article 
‘Persuading Parliament: Abortion Law Reform in the UK’, Gleeson examines the role 
that fetal anomaly played in influencing legislative change, and the impact of medical 
practitioners on abortion law reform.59 Throughout Gleeson’s article, fetal anomaly is 
placed as a central feature, and she states that ‘crucially, it was the argument for eugenic 
terminations that secured supposedly ‘liberal’ law reform in 1967’.60 Gleeson discusses 
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how concerns about the low population rate meant that abortion was not a legal focus in 
the early part of the twentieth century. However, the specific cases of rubella and 
Thalidomide would impact public perception of termination of pregnancy in the years 
that followed. In a similar manner to Hindell and Simms, Gleeson identifies 
Thalidomide as important in the campaign to alter abortion legislation, stating that 
abortion law reform ‘might have stagnated entirely’ had it not been for Thalidomide.61 
Previously, it was cases resulting from rubella infection that garnered sympathy 
amongst members of the public for allowing termination in cases of fetal anomaly. 
However, this increased sympathy was not enough to result in legislative change. 
Gleeson argues that the Thalidomide scandal, combined with a rubella epidemic in 
1964-1965, reinvigorated the ALRA’s abortion campaign.  
 
The way in which fetal anomaly was viewed within the abortion debate will be 
examined throughout chapter five of this thesis, with a discussion of attempts to alter or 
remove the fetal anomaly clause from legislation. Some of these issues have been 
examined by Gleeson, who argues that those who opposed the fetal anomaly clause 
within Steel’s Bill tended to be those who opposed abortion more generally, including 
the Catholic M.P. Norman St. John-Stevas, who was a key figure in the fight against 
abortion reform, and whose role will be discussed in chapters five and six.62 As 
highlighted above, it will be argued that termination as a result of fetal anomaly was 
viewed more favourably by many of those who discussed abortion. Gleeson highlights 
that the ALRA were publishing data which showed high levels of public support for 
terminations for fetal anomaly. However, as Gleeson points out, correspondence in The 
Times newspaper paints a slightly different story, with a difference of opinion evident 
between those who agreed with terminations in a case of fetal anomaly and those who 
disagreed. Similarly, magazines and newspapers will be examined within chapter six to 
chart opinions on the subject of abortion.  
 
One of the major groups involved in the abortion debate were the medical profession, 
and the role they played in influencing Steel is considered by several commentators. 
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One author who considers the medical profession in-depth is MacIntyre, whose article 
‘The Medical Profession and the 1967 Abortion Act in Britain’ is a detailed 
examination of the part they played within the abortion debate.63 MacIntyre highlights 
that clinicians had a variety of viewpoints, with some showing ‘extreme repugnance’ of 
abortion, whilst others viewed abortion as the ending of one life for the sake of 
another.64 Whereas some doctors argued that the sanctity of life was of the utmost 
importance, others viewed the overall health of the patient i.e. the woman, as being the 
most important factor. MacIntyre highlights that some doctors viewed health as a 
holistic concept, which involved taking social considerations into account. Dugald 
Baird’s views are discussed by MacIntyre in this context; a further examination of Baird 
and his opinions will take place in chapter five. 
 
MacIntyre also analyses the viewpoints of the professional medical groups who publicly 
discussed abortion. One of MacIntyre’s key arguments is that each group were 
professing views which would maintain their own professional standing. For the Royal 
Medico-Psychological Association (RMPA), this was arguing for a wide view of health, 
which would take into account more than just physical illness, whilst for the Royal 
College of Obstetricians and Gynaecologists (RCOG), this was trying to have abortion 
decisions and procedures kept under the control of gynaecologists. On both sides of the 
abortion debate, doctors were concerned with maintaining their professional freedom, 
and there was discussion about whether this would best be achieved with or without 
Steel’s Bill. Regardless of the differing viewpoints, the vast majority of the medical 
profession wanted to retain their control over who could have an abortion. As will be 
discussed in this thesis, the Abortion Act 1967 kept abortion decisions firmly in the 
hands of the medical profession, which could go on to hugely impact the women who 
were seeking terminations of pregnancy. As will be shown in chapter five, the area in 
which a woman lived could influence the likelihood of her securing a termination of 
pregnancy if requested, which as MacIntyre states ‘can have enormous implications 
both for individual women and for society as a whole’.65 These issues will be 
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specifically considered within the Glasgow region for this thesis, examining the case of 
Ian Donald. 
 
In his book Abortion, Doctors and the Law. Some Aspects of the Legal Regulation of 
Abortion in England from 1803 to 1982, John Keown examines the legislation which 
has been in place to cover abortion for more than a century, and considers the views of 
the medical profession to it.66 In a similar manner to MacIntyre, Keown outlines the 
views of some of the professional bodies who attempted to influence the legislation, 
including the RCOG, the British Medical Association (BMA), and the RMPA. 
Interestingly, Keown highlights that discussion by these medical professionals often did 
not centre only on the medical aspects of abortion, but also ‘on the desirability of 
reform, the appropriate scope of the Bill, and the wording of particular provisions’.67 A 
similar argument will be made in chapter five of this thesis, where the attempts by 
medical professionals to impact the changing abortion legislation will be considered. It 
will be seen that the views which were being aired by professional medical groups and 
also by individuals such as Baird and Donald, focused far more on the issue of the 
acceptability of abortion, as opposed to concerns with the safety of the procedure itself. 
 
Keown also examines how the Abortion Act 1967 has been interpreted by different 
medical professionals. Of interest to this thesis is the data indicating that high 
percentages of varied medical professional groups would support termination for 
reasons of fetal anomaly.68  These figures provide evidence for the general widespread 
acceptability of termination for reasons of fetal anomaly, a concept which, as noted 
above, will be discussed within this thesis. 
 
As can be seen from the above discussion, much of the literature which has been 
published on abortion has focused on Britain more broadly, without considering a 
specific regional view towards the changing legislation. However, two key scholars 
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have examined the abortion context from a Scottish perspective, investigating the 
specific nuances which existed. The work by Gayle Davis and Roger Davidson is of 
central importance to this thesis, as it helps to provide the geographical context of 
Scotland with regards to abortion legislation. A main focus of their work is on 
examining the role of two medical professionals who worked in Scotland, Ian Donald 
and Dugald Baird. As already noted, Baird and Donald held starkly contrasting views 
on the acceptability of abortion, with Baird holding a liberal viewpoint, whilst Donald 
had a highly restricted attitude. Their opinions would permeate throughout the regions 
in which they worked. Davis and Davidson also examine other important aspects of the 
abortion debates, looking at the broader influence of medical professionals and their 
response to the new abortion legislation, and also the different abortion laws which 
were in place for Scotland and England prior to the Abortion Act 1967. Their work will 
be examined within the next section of this literature review. 
 
As well as her work with Davidson, Gayle Davis has published several independent 
pieces, two of which will be considered here. In her chapter ‘The Medical Community 
and Abortion Law Reform: Scotland in National Context, c1960–1980’, Davis looks at 
the role of different medical groups, noting that most of the current literature has 
considered England and that ‘Scotland has been largely omitted’, a situation which she 
describes as ‘a particular shortcoming’.69 As this thesis considers developments 
occurring in the West of Scotland surrounding prenatal testing and abortion, it is hoped 
that it goes some way towards addressing this gap in the literature. Davis looks closely 
at the differences which existed in legislation between Scotland and England prior to 
1967, emphasising that the legislation which governed England, such as the Offences 
Against the Person Act and the Infant Life Preservation Act, did not apply in Scotland, 
where abortion was a common law offence.70 Davis highlights the differences in the 
definition of what constituted criminal abortion in Scotland and England, and discusses 
the different ways in which suspected cases were investigated. Davis describes how 
abortion law had the potential to be interpreted in a more liberal manner in Scotland 
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than in England. However, she argues that the possibilities of liberal interpretations of 
the legislation were not utilised by most doctors in Scotland prior to 1967. It is likely 
that illegal abortions were carried out in as high numbers in Scotland as in England.71  
 
Davis also discusses the movement towards the passing of the Abortion Act 1967, the 
various ways in which Scottish medical professionals were involved, and the responses 
of medical groups in Scotland to the Act when it had come into force. Of interest for 
this thesis is Davis’ discussion of the Lane Committee, which will be discussed in 
chapter five. Davis considers the differences in the concerns over the working of the Act 
between Scotland and England, which again highlights the importance of considering 
issues from a Scottish perspective.  
 
Within her online publication ‘The Great Divide: The Policy and Practice of Abortion in 
1960s Scotland’, Davis carries out a further examination of the influence that Baird and 
Donald had on abortion legislation and services within their respective regions.72 A key 
theme is that certain individuals were able to massively impact the working of the 
Abortion Act 1967. Davis outlines Baird’s early career, including a conflict he had with 
a Catholic priest in Glasgow over terminating the pregnancy of a woman who would 
otherwise have died, and charts the reasons behind his move to Aberdeen, which had a 
more liberal societal composition. The role of the Catholic Church in attempting to 
influence abortion legislation in the region of Glasgow will be considered in chapter six 
of this thesis, illustrating that these conservative attitudes remained in the decades after 
Baird moved to Aberdeen. Baird was unusual at the time, being willing to exploit the 
liberal interpretations of Scots common law unlike most of his colleagues.  
 
Ian Donald held completely opposing views to Baird, and was willing to make his anti-
abortion views known. Davis highlights Donald’s unwillingness to carry out 
terminations of pregnancy except in very limited circumstances. This thesis considers 
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the role of Donald but advances our understanding of his anti-abortion stance, exploring 
the situations in which Donald was willing to carry out terminations of pregnancy, and 
examines whether Ferguson-Smith influenced him in these situations. This adds a new 
dimension to the published literature on the subject, which does not currently consider 
these nuances in Donald’s practice. 
 
Davidson and Davis also compare the two clinicians within their book The Sexual State. 
They investigate Baird’s move into the political sphere and specifically highlight ways 
in which he influenced Steel when it came to designing the abortion legislation.73 
Interactions between individuals could affect important changes, as will be explored 
within chapter five. Davidson and Davis also look at the response of various religious 
groups to attempts to alter abortion legislation. They highlight that Steel was influenced 
by both the Church of England and the Church of Scotland’s writings about abortion, 
and also consider two of the main attempts to make abortion more restrictive once the 
legislation was in place, those by White and Corrie.  
 
The above themes are further developed in Davis and Davidson’s article ‘“A Fifth 
Freedom” or “Hideous Atheistic Expediency”? The Medical Community and Abortion 
Law Reform in Scotland, c.1960-1975’.74 The authors look at some of the differences 
which existed in the response to the Abortion Act 1967, and highlight that the same 
concerns were not always prevalent in Scotland as in England. They take this analysis 
further, by examining responses to the Lane Committee Report in their article ‘‘Big 
White Chief’, ‘Pontius Pilate’, and the ‘Plumber’: The Impact of the 1967 Abortion Act 
on the Scottish Medical Community, c.1967-1980’.75 This examination of the evidence 
submitted to the Lane Committee, and the responses to it, links to chapter five of this 
thesis, whereby by Davis and Davidson’s work on this subject is considered in the light 
of further archival research.  
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Davis and Davidson have categorised medical professionals as fitting into one of three 
groups immediately following the passing of the Abortion Act – those who believed 
women should be deciding for themselves about abortion, those who believed there 
were social as well as medical indications for abortion (but within this group some held 
ideas about women who were more ‘deserving’ of abortion), and those who interpreted 
the Act strictly and would only terminate if the mother’s life was in danger or the fetus 
‘grossly deformed’.76 As will be shown throughout this thesis, within the Glasgow 
region there were doctors who fitted into each of these categories.  
 
Davis and Davidson highlight some of the strategies employed by medical professionals 
to cope with the changes in legislation which fundamentally impacted their practice, 
including utilisation of the conscience clause, and trying to shift the focus to prevention 
of terminations through promotion of the importance of contraception education. A key 
part of their paper also involves examining the ways in which the medical profession 
utilised psychiatrists to try and deflect their own involvement with the changing 
abortion legislation. To discuss this, Davis and Davidson utilise an article which was 
written by the psychiatrist Ingram, titled ‘Abortion Games: An Inquiry into the Working 
of the Act’, which was published in 1971 when the new abortion legislation was in 
force.77 Ingram was based at the Southern General Hospital in Glasgow, and it is 
possible that he recognised many of the key figures involved in providing abortion 
services in the city as being responsible for taking part in the ‘games’ he goes on to 
discuss. Ingram’s article and the discussion within it were based on the book Games 
People Play by Berne, and within the article Ingram discusses a number of different 
games which he believes clinicians involved in delivering the Abortion Act 1967 were 
playing; the key groups he considers are general practitioners (GPs), gynaecologists, 
and psychiatrists. He also discusses the games that women seeking abortions were 
taking part in, as a result of the games being played by the medical practitioners in the 
above groups. Davis and Davidson take this original publication by Ingram and present 
their own extension of it, by specifically naming individuals and situations which they 
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could identify as having arisen in Scotland as a result of such ‘games’. Their analysis 
will be examined in chapter five of this thesis, alongside the presentation of primary 
source materials which provide a deeper insight into the specific situation occurring in 
the West of Scotland.  
 
In addition to considering the role of the medical profession in impacting abortion 
legislation, this thesis will also examine the views of religious organisations. One of the 
key publications which provides an insight into religious perspectives on the abortion 
debate is Abortion An Ethical Discussion. Published by The Church Assembly Board 
for Social Responsibility of the Church of England in October 1965, it provides a 
detailed analysis of their perspective towards the rightfulness of abortion.78 Of most 
importance for this thesis is the section which considers termination due to suspected 
fetal anomaly. Whilst the Church Assembly Board view fetal anomaly as a potentially 
acceptable reason for a termination, they acknowledge the impact continuation of the 
pregnancy might have on the woman concerned. This is of central importance, as fetal 
anomaly on its own is not viewed as a suitable reason for abortion by the Church 
Assembly Board – it would have to be shown that the suspected fetal anomaly would 
have a negative effect on the pregnant woman. The Church of England highlight that a 
pregnant woman upon learning of such an instance may ‘suffer such acute anxiety that 
her health is seriously impaired’, but that this situation results in the interests of the 
woman and the fetus being opposing.79 The difficulties with knowing if a pregnancy 
will be affected by a condition are explored, stating ‘Until it becomes possible – if it 
ever does – to diagnose with certainty the severe deformities despite which and with 
which the child will live, we are bound to accept this prognostic uncertainty as the 
inescapable context in which the decisions, moral and medical, have to be taken.’80 This 
quote highlights the very different situations which existed prior to and after the 
development of areas such as the detection of chromosome disorders in the fetus. As 
discussed in chapter five, with the advent of prenatal testing, the diagnosis of fetal 
anomaly would be seen as sufficient reasoning for a termination of pregnancy. 
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The key publication for the Church of Scotland is Abortion in Debate, which was 
published on behalf of their Board of Social Responsibility, and is presented in a format 
which is reflective of the differing viewpoints which exist within the church. 81 The 
preface affirms that ‘No issue has been discussed by the Church in recent years with 
more vigour and strength of feeling than that of abortion’.82 Each chapter has two 
contributors writing from different views. Both authors are then provided with the 
opportunity to reply, thus providing a ‘debate’ on paper. A variety of aspects of abortion 
are considered, including looking at abortion from the viewpoint of a doctor who won’t 
perform terminations of pregnancy. Another article examines the wider issues facing the 
medical profession surrounding abortion. Of use in this thesis are the chapters on the 
Church’s teaching on abortion issues – one author covers the subject of traditional 
teaching, whilst the other highlights the differing viewpoints which have existed within 
Christianity on the subject, providing an insight into the more static Catholic viewpoint 
when compared to the Protestant stance. The changing views of the Church of Scotland 
on the subject of abortion make for an interesting study, however, there is no detailed 
information on this available in published literature. This thesis therefore aims to 
address this gap in the literature, discussing the viewpoints that have existed within the 
Church of Scotland on the subject over the course of two decades. This will be an 
important addition to the knowledge base on attitudes towards abortion within religious 
organisations in Scotland. 
 
The views of religious organisations towards abortion have also been discussed more 
broadly by other commentators. Colin Francome, in his book Abortion Freedom: A 
Worldwide Movement, looks from a more international perspective at the development 
of abortion legislation, but also dedicates two chapters of his book to the specific 
changes which took place in Britain.83 Of particular use in examining religious 
responses to abortion is Francome’s description of campaigns such as that by the 
ALRA, and also the opposition which was raised by the Catholic Church, and groups 
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including SPUC. Whilst it does not specifically deal with the West of Scotland, it 
provides a useful framework on which to build the original primary research of this 
thesis concerned with the perspectives of different religious groups. Francome also 
devotes a chapter to detailing the debate which occurred in Britain post-1967, after the 
Abortion Act had been passed. This is of interest for this thesis, which will argue that a 
great deal of the opposition to abortion, particularly by the Catholic Church, was 
actually monopolised after the legislation had been passed.  
 
Others have also written from a religious perspective on the ethics and morality of the 
subject. Gilbert Meilaender has covered abortion and prenatal testing in his book 
Bioethics A Primer for Christians.84 In his chapter on prenatal testing, Meilaender states 
that Christians ‘ought to set themselves against prenatal screening’,85 and that they 
‘could do the world a considerable favor and could bear substantial witness to the 
meaning of God’s own love for the world if they would simply say no to routinized 
prenatal screening’.86 However, as will be discussed in this thesis, the reality of 
accepting or rejecting prenatal screening and testing is far more complex for people of a 
Christian faith.  
 
Anthony Fisher, in Catholic Bioethics for a New Millenium, examines similar issues to 
Meilaender, but covers these in a more in-depth and complex manner. Describing 
himself as someone who writes ‘as a Catholic moral theologian and Bishop’, Fisher 
frequently refers to scripture throughout his publication.87 Of interest for this thesis is 
Fisher’s examination of prenatal testing, which he views as having mainly negative 
consequences. Fisher links this to his perspective that prenatal testing will not be used 
therapeutically in the majority of cases. As will be shown throughout this thesis, this 
viewpoint can be seen to be consistent with published data, which shows that for certain 
conditions, the majority of women will choose to terminate a pregnancy after a positive 
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prenatal diagnosis. It is interesting to note that Fisher states that those who disagree with 
abortion more broadly also view ‘genetic and other antenatal testing with a view to 
possible termination of pregnancy’ as ‘also unethical’.88 However, as will be shown, 
this viewpoint does not seem to translate exactly into decision making, with religion 
shown to be only one of many factors influencing whether to terminate or continue with 
a pregnancy.  
 
IV. Witness Seminars 
In addition to the sources discussed above, a number of Witness Seminars have been 
undertaken by the History of Modern Biomedicine Research Group (which originated as 
the Wellcome Trust’s History of Twentieth Century Medicine Group), funded by the 
Wellcome Trust, on different areas in the history of genetics. The group define a 
Witness Seminar as ‘a particularly specialized form of oral history, where several 
people associated with a particular set of circumstances or events are invited to come 
together to discuss, debate, and agree or disagree about their memories’.89 Some of 
these Witness Seminars discuss events linked to prenatal testing, which are of use for 
this thesis. One of these Witness Seminars, titled Genetic Testing, took place in London 
in July 2001, with Malcolm Ferguson-Smith acting as one of the participants. A number 
of different themes were covered, including the development of cytogenetics. Ferguson-
Smith contributed his own testimony describing how he became involved in this field.90 
A more detailed description of his movement into the field is provided within this 
thesis. A number of other related themes are also covered within this Seminar, including 
linkage studies, biochemical genetics, and prenatal testing of metabolic disorders. There 
is also a detailed discussion of efforts to shift diagnosis further back in pregnancy – 
from second-trimester to first-trimester prenatal testing, and then on to pre-implantation 
genetic diagnosis for some conditions. The Witness Seminar provides a useful overview 
of the main individuals who were involved in the field, and also gives an insight into the 
interactions they had with one another. These interactions, Ferguson-Smith contends, 
are ‘special to the UK’, and he believes that the success of genetics in the UK ‘was 
made possible by each of us knowing one another, and deciding on sharing and having 
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common interests and common meetings’.91 The Witness Seminar helps to provide an 
overview of this network, and the impact that it had. 
 
Another Witness Seminar which has relevance for this thesis took place in London in 
September 2008, and was titled Clinical Genetics in Britain: Origins and Development. 
Many topics were covered, including the scientific work which was behind the 
development of clinical genetics as a field, and some of the key individuals who first 
worked as medical geneticists throughout Britain. It also considered the role that other 
bodies had played in the development of the field, including the Department of Health, 
and the Clinical Genetics Society, which became the British Society for Human 
Genetics. The development of the field of genetic counselling is also considered, with 
some of the key individuals who were centrally involved in setting up this area taking 
part in the discussions. One of the key areas discussed is the importance of the field of 
cytogenetics for the expansion of medical genetics more broadly. This argument is 
supported throughout this thesis, with much of the innovation in the prenatal testing 
field developing from the ability to detect when chromosome numbers differed from the 
standard 46 in humans. As John Bell states, ‘It was a time when the first laboratory 
function, cytogenetics, created the distinctive capabilities of the field that ultimately 
allowed the specialty to develop a unique position among the medical specialties.’92  
 
Useful information is also provided on several of the individuals who acted as pioneers 
in the field of clinical genetics. As previously highlighted, several of these were based 
in London at different periods throughout time (Lionel Penrose, John Fraser Roberts, 
Cedric Carter, and Paul Polani), whilst others were based elsewhere in the United 
Kingdom (Alan Stevenson in Oxford, Cyril Clarke in Liverpool, Rodney Harris in 
Manchester, and Alan Emery in Edinburgh). Interestingly, there is no real discussion 
about the work which was going on in Glasgow. It can be seen in the published text of 
the Witness Seminar that both Malcolm Ferguson-Smith and his successor Michael 
Connor sent their apologies for the event, which could explain this absence. However, 
with much of the discussion centring around developments which were occurring in 
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England, the particular situation in the West of Scotland is missing from this 
perspective. Indeed, Alan Emery, who spent much of his career in Edinburgh, highlights 
these differences between London and other areas within the Witness Seminar, stating 
that ‘One tends to forget where you’re coming from: if you’re in inner London and 
you’ve been with all these very famous people, of course the scene is set, but if you 
were outside it was very different.’93 This highlights the importance of regional 
perspectives in the development of a field, which was not linear in all areas throughout 
the United Kingdom.  
 
This can be seen in the example of discussing the importance of having specialists 
together in one field. Rodney Harris details that in the late 1980s a topic ‘that exercised 
us a great deal at that time was the question of getting clinicians and laboratory people 
to work closely together. It’s hard to believe now, but there was quite a lot of struggle 
going on over who controlled laboratories. The idea of it all being ‘under one roof’ took 
hold. Now, it was not literally under one roof, but it was spiritually under one roof.’94 In 
Glasgow, the Duncan Guthrie Institute had been opened in the early 1980s, with 
clinicians and scientists all working together in the one building. Throughout this thesis 
it is contended that working together in the one building was of key importance for 
enabling staff to carry out their work to a high standard, and for the passing of ideas 
between them. Therefore, the experience that Rodney Harris and perhaps others were 
facing in the late 1980s of clinicians and scientists being encouraged to work together, 
had already been occurring in Glasgow from the early years of the same decade. Thus, 
this Witness Seminar on the origins and development of clinical genetics in Britain, acts 
as a useful tool to consider the broader development of the field. It also provides an 
insight into some of the areas where similarities existed between different regions, and 
where differences were also developing over time. 
 
Another Witness Seminar was held in London in 2013, focusing on Clinical Molecular 
Genetics in the UK c.1975-c.2000. There was only a very limited amount of molecular 
genetics work happening in the medical genetics department in Glasgow during the time 
                                                          
93 Ibid., p. 40. 
94 Ibid., p. 49. 
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period of this thesis, and accordingly it is not covered here.95 Despite this, the Witness 
Seminar on molecular genetics contains information which would be useful for a wider 
study of some elements of prenatal diagnosis, notably the work which was going on to 
detect haemoglobinopathies. Bernadette Modell gives a detailed account of the 
development of prenatal testing for thalassaemia major, and whilst this specific 
condition is not relevant to the foci of this thesis, many parallels emerge with the 
milestones and challenges which were encountered in developing prenatal testing 
methods for this disease.96 A key theme, which Modell refers to several times, is the 
importance of the role of patients in driving the development of the testing, with many 
being 'afraid' to risk having another child with the condition.97 Modell gives a few 
specific examples, including one of a patient who wanted to be sterilised, but Modell 
encouraged them to wait as prenatal testing might become possible.98 This example 
exemplifies what many of those working on developing prenatal tests have argued, that 
the testing actually encouraged women to have more children, not fewer.  
 
However, it should be noted that, if a woman became pregnant prior to a prenatal test 
becoming available, she would have had to face the decision to continue or terminate 
the pregnancy without a diagnosis. Modell provides an example of a woman who 
                                                          
95 Professor Connor himself stated in his interview that there was no provision for molecular genetics 
within the Duncan Guthrie Institute when he moved to Glasgow in 1982, as molecular ‘didn’t exist as a 
diagnostic subject’ at that time. Specific space had not been set aside in the Duncan Guthrie, and 
molecular was therefore fitted in physically as best as possible in the Duncan Guthrie Institute, and the 
work expanded from the mid-1980s onwards. As the majority of the molecular work expanded into 
clinical practice after Ferguson-Smith had moved to Cambridge, the decision was taken not to focus on 
this as a specific area within this thesis. See MC interview, DS300143, p. 5. Interview with Mike Connor, 
3rd March 2016. Mike Connor completed his medical degree in Liverpool, before spending time working 
at Johns Hopkins University in Baltimore. He began working in the Department of Medical Genetics in 
Glasgow in 1982, and replaced Malcolm Ferguson-Smith as the Burton Chair of Medical Genetics when 
Ferguson-Smith moved to Cambridge in 1987. 
Further evidence showing the lack of established facilities for molecular genetics at that time in Scotland 
is given in the report Clinical Genetic Services in Scotland, published by the Working Group of the 
National Medical Consultative Committee in 1986. It was highlighted that at the time of writing the 
report, there were ‘no facilities in Scotland for providing patients and their families with DNA diagnosis 
other than through research support’. See National Records of Scotland, HH98/602, Report titled 
‘Clinical Genetic Services in Scotland Report of the Working Group Established by the National Medical 
Consultative Committee’, p. 57. 
96 E M Jones and E M Tansey, (eds) (2014) Clinical Molecular Genetics in the UK c.1975–c.2000. 
Wellcome Witnesses to Contemporary Medicine, vol. 48. (London: Queen Mary, University of London), 
pp. 21-26. 
97 Ibid., p. 23. 
98 Ibid., p. 24. 
38 
 
wanted prenatal testing, but there was not yet a technique available for obtaining fetal 
blood. Despite being told this, the patient wanted Modell's team to try prenatal 
diagnosis, as she stated that the ‘worst’ they could do was cause a miscarriage, and that 
she would terminate the pregnancy if they couldn't try prenatal testing.99 Modell 
comments that 'the patients really pushed the pace'.100 As will be seen in chapter two, 
Ferguson-Smith expressed similar views.  
 
Another witness seminar which was relevant to this thesis was Looking at the Unborn: 
Historical Aspects of Obstetric Ultrasound, which took place in March 1998 at the 
Wellcome Institute for the History of Medicine in London. This Witness Seminar 
focused on the development of ultrasound technology, with the key work in this field by 
Ian Donald a major focus throughout. Much of the discussion focuses on specific 
clinical developments and applications, with Stuart Campbell recalling the process by 
which he developed techniques to measure the fetus, and also his work on diagnosing 
anencephaly via ultrasound. Campbell was the first in the field to be able to make a 
diagnosis at an early enough stage that a woman could request a termination of 
pregnancy following an ultrasound diagnosis of anencephaly,101 and this will be 
discussed later in this thesis. Charles Whitfield describes some of the other key uses of 
ultrasound which are directly linked to prenatal testing, including using ultrasound to 
improve the safety of amniocentesis.102 He discusses the role that ultrasound played in 
biochemical screening programmes, by helping to date pregnancies and check for 
multiple pregnancies, etc.103 All of these themes will be covered within this thesis when 
the development of biochemical screening programmes is considered. Indeed, this thesis 
will highlight that the development of ultrasound in Glasgow, alongside the close 
working relationship of Ian Donald and Malcolm Ferguson-Smith, were contributory 
factors in Glasgow's ability to implement large scale biochemical screening 
programmes in pregnancy.    
                                                          
99 Ibid., p. 25. 
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101 E M Tansey and D A Christie, (eds) (2000) Looking at the Unborn: Historical Aspects of Obstetric 
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Thus, several of the Witness Seminars listed above provide further information on the 
development of the medical genetics field, and can help to give a broader geographical 
overview of much of the expansion which was occurring.104 They highlight the 
importance of recording individual’s memories to chart the work which was happening 
in a field, an approach which was taken throughout this thesis to record the experiences 
of those who worked in Glasgow. The group methodology of the Witness Seminars 
compliments the interview methodology employed in research for this thesis. 
 
V. The Importance of Local Case Studies 
It can be seen from the above discussion of the current literature, that material is 
available which provides information of the development of the prenatal testing field, 
and the permissive abortion legislation which enabled it to be widely applied. However, 
it is clear that much of the available literature covers Britain more broadly, with less 
material available on Scotland. As previously highlighted, to analyse the developments 
in prenatal diagnosis in detail, this thesis will utilise the case study of the region of the 
West of Scotland. This will enable a detailed study of both the development of the 
scientific and clinical aspects of the testing, alongside the response of medical 
professionals and religious organisations. To analyse the medical development of 
prenatal diagnosis, the life and work of Malcolm Ferguson-Smith and his colleagues 
will be examined. As has been discussed, Ferguson-Smith and his co-workers were at 
the forefront of many of the developments in prenatal testing. However, despite 
Ferguson-Smith’s contributions, very few papers have been published on his input into 
                                                          
104 Several other Witness Seminars have been considered to analyse their importance for this thesis, but 
were found to contain less material of direct use, including that titled Human Gene Mapping Workshops 
c.1973-c.1991. Whilst the mapping of the human chromosomes, and the wider human genome mapping 
project are of central importance in the history of the broader field of genetics, this work has fewer links 
with this thesis. Despite this, the Witness Seminar on the human gene mapping workshops may hold 
interesting material for scholars more widely interested in the development of the field of genetics. 
Other Witness Seminars fall into a similar category, such as Medical Genetics: Development of Ethical 
Dimensions in Clinical Practice and Research, which provides a great deal of information about the ethics 
involved in medical genetics more broadly, some of which was at a later time period than this thesis has 
considered. However, it would be a useful resource for considering the many ethical issues which can 
arise in this field. Similarly, the Witness Seminar Clinical Cancer Genetics: Polyposis and Familial 
Colorectal Cancer c.1975-c.2010 gives a detailed overview of a completely different aspect of genetic 
testing, this time for cancer, which could be of use to individuals looking at a wider history of genetic 
testing. Details of all of these publications can be found in the bibliography. 
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prenatal testing in the West of Scotland.105 A key feature of these published papers are 
that they tend to be celebratory in nature, and have been written as tributes. One of 
these, titled ‘A Tribute to Malcolm Ferguson-Smith, Founding Editor of Prenatal 
Diagnosis’ was written in 2006 to mark his retirement as editor-in-chief of the journal 
Prenatal Diagnosis.106 The article is only two pages in length, and lists some of 
Ferguson-Smith’s key achievements throughout his career. As would be expected with 
such an article, it is not a critical analysis of his life and work, and is instead a brief 
overview including main dates and events. Another paper which has been written about 
Ferguson-Smith is an article for the ‘Distinguished Cytogeneticist’ section of the journal 
Cytogenetic and Genome Research.107 This article is three pages long, and again 
provides more of an overview of some of Ferguson-Smith’s key contributions to the 
field of genetics. The article does, however, provide a Curriculum Vitae of Ferguson-
Smith, and also lists fifty selected publications. The other sources which provide an 
insight into Ferguson-Smith’s life and career include an article written by himself, titled 
‘Putting Medical Genetics into Practice’, which is understandably a personal account,108 
webpages on the University of Glasgow website, and the Wellcome Trust website,109 
and an in-depth interview with Ferguson-Smith, carried out by a fellow geneticist, Peter 
                                                          
105 Malcolm Ferguson-Smith’s contribution to the development of the prenatal diagnosis field was the 
subject of my dissertation for my taught MSc in History with an emphasis on the History of Medicine 
(the dissertation was titled ‘Malcolm Ferguson-Smith and the Development of Prenatal Diagnosis’ and 
was submitted in September 2015). However, this dissertation was a far smaller piece of work, which 
focused mainly on the work of Ferguson-Smith in a local context, and less on placing these 
developments in a national setting. The main focus was on the work which was happening in Glasgow, 
with a small consideration of Ferguson-Smith’s role in the wider research community. The dissertation 
used mainly sources from the Ferguson-Smith archive alongside published papers by Ferguson-Smith 
and his colleagues, and involved no oral history interviews with any of those involved in the field. 
Therefore, this PhD thesis is a vast expansion on this work, particularly as it involved several oral history 
interviews, and also considers the wider social circumstances that the developments in prenatal testing 
were situated amongst. As the dissertation formed part of a taught Master’s course, it has not been 
published, and is therefore not available to view publicly. 
106 Diana W. Bianchi and Charles H. Rodeck, ‘A Tribute to Malcolm Ferguson-Smith, Founding Editor of 
Prenatal Diagnosis’, Prenatal Diagnosis, 27:9 (2007), pp. 854-855. 
107 Peter Pearson, ‘Distinguished Cytogeneticist – Malcolm Ferguson-Smith’, Cytogenetic and Genome 
Research, 111:1 (2005), pp. 2-4. 
108 Ferguson-Smith, ‘Putting Medical Genetics’, pp. 1-23. 
109 For the Wellcome Trust see: 
‘Codebreakers: Makers of Modern Genetics’, Wellcome Library 
<http://wellcomelibrary.org/collections/digital-collections/makers-of-modern-genetics/> [accessed 22nd 
June 2018]. 
For the University see: 
‘Malcolm Ferguson-Smith’, The University of Glasgow Story 
<https://www.universitystory.gla.ac.uk/biography/?id=WH2412&type=P> [accessed 12th July 2018]. 
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Harper.110 For an individual who was responsible for the establishment of one of the 
first medical genetics institutes in the United Kingdom, this is surprisingly little 
material. Despite this lack of published material, there are a number of benefits to 
exploring the wider changes occurring in the prenatal testing field through the 
examination of a local region. Local case studies have been utilised by several scholars, 
whose approaches will be detailed below.  
 
Exploring the uses of biography, Hankins argues that examining an individual’s life and 
career ‘gives us a way to tie together the parallel currents of history at the level where 
the ideas and events occur’.111 This has been possible for this thesis through the 
examination of the Ferguson-Smith archive, and oral history interviews with Ferguson-
Smith and his colleagues, which provide a perspective on the regional developments 
occurring in the prenatal testing field. Another benefit of focusing on a specific actor in 
a particular location is that the volume of archival documents is more manageable, 
enabling a detailed analysis to be carried out, where all relevant documents can be 
studied. Lindee has highlighted that the volume of archival documents which exist for 
‘post-1945 science are quite frankly too rich, voluminous, dispersed, and complicated to 
be easily tamed’, however the use of ‘focused case studies’ can ‘facilitate broader 
pictures’.112  
 
The individual case-study approach has been taken by a number of researchers, when 
examining a larger topic of historical interest. In his chapter ‘What is the Use of Writing 
Lives of Recent Scientists?’ in The Historiography of Contemporary Science, 
Technology, and Medicine, Thomas Sӧderqvist charts his own experience of writing the 
biography of the immunologist Niels Jerne. Whilst initially setting out to write the 
                                                          
110 Peter Harper, ‘Interview with Malcolm Ferguson-Smith, 2003.’ Interviews with Human and Medical 
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112 Susan Lindee, ‘Human Genetics After the Bomb: Archives, Clinics, Proving Grounds and Board 
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biography of an ‘interesting person’ without a specific subject in mind,113 working on 
Jerne’s story led Sӧderqvist to become interested in the wider development of the field 
of immunology. The correspondence between Jerne and others in the emerging field, 
alongside the detailed notes that Jerne had taken at scientific meetings, led Sӧderqvist to 
believe that Jerne had been at the ‘epicenter’ of many of the key developments, and that 
the story of Jerne’s life and work could be used for ‘contextual-historical purposes’.114 
As Sӧderqvist has detailed, ‘The Jerne collection thus functioned as a lens into these 
exciting years of the new cellular and molecular immunology; he was the single 
package that wrapped up these currents.’115 Whilst this thesis does not contend that 
Ferguson-Smith was the ‘single package’ in relation to prenatal testing, Sӧderqvist’s 
ideas that an individual can act as a lens to provide an insight into new developments is 
a central component of this thesis. 
 
Other researchers have incorporated case studies of medical genetics into larger 
projects, including Ilana Lӧwy. In her recent book Imperfect Pregnancies, which is 
discussed in detail above, she dedicates a small section to charting the process of 
studying chromosomes at the University of Wisconsin in the 1960s, using the geneticist 
Klaus Patau as a central feature.116 By utilising published papers and correspondence 
between Patau and others, she examines the developments which occurred in 
chromosome studies in his department and further afield. She highlights that studies of 
‘Patau and his collaborators at the University of Wisconsin illustrate the dilemmas and 
hopes of pioneers of studies of chromosomal anomalies’.117 Examining the development 
of prenatal testing in the West of Scotland under the leadership of Ferguson-Smith 
provides a similar illustration, with both the aims of his department, and the setbacks 
they faced, able to be analysed in detail. Indeed, similarities can be discerned between 
the work being carried out by Patau, and that of Ferguson-Smith. Lӧwy discusses a case 
where a geneticist from another department advised the mother of a child with Down’s 
                                                          
113 Thomas Sӧderqvist, ‘What is the Use of Writing Lives of Recent Scientists?’, in The Historiography of 
Contemporary Science, Technology and Medicine. Writing Recent Science, ed. by Ronald E. Doel and 
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114 Ibid., p. 107. 
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syndrome to ask Patau to carry out a chromosome test on her son. However Patau 
replied to state that their lab ‘dealt with basic research only’, and that he believed there 
was no need for a specialised laboratory dealing with ‘routine chromosome analyses’.118 
As will be seen later in this thesis, Ferguson-Smith also faced restrictions due to the 
head of the genetics department in Glasgow stating that they focused on research and 
not clinical diagnoses. In contrast to Patau, Ferguson-Smith felt there was a real need 
for a laboratory specialising in providing these routine chromosome analyses. Looking 
at a small case study in both of these examples provides an insight into some of the 
issues which were arising, and how individuals might have viewed these developments 
in a far different manner from one another. 
 
Alexandra Stern’s book Telling Genes: The Story of Genetic Counseling in America 
takes this approach further, whereby she uses a variety of case studies to explore the 
development of genetic counselling in America. Similar sources to this thesis are used, 
including archival research and oral history testimonies.119 One chapter of the book is 
particularly useful for this thesis, as it charts the development of prenatal diagnosis at 
Johns Hopkins University in Baltimore, in the United States of America. Stern guides 
the reader through the various stages of prenatal diagnosis development and 
implementation within the Prenatal Diagnostic Center at Johns Hopkins, telling the 
stories of a variety of individuals who were involved. By utilising this specific centre as 
a case study, it is possible for Stern to discuss the twists and turns which are linked to 
the development of such a new enterprise, including the changing number of patient 
referrals, and the specific results of prenatal tests for these patients.120 This approach is 
taken in this thesis, whereby the analysis of the Department of Medical Genetics in 
Glasgow also incorporates such information. These details are not usually present in 
larger scale studies of prenatal diagnosis, which chart the development of the 
technologies and their implementation overall, meaning that local nuances in testing 
patterns are often missed. 
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119 Alexandra Minna Stern, Telling Genes: The Story of Genetic Counseling in America, (Baltimore: Johns 
Hopkins University Press, 2012), p. 3. 
120 Ibid., pp. 146-169.  
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Perhaps the publication which follows the most similar path to this thesis is a study of 
the origins of prenatal testing in Madrid, written by María Jesús Santesmases. 
Santesmases follows the story of two clinicians, Andrés Sánchez Cascos and Emilia 
Barreiro, who established a laboratory for chromosome diagnosis in Madrid in the 
1960s.121 Many parallels can be seen in their story to Ferguson-Smith’s early career, 
which will be discussed in chapter two, including time spent abroad to learn the 
necessary skills to set up such a department,122 and their small beginnings in a single 
room which only had a centrifuge, a microscope and a heater.123 By focusing on the 
case study of these individuals, Santesmases is able to go in to a great deal of detail 
about the exact processes which were followed by the pair when carrying out 
chromosome analysis. The laboratory skills required for culturing chromosomes were 
initially learned whilst working on blood samples from adult patients, and Santesmases 
describes the entire process from the collection of a 15-20ml blood sample, right 
through to the viewing and photographing of chromosomes under the microscope.124 
These skills could then later be adapted for analysing the chromosome constitution of 
the fetus, using the cells found in amniotic fluid. This level of detail is an important 
source of information for the historical record, and many of the interviewees for this 
thesis went in to a similar descriptive mode when asked about the techniques and 
laboratory tests they had regularly carried out.  
 
By focusing on a local area, key differences can also be highlighted with other regions. 
Perhaps most importantly for the clinicians involved in Santesmases’ study was the lack 
of permissive abortion legislation which existed in Spain during the time period of the 
charted developments. This meant that, in contrast to Scotland, prenatal testing could be 
used for information-gathering purposes only. However, Santesmases discussed how 
women who had the financial means would go abroad to have a termination of 
pregnancy.125 Again, in contrast to the situation in Glasgow, those clinicians in Madrid 
who carried out amniocentesis were ‘publicly criticised … for merely mentioning the 
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technique at public conferences and for doing prenatal tests’.126 It is clear from 
Santesmases’ study that utilising the case study of individuals involved in setting up a 
department which carried out prenatal testing, can provide a detailed insight into the 
science and clinical practice which was taking place, but which can also give 
information about the wider social context these individuals were placed amongst. This 
approach is particularly useful for the study of the situation in Glasgow, whereby 
scientific developments in prenatal testing were occurring in the department led by 
Ferguson-Smith, despite the outspoken opposition to abortion by the Catholic Church. 
 
A similar approach has been taken by Peter Coventry and John Pickstone, who have 
examined the emergence of genetics as a medical specialism in the city of Manchester 
in England. Although looking at the wider field of genetics, Coventry and Pickstone 
contend that their study of a specific city uses ‘a local focus to bring together many 
levels of phenomena – from laboratory tests to NHS reforms, from the politics of 
medical specialisms to the workings of the Abortion Act’.127 This thesis aims to follow 
a similar path, using the case study of Glasgow to analyse the mix of scientific, social 
and cultural factors which impacted on the development of prenatal diagnosis in the 
region. Within their paper, Coventry and Pickstone chart the work which was occurring 
in the field of genetics in Manchester both prior to and after the implementation of 
prenatal diagnostic techniques, outlining some of the key figures and departments 
involved in a variety of research and clinical practice. A useful parallel emerges in the 
article with the description of the development of medical genetics under the consultant 
Rodney Harris. Coventry and Pickstone describe the increasing demand from the early 
1970s onwards for chromosome diagnosis for Down’s syndrome, which led to staffing 
and resourcing issues.128 As the demand for prenatal diagnosis increased throughout the 
1970s, calls were made for more staff and resources to be made available, and Harris 
himself was writing to the health board to express his concerns about the clinical and 
legal dangers which could result from such a situation. As will be seen later in this 
thesis, this situation is almost an exact replica of the challenges which were being faced 
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in Glasgow by Ferguson-Smith and his colleagues.129 By focusing on a local area these 
specific problems become noticeable. Whilst these issues may be lost in a larger history 
of a field, they are essential to understanding the development of a new medical 
specialism, and highlight the less than straightforward trajectory which is often 
characteristic of the implementation of prenatal testing programmes.  
 
In addition to the parallels which can be drawn between the development of genetics in 
Manchester and Glasgow, within their article Coventry and Pickstone specifically 
mention the work of Ferguson-Smith, and the ‘key site’ that was run in Glasgow by 
him.130 In the ‘Concluding observations’ section of their paper, they highlight the need 
for more research to be carried out which would give a similar insight into the 
development of other regional genetics centres throughout the United Kingdom, and 
they were especially keen for work to be carried out on the development of genetics in 
Scotland. They highlight the close ties which existed in the cities of both Glasgow and 
Edinburgh between the teaching hospitals and the regional services; within this thesis 
these ties become clear within Glasgow, when examining the relationship between 
Ferguson-Smith and Ian Donald. The Department of Medical Genetics in Glasgow was 
located in close proximity to two of the most prominent hospitals in the city, and 
Ferguson-Smith and Ian Donald had a working relationship which was key to many of 
the developments in the prenatal testing field in Glasgow. Thus, these close ties, as 
Coventry and Pickstone have suggested, had an impact on the expansion of prenatal 
work which was occurring in the West of Scotland. It is hoped that this thesis will 
contribute to the body of work that Coventry and Pickstone felt was lacking on the 
development of other regional centres of genetics, and will also lend support to their 
opinion that ‘a focus on local services’ is important ‘not just because they are 
constitutive of wider changes, but because they allow detailed study of the range of 
factors and contingencies that are involved in the development of medicine’.131 
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VI. Research Questions 
As can be seen from the information presented above, there are scholars who have 
undertaken work to chart the history of the prenatal diagnosis field, and the changing 
abortion legislation. Whilst these studies provide a useful framework for placing further 
research on the history of prenatal testing against, it has been shown that they tend to 
focus on the development and/or implementation effects of prenatal testing technologies 
and social change spread over large regions. As has been emphasised above, it can be 
argued that there are several benefits to analysing these developments in a specific 
geographical region, which can then be expanded to analyse greater social issues. This 
introduction has argued that the West of Scotland presents a unique set of circumstances 
which have yet to be studied in detail with regards to prenatal testing. The technical 
developments and social responses occurring within the region merit investigation, 
which they are currently lacking. This thesis will therefore consider the following 
research questions: 
 
I) How did invasive and non-invasive prenatal testing techniques develop from the 
1950s through to the late 1980s? 
II) What role did Ferguson-Smith and his colleagues in the West of Scotland play in 
these developments, particularly with regards to testing for chromosome conditions and 
neural tube defects? 
III) How was fetal anomaly viewed within debates on changing abortion legislation, and 
was the fetal anomaly clause in the Abortion Act 1967 seen as acceptable by members 
of the medical profession, including in the West of Scotland? Additionally, how did the 
medical profession in Scotland respond to the implementation of the Abortion Act more 
broadly? 
IV) How did religious organisations, namely the Church of Scotland and the Roman 
Catholic Church, respond to the Abortion Act 1967, and also to the advent of prenatal 
testing? 
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These questions will be considered using a variety of sources, which will be discussed 
in detail in the following section on methodology. 
 
VII. Methodology 
Sӧderqvist, writing on the historiography of recent and contemporary technoscience, 
highlighted a number of key methodological challenges which could face the 
researcher. These included a lack of available archives, the sheer volume of publications 
available for analysis, the issues associated with using oral history for projects, and the 
difficulties of writing about scientific subjects in detail, when not scientifically 
trained.132 Despite the potential drawbacks of studying contemporary science, all of 
these challenges were successfully overcome when carrying out research for this thesis, 
as will be discussed throughout this section. A variety of sources have been used 
throughout this project to enable the analysis of the scientific, clinical and social 
developments which occurred in prenatal testing from the 1950s to the late 1980s, 
including archival sources, oral history interviews, and published newspapers, 
magazines and journal articles.  
 
Contrary to Sӧderqvist’s concerns about the lack of available archives, one of the key 
sources which formed the initial basis for the development of this research project was 
the Malcolm Ferguson-Smith archive, which is housed at the University of Glasgow 
Archives. This archive is vast but highly accessible, largely due to the fact that it has 
been catalogued and digitised as part of the Wellcome Trust funded Codebreakers: 
Makers of Modern Genetics project.133 The digitisation of the archive has resulted in the 
majority of information being available in PDF format, circumventing the concerns 
Comfort has raised about limitations of access in archives, with researchers only being 
able to access ‘one box, folder, or even letter at a time – each text under analysis is 
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surgically isolated to prevent cross-contamination’.134 The archive contains a wide 
range of resources from the period 1957-2008, including material relating to medical 
genetics, details of publications, and a vast array of correspondence. It was possible to 
have several PDF files open simultaneously, enabling a more in-depth analysis of the 
sources. All relevant documents in the archive were examined, and the correspondence 
section proved to be very insightful for this thesis. It was possible to chart some of the 
professional relationships and friendships that Ferguson-Smith had with others, both 
within and outside the medical and scientific fields, through his letter writing. A sense 
of Ferguson-Smith’s personality also emerged through the reading of these letters, and it 
became clear how involved he was with the medical genetics field more widely, and 
how his clinical opinions were sought with increasing frequency as his academic career 
advanced.  
 
Whilst the archive was a very useful source for the project, as with any curated 
documents, there can be issues related to the collection. It is highly unlikely that the 
archive itself contains a full record of all the documents Ferguson-Smith possessed 
throughout his career. Particularly within the correspondence section, it is likely that 
letters that were sent and received are missing, perhaps as a result of being misplaced 
over time. Within any archival collection, source bias is also an important consideration, 
both from the perspective of the individual who the records belong to, and the 
institution where the archival documents are being made available. From the 
perspective of the individual, there is the possibility that items have been deliberately 
excluded, perhaps because they did not view them as being of importance, or because 
they do not wish them to be made publicly available, either for a set period of time or 
permanently. From an institutional perspective, archival collections have to be 
organised and ordered into subsets within the wider collection, which could result in 
documents being categorised differently than the way the individual intended them to be 
catalogued. Items may also not be accepted by archives when presented by an 
individual, or they may not be included within a wider collection because they are 
deemed as not belonging to a certain category within which they have been assigned. 
Additionally, for data protection reasons some material is unavailable to scholars, as is 
                                                          
134 Nathaniel Comfort, ‘When Your Sources Talk Back: Toward a Multimodal Approach to Scientific 
Biography’, Journal of the History of Biology, 44:4 (2011), p. 666. 
50 
 
the case with the records which exist on Malcolm Ferguson-Smith at the University of 
Cambridge. Thus, there is a human element involved in the collection and curation of 
archival material, alongside accessibility issues, which can lead to a lack of a complete 
picture forming if archive documents alone are used as source material.  
 
In the case of the Ferguson-Smith archive, the vast majority of the collection is made up 
of typed or hand-written sources, with only a small number of items in other formats, 
including video and photographic material. Whilst such sources are exceptionally 
valuable, they will fail to capture the nuances of conversations and relationships that 
exist within a working department. It became particularly clear when analysing the 
archive that a key group of individuals were missing from the written record – 
Ferguson-Smith’s colleagues. That this group was not recorded in the archive was 
understandable; Ferguson-Smith and his colleagues worked in the same building as one 
another and were able to discuss ideas in person, rather than writing letters to one 
another. However, these members of staff were centrally involved in the running of the 
department, carrying out the prenatal testing and screening programmes, and it seemed 
important that their recollections should be recorded. This led to the decision to carry 
out a number of oral history interviews with a variety of staff members who had played 
different roles in medical genetics in Glasgow.135  
 
From the beginning of the research project it was recognised that it was important to 
interview Malcolm Ferguson-Smith and his wife Marie Ferguson-Smith, who had 
worked side-by-side. However, the decision to expand the oral history aspect of the 
project gave many others, such as technicians and research scientists, an opportunity to 
tell their stories, which greatly influenced the direction of the project. Key work by 
Tansey has highlighted the importance of recording the voices of technicians, a group 
she argues play ‘key roles in both the routine maintenance and innovative research work 
of a laboratory … metaphorically – and quite literally in some circumstances – they 
keep alive the very ‘culture’ of a laboratory’.136 Despite the importance of technicians 
                                                          
135 Details of each of the interviewees can be found in Appendix 3. 
136 E.M. Tansey, ‘Keeping the Culture Alive: The Laboratory Technician in Mid-Twentieth-Century British 
Medical Research’, Notes & Records of the Royal Society, 62:1 (2008), p. 78. 
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for the central running of a laboratory, they are distinctly lacking in the historical 
record. As Tansey has reported, they ‘have proved a difficult group to trace historically. 
They rarely leave material records in archives, write reminiscences or receive 
obituaries. They can be troublesome to track via published staff lists … and are 
frequently not even acknowledged in the scientific papers to which they contribute’.137 
Whilst in the department run by Ferguson-Smith, technicians did appear on staff lists 
and received credit on publications, as noted above, none of them have left behind 
records in the archives. However, as Paul Thompson has described, a ‘cumulative 
process of transformation is set in motion’ when new evidence is brought forward by 
groups of people who have traditionally been ignored in history, which he argues results 
in ‘historical writing itself’ becoming ‘enlarged and enriched’.138 This was certainly the 
case for this thesis, where the department members interviewed added a great deal of 
useful information to the project. The decision to track down, interview and include 
these individuals supports Thompson’s argument that ‘By giving a central place in its 
writing and presentation to people of all kinds, history gains immensely.’139 The 
specific details of the interview process will be discussed in the following section.  
 
Interviewees for this project comprised several different groups, including those who, as 
described above, had worked in medical genetics in Glasgow. Other groups included 
people who had worked in prenatal testing in other regions, and religious figures 
including priests, and a midwife who was strong in her Catholic faith. These 
participants were recruited in a number of ways for this research project. During my 
initial interviews with Malcolm and Marie Ferguson-Smith, they mentioned colleagues 
who had been centrally involved in the work of the medical genetics department 
throughout the time period of this thesis. Some of these individuals were still working in 
the current medical genetics department in Glasgow, and were therefore contacted by 
myself via email to enquire about their willingness to take part in the project. Others 
could not be contacted directly, due to changes in their circumstances, such as that they 
had retired or changed job role. To ensure confidentiality was maintained, the current 
                                                          
137 Ibid. 
138 Paul Thompson, The Voice of the Past: Oral History, 3rd Edition, (Oxford: Oxford University Press, 
2000), pp. 8-9. 
139 Ibid., p. 12. 
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head of the medical genetics department agreed to pass on letters to these individuals 
where address details were available. The letters were written and put in stamped 
envelopes by myself, and address details were added by the current head. Also, a 
number of individuals contacted me directly, having heard about the project from 
others, who were keen to be involved and tell their stories. One interviewee was 
suggested by a current staff member of a medical genetics department in Edinburgh, 
and others became involved after hearing presentations about this project at seminars 
and events. Both priests were recruited directly by email; one was suggested by a 
personal contact as he had studied medicine before entering the priesthood, the other 
was suggested by his fellow priest, who knew that his colleague had an interest in 
bioethics. Thus, a broader pool of interviewees was gathered, which ensured that not all 
those interviewed had been chosen by the Ferguson-Smith family.  
 
Once contact had been established with an interviewee, and they had confirmed that 
they would be interested in participating in the project, a suitable interview date and 
time was agreed upon. Interviews took place in a number of locations, as decided by the 
interviewees themselves. Locations included in the homes of the interviewees, at their 
place of work, in meeting rooms at the University of Glasgow, and one in a public café, 
at the request of the interviewee. Each interviewee had been made aware prior to 
meeting what the focus of this PhD research was, and upon meeting were given a copy 
of the Participant Information Sheet to read, and the consent form to sign (see Appendix 
1 and 2). They were also informed that the transcript of their interview would be 
available to view, and edits to the transcript would be permitted. Interviews were 
unstructured, but with similar themes covered throughout, such as education, work 
history, and personal recollections of stories related to prenatal testing and medical 
genetics more widely. The content of the interview and the time spent discussing a 
variety of subjects was different for each interviewee, due to the unstructured nature of 
the interviews. Interviews were recorded using an Olympus digital recorder, and all 
interviewees were made aware that the recorder could be paused at any time.  
 
After the interviews were completed, all were transcribed using verbatim transcription 
style as closely as possible. The completed transcript was then sent by email or post to 
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the interviewee, who was able to read through the interview, and make changes as they 
deemed fit. Interviewees were made aware that the verbatim style had been used to 
closely reflect the spoken word, and preserve dialect characteristics etc. However, some 
interviewees chose to edit their transcript to read in a more grammatically correct 
manner. No edits to any transcripts were made by myself. The questions and discussion 
points raised by me are completely unedited in all transcripts. All completed transcripts 
were stored in a locked filing cabinet in my office in the University of Glasgow, 
alongside the digital sound recordings of the interview. The completed and approved 
transcripts from each interviewee were the material consulted to select quotes for this 
thesis. On a few occasions, interviewees had not edited their transcript for a variety of 
reasons, despite intending to do so. In these instances, only specific quotes were used, 
and only after the interviewee gave their full consent for these particular quotes to be 
included.  
 
After returning a completed transcript, the interviewee played no further role in the 
interview process, including the selection of quotes. This process was completed by 
myself. None of the interviewees, including Malcolm Ferguson-Smith, had knowledge 
of the quotes which had been chosen, or the context in which they were presented, such 
as having access to draft chapters. This decision was made to minimise the influence 
that any interviewee could have on the project with regards to selection of material for 
inclusion in this thesis. Particularly in the case of Malcolm Ferguson-Smith, it was 
hoped that this would reduce the potential for his curating his own biography through 
the interview process. In many cases, the interview material which was incorporated 
was selected as it provided information on an aspect not available through archival or 
other published documents. Personal recollections of the medical genetics department 
were also viewed as being of importance for inclusion. As well as providing illustrative 
quotations, the interviews broadened my understanding of the functioning of many 
aspects of the medical genetics department, particularly laboratory work and service 
provision. The interviews also enabled me to develop a sense of the place that the 
medical genetics department was, and the relationships which existed between the staff 
members working there. 
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The use of oral history in this project was therefore multi-faceted, and was not solely 
used to record the voices and memories of those who worked in the prenatal field. Lynn 
Abrams has highlighted that there are three models of oral history usage when it comes 
to interpreting the interviews, and two of these were used throughout the project. The 
first she describes as the ‘reminiscence and community model’ which involves 
‘undertaking oral history interviews for the sole purpose of recovering voices and 
placing them on the historical record’.140 Whilst it was not the sole aim of the interviews 
I carried out, it was part of the reason for interviewing such a wide range of individuals, 
to ensure that their names and stories were collected for the historical record. However, 
Abrams also describes a second model, which she terms ‘evidential’, which 
‘encompasses the application of oral history for evidence gathering, the use of oral 
testimony as data, providing information to support an argument and illustrative 
material for publication’.141 This was also a central use of the oral history testimonies I 
gathered, which helped to provide more information than could be found in published 
scientific papers and archive documents. The oral testimony became a source of data in 
itself, which could be used to support or dispute published historical accounts. The 
approach I took throughout this thesis to the use of oral history is reflective of 
Thompson’s view that oral histories have a ‘triple potential’, which include ‘to explore 
and develop new interpretations, to establish or confirm an interpretation of past 
patterns or changes, and to express what it felt like’.142 This last potential, the 
expression of feelings, was particularly important throughout the project, as prenatal 
testing is an emotive subject. I wanted to find out the details of what was not in the 
published record from my interviewees, and how they felt in respect of a number of 
developments in the field. 
 
Hoddeson has commented that ‘Oral history interviews can breathe life into the research 
and writing of recent history. By filling in the nerves and connective tissue (motives, 
inspirations, fears, obsessions, etc.) that link actions with each other, participant 
accounts can animate a narrative with details not found in documents, shade it with 
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nuances, and vitalize interpretations with insights into diverse points of view.’143 It is a 
firm belief that oral history had this effect on the project, helping me to gain a better 
understanding of the individuals who were involved in medical genetics in the West of 
Scotland, and how they interacted with their job role, and with one another. However, 
whilst oral history added a great deal to this project, as mentioned by Sӧderqvist, it is 
not without nuances, which should be addressed. Abrams has spoken of the 
interpersonal relationship between an interviewer and an interviewee, and how the 
interviewer ‘by word, deed and gesture in the interview solicits a narrative from the 
narrator; a different interviewer would solicit different words, perhaps even a very 
different story or version of it’.144 This is particularly fitting for considering my own 
scientific background, which the interviewees were made aware of. It is possible that 
knowing I had spent time in a laboratory and understood a number of scientific 
techniques would have altered the details presented by some interviewees. When many 
of them discovered that I had undertaken a scientific undergraduate degree they were 
comfortable going in to detail about procedures and techniques they had used in the 
laboratory over the years, knowing that I would understand the language. This helped to 
circumvent the methodological challenge of lack of scientific training which was 
highlighted by Sӧderqvist at the beginning of this section. My own beliefs that 
technicians and those scientists carrying out the work on a daily basis are essential for 
the running of a department would most likely have been picked up on by those I was 
interviewing, and perhaps could have impacted their stories. 
 
In addition to my own background, interviewees were also aware of the focus of my 
project, which involved using Malcolm Ferguson-Smith as a case study. The Participant 
Information Sheet clearly described that the focus of the project was Malcolm 
Ferguson-Smith, and that transcripts would be housed in his archive at the University of 
Glasgow, if permission was given to do so. Abrams has described how ‘There are two 
people involved in an interview, which means two worlds, or subjectivities, are 
colliding’.145 However, I would also argue that within my interviews there was often the 
                                                          
143 Lillian Hoddeson, ‘The Conflicts of Memories and Documents. Dilemmas and Pragmatics of Oral 
History’, in The Historiography of Contemporary Science, Technology and Medicine. Writing Recent 
Science, ed. by Ronald E. Doel and Thomas Sӧderqvist, (Oxon: Routledge, 2006), p. 187. 
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presence not only of myself and the interviewee, but of Ferguson-Smith himself. Whilst 
not physically present at any interviews except for those carried out between myself and 
him, all those I interviewed for the project were aware that Ferguson-Smith knew about 
the project and was supportive of it, and that their testimonies would eventually be 
deposited in the Ferguson-Smith archive if they agreed to do so.  
 
It could therefore be argued that the framing of this project had the potential to 
influence the pool of interviewees. Given the nature of the project, it is likely that those 
who agreed to be involved held positive memories of their time working in the medical 
genetics department under the leadership of Ferguson-Smith, as they were often keen to 
give up their time to speak in detail about their experiences. Employees who only 
worked in the department for a short time were unlikely to be suggested as potential 
interviewees, and it is also less likely that their forwarding address details would have 
been available. Thus, if there were individuals who worked in the department for shorter 
periods and perhaps did not have as positive an experience, they would have been hard 
to locate and invite to take part in the project. That the interviewees were made aware of 
the focus of the project prior to the interview could have impacted the response to the 
invitation to interview – if an individual did not wish to speak about their time in the 
department, they were under no obligation to reply to communications inviting them to 
do so. Additionally, due to the small numbers of staff who worked in the department at 
certain time periods, it was not possible to anonymise transcripts – identification would 
be possible by reading the stories they told which would often contain references to 
time frames, even if names had been redacted. Again, this is likely to have impacted the 
information that interviewees would have contributed whilst recounting the history of 
the department from their own perspective, as they would be aware that their colleagues 
could access their interview transcripts in the future.  
 
All interviewees were given the option to read their completed transcript, and make 
changes to this document. Whilst from an ethical standpoint this was the correct path to 
follow, it also gave interviewees a chance to self-censor the information they had 
volunteered during the interview process. However, as highlighted above, the vast 
majority of the interviewees used the editing process to tidy up their grammar, and in 
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some cases, to clarify details, such as names and dates etc. that they felt were unclear 
from the transcript, as opposed to removing specific information. Some interviewees 
made several changes, whilst others made none at all. For Ferguson-Smith himself, 
there was likely to be an understanding of his place in the history books, and this could 
have impacted the events he discussed. He would likely have been more aware than 
many of the other interviewees that what he said in our discussions would form a lasting 
legacy, both within the University of Glasgow archives, and further afield. This could 
possibly lead to a more censored interview, which would perhaps provide more 
information on material which Ferguson-Smith knew was already available in the public 
record, as opposed to more personal recollections. As Ferguson-Smith had already taken 
part in a detailed oral history interview with Peter Harper in the past, it is likely that he 
had some experience with sorting his memories into a narrative that he was comfortable 
sharing. Being given an opportunity to edit the transcript potentially furthered this 
process. However, as with the other interviewees discussed above, Ferguson-Smith 
mainly focused on editing the grammar in the transcript, to reflect that of a more 
traditional text document, as opposed to a verbatim style transcription. He also utilised 
the opportunity to clarify details within the text itself, as some of the others did.  
 
That this sort of historical awareness could cause problems has been discussed by other 
scholars, as highlighted by Sӧderqvist when detailing his project writing the biography 
of the immunologist Niels Jerne. He described how himself and Jerne ‘became involved 
in a subtle continuous negotiation over the control of the story’ over a period of four 
years, with Jerne expressing concerns about how Sӧderqvist would manage to 
understand all of the science involved with the project, having no scientific training.146 
This highlights a difficulty which can be encountered when writing the history of an 
individual who is aware of their historical presence. For Ferguson-Smith, this could 
have been reflected in the individuals that he suggested would be important people to 
interview as part of this project. It is unlikely that he would have recommended 
speaking to individuals that he had not formed a working relationship with, or who were 
not centrally involved in some aspect of the department. As Ferguson-Smith would have 
played a key role in shaping the careers of many of these individuals, this could have 
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led to a pool of interviewees who were more likely to speak positively about Ferguson-
Smith, and the department more broadly. However, as mentioned earlier in the 
methodology section, there were several interviewees who were not directly suggested 
by or linked to Ferguson-Smith; it is hoped that their testimonies help to alleviate 
possible concerns about the ability of Ferguson-Smith to curate his own biography 
through this project. 
 
All of the issues raised above link to the question of the reliability of oral history 
testimony for providing an accurate historical picture. Whilst there are issues involved 
in interviewing on an individual basis, it does provide the interviewee with the 
opportunity to provide a detailed account of their recollections. However, the reliability 
of these recollections is a source of discussion with regards to oral history; memory is 
known to be unreliable, and time can alter the perception of events. Thompson has 
highlighted how with interviews which stretch further back in time there is the ‘added 
possibility of distortions influenced by subsequent changes in values and norms, which 
may perhaps quite unconsciously alter perceptions’.147  As many of those interviewed 
have now retired, it is possible that looking back on their working careers as an overall 
experience would have coloured their view, with the small everyday frustrations being 
forgotten, in favour of the key events they recalled as being of particular importance. As 
all of the interviewees knew of the subject matter prior to the interview taking place, it 
is likely that they would have been actively thinking back over their career, selecting 
key events which would end up forming their narrative. It is also possible that memories 
of events are changed over time, however these distortions are of interest in themselves. 
Why one interviewee remembered an event in a slightly different manner from another 
serves to highlight the importance of the people involved in this work, and helps to form 
a more vivid picture of how these individuals worked together whilst retaining their 
sense of self. These nuances bring an added dimension to the story being told 
throughout this thesis, which paper documents alone could not achieve.  
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Whilst it was clear that the particular developments which were occurring in the area of 
prenatal testing in Glasgow could be accessed through archival documents and oral 
history interviews, as has been discussed above, relying solely on these sources could 
result in a biased account being written. There is therefore a need for information to be 
gathered from other sources which could provide a different perspective on the 
developments which were occurring in the medical genetics department in Glasgow, 
and for these developments to be placed in a national and international scientific and 
medical context. To enable analysis of how the work in Glasgow compared to the 
situation in other geographical areas, a number of scientific and clinical publications 
were examined. The challenge of interpreting a vast amount of publications as a caveat 
of contemporary scientific history which was highlighted by Sӧderqvist, was apparent 
when researching the material for this thesis, and so the decision was taken to choose 
key sources to analyse in detail. Two of the main sources used were the medical 
journals The Lancet and the British Medical Journal. Every issue of these journals from 
1950 to 1990 were examined, and all relevant articles on prenatal testing and abortion 
were considered. This led to a far more enriched understanding of how the field of 
medical genetics and prenatal testing were developing more widely, and where the work 
of Ferguson-Smith and his colleagues fitted in. A number of other medical and 
scientific journals were also examined, including the British Journal of Obstetrics and 
Gynaecology, Prenatal Diagnosis, Clinical Genetics, the Journal of Medical Genetics, 
the Journal of Medical Ethics, and the Scottish Medical Journal. Again, each of these 
played a key role in enabling the work happening in the West of Scotland to be situated 
in a wider context.  
 
By examining these varying journals, it also became possible to gain an insight into the 
wider social circumstances which were surrounding prenatal testing, including debates 
on the ethics and morality of termination of pregnancy. Both The Lancet and the British 
Medical Journal were particularly insightful for this purpose, as both contained large 
correspondence sections in each issue, which were often the site of heated debates 
amongst clinicians surrounding abortion issues. All relevant articles on abortion from 
all of the journals listed above were examined in detail, and assisted in the 
understanding of the changing social landscape in the 1960s surrounding termination of 
pregnancy.  
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As a key aim of this thesis is to examine the wider social response to prenatal testing, 
particularly of religious organisations, sources other than scientific and clinical journals 
were also examined to further aid understanding. As noted above, to build up a picture 
of how religious organisations in Scotland responded to prenatal testing, the views of 
two of the main groups at that time were considered, the Church of Scotland and the 
Roman Catholic Church. It was felt that newspaper and magazine publications by these 
organisations and their followers would provide an important insight into how they 
were responding to the development of prenatal testing. Two key publications for the 
Roman Catholic Church were considered for the period 1966 to 1987, The Tablet and 
the Scottish Catholic Observer, both of which were weekly newspapers. For the Church 
of Scotland the weekly Protestant newspaper publication The British Weekly was 
examined, alongside the monthly magazine publication of the Church of Scotland, Life 
and Work, both also from 1966 to 1987. Upon examination of these sources it became 
clear that Life and Work and the Scottish Catholic Observer would provide the best 
insight into the situation in Scotland. Both The Tablet and The British Weekly focused 
more on developments occurring throughout the United Kingdom more widely, often in 
England, which did not always reflect the situation in Scotland. It was therefore decided 
that Life and Work and the Scottish Catholic Observer would be the key sources of 
material for consideration of religious perspectives, and both publications were analysed 
for any discussion on abortion and/or prenatal testing. 
 
The archive of Ian Donald was also considered. This is housed at the Mitchell Library 
in Glasgow, and was a useful source for providing an insight into the specific situation 
in the city whereby accessibility to abortion services was linked to the views of senior 
medical professionals. As highlighted above, interviews were also carried out with two 
Catholic priests and a Catholic midwife, to gain an understanding of the current 
perspective on prenatal testing and abortion within the Catholic Church. They were able 
to discuss religious teachings from the time period being examined, to highlight how 
these have impacted current beliefs. A number of the interviews I carried out with staff 
who had worked within the medical genetics field in the West of Scotland also 
discussed the subject of religion, specifically linked to prenatal testing and abortion. A 
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theme which emerged was whether or not religious identification impacted prenatal 
decision making, as this was discussed by a number of interviewees. To examine this 
interaction further, journal articles and books from a variety of authors were considered. 
These sources were examined to discern whether a link did exist between the choices 
that individuals made when faced with prenatal testing, and whether their religious 
identification, or more concisely, their religious adherence, played a role in their 
decision-making process. This information was gathered by considering material found 
in articles published at the beginning of the study time period, all the way through to 
current publications. 
 
By utilising a number of different sources for this project, a complex and detailed 
understanding of the changes in the field of prenatal testing has developed. Utilising 
archives and oral history enabled the voices of those involved in the story from a 
Glasgow perspective to be told, and added a greater personal slant to the research. Due 
to the vast nature of the Ferguson-Smith archive, and his role as a key figure, the 
decision was taken to focus on this as the main archival source. Due to the quantity of 
documents in his archive, a great deal of time was required to analyse them in sufficient 
detail to ensure academic rigour. There are items contained within his archive, such as 
reports, which are related to the entire department, and not solely his person 
recollections. The inclusion of such items further highlights this archive as the most 
relevant source to be studied.  
 
Another potential archive source which was considered for examination was the 
University of Cambridge archives, to elucidate if any resources were available which 
would provide further insight into Ferguson-Smith’s move there. However, whilst it was 
confirmed that files do exist on Ferguson-Smith in that archive, as mentioned above, 
they are all closed to scholars due to data protection legislation. Therefore, these 
documents could not be accessed. Due to the vast volume of data which was present in 
the Ferguson-Smith archive, and the large numbers of oral history interviews which 
were carried out for this thesis, comparative archive studies were not carried out at other 
institutions, such as the University of Edinburgh. However, this could be an interesting 
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resource if a future study was carried out which compared the development of prenatal 
testing services in the East and West of Scotland. 
 
As the scientific and medical discoveries which were occurring in the prenatal field 
coincided with a period of major social change in the United Kingdom with the 
implementation of the Abortion Act 1967, it was essential also to consider social 
responses to the testing. The response of the medical profession and religious 
organisations needed to be considered in detail, and this was achieved through the use 
of newspapers, magazines, journal articles and oral history interviews. The examination 
of material from the National Records of Scotland provided an insight into the views of 
the medical profession and those involved in the debates surrounding changing abortion 
legislation, including towards fetal anomaly. The Ian Donald archive also provided 
primary source material which was useful to analyse the specific impact that he had on 
the region of Glasgow. The high number of newspaper and magazine articles which 
were available for study required careful consideration, with each analysed in detail to 
glean any relevant information for this thesis. 
 
Combining all of these sources highlights the importance of the scientific and medical 
developments which were occurring, but also shows that these developments were 
being driven by human agency. The implementation and spread of prenatal testing was 
a combined result of technical advances, and of individuals and society pushing them 
forward. 
 
VIII. Chapter Outline 
Chapter one focuses on the scientific and clinical developments which occurred 
throughout the 1950s to 1980s, which contributed towards making prenatal testing 
possible. It will examine the development of amniocentesis, and will argue that the 
discovery of the chromosome number in humans was essential to the formation of the 
prenatal testing field. The risks surrounding invasive prenatal testing methods will be 
examined, and it will also consider the move towards developing first trimester testing 
in the form of chorionic villus sampling. It will argue that the increased risk of 
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miscarriage associated with amniocentesis and chorionic villus sampling led researchers 
and clinicians to work on creating new screening programmes which changed the field 
of prenatal testing entirely. 148 These large-scale screening programmes opened up 
prenatal detection of a number of conditions to all pregnant women, and not just those 
who were known to have an increased chance of having a fetus with an anomaly. One of 
these less invasive testing methods was ultrasound, and it will argue that the diagnostic 
application of this technology owed a great deal to the individuals who developed its 
use in Glasgow. Consideration of the various technologies and techniques which 
resulted in the development of the prenatal testing field is essential for the chapters 
which will follow, which analyse the running of prenatal services for conditions such as 
chromosome anomalies and neural tube defects. Without an understanding of the 
development of the invasive and non-invasive testing methods, and the scientific 
discoveries which enabled them, it would not be possible to analyse the development 
and running of prenatal services in Glasgow and other locations. 
 
To examine the development of prenatal services in Glasgow and the West of Scotland, 
the case study of the Glaswegian geneticist Malcolm Ferguson-Smith is being used as a 
conduit to explore these processes throughout this thesis. Chapter two will focus on the 
development of medical genetics in Glasgow, under the leadership of Ferguson-Smith. 
This chapter will consider several decades of Ferguson-Smith’s life, c. 1950 to c. 1990, 
but will mainly focus on the time period of 1955 to 1987. 1955 is the year that 
Ferguson-Smith graduated with his medical degree, and 1987 is the year that he left his 
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currently the recommended term by the Royal College of Obstetricians and Gynaecologists (RCOG). This 
term was initially suggested in 1997, as part of the recommendations from the 33rd RCOG Study Group. 
Under the ‘Recommendations for health education and health policy’ section of their report, the study 
group stated that ‘the term ‘abortion’ should be replaced’, and more specifically that ‘Spontaneous 
abortion should be replaced by miscarriage’. See Royal College of Obstetricians and Gynaecologists 33rd 
Study Group, ‘Recommendations from the 33rd RCOG Study Group’, in Problems in Early Pregnancy: 
Advances in Diagnosis and Management, ed. by J.G. Grudzinskas and P.M.S. O’Brien (London: RCOG 
Press, 1997), p. 330. These recommendations were taken up for use by the RCOG in 2006, and 
information on the recommended terminology can be found in their Green-top Guideline published in 
that year. See Royal College of Obstetricians and Gynaecologists, ‘The Management of Early Pregnancy 
Loss’, Green-top Guideline, no. 25, (2006), pp. 1-2. As noted above, the changing movement towards the 
use of the word ‘miscarriage’ occurred throughout the 1990s and 2000s, which is after the study period 
of this thesis. Therefore, throughout the time period of this PhD thesis other terms were frequently 
used, including ‘spontaneous abortion’. To ensure historical accuracy, where necessary the original term 
will be used in direct quotes. Outside of such examples, the term ‘miscarriage’ will be used where 
possible.  
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position at the University of Glasgow. These dates therefore provide an overview of his 
career at the University of Glasgow. His early education and career will be considered, 
to trace his interest in the field of genetics, and how he became involved in studying 
chromosomes. It will be argued that a lack of interest in human chromosome research 
from others working in the field of genetics at the University of Glasgow led to 
Ferguson-Smith moving to the United States to pursue his chromosome research 
further, where he would develop a number of skills which would be essential for a 
career in medical genetics. This chapter will emphasise the strong connection that 
Ferguson-Smith felt to his home city, and how this influenced his decision to return to 
Glasgow to set up his own department. The expansion of medical genetics services 
under his leadership will be considered, and the financial challenges that the department 
faced over several decades will be highlighted. His move to the University of 
Cambridge in 1987 will also be discussed, alongside the impact this had on the running 
of the department, and how his departure affected his colleagues. 
 
By considering the development of medical genetics in the West of Scotland, a detailed 
picture emerges of the expansion of prenatal testing in the region during this period. 
Throughout the time that Ferguson-Smith was leading medical genetics in Glasgow, one 
of the key antenatal testing programmes carried out by the department aimed at 
detecting chromosome disorders in the fetus. Chapter three will therefore examine the 
changes which occurred in the investigations into chromosome anomalies, not only in 
Glasgow, but also nationally and internationally. This chapter will begin with a 
consideration of the early work of researchers who were focused on analysing patterns 
of heredity for chromosome conditions before prenatal testing was possible. It will be 
argued that the development of amniocentesis, combined with the Abortion Act 1967, 
led to the expansion of the detection of chromosome anomalies in the fetus. The 
experience of the department led by Ferguson-Smith in implementing testing 
programmes for these conditions will be considered, and will be compared with that of 
other departments to highlight the similarities and differences between them. The 
technical issues and the debates surrounding the maternal age effect which were 
happening within the scientific and medical community will be examined, which will 
emphasise the difficulties associated with implementing a new form of medical testing. 
These difficulties were not only seen in the discussions taking place in medical journals 
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but, for some regions, were also reflected in lower than expected uptake rates of 
prenatal testing programmes. Some of the reasons behind these low uptake rates will be 
considered, and it will be argued that the development of serum screening programmes 
for chromosome anomalies had an impact on increasing the number of women 
participating in prenatal testing. 
 
Chapter four will have a similar structure to chapter three, however it will focus on the 
development of testing for neural tube defects in the fetus. Beginning with an analysis 
of the discoveries which led to the testing becoming a clinical reality, it will then 
examine how the testing for these conditions developed in the West of Scotland within 
the medical genetics team led by Ferguson-Smith. The prenatal detection of neural tube 
defects became possible when a linkage was found between the conditions, and a 
molecule known as alpha-fetoprotein. This finding was published in 1972 by two 
researchers based in Edinburgh, David Brock and Roger Sutcliffe. As a key function of 
the medical genetics department in Glasgow was carrying out prenatal testing, the 
detection of neural tube defects formed a central component of the department’s 
workload, despite the majority of neural tube defects not being linked to a genetic 
cause. As with chapter three, the experiences of the Ferguson-Smith group in the 
detection of these conditions will be considered, alongside reports from other clinical 
and scientific research teams, both throughout the United Kingdom and further afield. 
Some of the technical issues will be highlighted, and the work by researchers to develop 
ways of moving to less invasive testing for neural tube defects will be examined. The 
formation of serum screening programmes will be discussed in detail, and the regional 
disparities which emerged with their formation will be analysed. One key area where 
the research into neural tube defects differed from that of chromosome disorders, was 
the work which began in the 1970s and 1980s that suggested that vitamin 
supplementation could possibly prevent the formation of neural tube defects in the fetus. 
These findings caused many debates within the scientific and medical communities, and 
the ethics of clinical trials to either substantiate or disprove these findings will be 
discussed at length.  
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The possibility of preventing the formation of neural tube defects in the fetus, as 
opposed to terminating a pregnancy found to be affected, had the potential to greatly 
impact the prenatal testing field. It circumvented the issues associated with termination 
of pregnancy, to which a number of moral, religious and/or ethical objections were 
voiced. Chapters five and six will move away from considering scientific and clinical 
developments, and will instead examine the social context in which prenatal testing was 
situated. As highlighted in chapter two, the implementation of the Abortion Act 1967 
was crucial for the development of prenatal testing, and chapter five will examine the 
processes which led to this legislation. It will consider early attempts to make abortion 
legislation more liberal, and will examine some of the key groups involved in these 
processes. A central argument of this chapter will be that fetal anomaly played an 
important role in impacting abortion legislation, and it will be argued that many medical 
professionals and members of the public viewed abortion for fetal anomaly as more 
acceptable than abortion for other reasons. How fetal anomaly was discussed within 
debates on the legislation will be examined, and it will be highlighted that some of the 
key concerns which were raised were related to the uncertainty of a diagnosis. Many of 
these debates on the fetal anomaly clause took place prior to the widespread 
implementation of prenatal testing, whereby it was far more difficult to correctly 
diagnose a condition prenatally in the fetus. It will be argued that by the time Steel’s 
Bill was progressing, the fetal anomaly clause was widely accepted, with few 
individuals opposing this part of the legislation, or attempting to amend it.  
 
The perspectives of several key professional medical bodies towards the subject of 
abortion will also be discussed within this chapter, and it will be suggested that each of 
these groups worked in such a way as to protect their own professional autonomy when 
campaigning either for or against changes to the abortion legislation. As much of this 
thesis focuses on the development of prenatal testing in Scotland, the views of two of 
the key obstetricians/gynaecologists in the country, Ian Donald and Dugald Baird, will 
be examined in detail. This analysis is particularly detailed in this chapter for Donald, as 
he was based in Glasgow and worked together with Ferguson-Smith on clinical cases 
and research projects. Other academics, such as Gayle Davis and Roger Davidson, and 
also Malcolm Nicolson, have examined the views of Ian Donald prior to this thesis. 
However, a key aim of this chapter is to further develop this work, by considering 
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Donald’s views on termination of pregnancy for fetal anomaly, and the potential impact 
that his friendship with Malcolm Ferguson-Smith had on his clinical practice. This 
chapter will also consider the responses of several medical and religious groups to the 
publication of the Lane Report.  
 
It was, however, not only those in the medical profession who could impact abortion 
legislation, and one of the key sets of groups who were keen to voice their opinions 
were religious organisations. Within chapter six, a more detailed examination will take 
place of the viewpoints of the Roman Catholic Church and the Church of Scotland. This 
chapter will begin with a broad overview of the views of these religions to the subject of 
abortion, and will then consider what efforts were made by both of these groups to 
influence abortion legislation when it was being drafted. It will argue that whilst the 
Church of Scotland were working to influence the exact wording of David Steel’s Bill, 
the Catholic Church were unprepared for the fight against abortion. The perspectives of 
the Church of Scotland and the Catholic Church in the two decades following the 
implementation of the Abortion Act 1967 will be examined, with a consideration of 
whether they supported or opposed the more permissive abortion legislation. The next 
section of this chapter will consider whether religious identification and/or belief 
impacts decision making in prenatal testing situations. Whilst it might be expected that 
there would be a conflict between the teaching of the Catholic Church and prenatal 
testing, that might result in a termination of pregnancy, it will be shown that such 
tension does not seem to be completely reflected in decision making. It will be argued 
that many factors including religious observation can impact prenatal decision making. 
The decisions surrounding prenatal testing are multi-faceted and complex for each 
woman, and cannot be linked, solely or directly, to religious identification in the 
majority of cases.   
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Chapter One – The Development of Invasive and Non-Invasive Prenatal 
Testing Techniques 
 
I. Introduction 
For the majority of women who have been pregnant in recent decades, prenatal 
diagnostic testing has become a frequently offered procedure for the detection of fetal 
anomalies during pregnancy. From non-invasive methods, such as visualising the fetus 
by ultrasound, through to invasive tests including amniocentesis and chorionic villus 
sampling (CVS), prenatal testing has become centrally involved in the clinical care of 
pregnant women. Despite this integration, prenatal diagnosis has had a relatively short 
history. Whilst it had long been recognised that many medical conditions were 
inherited, it was not until the late 1950s that it became possible to identify any specific 
genetic conditions during pregnancy using prenatal testing methods. It has only been in 
the past few decades that the mysteries of fetal development have begun to be 
unravelled.  
 
To analyse these changes in antenatal care, it is important to consider the historical 
development of the techniques and methods which made prenatal diagnosis possible. 
An understanding of these developments is essential for the reading of this thesis, as the 
use of amniocentesis, CVS and ultrasound formed the key components of prenatal 
testing in the medical genetics clinics and laboratories in Glasgow and beyond. This 
chapter will therefore provide a comprehensive history of these three key methods, to 
enable a detailed analysis to be made of prenatal testing programmes in future chapters.  
 
This chapter will firstly examine the development of amniocentesis, considering a 
number of scientific and clinical events which highlighted its potential for use in 
detecting conditions prenatally. It will then examine the use of amniocentesis in testing 
for both chromosome anomalies and neural tube defects, arguing that for chromosome 
anomalies, the identification of the correct chromosome number in humans was 
essential for the testing to become clinically useful. It will also consider some of the 
main drawbacks associated with the testing, including the increased miscarriage rate 
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linked to the procedure, and the importance of clinician experience in reducing the 
number of fetal losses in this manner. The development of CVS will then be considered, 
including the rationale behind developing a test which could take place in the first 
trimester of pregnancy. It will argue that the increased miscarriage rate associated with 
this procedure when compared to amniocentesis resulted in the test being less popular 
with pregnant women than expected, highlighting the unpredictable nature of uptake 
rates of new testing methods. 
 
The chapter will then argue that the increased miscarriage rate associated with both 
amniocentesis and CVS encouraged researchers to develop less invasive prenatal 
screening programmes, which could be used on the entire pregnant population with less 
risk of miscarriage. The development of screening programmes using biochemical 
markers will be outlined, as these programmes will form a central focus of future 
chapters, particularly chapter four, examining neural tube defects. The history of 
ultrasound and the move towards using it as a tool in prenatal testing will also be 
examined, outlining how ultrasound became centrally involved in directly detecting 
structural anomalies in the fetus, and also improved the safety of invasive testing 
methods such as amniocentesis.  
 
II. The History of Amniocentesis 
Amniocentesis is described by Sutton as the ‘mainstay of prenatal diagnosis’,1 so it is 
fitting to begin this chapter with a discussion of its development. Amniocentesis is an 
invasive prenatal diagnostic technique which can test for a variety of conditions 
including chromosome disorders, single gene defects, and neural tube defects.2 The 
transabdominal amniocentesis procedure is shown in Figure 1.1: 
 
                                                          
1 Agneta Sutton, Prenatal Diagnosis: Confronting the Ethical Issues, (London: The Linacre Centre, 1990), 
p. 23. 
2 Ibid., p. 20. 
70 
 
 
Figure 1.1 – Showing the transabdominal procedure of amniocentesis, which involves 
the insertion of a needle into the amniotic sac, through the abdominal wall, to remove 
amniotic fluid.3 
 
Amniocentesis is typically carried out in the second trimester, at 15 to 17 weeks of 
pregnancy, and involves the removal of 20-30ml of amniotic fluid, to harvest fetal cells 
(amniocytes).4 The use of amniocentesis as a diagnostic tool during pregnancy was 
described in 1952 by Douglas Bevis, a researcher based in Manchester. He studied 
amniotic fluid to assess the possibility of predicting the severity of haemolytic disease 
in fetuses of a Rhesus negative mother sensitised to the Rhesus antigen.5 Bevis used the 
amniotic fluid to measure the concentrations of iron and urobilinogen, and showed that 
the ‘results of analysis of the liquor amnii taken at various times in pregnancy indicate 
that the concentrations of non-haematin iron and urobilinogen offer a reliable guide to 
the outcome for the fetus’.6 Dependent upon the result of the test, clinicians would 
                                                          
3 ‘Amniocentesis’, Mayo Clinic  
<http://www.mayoclinic.org/tests-procedures/amniocentesis/multimedia/amniocentesis/img-
20008561> [accessed 8th May 2018]. 
Transabdominal amniocentesis is the method currently used by clinicians. Transvaginal amniocentesis 
was performed in the past, however this was not widely adopted due to concerns about sepsis and the 
procedure inducing abortions. See A.C. Turnbull and I.Z. Mackenzie, ‘Second-Trimester Amniocentesis 
and Termination of Pregnancy’, British Medical Bulletin, 39:4 (1983), p. 1. 
4 Lynn B. Jorde, John C. Carey and Michael J. Bamshad, Medical Genetics, 4th Edition, (Philadelphia: 
Elsevier, 2010), p. 267. 
5 D.C.A. Bevis, ‘The Antenatal Prediction of Haemolytic Disease of the Newborn’, The Lancet, 259:6704 
(1952), p. 395.   
6 Ibid., p. 397. 
71 
 
either induce birth, and/or give a blood transfusion as soon as the baby was born, with 
the main aim of saving the life of the baby.7   
 
Bevis had shown that analysis of amniotic fluid could enable the prediction of the 
effects of a medical condition on a fetus before it was born, and also influence the 
outcome of the birth. It was a few years later that one of the next key developments 
using amniocentesis occurred, when in 1956 two Danish researchers, Fritz Fuchs and 
Povl Riis, showed that amniocentesis could be used for fetal sexing. They collected 
amniotic fluid in the middle of pregnancy or at term, and found that the sex of the fetus 
could be identified by the presence of sex chromatin, which is found in female cells but 
not in male cells.8 Determining the sex of the fetus enabled parents who were carriers of 
sex-linked genetic conditions to select against having a child with the condition, through 
termination of possibly affected fetuses. For example, in the case of haemophilia, a 
woman who is a carrier of the condition has a 50% chance of passing this gene onto her 
children. As outlined in Figure 1.2, if the affected gene is passed to her son then he 
would have haemophilia, and if it is passed to her daughter then she would be a carrier. 
Whilst the carrier daughter would be unaffected, she could herself pass the condition 
onto the next generation. Thus, the pregnant woman could choose to terminate a male 
pregnancy to avoid having a child who was directly affected by the condition.  
 
                                                          
7 Ilana Lӧwy, ‘Prenatal Diagnosis: The Irresistible Rise of the ‘visible fetus’’, Studies in History and 
Philosophy of Biological and Biomedical Sciences, 47 (2014), p. 291. 
8 Fritz Fuchs and Povl Riis, ‘Antenatal Sex Determination’, Nature, 177:4503 (1956), p. 330. 
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Figure 1.2 – Showing the patterns of haemophilia inheritance. The black X represents 
the unaffected gene, and the red X represents the affected gene. If the affected gene is 
passed on to the daughter then she will become a carrier, and if passed on to the son 
then he will be affected by the condition.9 
 
Lӧwy has discussed the work of Fuchs and Riis in the context of a 1956 Danish Act, the 
Pregnancy Act, which permitted termination of pregnancy for a fetus which might be 
affected by a hereditary disease.10 She has stated that the law was ‘unmistakably 
eugenic’.11 However, the case of a patient seen by Fuchs and Riis highlights the 
difference which can arise between the overall character of a law, and the individual 
application of it. The patient of Fuchs and Riis was a known carrier of haemophilia and 
had previously given birth to a son who had haemorrhaged and died within a few hours 
of his birth. When the woman discovered she was pregnant again, she had decided to 
terminate until she found out there was the option to determine the sex of the fetus. The 
                                                          
9 ‘Hemophilia A and B’, Indiana Hemophilia & Thrombosis Center, Inc.  
<https://www.ihtc.org/patient/blood-disorders/bleeding-disorders/hemophilia-a-and-b/>  
[accessed 7th August 2018] (section titled ‘Causes of Hemophilia’). 
10 Lӧwy, ‘Prenatal Diagnosis: The Irresistible Rise of the ‘visible fetus’’, p. 291. 
11 Ibid. 
73 
 
fetus turned out to be female and she opted to continue with the pregnancy, and went on 
to have a healthy baby girl.12 Thus knowing the sex of her baby actually led her to 
choose to continue with a pregnancy which she would have otherwise terminated. The 
testing could therefore lead to increased numbers of continuing pregnancies in women 
who were carriers of sex-linked conditions.  
 
Whilst Bevis, Fuchs and Riis used amniocentesis to gain general information about the 
fetus, it was not until the mid-1960s that it became possible to analyse the fetus on an 
individual level to gain information about its genetic constitution. These developments 
occurred as a result of advances in the field of cytogenetics, which involves the study of 
the structure and function of chromosomes. A critical moment in the discipline of 
cytogenetics occurred in 1956, when the correct chromosome number in humans was 
identified as 46 by Joe-Hin Tjio and Albert Levan of the Institute of Genetics in Lund, 
Sweden. Smeets has stated that this discovery ‘paved the way for the start of a new era 
of clinical cytogenetics’13 and Garcia-Sagredo attributes the ‘birth of modern human 
cytogenetics’ to the publication of the information ‘that the diploid number of 
chromosomes in humans is 46’.14 The story of the discovery of the correct human 
chromosome number has been discussed in detail by Kottler. He has described how 
human chromosomes were first observed in the 1870s and counted in the 1890s, with 
estimates of the chromosome number varying between 8 and 50.15 Whilst most reports 
placed the number of diploid chromosomes at around 24, cytologist Hans de Winiwarter 
disagreed with these findings. He had studied chromosomes for several decades, and 
published a paper in 1912 which reported human chromosome numbers of 47 in 
spermatogonia and 48 in oogonia.16 Human chromosome research was furthered in the 
1920s when Theophilus Painter began working on mammalian chromosomes and was 
able to confirm Winiwarter’s findings that the human chromosome number was in the 
40s. Painter was sure the chromosome number was either 46 or 48, but could not decide 
                                                          
12 Ibid. 
13 Dominique F.C.M. Smeets, ‘Historical Prospective of Human Cytogenetics: From Microscope to 
Microarray’, Clinical Biochemistry, 37:6 (2004), p. 440. 
14 J.M. Garcia-Sagredo, ‘Fifty Years of Cytogenetics: A Parallel View of the Evolution of Cytogenetics and 
Genotoxicology’, Biochimica et Biophysica Acta, 1779:6 (2008), p. 363. 
15 Malcolm Jay Kottler, ‘From 48 to 46: Cytological Technique, Preconception, and the Counting of 
Human Chromosomes’, Bulletin of the History of Medicine, 48:4 (1974), p. 467. 
16 Ibid., p. 469. 
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which of these figures was correct.17 Despite his own comment that ‘in the clearest 
equatorial plates so far studied only 46 chromosomes have been found’ he eventually 
settled on 48 as the definitive number. 18 Kottler has theorised that Painter was 
influenced by Winiwarter’s work, and as Painter was sure that Winiwarter had 
definitively shown the existence of a minimum of 47 chromosomes, this impacted on 
his decision to put the chromosome count at 48.19  
 
It took several decades for technical advances to occur which would lead to the 
challenge of this figure. These advances began in the area of tissue cell culture as a 
result of work carried out in 1951 and 1952 by T.C. Hsu. Hsu found that altering the 
tonicity of the balanced salt solution which was used to rinse tissue cell cultures enabled 
chromosomes to be clearly visualised. Until this point chromosomes had been 
notoriously difficult to see, so this discovery was a ‘turning point of critical 
significance’.20 Despite these improved visualisation techniques, Hsu and others 
continued to put the chromosome number at 48. Whilst Hsu himself found it difficult to 
fit his own findings to the proposed number, it was so entrenched in the scientific 
literature that he felt it had to be correct. When necessary Hsu even ‘reinterpreted long 
chromosomes as two shorter chromosomes aligned end-to-end in order to raise lower 
counts to the expected 48’.21 Kottler has argued that this shows the ‘reigning strength’ 
of preconceived ideas in science, and Hsu himself believed that if he had analysed his 
cells without these preconceptions then he would have been the one to discover the 
correct chromosome number in humans.22 
 
Advanced cell preparation techniques enabled clearer visualisation of human 
chromosomes, and two of the researchers in this field, Tjio and Levan, worked to 
exploit these developments. These techniques included using a hypotonic solution to 
rinse the cells, as discovered by Hsu, and also adding colchicine to cell cultures. 
                                                          
17 Theophilus S. Painter, ‘The Y Chromosome in Mammals’, Science, 53:1378 (1921), pp. 503-504. 
18 Ibid., p. 503. 
19 Kottler, ‘From 48 to 46’, p. 475. 
20 T. C. Hsu, Human and Mammalian Cytogenetics An Historical Perspective, (New York: Springer-Verlag, 
1979), p. 21. 
21 Kottler, ‘From 48 to 46’, p. 491. 
22 Ibid. 
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Colchicine causes the cells to be arrested in the metaphase stage of mitosis, where they 
can then be examined with more ease.23 Tjio counted 46 human chromosomes in a clear 
preparation which could not be doubted. The findings were published by Tjio and 
Levan in 1956, who ended the main body of their paper with the cautious but rational 
note that ‘we do not wish to generalise our present findings into a statement that the 
chromosome number of man is 2n=46, but it is hard to avoid the conclusion that this 
would be the most natural explanation of our observations.’24 The observations of 46 
chromosomes were quickly confirmed by others including Ford and Hamerton.25 As 
shown in Figure 1.3, the 46 chromosomes in humans are made up of 23 pairs – 22 of 
these pairs are autosomes, which are ordered numerically by size and are the same in 
both males and females. The 23rd pair are the sex chromosomes, composed of X and Y 
chromosomes, where biological males are XY and biological females are XX. 
 
 
 
Figure 1.3 – Showing the human chromosome karyotype. All autosomes are shown as 
pairs, and the sex chromosomes are that of a genetic male.26 
                                                          
23 Clare O’Connor, ‘Mitosis and Cell Division’, Scitable by Nature Education 
<https://www.nature.com/scitable/topicpage/mitosis-and-cell-division-205> [accessed 8th May 2018] 
(section titled ‘Metaphase’). 
24 Joe Hin Tjio and Albert Levan, ‘The Chromosome Number of Man’, Hereditas, 42:1-2 (1956), p. 5. 
25 C.E. Ford and J. L. Hamerton, ‘The Chromosomes of Man’, Nature, 178:4541 (1956), p. 1021. 
26 ‘A Karyotype of Human Chromosomes’, Scitable by Nature Education 
<https://www.nature.com/scitable/content/a-karyotype-of-human-chromosomes-6873458> [accessed 
7th August 2018]. 
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Ferguson-Smith has commented that Tjio and Levan ‘heralded in the modern era of 
human cytogenetics’ with their findings.27 However, it was a combination of these 
discoveries with the finding that chromosomes could be analysed from amniotic fluid 
which would have such a big impact on prenatal testing. This discovery occurred in 
1966, when Steele and Breg showed that some cells taken from human amniotic fluid 
were not only viable, but could be grown in culture and also karyotyped. Their neat 
summary statement that ‘chromosome analysis of the fetus in utero is therefore 
feasible’28 gives little clue that their findings would assist in the creation of a new field 
of medical testing.  
 
With the human chromosome count having been established as 46, it quickly became 
possible to identify chromosome anomalies that diverged from this number, which 
changed previously held beliefs about certain conditions. For example, in 1952 Ursula 
Mittwoch had examined a Down’s syndrome testicular sample and found the 
chromosome count to be 47 or 48. As the chromosome number at that time was thought 
to be 48, the conclusion was reached that the chromosome counts were the same as in 
those without the condition.29 It was not until 1959 that a paper published by Jerome 
Lejeune, Marthe Gautier and Raymond Turpin confirmed that those affected by Down’s 
syndrome had 47, rather than 46 chromosomes, which we now know is the result of an 
extra chromosome 21.30 With knowledge of the extra chromosome number in Down’s 
syndrome combined with Steele and Breg’s discovery, it became possible to test 
pregnant women to see if they were carrying a fetus which had the condition. Other 
chromosome disorders were also being researched, including sex chromosome 
anomalies. Polani, working collaboratively with Ford, showed that patients with 
Turner’s syndrome had only 45 chromosomes, including only one X chromosome and 
no Y chromosome,31 and Jacobs showed that patients with Klinefelter’s syndrome had 
                                                          
27 Malcolm A. Ferguson-Smith, ‘Cytogenetics and the Evolution of Medical Genetics’, Genetics in 
Medicine, 10:8 (2008), p. 554. 
28 Mark W. Steele and W. Roy Breg, Jr., ‘Chromosome Analysis of Human Amniotic-Fluid Cells’, The 
Lancet, 287:7434 (1966), p. 385. 
29 Peter S. Harper, A Short History of Medical Genetics, (Oxford: Oxford University Press, 2008), p. 152. 
30 Peter S. Harper, Landmarks in Medical Genetics, (Oxford: Oxford University Press, 2004), pp. 72-73. 
31 C.E. Ford, K.W. Jones, P.E. Polani, J.C. De Almeida and J.H. Briggs, ‘A Sex-Chromosome Anomaly in a 
Case of Gonadal Dysgenesis (Turner's syndrome)’, The Lancet, 273:7075 (1959), p. 711. 
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47 chromosomes – two X chromosomes and one Y chromosome.32 All of these studies 
were of great relevance to prenatal testing; having the knowledge of the genetic 
mechanisms underpinning numerous conditions allowed for diagnosis of these 
conditions in the fetuses of pregnant women when prenatal testing facilities became 
available. The ability to diagnose chromosome anomalies also became easier from 1968 
onwards, when new staining techniques became available, using quinacrine 
dihydrochloride (Q-banding). When chromosomes were exposed to quinacrine, bands of 
different fluorescence showed up, which were distinct for each chromosome.33 This 
made it much easier to identify which chromosome an anomaly was on, thus aiding 
diagnosis. 
 
The diagnostic application of amniocentesis was expanded in 1972 by two researchers 
based in Edinburgh, David Brock and Roger Sutcliffe. They showed that analysis of 
amniotic fluid could also be used to detect neural tube defects (NTDs) in the fetus, such 
as spina bifida and anencephaly. Brock and Sutcliffe were interested in the analysis of 
biochemical markers for NTDs in amniotic fluid, and after researching and discounting 
the role of several molecules, they discovered that alpha-fetoprotein (AFP) could be 
used as a marker for fetuses with anencephaly and spina bifida. They found that levels 
of this protein were greatly raised in pregnancies affected by these conditions, and 
suggested that measuring AFP would be ‘valuable in the early antenatal diagnosis of 
anencephaly and spina bifida and will enable termination of these pregnancies’.34 This 
suggestion proved to be correct, and it became possible to detect a number of fetuses 
with neural tube defects in this manner. 
 
Although the development of amniocentesis as a medical tool to detect chromosome 
anomalies and neural tube defects was a major scientific and medical breakthrough, the 
procedure was affected by a number of clinical, technical and ethical issues. The 
                                                          
32 Patricia A. Jacobs and J.A. Strong, ‘A Case of Human Intersexuality Having a Possible XXY Sex-
Determining Mechanism’, Nature, 183:4657 (1959), p. 302. 
33 Susan Lindee, Moments of Truth in Genetic Medicine, (Baltimore: The Johns Hopkins University Press, 
2005), p. 118. 
34 D.J.H. Brock and R.G. Sutcliffe, ‘Alpha-fetoprotein in the Antenatal Diagnosis of Anencephaly and 
Spina Bifida’, The Lancet, 300:7770 (1972), p. 197. 
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technical and ethical issues will be discussed in subsequent chapters, but it is important 
to consider here the clinical implications of fetal loss that were associated with the 
testing. Whilst amniocentesis is currently linked to a 0.5-1% increase in miscarriage rate 
when carried out after 15 weeks gestation, 35 when the technique was first developed the 
potential risks to the pregnant woman and her fetus were unknown. Clinicians worked 
on learning the skills required for successful amniotic fluid sampling by carrying out the 
procedure on women who were seeking termination of pregnancy (these terminations 
usually being sought for social reasons). Several papers highlight this practice, with 
Nelson and Emery describing carrying out amniocentesis ‘before installation of 
hypertonic solutions for induction of abortion’,36 and Hasholt collecting ‘amniotic fluid 
obtained from normal pregnancies by transvaginal amniocentesis before inducing 
abortion’.37 However, those working in the medical genetics field were acutely aware of 
the need to demonstrate risk figures associated with amniocentesis, relative to 
pregnancies which were not being terminated either immediately or shortly after the 
procedure was carried out.  
 
A number of published studies appeared in the 1970s and 1980s from departments 
across the world, with varying fetal loss rates being quoted. In 1977 Philip and Bang 
published results of a study in which 0.3-0.7% of the ‘spontaneous abortions’ which 
occurred may have resulted from amniocentesis.38 Others found similar fetal loss rates, 
with Munk-Andersen and colleagues reporting that the ‘risk of abortion after 
amniocentesis apparently does not greatly exceed the spontaneous abortion risk for the 
same gestational age’.39 These findings are consistent with the results of two larger-
scale collaborative studies, one carried out by the National Institute of Child Health and 
Development in the United States of 1040 women undergoing diagnostic amniocentesis, 
and one collaborative study carried out in Canada which involved monitoring 1223 mid-
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trimester amniocentesis.40 In both of these studies no difference was found between the 
amniocentesis group and control groups with regard to obstetric outcome. A slightly 
higher fetal loss rate was reported in a large study published in 1978 by the Medical 
Research Council (MRC) in the United Kingdom, where 2428 women undergoing 
amniocentesis were studied. The MRC trial found that the fetal loss rate was 2.6% in 
women undergoing amniocentesis, compared to only 1.1% in the control group, leading 
to a difference in fetal loss of 1.5%.41 Similar findings of increased loss rates were 
reported by Webb and colleagues in 1980 (a risk of 1 to 1.5%),42 and Tabor and 
colleagues in 1986 also found there were more miscarriages in their amniocentesis 
group (1.7%) compared to their control group (0.7%).43  
 
The differences in these findings could result from a number of reasons, including the 
methodological designs of these studies. Adequate matching of controls and subjects is 
of clear importance if fetal loss rates are to be accurately compared between the two 
groups. However even a study as large and collaborative as the MRC report had 
difficulties in correctly matching women. As described by Turnbull, ‘it sometimes took 
weeks or even months to find a suitable control. As the main study proceeded, analysis 
revealed that the incidence of abortion was higher in subjects than in controls, and the 
possibility was raised that this might result from controls being entered later into the 
study than the subjects, thus providing a control group at lesser risk of abortion’.44 The 
chance of miscarriage decreases as a pregnancy progresses, which could lead to skewed 
results. It was discovered that, in one centre, if the pregnancy of a control miscarried, 
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then this person would be replaced by a control with a continuing pregnancy, thus 
leading to the lowering of the miscarriage rates in the control group.45  
 
Another area which is important to consider when examining varying fetal loss rates is 
the impact of experience of the technique and availability of modern obstetric 
equipment, such as ultrasound, to improve pregnancy outcomes. In a formal discussion 
on the subject Ferguson-Smith highlighted that many people in the field were ‘very 
anxious about the forthcoming results of this MRC trial’ as it ‘lumps together a great 
deal of information from different centres of different quality’.46 As more 
amniocenteses were carried out by obstetricians, their skill level in carrying out the 
procedure improved, and this is correlated in some studies with a declining fetal loss 
rate. Leschot, Verjaal and Treffers analysed the number of fetal deaths and miscarriages 
which were associated with different amniocentesis numbers, having carried out 3000 
amniocenteses in total. Of these 3000, between the 1st and 500th procedure the fetal 
death rate was 2.0%, this dropped to 1.3% between the 501st and 1500th, and 0.5% from 
the 1501st to the 3000th amniocenteses carried out. This highlights a declining fetal loss 
rate as experience is gained with the technique. They also considered whether the 
individual experience of the obstetrician could impact fetal loss rate, and found that in 
obstetricians who had carried out fewer than 10 amniocenteses, the loss rate was 3.7%. 
This decreased to 1.8% when obstetricians had carried out between 11 and 50 
amniocenteses, and 0.3% when more than 50 had been carried out.47 As different 
obstetric departments may have gained experience with amniocentesis at differing 
paces, the fetal loss rate could have changed at a non-uniform rate across various 
centres. As the risk of miscarriage as a result of amniocentesis is still quoted as 0.5-1%, 
these early studies were generally quite accurate in assessing risk of fetal loss. Despite 
this risk, amniocentesis is still used to diagnose a number of conditions prenatally today, 
                                                          
45 Ibid. 
46 Comments made by Ferguson-Smith in the Discussion section of Turnbull, ‘Amniocentesis – The 
Medical Research Council Study’, p. 36. 
47 N.J. Leschot, M. Verjaal and P.E. Treffers, ‘Risk of Midtrimester Amniocentesis; Assessment in 3000 
Pregnancies’, British Journal of Obstetrics and Gynaecology, 92:8 (1985), pp. 805-806. 
81 
 
including Down’s syndrome and other chromosome disorders, in addition to conditions 
such as cystic fibrosis and muscular dystrophy.48 
 
III. The Importance of Early Diagnosis – The Implementation of Chorionic Villus 
Sampling 
Whilst amniocentesis played a key role in providing prospective parents with greater 
reproductive choice, it had the drawback of taking place in the second trimester of 
pregnancy. By this stage most women had felt the baby move and were bonding with 
their child, in addition to being visibly pregnant. Lӧwy has highlighted that in the early 
days of prenatal testing ‘many physicians were not aware of the distress produced by a 
termination of pregnancy for foetal indications’ and ‘viewed the abnormal foetus as a 
‘problem’ and its removal as a ‘solution’’.49 However, over time it became recognised 
that the decision to terminate a longed for pregnancy was not easy, and to do so in the 
second trimester was thought by some to be particularly difficult for many parents. A 
study by White-Van Mourik and colleagues of couples who had undergone a 
termination in their second trimester as a result of a positive prenatal diagnosis showed 
an array of emotions felt by those affected, including depression, guilt and shame.50 
Second trimester termination of pregnancy is also more medically challenging and those 
working in the field at this time were aware of the ‘grave complications’51 that could 
accompany such terminations, and the benefits of replacing this with ‘early termination 
by suction curettage … carrying a much lesser risk to the mother’.52 A technology 
which allowed prenatal diagnosis to be undertaken earlier in pregnancy was highly 
sought after, and work began on developing an appropriate technique in the late 1960s. 
However, it was not until the 1980s that this goal was achieved and implemented into 
clinical practice, in the form of chorionic villus sampling (CVS). CVS involves the use 
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of a catheter to extract several milligrams of fetal trophoblastic tissue for genetic 
analysis, using either a transcervical or transabdominal approach, approximately ten or 
eleven weeks into the pregnancy.53 These two approaches are shown in Figure 1.4 and 
Figure 1.5: 
 
Figure 1.4 – Transabdominal CVS. A fine needle is guided through the wall of the 
abdomen into the placenta, under ultrasound control, and a biopsy of the placental tissue 
is taken.54 
 
Figure 1.5 – Transcervical CVS. A catheter is inserted through the vagina and cervix, 
and guided towards the placenta using the ultrasound scanner. The catheter will then 
collect tissue samples from the placenta.55 
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Two of the first researchers to work on CVS in the 1960s were Mohr and Hahnemann, 
who were based at the Aalborg Hospital in Denmark. In 1968 Mohr described the use of 
an instrument to ‘cut off and collect any foetal membrane tissue’ which he hoped could 
be analysed to enable the diagnosis of genetic conditions in the early stages of 
pregnancy.56 In collaboration with his colleague Hahnemann, Mohr designed a more 
specialised instrument that was 6mm in diameter and contained a fibre optic device to 
allow direct visualisation of the chorion. Hahnemann trialled CVS on 94 women who 
were about to undergo an abortion, either immediately following the CVS procedure (67 
cases) or 8 days after the procedure to allow for observation (27 cases).57 Only 38% of 
the biopsies were successful, and in the outpatient group where CVS was performed 
several days prior to termination, ‘42% of studies would have entailed termination of 
pregnancy even if this had not already been planned i.e. the complications of the study 
were not consistent with continued pregnancy’.58 A similar study of transcervical 
placental biopsies was published by Kullander and Sandahl in 1973 who also trialled the 
procedure on 39 women undergoing termination of pregnancy. Two fetal losses were 
recorded as a result of infection, and of the 39 biopsy samples taken, only 20 were able 
to be successfully cultured to gain knowledge about the fetal karyotype.59 The high fetal 
loss rate experienced by Hahnemann, and the low culture success of Kullander, 
highlighted that, although CVS had promise, further work would be needed to improve 
the technique to a standard that was suitable for clinical practice. 
 
The first successful CVS case was reported in 1975, by a team of Chinese researchers 
who had used a simple instrument with no fibre optic capacity to characterise the sex of 
fetuses. They used an aspiration technique to obtain fetal tissue from 100 women and 
reported four miscarriages.60 However, research teams in the United States were unable 
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to replicate their results, with their efforts hindered by contamination of samples with 
maternal cells.61 After these attempts, the idea of prenatal diagnosis in the first trimester 
of pregnancy lay dormant for a number of years.62 It was not until 1982 that Kazy et al. 
published their report in Prenatal Diagnosis detailing the success of 165 biopsies 
carried out at 6 to 12 weeks of pregnancy using a needle of 1.7mm in diameter. They 
reported no miscarriages, and all women who chose to continue their pregnancy 
delivered the child as expected.63 In December of 1982 several reports appeared in The 
Lancet of successful uses of CVS, highlighting the applicability of the technique. 
Gosden and colleagues demonstrated that fetal sex could be determined from chorionic 
biopsy samples taken from the fetus in the first trimester of pregnancy,64 and Old et al. 
successfully diagnosed β-thalassaemia, a blood disorder that reduces the production of 
haemoglobin, from a fetal tissue sample obtained via a chorionic villus biopsy.65 In 
1983 Brambati and Simoni used the technique to diagnose a case of Down’s syndrome 
at 11 weeks of pregnancy,66 and Simoni also showed that it was possible to gain 
information on the fetal karyotype in just a few hours using a ‘direct prep’ method. This 
method did not involve the traditional cell culture techniques used previously, which 
resulted in long waiting times for results.67  
 
Whilst CVS was becoming technically feasible, concerns were beginning to emerge 
about the fetal loss rate associated with the procedure. The data presented a confusing 
picture, with fetal loss rates varying amongst studies; for example, Muggah et al. 
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reported a post-CVS miscarriage rate of 6.3%,68 whilst Jackson and colleagues reported 
a 2.2% miscarriage rate.69 Larger scale studies included the Report of a World Health 
Organisation (WHO) consultation on the risk evaluation of CVS, which pooled data 
from three large centres, and found that the fetal loss rate was 3.4% in the first few 
hundred cases in each centre, which fell to 1.7% as the CVS programme progressed.70 
This highlights that, in a similar manner to amniocentesis, as operator experience 
improved, fetal loss rates dropped. The WHO report concluded that when ‘corrected for 
background losses obviously unrelated to CVS, the incidence of fetal loss following 
CVS appears to be no greater than 0.7 per cent’.71 However, a similar large scale study 
carried out by the MRC in Europe evaluated the safety of CVS compared to 
amniocentesis in a study of around 3000 women, and found less reassuring results. It 
was found that ‘chorion villus sampling in the first trimester reduces the chances of a 
successful pregnancy outcome by 4.6%’ when compared to second-trimester 
amniocentesis.72 The current miscarriage risk rate as a result of CVS is given as 1-2%, 
which is higher than the amniocentesis miscarriage risk rate of 0.5-1%, but current 
National Health Service guidance also states that it is unclear how many of these 
miscarriages would have occurred without a CVS procedure being undertaken.73  
 
Whilst researchers and clinicians had been keen to develop CVS for first trimester 
testing, it is interesting to note that CVS did not become as popular a choice for women 
as the medical profession expected. The development of CVS co-existed with a belief 
that women would be keen to find out about anomalies earlier in pregnancy, but it 
seems that this did not occur in practice. As Hogan discusses, many women preferred to 
remain with amniocentesis due to the slightly lower risk to the fetus associated with this 
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procedure.74 The exception to this trend seemed to be women who had an increased 
chance of having a fetus affected by a genetic condition, possibly one that the woman 
herself was a carrier for. This group seemed to be more willing to accept the higher risk 
associated with CVS in favour of receiving earlier results, possibly because of 
heightened awareness of the likelihood of their fetus having an anomaly.75 In addition to 
concerns about the miscarriage rate, the premise around which CVS was developed, that 
termination of pregnancy at an earlier gestation would be psychologically ‘easier’ on a 
woman, did not prove to be applicable in many cases. A study carried out by Kolker in 
1993, which investigated the experiences of women who had a termination of 
pregnancy for fetal anomaly after either amniocentesis or CVS, found that whilst ‘late 
terminations are physically and emotionally traumatic, first-trimester abortions for 
abnormality carry a burden of their own’, which they felt was ‘largely unrecognized by 
caregivers and society at large’.76 They interviewed a number of genetic counsellors 
whose views supported these findings. One described how it was ‘devastating’ for 
families to receive a diagnosis of anomaly, and that it ‘hurts just as much whether they 
are at 12 weeks or 18 weeks … because they wanted that baby’.77 Whilst termination in 
the first trimester may be ‘simpler, cheaper, and safer for the woman’, it does not 
necessarily mean it is emotionally easier;78 it is ‘wanted-ness, not gestational age’ which 
is the ‘critical factor’.79 Rothman has also argued this point in The Tentative Pregnancy, 
where she states that ‘The meaning of the abortion lies in the meanings the pregnancy 
holds for the woman … if the fetus is to be her child, if she has chosen to have this baby 
… then she considers that fetus to be a person. It is her baby. She means it to be her 
baby. To abort an accident is one thing. To abort your baby, even your very imperfect 
baby, is something else again.’80  
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Other studies have shown that the severity of the condition is a more important factor in 
a woman’s decision to terminate a pregnancy than her stage of gestation, with her 
decision ‘focused on the severity of the disorder and only marginally influenced by 
when in gestation the decision is made’.81 These varying opinions highlight the 
importance of providing women with a number of options for prenatal testing, and 
emphasise that medical tests are often developed in the absence of consultation with the 
groups who will be utilising them, and that these tests may prove not to be as popular as 
expected. 
 
In addition to the higher fetal loss rate associated with CVS, the testing has also faced 
other issues which could have affected uptake rates, with one of the most important 
being the ‘fetal limb defect controversy’.82 Described in detail by Hogan, this 
controversy began in the early 1990s when reports began to surface linking CVS with 
defects in the form of missing fingers, toes and limbs in fetuses that had undergone the 
testing. The key paper describing these limb defects appeared in The Lancet in March 
1991, by Firth and colleagues, which reported that among 289 pregnancies where CVS 
was carried out at 56-66 days’ gestation, 5 babies with severe limb abnormalities were 
identified.83 The authors concluded their paper with a note that they were aware the 
findings may have occurred by chance, but that they were concerned that CVS could 
have been a cause of the abnormalities found, and encouraged others in the field to 
examine their own experience for similar cases. In the months that followed, others 
from around the world, including researchers in Italy and China, wrote in to The Lancet 
with their own experiences, some of which seemed to further implicate CVS as a 
possible cause of limb defects. Mastroiacovo and Cavalcanti reported 4 cases of limb 
defect in their own study, and stated that their findings ‘suggest an increased risk for 
transverse limb-reduction defect associated with CVS at any gestational age’.84 Hsieh 
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and colleagues also reported 4 fetal limb-reduction defects in their CVS cases, and 
concluded that ‘limb defects cannot easily be dismissed as a possible complication of 
CVS’.85 However, others working in the field were not as convinced, citing their own 
data that limb abnormalities did not seem to be increased in babies where their mothers 
had undergone CVS.86 Despite uncertainty about the role of CVS in limb defects, stories 
linking the procedure and outcome began to appear in the press, interest in CVS 
reportedly began to decline amongst women, and some medical professionals suggested 
that women should not be offered the testing until this link could be examined in 
detail.87 An investigation into this link was carried out and the results of just under 
139,000 CVS tests were published in 1996 which showed that the number of limb 
defects did not differ significantly in fetuses that had undergone CVS than what would 
be expected in the general population.88 Whilst this may have put an end to the 
controversy, it is reasonable to believe that this could have had an impact on the uptake 
of the testing during this time period. Indeed, the George Washington University 
Medical Center, reported that their annual number of CVS procedures had dropped by 
half between 1991 and 1992.89 
 
IV. The Development of Non-Invasive Screening Programmes 
The previous sections have considered two invasive testing methods for prenatal 
diagnosis, but as discussed above, some women would choose to forego testing if they 
felt that the risk to the fetus was too high. As a result of the risks involved, when 
prenatal diagnosis was developing it was mainly offered to those who were perceived as 
having a high chance of carrying a fetus with an anomaly, either because they had 
previously had a child with one of the conditions which could be tested for, or because 
of advanced maternal age, which is linked with an increased likelihood of chromosome 
anomaly in the fetus. However, offering testing to these small numbers of women did 
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not result in high detection rates in the overall pregnant population, as the majority of 
chromosome disorders and neural tube defects occur in the pregnancies of women who 
have not had previous experiences with either of these conditions. For example, in the 
case of neural tube defects, only 5% of cases have a previous history of such conditions, 
so the use of amniocentesis in women known to be at risk ‘cannot reduce significantly 
the overall incidence of affected fetuses born in the community’.90 As a result of the 
lack of ‘success’ of many prenatal testing programmes, researchers were keen to 
increase the number of fetal anomalies which were detected, and the potential 
implications of prenatal screening programmes began to be explored.91  
 
Screening programmes were designed to detect members of the pregnant population 
who had a higher chance of having a fetus with certain conditions, such as neural tube 
defects, to provide them with the option of further diagnostic testing. One of the first 
screening programmes that was developed involved the use of alpha-fetoprotein (AFP), 
which had been found in raised quantities in the amniotic fluid if the fetus had a neural 
tube defect. Continued research by Brock showed in 1973 that it was possible to 
diagnose anencephaly through increased concentrations of AFP in maternal serum, as 
AFP migrates across the placenta.92 This procedure circumvented the risk of the 
invasive amniocentesis procedure as it only required a blood sample from the pregnant 
woman, paving the way for genetic screening of the pregnant population. However, 
although the screening programmes could identify women who had an increased 
likelihood of their fetus having a NTD, they could not offer a definitive diagnosis, and 
clinicians were not willing to terminate pregnancies on the basis of a high chance 
screening result. It was therefore essential that amniocentesis testing was offered to 
those with raised levels of AFP in the maternal serum to confirm a diagnosis and lead to 
a termination of the pregnancy if requested.  
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The detection rates and acceptability of such screening programmes differed greatly 
between departments and regions throughout the United Kingdom, and the specific 
details of the testing and the issues associated with it will be discussed in chapter four. 
Briefly, in areas with a high incidence of neural tube defects the screening was seen as 
being widely ‘successful’, decreasing the number of babies born with anencephaly and 
spina bifida.93 For example, in the West of Scotland, maternal serum AFP screening 
followed by ultrasound and amniocentesis was associated with a decrease of liveborn 
babies with neural tube defects from 4.3 per 1000 in 1976 to 1.7 per 1000 in 1981. 94,95 
In contrast, a maternal serum AFP screening programme was carried out in Norfolk for 
two years, but was then discontinued as it did not fulfil the expectations held by staff 
there that it would ‘prevent the birth of most live babies with neural tube defects’.96  
 
As time progressed, other screening programmes began to develop, and AFP was also 
found to be a useful diagnostic marker for Down’s syndrome. In 1984 Merkatz and his 
co-workers found that maternal serum AFP levels were around 25% lower in 
pregnancies affected by Down’s syndrome than in pregnancies which did not have the 
condition.97 Until this point, advanced maternal age and prior pregnancies with genetic 
anomalies had been the key indicators for amniocentesis to test for Down’s syndrome, 
but testing of serum AFP levels allowed many more women to be screened for the 
condition, and offered amniocentesis when deemed appropriate by their clinician. Over 
time several other markers were found to aid in the screening for Down’s syndrome, 
including human chorionic gonadotrophin and unconjugated oestriol.98 A new screening 
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strategy was developed which combined these markers with maternal serum AFP and 
maternal age to provide a likely probability of Down’s syndrome in the fetus. These 
discoveries changed the field of prenatal diagnosis in an unprecedented manner, 
facilitating mass screening of the pregnant population. 
 
V. The Importance of Ultrasound 
Although screening opened up the possibility that many more women could have 
prenatal testing if required, it was still necessary for pregnant women to undergo an 
invasive amniocentesis to confirm or disprove the suspected diagnosis. Exceptions to 
this rule began to emerge with the development of ultrasound, perhaps the most well-
known non-invasive prenatal testing method. Pioneered in Glasgow by Ian Donald and 
Tom Brown, ultrasound made it possible for the first time to safely visualise the fetus 
inside the womb. Thus, whilst amniocentesis and CVS enabled clinicians to analyse the 
genetic constitution of the fetus, ultrasound permitted them to examine the fetus for 
physical anomalies. 
 
Although the technology was not implemented in routine prenatal testing until the 
1970s, it was around 1954 that Donald developed a serious interest in examining the 
medical possibilities of ultrasound. This interest first began when Donald served as a 
Medical Officer in the Royal Air Force during the Second World War,99 and was further 
piqued by reading the textbook Ultrasonics, which described the physics of 
ultrasound.100 In 1955 Donald began to turn this interest into something tangible when 
he was introduced to a director at Babcock and Wilcox, an industrial fabrication 
company in Glasgow. This meeting was arranged after Donald operated on a female 
patient whose husband was a research director at the firm.101 He was taken on a tour of 
                                                          
Screening Test for Down’s Syndrome’, British Journal of Obstetrics and Gynaecology, 95:4 (1988), pp. 
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the factory, and whilst there he encountered ultrasound being applied to biological 
material, in the form of ultrasound technicians testing their ultrasonic flaw detectors on 
their thumbs. Echo spikes appeared in the oscilloscope screens of their machines when 
they did so, and if these were of the correct size then the technicians knew that the 
settings and sensitivity of the machines were configured correctly.102  
 
Donald was keen to investigate whether the metal flaw detection equipment used at 
Babcock and Wilcox could be used for a clinical purpose, and after gaining permission 
to use their machines he took a number of specimens to the factory to be examined in 
July 1955. Donald wanted to determine if the metal flaw detector could distinguish 
between a cyst and a fibroid, and to his delight the difference was clear. In The 
Captured Womb, Oakley describes how Donald’s enthusiasm shows through in his 
description of the events of that day, when he stated: ‘I shall never forget it, because 
that was when I realised we’d struck oil … this was it. There was no getting away from 
it.’103 Despite the success of these tests, it took another three years before ultrasound 
was shown to have a use in the detection of pregnancy, and it was in 1958 that the first 
image of the fetus as visualised by ultrasound was published in a paper by Donald, 
Brown and MacVicar. Their image showing the uterus of a woman fourteen weeks into 
her pregnancy was poignant not only because it showed the fetus at such an early stage, 
but also because the woman had been scanned for a suspected fibroid.104 Thus 
ultrasound could be used to ‘diagnose’ pregnancy.  
 
Over the next few years ultrasound was implemented in Glasgow, and in 1963 Donald 
and his team made an unexpected discovery which led to even better visualisation of the 
fetus. Patients were instructed to empty their bladder before the scan, but one woman 
was kept waiting for her appointment and hers filled up. She was too nervous to ask to 
use the bathroom, and went in for her appointment with a full bladder;105 the examining 
obstetricians found that the sound waves of the ultrasound went straight through the 
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liquid and provided a ‘window into the pelvis’ which allowed a view of the uterus in 
‘all its outlines, contours, length, dimensions, the lot’.106 Donald himself described it as 
a ‘beautiful view’, and it formed the basis of the full bladder test to allow clearer 
visualisation of the uterus.107  
 
It was evident that ultrasound could be of great use in the clinical care of pregnant 
women by enabling visualisation of the fetus. It had the potential to be of particular use 
in the detection of neural tube defects. This was realised in 1972 by Stuart Campbell 
and colleagues who diagnosed an anencephalic pregnancy at 17 weeks gestation which 
led to an elective termination of the pregnancy.108 This was the first time that ultrasound 
had been used to detect a medical condition in the fetus early enough to enable 
termination. As experience was gained using ultrasound a number of other conditions 
could also be detected prenatally, including spina bifida and microcephaly,109 alongside 
other non-neural conditions such as renal tract anomalies.110 In some cases termination 
of pregnancy was carried out after diagnosis of such anomalies by ultrasound, without 
further invasive testing. 
 
Alongside direct detection of fetal anomalies such as anencephaly, ultrasound also 
played less direct roles in the screening of neural tube defects. The maternal serum AFP 
screening programmes which were being implemented throughout the United Kingdom 
benefitted greatly from having ultrasound available to them, as false positive and 
negative screening results were often caused by factors which could be ruled out by 
ultrasound. Some of the most common reasons for a maternal AFP figure which did not 
correlate with the expected outcome of the pregnancy included an incorrect estimation 
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of gestational age, undetected multiple pregnancies, and missed ‘abortions’ 
(miscarriages).111 As stated by Campbell ‘AFP varies in maternal blood and in amniotic 
fluid with gestational age and values can only be correctly interpreted if the gestational 
age has been accurately determined by ultrasonic fetal measurements.’112 Thus suitable 
ultrasound machinery was essential to ensure the accuracy of a serum test, leading in 
turn ‘to the avoidance of unnecessary amniocentesis’.113 Ultrasound could also be used 
to investigate the likelihood that a raised AFP level was truly indicative of a neural tube 
defect by examining the fetus for physical anomalies, thereby potentially avoiding the 
termination of pregnancies as a result of a false positive AFP test.114 The view of some 
medical genetics centres, including that run by Ferguson-Smith in the West of Scotland, 
was that staff with experience of obstetric ultrasound were vital for AFP screening 
programmes.115 
 
The use of ultrasound to detect fetal conditions was taken further in the 1990s, when it 
became possible to screen for Down’s syndrome using ultrasound. A number of studies 
had shown a link between the collection of fluid behind the fetal neck (nuchal 
translucency) and chromosomal anomalies.116 Nicolaides and colleagues used 
ultrasound in 1992 to visualise nuchal translucency thickness in the first trimester of 
pregnancy, and showed that the incidence of chromosomal anomalies was linked to 
nuchal translucency of greater than 3mm. They found that only 1% of fetuses with a 
nuchal translucency of less than 3mm were found to have chromosomal anomalies 
compared to 35% of those in which it was greater than 3mm.117 In 1994 they carried out 
                                                          
111 Robinson, Hood, Adam, Gibson and Ferguson-Smith, ‘Diagnostic Ultrasound: Early Detection of Fetal 
Neural Tube Defects’, p. 705. 
112 Campbell and Rodeck, ‘The Role of Ultrasound and Fetoscopy’, p. 87. 
113 Ibid. 
114 Ibid., p. 90. 
115 M.A. Ferguson-Smith, H.A. Rawlinson, H.M. May, P.N.C. Gent and J.G. Ratcliffe, ‘Maternal Serum 
Alphafetoprotein in Prenatal Screening for Open Neural Tube Defects’, in The Diagnosis and 
Management of Neural Tube Defects A Scientific Meeting of the Royal College of Obstetricians and 
Gynaecologists, ed. by J.A. Jordan and E.M. Symonds (London: The Royal College of Obstetricians and 
Gynaecologists, 1978), p. 64. 
116 K. H. Nicolaides, M.L. Brizot and R.J.M. Snijders, ‘Fetal Nuchal Translucency: Ultrasound Screening for 
Fetal Trisomy in the First Trimester of Pregnancy’, British Journal of Obstetrics and Gynaecology, 101:9 
(1994), p. 782. 
117 K H Nicolaides, G Azar, D Byrne, C Mansur and K Marks, ‘Fetal Nuchal Translucency: Ultrasound 
Screening for Chromosomal Defects in First Trimester of Pregnancy’, British Medical Journal, 304:6831 
(1992), p. 868. 
95 
 
a study on 1273 pregnant women, examining them with ultrasound between ten and 
thirteen weeks of pregnancy to measure fetal nuchal translucency thickness. They found 
that 84% of trisomy 21 fetuses had nuchal translucency of greater than 3mm, compared 
to only 4.5% of chromosomally unaffected fetuses.118  
 
In addition to providing direct diagnoses, ultrasound was also beginning to improve the 
safety of invasive prenatal testing methods. This is shown in the 1972 publication by 
Bang and Northeved, based in Copenhagen, which described ultrasound-guided 
amniocentesis. Before ultrasound was used in amniocentesis, the procedure had been 
carried out blind, with the puncture site located by external palpation of the uterus in the 
abdomen.119 By using ultrasound to assist with amniocentesis, practitioners could use a 
one-dimensional A-mode ultrasound scan to visualise a free pocket of amniotic fluid 
and mark the point of entry for the needle on the abdomen, thereby minimising the 
injury risk to the placenta. This increased safety was reported by Harrison et al. in 1972 
who showed that the incidence of fetomaternal transfusion, which is caused by damage 
to the placenta, was halved when using ultrasound-guided amniocentesis.120  
 
Several technical innovations have helped to further enhance the use of ultrasound in 
prenatal testing. For instance, the addition of grey-scaling enhanced the imaging of soft 
tissue structure. Ultrasound can now be used to diagnose multiple pregnancies, 
determine the size and age of the fetus or fetuses, and recognise a range of structural 
fetal anomalies including problems with limb formation. The development of quicker, 
portable ultrasound scanners further assisted with their incorporation into antenatal care.  
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VI. Conclusion 
The field of prenatal testing has developed at a rapid pace since its inception in the 
1950s, with many of the techniques being quickly incorporated into clinical practice. 
The development of amniocentesis and CVS enabled in-depth genetic analysis of the 
fetus before it was born, but neither tests were without risk. Despite the increased 
chance of miscarriage associated with both amniocentesis and CVS, many women were 
still keen to undergo the testing to plan for their future. This demonstrates the demand 
for knowledge about the fetus which exists amongst many women, and also shows the 
impact that prenatal diagnosis has had on the female population, who now have the 
option to find out information about the fetus prior to birth.  
 
This chapter has highlighted how the interactions between laboratory research and 
clinical developments paved the way for invasive prenatal testing to become an 
established aspect of antenatal care, using amniocentesis and CVS as examples. Whilst 
there was considerable uptake of these tests, those involved in prenatal testing were 
keen to develop alternative methods which carried less risk of miscarriage. This drive, it 
has been argued, led to the development of non-invasive prenatal screening 
programmes, such as those involving biochemical markers in the maternal serum. 
However, even these screening programmes were not truly non-invasive, as an 
amniocentesis or CVS procedure was still required to confirm diagnosis of the 
suspected anomaly before termination could take place. It could therefore be argued that 
the only truly non-invasive prenatal method is that of ultrasound, which made it 
possible to visualise physical anomalies of the fetus in utero. Ultrasound also played an 
essential role in improving the efficiency of maternal serum screening programmes and 
the safety of amniocentesis, placing it in a central role in the provision of antenatal care.  
 
The technical developments discussed in this chapter have resulted in more information 
for prospective parents to enable them to make decisions regarding their reproductive 
future. However, it is important to note that there are members of society who do not 
view the testing and information it provides as a positive development – their views will 
be discussed in chapters five and six in this thesis. The next chapter of this thesis will 
examine the development of the medical genetics field in Glasgow under the leadership 
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of Malcolm Ferguson-Smith, followed by a chapter on the detection of chromosome 
anomalies, and one on the detection of neural tube defects, respectively. Within all of 
these chapters the use of the invasive and non-invasive prenatal testing methods will be 
discussed in detail, emphasising the important nature of the developments presented in 
this chapter.  
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Chapter Two – The Formation and Expansion of Medical Genetics in 
Glasgow, Under the Leadership of Malcolm Ferguson-Smith 
 
I. Introduction 
As shown in the previous chapter, the field of genetics has progressed at a fast pace over 
the last few decades, with a key development being the advent of prenatal diagnostic 
testing. This development has been of great significance, as previously the information 
which was available about the health of a fetus before birth was limited. One of the key 
aims of this thesis is to understand how prenatal testing developed in the specific 
geographical region of the West of Scotland. This is of importance, as the major 
developments occurring in this area have never been examined in detail. This research 
will look at the period between 1950 and 1990, using the case study of a local 
Glaswegian geneticist, Malcolm Ferguson-Smith. Described as both ‘eminent’1 and a 
‘pioneer of methods for prenatal diagnosis of genetic disease’,2 Ferguson-Smith was the 
key figure who helped to develop and implement prenatal testing in the West of 
Scotland. To gain a greater understanding of the contributions made by Ferguson-Smith, 
it is important to consider a biography of his life and career, as this provides an insight 
into the circumstances which led to his involvement in this area.  
 
This chapter will begin by exploring Ferguson-Smith’s education and early career, 
examining some of the key events and contacts that stimulated his interest in genetics as 
a subject area, particularly with regards to chromosome studies. It will highlight how a 
lack of interest in human chromosome work in Glasgow led to Ferguson-Smith moving 
to Johns Hopkins University in Baltimore, where the opportunity to develop skills in 
analysing chromosomes was responded to with enthusiasm. This chapter will then argue 
that a sense of loyalty to his home city led Ferguson-Smith to return to Glasgow, and 
will detail the difficulties faced when trying to establish medical genetics there. 
                                                          
1 Malcolm Nicolson and John E.E. Fleming, Imaging and Imagining the Fetus: The Development of 
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The next area for analysis will be the expansion of medical genetics in Glasgow under 
the leadership of Ferguson-Smith, including the establishment of a regional genetics 
service, and the increasing number of tests which were being carried out within the 
laboratories and clinics. These increased numbers of tests led to a need for more space, 
and the process of the planning and development of the Duncan Guthrie Institute of 
Medical Genetics will be examined. Finally, Ferguson-Smith’s surprise move to the 
University of Cambridge will be considered, and his rationale behind this decision 
discussed. The impact of this decision on the staff working for Ferguson-Smith will be 
examined, as will, briefly, his later career in Cambridge.   
 
II. Education and Early Career of Malcolm Ferguson-Smith 
Malcolm Ferguson-Smith was born on the 5th September 1931 in Glasgow, the youngest 
of four siblings, all of whom would go on to pursue careers in medicine.3,4 These career 
choices were perhaps not a great surprise, as the Ferguson-Smith family were well 
entrenched in the medical sphere. Ferguson-Smith’s father was the distinguished 
dermatologist John Ferguson-Smith, Consultant Physician in Diseases of the Skin at the 
Glasgow Royal Infirmary, and Lecturer in Dermatology at the University of Glasgow.5 
Malcolm Ferguson-Smith was surrounded by medical influences from a young age – his 
family home in Woodside Place in the city was the house in which Lister had lived 
whilst he was developing his antiseptic techniques in Glasgow, and his father ran a 
medical consulting practice from home in the afternoons, which his mother helped to 
maintain.6 Ferguson-Smith recalled that the area of Glasgow they lived in was so full of 
medics that it was ‘known locally as “the valley of the shadow of death”’.7 
                                                          
3 All interview file names begin with ‘DS’ followed by a number, except for those carried out with KM 
and MEFS. Interviews have been transcribed and will be stored in the Ferguson-Smith archive at the 
University of Glasgow upon completion of the PhD.  
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Despite being surrounded by strong academic influences, Ferguson-Smith’s early 
education did not get off to a remarkable start. He was educated at Glasgow High 
School from the age of five until ten, before his father decided to withdraw him from 
the school as he did not think he was working hard enough.8 Ferguson-Smith recalled 
that he ‘hadn’t been doing very well during wartime’ and ‘was said to be lazy and badly 
behaved in class’ and his father therefore decided to send him to Craigflower 
Preparatory School in Fife.9 Once at this preparatory school his academic progress 
improved and at the age of thirteen he passed his common entrance exams and moved to 
Stowe Boarding School in Buckinghamshire, where he would remain until 1949.10 He 
recalled that it ‘was not a particularly exciting time for me at school although it was a 
lovely place’. However, his educational experiences at Craigflower and Stowe 
stimulated his interest in biology, and whilst at Stowe he won a biology prize for his 
dissection of a dogfish.11 Ferguson-Smith recalled with some humour that his biology 
teacher at school ‘never thought I’d ever become a doctor’ because he ‘thought I wasn’t 
working hard enough’, but at the end of his school career he secured admission to study 
medicine at the University of Glasgow.12 
 
Ferguson-Smith began his medical studies in 1949 and throughout his time at the 
university he was a successful student who was awarded prizes in Clinical Surgery and 
Medical Paediatrics.13 After graduating in 1955 he completed two residencies; one as a 
House Physician with Dr William Snodgrass, and the other as a House Surgeon with Sir 
Charles Illingworth.14 He had great respect for Snodgrass, but ‘crossed swords’ with 
Illingworth for several reasons, one of which was that Illingworth ‘didn’t think much of 
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genetics’.15 Although Ferguson-Smith was not yet working in genetics, this highlights 
that his passion for the subject was already developed and that this was an area he felt 
strongly about. After completing his degree and residencies Ferguson-Smith wanted to 
specialise in general medicine, and decided that the best way to gain knowledge of this 
field was to apply for a job in pathology, as he felt that if ‘one understood the science of 
disease then one would be better placed as a physician’.16 In 1956 he was appointed 
Senior House Officer in Pathology at the Western Infirmary in Glasgow, under 
Professor Dan Cappell.17 His time spent here influenced his career in such a notable 
way. Whilst he was based in the department the esteemed pathologist Bernard Lennox 
was looking for a trainee to help him with a nuclear sexing project; upon visiting the 
workroom of the trainees, Lennox found Ferguson-Smith at his microscope and 
commented ‘something to the effect that as I did not appear to be overworked would I 
be interested in joining him in a nuclear sex project’.18 After reading one of Lennox’s 
editorials Ferguson-Smith was ‘hooked’, and thus began his extended interest in 
chromosome disorders.19  
 
Lennox was interested in studying Klinefelter’s syndrome, a chromosomal disorder 
which affects male physical and cognitive development, and which we now know is due 
to the presence of an extra X chromosome. However, at that time it was proposed that 
Klinefelter’s was a sex chromosome anomaly disorder in which males had ‘female’ 
nuclear sex, so Lennox suggested that Ferguson-Smith should begin by looking for sex 
chromatin (present in females but not in males) in male children with undescended 
testes.20 Lennox thought that these children were ‘the most likely source’ of patients 
with Klinefelter’s,21 but despite Ferguson-Smith studying 115 males, no cases of 
Klinefelter’s were found.22 A key figure involved in this work was Mr Mack, the 
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surgeon in charge of urology at the Western Infirmary in Glasgow, who gave Ferguson-
Smith access to patients and samples for testing, and allowed him to collect testicular 
biopsy samples from patients who were infertile.23 Ferguson-Smith recalled the process 
of these first studies into Klinefelter’s syndrome, and the subsequent work on infertile 
males which followed this, in great detail during his interview: 
 
So I looked at a whole series of Mr Mack’s patients with undescended 
testes and didn’t find a single Klinefelter. But having been with Mr Mack 
and having read up about Klinefelter’s syndrome I knew they were all 
infertile so I asked him if he had seen any of these patients at his infertility 
clinic. He said no he hadn’t and I said (off my own bat) would you mind if 
I went into the infertility clinic and looked for them there. The eighth 
person I tested for the sex chromatin body was a Klinefelter and there were 
soon others. And that resulted in the first paper I wrote with Dr Lennox on 
the frequency of Klinefelter’s syndrome among subfertile patients with 
either no sperm in their semen samples or with very few. About 11% of 
these patients had Klinefelter’s syndrome. I became very interested in 
these patients with Klinefelter’s syndrome and took careful histories.24 
 
It was thought at this time that patients with Klinefelter’s were sex-reversed females 
with two X chromosomes, but studying the testicular biopsy of one of Mr Mack’s 
patients made Ferguson-Smith query this presumption: 
 
And then another patient was referred to Mr Mack with query Klinefelter’s 
syndrome. He was a young man who had been examined for his army 
medical and found to have small testicles. Mr Mack did a testicular biopsy 
on this man and I got the biopsy to examine and sure enough he was a 
Klinefelter. But when I looked at the testicular biopsy it was very unusual 
because I found one tubule that had complete spermatogenesis with mature 
sperm.25 
 
This finding convinced Ferguson-Smith of the need to study these chromosomes in 
greater detail to gain a better understanding of the condition. Whilst these findings were 
of great interest, his enthusiasm was not reflected by others working in Glasgow during 
this time period. Upon approaching the head of genetics, Guido Pontecorvo, with his 
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findings, Ferguson-Smith found him to be not ‘the least bit interested, he said “we don’t 
look at chromosomes here as we are more interested in biochemical genetics”’.26 
However, he suggested that Ferguson-Smith contact Charles Elliott, the person most 
interested in chromosome research in Glasgow.27 Elliot was working on the 
chromosomes of a fungus, Aspergillus, but he put Ferguson-Smith in touch with Charles 
Ford, an expert on mammalian chromosomes who was based at the Medical Research 
Council Radiobiological Research Unit in Harwell.28 Ford informed Ferguson-Smith 
about a bone marrow preparation technique he was developing to visualise 
chromosomes; Ferguson-Smith attempted to replicate this technique, but had little 
success. 
 
III. The Move to Johns Hopkins University 
One of the reasons behind this lack of success was that Ferguson-Smith was working to 
develop the technique in his free time in the evenings and at weekends, and was unable 
to dedicate time during his working schedule to advance his skills in this area. It was 
suggested by Professor Cappell that he would benefit from undertaking a fellowship 
elsewhere, where he could focus on developing his chromosome visualisation 
techniques.29 Ferguson-Smith was put in touch with Victor McKusick of Johns Hopkins 
University in Baltimore in the United States, who was setting up a medical genetics 
laboratory. After an interview in Liverpool, arrangements were made for Ferguson-
Smith to join McKusick to work on developing the bone marrow preparation technique 
to enable analysis of the chromosomes in Klinefelter’s.30 A letter to Ferguson-Smith on 
the 6th October 1958 confirmed that Johns Hopkins were able to offer him a place as a 
Research Fellow to start as soon as was suitable, with a salary of $325 per month.31  
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29 MAFS interview, DS300115, p. 4. 
30 UGC 188/1/1/4, Correspondence between Ferguson-Smith with Professor John Anderson, p. 5 (letter 
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Ferguson-Smith travelled to Baltimore in February 1959,32 and his arrival coincided 
with one of the most prominent chromosome discoveries, the finding that Down’s 
syndrome was caused by an extra copy of chromosome 21. It is reasonable to postulate 
that such a discovery would have had an impact on Ferguson-Smith – whilst he was just 
beginning his own career examining chromosomes and had not managed to garner any 
interest in the subject area back in Glasgow, other researchers were showing that the 
field held real possibilities for scientific and clinical discoveries. Ferguson-Smith 
himself has described how it seemed that he had ‘arrived in the USA at a most 
opportune time for studying human chromosomes’.33 However, upon his arrival at Johns 
Hopkins, Ferguson-Smith found that his laboratory consisted of nothing more than a 
cupboard off the secretary’s office, which had no equipment.34 Despite this, he was 
keen to persevere; he ‘tentatively suggested’ that his new department purchase a 
microscope for his work, and wrote to Lennox that ‘you may imagine my surprise when 
the latest model actually materialised’.35 That Ferguson-Smith was surprised at such a 
development is perhaps reflective of the different financial climate for research and 
medical genetics in the United States when compared with Glasgow. This was a 
difference which would be seen to be pronounced when Ferguson-Smith contemplated 
moving back to Glasgow from Hopkins and the financial difficulties he faced, both 
regarding a drastic cut to his salary and in securing funding to set up his own laboratory 
in Scotland. These issues will be highlighted later in the chapter. 
 
Whilst he was based at Johns Hopkins, Ferguson-Smith made a ‘fortunate’ contact in 
the form of Lawson Wilkins, who was second in command of the Department of 
Paediatrics. Ferguson-Smith attended Wilkins’ clinic regularly, which led to him seeing 
patients with various sex anomalies, including Klinefelter’s and Turner’s syndrome.36 
Wilkins was keen for Ferguson-Smith to study the chromosomes of his patients and this 
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gave Ferguson-Smith a great deal of data to work with: this arrangement highlights the 
impact that genetic laboratory research could have on clinical practice if the two 
disciplines worked together. Ferguson-Smith also made key contacts with several other 
geneticists including T.C. Hsu and Albert Levan. In the spring of 1959, he spent four 
days at the Texas Medical Center in Houston with Hsu and Levan, learning tissue 
culture and chromosome photography techniques. Hsu wrote to Ferguson-Smith in May 
of 1959 to thank him for visiting, and spoke of the ‘great stir’ it had caused amongst the 
local clinicians, who were ‘fascinated’ by his talk.37 For Ferguson-Smith, the visit 
compounded the belief he had been forming over the last few years that he wanted to 
follow the ‘fascinating path’ of genetic research ‘as far as I am able’.38 Within two 
weeks of spending time with Tsu and Levan and ‘benefitting from their advice’, 
Ferguson-Smith was able to obtain good chromosome samples from bone marrow, and 
draw diagrams of these using his new microscope.39  
 
Lack of space became a problem for McKusick’s department as the field of 
chromosome work expanded, and in the summer of 1959 permission was given to 
convert a nearby men’s bathroom into a cytogenetics laboratory and photographic dark 
room.40 Ferguson-Smith helped with the design of both of these rooms, which would 
have been a very useful learning experience for his future work designing his own 
laboratories in Glasgow. Despite intending to stay for only one year at Johns Hopkins, 
by October of 1959 Ferguson-Smith had been offered an extension of his contract to 
continue with his chromosome research,41 an offer he had accepted by the start of 
1960.42 By January of 1961 Ferguson-Smith had written to Levan to say that he would 
be ‘astonished to see us in our new little laboratory designed carefully by me to make 
the most use of space’ and spoke of the expanding department which consisted of more 
research fellows, technicians, and even a research student.43 Ferguson-Smith remained 
at Hopkins until October of 1961, and by the time he left to return to Glasgow as a 
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Lecturer in Medical Genetics, the laboratory he was part of had become the first 
diagnostic laboratory in the United States, receiving patient samples for chromosome 
analysis from several states.44  
 
IV. The Return to Glasgow as Lecturer in Medical Genetics 
Ferguson-Smith’s return to Glasgow was bittersweet. Whilst he felt he owed ‘Glasgow, 
and particularly the Western Infirmary Pathology Department, a tremendous debt’, and 
this was one of his ‘major reasons’ for turning down the offer of an Assistant 
Professorship in Medicine at Johns Hopkins Hospital,45 he was aware of the issues 
facing the University of Glasgow including lack of research space, and he was ‘very 
anxious not to leave a situation where I am productive for a post however attractive, 
where my studies are arrested due to a temporary lack of facilities’.46 His time spent at 
Hopkins made him determined that it was part of his ‘future mission to put medical 
genetics into practice in Glasgow’,47 and it was this that influenced his decision to 
return home. He recalled how he ‘was going from a place like Hopkins back to Glasgow 
to try and bring what I’d learned back to help Glasgow medicine. Why else should I 
come back to earn one third of my Baltimore salary to a place that doesn’t know 
anything about medical genetics?’48 Despite his reservations, Ferguson-Smith 
recognised the opportunity that a move back to Glasgow could provide. In a recent 
interview he stated that ‘it was very good for me because I was the one person in 
Glasgow who was doing anything to do with this. So I had the ball at my feet, 
everybody was interested and supportive and there was no opposition [laughs].’49 
 
The decision to return to Glasgow was, however, initially hindered by a lack of funding 
available to set up the department Ferguson-Smith had envisaged. A number of 
communication issues arose as a result of the geographical distance between Ferguson-
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Smith, still based in Baltimore, and his supervisors and co-workers in Glasgow. 
Communication was by written letter, sent via air mail, which could take long periods to 
arrive, resulting in a misunderstanding which contributed towards Ferguson-Smith 
having a grant application rejected by the Medical Research Council (MRC), who were 
thought to be the most likely to fund the establishment of a medical genetics 
department.50 Guido Pontecorvo, the head of the Department of Genetics where 
Ferguson-Smith was to be based upon his return, had advised Ferguson-Smith that if he 
wished to apply to the MRC for funds then he should write to them directly to obtain an 
application form.51 Pontecorvo had been in touch with an individual at the MRC ‘who 
gave him the impression that the chance of getting funds might be very good’.52 
However, Ferguson-Smith then received a letter from his other supervisor, Professor 
Dan Cappell, based in pathology, who advised him to submit a funding application to 
the Advisory Committee for Medical Research (ACMR).53 Assuming that Professors 
Pontecorvo and Cappell had come to an agreement that he should apply to the ACMR, 
Ferguson-Smith did not send off an application to the MRC, only to receive a letter 
from Pontecorvo querying why they had not received the application.54 Ferguson-Smith 
wrote of it being ‘most frustrating for me not to be on the spot in Glasgow where such a 
situation would so easily have been avoided’,55 and of his feeling ‘greatly the 
disadvantage of the distance between Baltimore and Glasgow’.56 Funding applications 
were subsequently submitted to both the MRC and ACMR. Neither were successful, 
with the amount of money requested being deemed too large by both groups.57 
 
Ferguson-Smith’s immediate response to the news that these funding applications were 
unsuccessful ‘was one of extreme disappointment, particularly as I had been led to 
believe by Professor Pontecorvo that my chances were exceedingly high because all the 
preliminary arrangements for the favourable reception of the application had been made 
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in advance’.58 He wrote once again of the frustration he felt at the geographical divide 
‘by being so far away and being thus so entirely dependent on others who have other 
and more important things to take up their time’.59 He was also concerned that by 
putting in an application for such a large sum of money that he had given the MRC ‘the 
impression that I am a spoilt boy from the United States – an impression which will be 
hard to overcome in the future’.60 The application had been sent to the MRC with no 
corrections made by more senior members of staff, and so Ferguson-Smith had 
mistakenly included the costs for everything he would need, unaware that this was not 
following protocol. However, determination by all those involved in the process 
resulted in funds being found from the University of Glasgow for his work, and 
Ferguson-Smith returned to Glasgow in 1961 as the first Lecturer in Medical Genetics 
appointed in the city. His vision of returning to a well-developed laboratory had not 
come to fruition, but he was provided with one room within the university, and had 
access to communal laboratory facilities such as a room for washing glassware. Funding 
was found for basic equipment such as microscopes, and the University also agreed to 
pay the salary of a science graduate, Patricia Ellis, who would assist Ferguson-Smith 
with the work.61 
 
The above description highlights the issues that Ferguson-Smith faced upon his return 
to Scotland from the United States. Problems with funding and lack of space would be 
recurrent throughout his career, as they are for many researchers. That Ferguson-Smith 
was trying to establish a new department accounted for a large proportion of this, and it 
is possible to imagine his frustration at a number of these administrative hurdles which 
were detracting from his work. It is of interest to consider whether his desire as a 
Glaswegian to return to his home city played a part in his determination to succeed in 
bringing medical genetics to the region. Prior to his return to Scotland he had expressed 
his ‘sincere desire to set up in Glasgow as good a cytogenetics unit as possible’ as he 
was ‘convinced that there is a great future in this line, and I don’t see why Glasgow 
shouldn’t play a bigger part in its development’.62 As highlighted previously, he was 
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returning to a city which knew nothing about his field and was being paid a far smaller 
salary; it is difficult to envisage an academic leaving an established post where funding 
was guaranteed, to return to these problems unless they have a strong connection with 
the region. Throughout all of his discussions surrounding his return to Glasgow, he was 
keen to emphasise that he specifically wanted to return to the region, writing in one 
letter that this was for ‘personal, family, and academic reasons’.63 It therefore seems 
likely that this decision was due to his connection to Glasgow – he extended his stay at 
Johns Hopkins and his work was progressing well, and there is no hint in any of the 
archive documents that his desire to return to Glasgow was due to him wanting to leave 
Johns Hopkins. Indeed, Ferguson-Smith was happy to stay at Johns Hopkins until 
‘suitable conditions’ could be found for his return to Glasgow, which would enable him 
to continue his research.64 He has also described how he was ‘incredibly lucky’ to get to 
spend time at Johns Hopkins, an institution he described as ‘world class’.65 He 
discussed being ‘tempted’ to stay in the United States, however he felt he had an 
‘obligation’ to return to Glasgow, and bring his developing medical genetics expertise 
with him.66 Whilst it cannot be known if medical genetics would have developed into 
such a strong field in the West of Scotland if an individual other than Ferguson-Smith 
had been involved, it is clear to see that he played a central role in this process. That 
Ferguson-Smith had personal ties to the West of Scotland, and was driven to bring 
medical genetics to the region, resulted in the establishment of a whole new area of 
clinical and scientific medicine in Glasgow. 
 
V. The Expansion of Medical Genetics in Glasgow   
With Ferguson-Smith’s appointment in 1961, the first medical genetics unit was 
informally established in Glasgow in the form of a small human cytology research 
department, comprising one room within the university.67 The human cytology 
department was focused on research and teaching only, and had no responsibility for 
providing diagnostic services, an arrangement Ferguson-Smith felt was ‘decidedly 
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unfavourable to the clinical and more strictly genetic aspects of human cytogenetic 
research’.68 Between 1961 and 1963 the Western Infirmary Pathology Department was 
responsible for providing nuclear sexing and chromosome analysis services. However, 
despite a close working relationship between pathology and medical genetics, the high 
number of cases meant that patient samples were often not seen by a geneticist. 
Ferguson-Smith was based in the Department of Genetics, and not the Department of 
Pathology, and Pontecorvo stressed that ‘the Department of Genetics is not a clinical 
department, and we are in no way connected with the National Health Service’.69 
Pontecorvo did however permit Ferguson-Smith to investigate ‘cases in which he may 
decide that the research interest is sufficient to warrant the labour and cost of an 
investigation’.70 
 
Ferguson-Smith felt that merely being permitted to investigate cases of research interest 
was not sufficient. He was keen to develop a more ‘clinically-orientated Medical 
Genetics Unit’, and he wrote in 1964 that he had been ‘fighting here (without any sign 
of success) for the past few years’ for the establishment of such a unit.71 He considered 
that it was a ‘most important deficiency’ that many cases were not seen by a geneticist, 
and he proposed that this could be remedied by the formation of a combined diagnostic 
and research unit in human cytogenetics.72 A proposal for such a service was written up 
by Ferguson-Smith on the 22nd July 1964, and subsequently submitted to the Western 
Regional Hospital Board for consideration. By this time, the demand for diagnostic 
services had gone ‘well beyond the stage’ where it could be handled through an 
informal arrangement between pathology and medical genetics. It was therefore 
suggested that a diagnostic chromosome laboratory should be established ‘within one of 
the hospitals of the region, physically distinct from the University Research Laboratory 
but supervised by the Lecturer in Medical Genetics’.73  
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Temporary accommodation was arranged for the laboratory in the Queen Mother’s 
Hospital in Glasgow by the Professor of Child Health, James Hutchison. Hutchison was 
interested in chromosome disorders,74 and provided Ferguson-Smith with access to the 
‘examination of selected patients’ for his work.75 In 1965 the Chromosome Diagnostic 
Service was established by the Western Regional Hospital Board,76 directed by 
Ferguson-Smith, with weekly genetics clinics held in the accommodation provided by 
Hutchison in the Queen Mother’s Hospital. After a number of years working to achieve 
this, Ferguson-Smith was pleased with the outcome, which he hoped would enable him 
to play ‘a slightly more clinical role once more’, as his appointment would become a 
joint one in the Departments of Child Health and Genetics.77  
 
Between 1965, when the Chromosome Diagnostic Service was established, and 1970, 
when it moved into specialised laboratory accommodation, the demand for services 
continued to grow. In 1966 there were only 25 clinic consultations, rising to 125 in 
1970. In 1969 the first amniotic fluid samples were tested within the laboratory.78 The 
new purpose built accommodation, which replaced the laboratories in the Queen 
Mother’s Hospital, opened on the 11th May 1970 at the Royal Hospital for Sick 
Children, Glasgow.79 Figure 2.1 shows the geographical locations of these buildings in 
relation to one another: 
                                                          
74 Ibid., p. 52. 
75 Ibid., p. 46. 
76 UGC 188/2/2/2/5, Memoranda on 'Department of Medical Genetics, Yorkhill Hospitals. Current Status 
and Future Development' 1977, and 'Medical Genetics at Glasgow University' 1979, p. 9. 
77 UGC 188/3/2/5/2, Ferguson-Smith Correspondence with Dr Richard E Goodman, p. 2 (letter dated 23rd 
August 1965). 
78 UGC 188/2/2/2/5, Memoranda on 'Department of Medical Genetics, Yorkhill Hospitals. Current Status 
and Future Development' 1977, and 'Medical Genetics at Glasgow University' 1979, p. 20. 
79 The site which housed both the Queen Mother’s Hospital, and the Royal Hospital for Sick Children, 
was known locally as the Yorkhill site. 
112 
 
© Crown Copyright and Landmark Information Group Limited (2018). All rights 
reserved. (1960s). 
Figure 2.1 – Showing the locations of the Queen Mother’s Hospital, and the Royal 
Hospital for Sick Children in Glasgow.80 
 
The Royal Hospital for Sick Children housed a number of different departments, 
including the medical genetics unit.81 The laboratory increased in size considerably, 
from 128 square feet in 1965, to 646 square feet in 1970. Staffing levels also grew, with 
the number of scientific officers increasing from 1 in 1965 to 5 in 1970.82 Ferguson-
Smith was promoted to Senior Lecturer in 1965, and was given an honorary consultant 
contract ‘in respect of his clinical responsibilities at the Royal Hospital for Sick 
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Children’.83 In a report to the University Court for the session 1969-70, Ferguson-Smith 
commented that it was believed that this was ‘the first time special accommodation for 
Medical Genetics has been provided in a hospital by the Health Service’, which 
emphasises the pioneering role that the West of Scotland was playing in providing 
chromosome diagnostic services.84 
 
In a letter written in October 1970, Ferguson-Smith outlined the main activities 
underway in medical genetics in Glasgow at that time. He was still ‘the sole practitioner 
of Medical Genetics in Glasgow and the West of Scotland’, and his clinical duties 
included ‘providing a Genetic Counselling Service and a Chromosome Diagnostic 
Service for Glasgow and the West of Scotland’.85 He was involved in teaching, and had 
ongoing research projects, including one on chromosome mapping.86 During this time 
period, when the department was increasing in size, Ferguson-Smith had several people 
working with him who would remain in his department for a number of decades. One of 
these individuals was Elizabeth Boyd, who had done doctoral research under the 
supervision of Bernard Lennox, and subsequently worked with Ferguson-Smith. She 
recalled in an interview that she remembered feeling that she had ‘got as far as I could 
with the subject in pathology and that it would be much better to go down to genetics’, 
where she was to be based in the diagnostic side of the department.87 It would appear 
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that this was a positive decision, as she would go on to spend her full career in the 
Department of Medical Genetics, where she continued to work in diagnostics, using 
blood and bone marrow samples to analyse the chromosome constitutions of patients.88 
Having a staff member to work in this role would have ensured that the patient samples, 
which were often not seen by a geneticist when the chromosome service was run by 
pathology, were now being analysed with a genetic perspective in mind. 
 
Another individual who was centrally involved during this time period was Marie 
Gzowska,89 who would go on to become known as Marie Ferguson-Smith, after 
marrying Malcolm in July 1960.90 They met at Johns Hopkins University, where Marie 
had a summer job working for Victor McKusick while undertaking a degree in history 
and economics.91 She was assigned to help Malcolm Ferguson-Smith with 
administrative and clerical duties on one of his research projects, but later discovered 
she was good at photographing chromosomes.92 She also began carrying out some 
laboratory work, setting up and working with microscopes, in addition to discovering a 
talent for culturing cells in the laboratory.93 She became certain that her key interest lay 
not in history and economics, but in genetics, and decided that any further study she 
would do would be in this field.94 It is interesting to note that both Malcolm and Marie 
Ferguson-Smith became certain that they would pursue careers in genetics as a result of 
their time spent at Hopkins, where medical genetics under McKusick was a flourishing 
field. 
 
The expansion of the number of staff members in the department which occurred from 
1965 onwards, and the move into larger, more specialised accommodation in 1970, took 
place at a crucial time point for the development of prenatal diagnostic services. 
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Prenatal diagnostic testing was first carried out in Glasgow in 1969, and the demand for 
the service grew dramatically over the following years. Ferguson-Smith and his 
colleagues were at the forefront of many of the developments in prenatal diagnostic 
testing, and were key contributors towards the implementation of tests for spina bifida 
and other conditions. When the laboratory first began using amniocentesis as a prenatal 
diagnostic tool in 1969, it was with the aim ‘of saving pregnancies which would 
otherwise be terminated on the grounds of substantial risk of foetal abnormality’.95 This 
links back to the idea presented in the introduction, that for many of those involved in 
the early days of prenatal testing, the intention was to increase the number of children 
born, as opposed to terminating on what some argued were eugenic grounds. Indeed, 
Ferguson-Smith has emphasised that in the majority of cases, women were able to be 
reassured that the fetus did not have the condition being tested for, and could continue 
with their pregnancy. He has highlighted that many of the women who had prenatal 
testing would not have considered another pregnancy without the option of the testing.96  
 
As the technology advanced, so too did the workload, and by 1973 there were 240 clinic 
consultations and 101 amniotic fluid samples processed. Many of these patients and 
samples were coming from outside the Yorkhill Hospital group, including more than 
two thirds of the samples for genetic analysis, and around 70% of the patients being 
referred to the clinic. Those involved in medical genetics felt that this should be 
recognised, and so proposed to the Western Regional Hospital Board in February of 
1973 that the Department of Medical Genetics should be formally designated as the 
“Regional Genetic Advisory Service”.97 This proposal was agreed upon on the 16th 
October, 1973,98 shortly after Ferguson-Smith was awarded the newly created Burton 
Chair of Medical Genetics in the same year. 
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VI. The Duncan Guthrie Institute of Medical Genetics 
With the demand for genetic services continuing to increase, it became apparent that the 
laboratory facilities available to the Regional Genetic Advisory Service were 
inadequate. The department was still based on the Yorkhill site for its clinical work, but 
due to an increased need for space the staff were partially housed in ‘Transline’ 
temporary accommodation units.99 Their research laboratories were still based in the 
University Department of Genetics, which was in a separate building in Church Street 
in Glasgow, located away from the Yorkhill hospital site,100 as shown in Figure 2.2: 
 
© Crown Copyright and Landmark Information Group Limited (2018). All rights 
reserved. (1960s). 
Figure 2.2 – Showing the different geographical locations of the Queen Mother’s 
Hospital and the Royal Hospital for Sick Children, located at Yorkhill, and marked with 
the blue circle, and the research laboratories in Church Street, marked by the orange 
diamond.101 
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After being appointed Burton Chair of Medical Genetics, Ferguson-Smith approached 
the founder of the National Fund for Research into Crippling Diseases, Duncan Guthrie, 
to enquire about a possible grant to build some new portacabins to expand medical 
genetics further. The National Fund offered to help out with the costs, not for more 
temporary accommodation, but for the building of an entire institute for medical 
genetics if Ferguson-Smith could also secure equal funding from the University of 
Glasgow and the Greater Glasgow Health Board.102 The need for this extra 
accommodation is evident when the work which was going on in the department is 
considered. Research areas included chromosome mapping, the use of banding 
techniques to analyse chromosome anomalies in more detail, studies of sex 
chromosome disorders, and analysis of recurrent miscarriage, amongst other areas of 
work.103 This was in addition to the clinical diagnostic services that were also being 
provided. As shown in Figure 2.3, the number of laboratory tests which were being 
carried out from 1970 onwards increased dramatically:  
 
Figure 2.3 – Showing the annual workload from 1965 to 1978, with the number of tests 
highlighted with a black box. Tests shown include number of amniotic fluid and serum 
AFP samples processed each year.104 
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In 1977 Ferguson-Smith wrote of how ‘very hectic’ their laboratory had become – in 
one year they were culturing around 850 amniotic fluid cultures, 200 other fibroblast 
cultures, 1000 blood cultures, and 17,000 serum samples.105 He hoped that ‘perhaps in 
three years time we will have a better building and adequate staff for this work. 
Meanwhile, it is rather a struggle.’106 This struggle would however be the driving force 
behind several years of work to raise the appropriate funds. After approaching both the 
University and the Health Board, Ferguson-Smith found that ‘astonishingly’ everyone 
agreed with the proposals to split the costs.107 Upon returning to the Health Board with 
details of the required funds in 1976, Ferguson-Smith was informed that the initial costs 
he had been provided with were not correct, and that in order to fund the building it 
would have to be reduced in size by 30%.108 He later recalled how the department were 
‘totally despondent’ upon receiving this news, and that they had been told that research 
laboratories were not essential.109 Despite these setbacks, the project was saved by a 
large donation from the Hugh Fraser Foundation and building work began. The end 
result was the Duncan Guthrie Institute of Medical Genetics, which opened in Glasgow 
in October 1980. 
 
At the inauguration of the building Ferguson-Smith did not shy away from the trouble 
that these financial difficulties had caused. He outlined the monetary problems the 
project had faced, and how it had been saved by the large grant from the Hugh Fraser 
Foundation.110 He also spoke of the more general atmosphere of recession which was 
pervading, with mention of the ‘rather modest inauguration’ where due to ‘hard times, 
tea has to serve for champagne’.111 In another document he commented that amongst 
‘the depressing environment of remedial works and in an atmosphere of recession and 
general reduction of services to patients’, it was positive to see the ‘growth and new 
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development’ of the Duncan Guthrie Institute at Yorkhill.112 Ferguson-Smith and his 
colleagues were ‘enthusiastic and excited about the potential of the new facilities for our 
future work’, but felt that there remained ‘considerable anxiety about the future 
stemming from the national recession in general and the economies being forced on the 
National Health Service in particular’. They raised concerns that there would not be 
enough staff and equipment to realise the full potential of the new Institute.113  
 
These concerns were not unfounded, as over the next few years the financial climate 
continued to impact the new Institute. A number of letters commented on cuts to 
services and financial difficulties over the following years, with one from a Doctor 
Stewart based in Ayrshire who was unhappy with the length of time it was taking to 
receive results from amniocentesis.114 Ferguson-Smith replied to him in February 1980 
commenting that ‘In recent times, like everyone else, we have suffered from the freeze 
on development and have been unable to employ the staff which it is recognised is 
required for our work load’, and that the ‘standard of service is directly related to the 
number and quality of staff we are allowed to employ’.115 These problems appeared to 
continue as, in 1981, Ferguson-Smith wrote to a colleague in Australia, outlining that 
the recession was ‘hitting the development of services very hard’.116 By 1982 there were 
still financial troubles, with Ferguson-Smith thanking a fundraiser by letter, informing 
him that ‘In these times when the recession is biting even deeper each month, we rely 
more and more on the support of generous donations like yours to carry on this work. 
My colleagues and I are therefore deeply grateful to you for this generous gift.’117  
 
These monetary struggles can also be seen in the loss of a lectureship position for the 
department, which had been funded by the University of Glasgow. In 1981 Ferguson-
Smith stated his case to the ‘Faculty of Medicine Academic Development Committee’ 
to fill the post of Lectureship in Medical Genetics, which was to become vacant with 
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the early retirement of the staff member Jean Patrick.118 The document stated that ‘If the 
Lecturer post were abolished the total responsibility for the work of 58 people, 
including all teaching, provision of genetic consultations and other genetic services to a 
population of 3 million and supervision of several major research projects would remain 
with the Professor. In the event of his leave of absence, illness or death there would be 
no one qualified to deputise for him.’119 Even with these implications, the lectureship 
was not renewed, and from September 1981 ‘the entire responsibility for teaching, 
clinical work, laboratory reports and research projects remained with the Professor’, 
Ferguson-Smith, until August of 1982.120 
 
However, the situation did begin to improve from 1982 onwards. Several new staff 
members were recruited over the following few years, including Mike Connor, 
appointed as a National Health Service (NHS) Consultant in Medical Genetics in 1982, 
and Nabeel Affara, awarded a Lectureship post in Human Molecular Genetics.121 A 
number of my interviewees also began their careers in the early 1980s, and have 
provided an insight into life working in the Institute. The Duncan Guthrie Institute was 
believed to be ‘the first of its kind in the U.K.’, ‘designed and built to provide the 
community with comprehensive genetic services and to provide facilities for teaching 
and research in Medical Genetics’.122 It housed both clinical and scientific staff in the 
one building, and, alongside providing diagnostic services, the staff were also involved 
in research. Having scientific and clinical staff housed together in the same 
accommodation was very unusual at this time in medical genetics. However, many of 
the interviewees commented on how positive this arrangement was. As one clinician 
recalled, ‘Where Malcolm had really excelled was he had the vision to build the first 
integrated NHS clinical, NHS diagnostic and university research genetics Institute in 
Britain. It was just incredible to be working in that kind of hot-bed with all these 
different specialties within the one place and we could communicate together very 
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easily, it was a very exciting time.’123 Others also commented on the importance of this 
ease of communication, whereby ‘you could go up a stair and talk to somebody, it was a 
huge area and there was a lot of cross-collaboration that went on’,124 which resulted in a 
‘very close community’ and ‘cross-fertilisation of staff and ideas’.125 This model, where 
clinical and research services were integrated, would end up being ‘adopted across the 
world’,126 and several visiting scientists and clinicians would come to undertake training 
there. As one interviewee commented, ‘there can’t be many departments in the country 
that don’t have someone who’s been through the Duncan Guthrie’.127  
 
This close communication can be clearly seen in the weekly Wednesday meetings 
which were held within the department, which many interviewees recalled as being a 
central feature of their week. The entire staff of the Institute would come together to 
discuss the work which was going on in the different departments, on both the clinical 
and research fronts. Ferguson-Smith would ‘send someone round to go and get people 
… because there was no excuse’ and if you had laboratory work which would need 
attended to during the time of the meeting then ‘you couldn’t start it, because it was 
very important’.128 Whilst several of the attendees at the meetings recalled that it was 
‘torturous’ to sit through them as they involved the reporting of so many figures, they 
were appreciative of how educational these could be. The importance of the meetings 
was highlighted by two of the interviewees, with one explaining how they used to have 
‘a weekly Wednesday meeting, Wednesday lunchtime, and every part of the department 
reported back and we used to sit and go through everything from a month before. So 
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we’d sit and we’d talk about all the cases we’ve counted X number of bloods and we 
found these abnormalities and we’ve found so many prenatals and we’ve found these 
abnormalities and we listed them and we talked about some of them and someone 
would present.’129 Although he recalled that the ‘figures were just dreadful’, the 
meetings were useful because ‘it really helped you learn and you would find out about 
things that were going on elsewhere’.130 He also recalled Ferguson-Smith’s ongoing 
interest in sex chromosome disorders, and how, when those working in cytogenetics 
found such anomalies and presented details of them at the weekly meetings, Ferguson-
Smith would ‘jump up in interest’ and there was ‘real interest and scrutiny’ surrounding 
such cases.131 The interests that first propelled Ferguson-Smith into studying 
chromosomes remained with him throughout his career.  
 
Another member of the department has commented that they also thought the meetings 
were ‘a way of Professor Ferguson-Smith keeping in touch with everything, he liked to 
have his finger on all the areas of the department’.132 When the overall workload for the 
department is considered, it is perhaps not surprising that Ferguson-Smith was keen to 
arrange these meetings to remain informed about the work which was going on. Figures 
2.4 and 2.5 show the many research grants which Ferguson-Smith had been awarded, 
highlighting the vast numbers of projects which were occurring within the department: 
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Figure 2.4 – Research grants awarded between 1965 and 1979.133 
 
 
Figure 2.5 – Research grants awarded between 1980 and 1984.134 
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In addition to these research grants, Ferguson-Smith was responsible for overseeing the 
work of all the staff in the department, which had grown to 78 members by 1984.135 The 
department was also providing a clinical service in peripheral genetics clinics in the 
community. 
 
VII. The Move to Cambridge 
This intense workload would continue expanding until 1987, when Ferguson-Smith 
moved from Glasgow to Cambridge to take up the post of Chair of Pathology. The 
move was an unexpected one for him, as he had not actually applied for the job. In a 
recent interview he recalled the moment he received the news: 
 
It was in the early summer of 1986 that I received a phone call from 
Richard Adrian the Vice-Chancellor of the University of Cambridge telling 
me that I’d been elected Professor of Pathology in Cambridge. I was 
exceedingly surprised and I laughed and said this must be a mistake as I 
hadn’t applied for the job, I didn’t know it existed and in any case I’m not 
a pathologist; although I’ve trained in pathology my specialty is in medical 
genetics. And he said oh well I don’t know anything about that, but I know 
that you’ve just been elected by our Board of Electors. So I pulled myself 
together and said I’d be happy to come down and discuss this with you and 
with the department and learn to what I’ve been elected.136 
 
Despite having ‘no thought of moving from Glasgow’, he realised that this could be an 
important career move for him.137 After several meetings and an array of 
correspondence, it was agreed that the University of Cambridge would purchase the 
equipment Ferguson-Smith felt was essential for the department, and would find job 
roles for two of his key staff,138 which surprised Ferguson-Smith as he had ‘fought for 
years to try and get one lectureship position in Glasgow’.139 Alongside these incentives, 
another key factor in his decision to accept the job was the realisation that he was also 
being asked to set up a medical genetics department in Cambridge; he was aware that no 
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regional genetics service existed in the area, and was keen to remedy this. Notes for one 
of his trips to Cambridge outlined plans to establish an East Anglia Regional Genetic 
Service, which would provide a chromosome diagnostic service, amongst other plans.140 
Ferguson-Smith felt that this was an opportunity ‘to make a greater impact on helping to 
get medical genetics more recognised in medicine, which was one of the main aims of 
my career. I felt that I should take this opportunity seriously.’141 He expressed his 
formal interest in the post to the Vice-Chancellor of the University of Cambridge in July 
1986, citing as one of his reasons that he believed he could ‘help to introduce the 
modern developments of molecular genetics into clinical practice in East Anglia’.142  
 
In his letter of resignation to the Principal of the University of Glasgow on the 12th 
March 1987, Ferguson-Smith stated that ‘I shall always look back with great pleasure 
on my 26 years association with Glasgow University as a member of staff. It has been a 
great privilege to have the opportunity of helping to pioneer Medical Genetics here.’143 
It was not an easy decision to leave, and Ferguson-Smith recounted that, when he was 
first contacted about the job in 1986, ‘it had only been six years since the Duncan 
Guthrie Institute had been opened and had been my work, helped by my wife … since 
we’d come to Glasgow. And of course we’d been by that time twenty-five years in 
Glasgow, and had worked very hard to develop the Institute and get it going, and I had 
no particular plans to leave.’144 It is therefore perhaps not surprising that many of the 
staff members working in the Duncan Guthrie Institute did not foresee such a move. 
Several of Ferguson-Smith’s colleagues whom I interviewed recalled how they felt 
when they found out that Ferguson-Smith was to leave the department. One commented 
that ‘Surprise was the first thing I think everyone was really amazed that he was leaving 
because we thought that he had obviously built up that department. It was his – he had 
built it up from scratch and it was his creation and the thought that he was going to 
leave just seemed so unexpected. I think that was the main thing.’145 This theme that he 
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was leaving behind his ‘creation’ was echoed by another interviewee: ‘I think it was 
quite keenly felt by the whole department because it was essentially Malcolm’s baby 
and he set it all up and he was quite a driving force. But yeah it was keenly felt, 
definitely keenly felt.’146 The second interviewee quoted here emphasised the strong, 
founding role that Ferguson-Smith had played in the department, as he felt when he left 
that it was ‘like losing your dad basically’.147 This individual spent all but a few years of 
his career in medical genetics, beginning work with Ferguson-Smith when he was a 
young man, and progressed through the ranks under his supervision. 
 
The man who replaced Ferguson-Smith as the Burton Chair of Medical Genetics was 
Professor Michael (Mike) Connor, who had been working with Ferguson-Smith since 
1982. He had followed a similar career path to Ferguson-Smith, working at the Moore 
Clinic with Victor McKusick in Johns Hopkins University,148 and was appointed the 
first NHS Consultant in Genetics in Scotland in Ferguson-Smith’s department.149 
However, Connor recalled with some humour during his interview that the prospect of 
taking over the role was ‘scary’. He was already responsible for the clinical aspects of 
genetics within the department, but his new role would require him to take over the 
running of both the research and university side of the job in addition to this. Several 
different areas would be brought in or expanded under his leadership, including 
molecular genetics, newborn screening, and cancer genetics.150 He became the head of a 
department with over 100 staff, but received no induction or training, and recalled a 
moment of panic when he first looked through the account books for the department and 
thought they were not even financially solvent, only to be reassured by the university 
accounts staff that all was well.151  
 
The view of the majority of those I interviewed was that Connor adapted to the role 
well, with one describing how in his opinion Connor ‘carried on where Malcolm left off 
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basically and it was seamless, absolutely seamless’.152 Another recalled that they could 
not think of anything ‘that was particularly different’ when Connor took over.153 One 
interviewee commented that, whilst of course there was a ‘personality change’ with the 
move from Ferguson-Smith to Connor, the department continued to grow in size and 
scope under his leadership.154 Some did, however, feel that the working environment 
under Connor was less rigorous than it had been when Ferguson-Smith was running the 
department. One commented ‘We still had the Wednesday meetings although they 
weren’t quite as demanding shall we say. But they then kind of petered out really and 
we didn’t have them.’155 Professor Connor did however give weekly talks on a variety 
of relevant subjects, and also took employees round the hospital wards so that they 
could appreciate the clinical implications of their work.156  
 
One interviewee voiced his concerns that the department ‘wasn’t as intense a place, it 
was a more relaxed atmosphere’, and he felt that the research aspect of the department 
deteriorated after Ferguson-Smith left.157 This is an assertion that Ferguson-Smith 
agrees with. He described how when he left the department was ‘flourishing, and in fact 
it was probably the most active genetics service in the United Kingdom. It certainly was 
the biggest and was working extremely well. Perhaps it’s a good time to leave a job 
when it’s flourishing because the momentum would hopefully carry it on. I’m sorry to 
say that the research fell off quite a lot when I left but the service continued unabated, 
they have always provided a first class service and that was a good legacy to leave when 
I moved to Cambridge.’158 Thus, it can be seen that the research and the service aspects 
of the medical genetics department were viewed as distinct entities by Ferguson-Smith. 
That Connor continued to expand the service element is clear, but for some 
interviewees, the research aspects and projects of the department decreased after 
Ferguson-Smith left. However, for others within the department, Ferguson-Smith’s 
move allowed them to step up and take on more responsibility within their role. For 
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Gordon Graham, this was linked to the stage of his career when the change in leadership 
happened. He has described how he found that for him personally, the research aspect 
was better under Connor, however he attributed this to being ‘in a position to take 
advantage of it’.159 He described how ‘in the seven years I knew Malcolm I was still a 
kind of wet behind the ears and young and still learning my trade in the service side of it 
and it wasn’t really until Mike took over in the 80s that I kind of was more involved in 
doing other things and at that point extending into research’.160 The experience differed 
for individuals, dependent on their particular roles and career stages. 
 
Thus, whilst the research aspect of the department may have been seen by some to have 
diminished under Connor’s leadership, it seems that there is agreement that the service 
aspect of the department continued to develop. This is seen in Coventry and Pickstone’s 
comment that after Ferguson-Smith’s departure, Connor ‘has since established the 
department at Glasgow as the largest medical genetic service in Europe serving some 3 
to 5 million people’.161 Interestingly, one interviewee commented that in present day the 
department is definitely more ‘service based’, linking this to factors such as 
accreditation.162 Thus, from this perspective, the move away from research was partly as 
a result of the formalisation of procedures and testing within medical genetics 
laboratories, which were not as prevalent throughout the 1960s and 1970s. Douglas 
Wilcox has also noted that Mike Connor ‘oversaw a huge expansion in the department 
both in terms of patients seen and in numbers of staff’, emphasising Connor’s 
commitment to continue to expand the medical genetics service.163  
 
One of the most crucial areas which developed under Connor’s leadership was the 
service work in molecular genetics. As discussed in the introduction, prior to his move 
to Cambridge, Ferguson-Smith had been involved in putting in a funding bid for a 
molecular genetics consortium to run in Scotland. It was the later 1980s before 
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molecular genetics began to be implemented as a clinical service, with much of the 
work prior to this focusing on research.164 Connor played a key role in developing this 
service, building upon the early research work in molecular genetics which had been 
done in Glasgow under Ferguson-Smith.  
 
Another area that Connor developed was the MSc course in Medical Genetics, which 
had been set up by Ferguson-Smith. Upon Ferguson-Smith’s departure, the course 
numbers fell to one student, and Connor approached Douglas Wilcox to enquire if he 
would be interested in taking on the course and developing it. Wilcox readily agreed, 
and throughout the years that Wilcox taught on the course, there were over 700 
graduates.165 Others within the team recalled that the MSc course ‘expanded a great deal 
under Professor Connor and grew and grew’ but that the course ‘didn’t involve sort of 
innovative research to any great extent’.166 
 
For Ferguson-Smith, the process of taking over a new department upon his move to 
Cambridge was not without its challenges. He was appointed as the Director of the East 
Anglia Regional Genetics Service, and drew on his experience from setting up the 
regional service in the West of Scotland to implement a similar scheme in East Anglia. 
This was a large undertaking as when he arrived in Cambridge in 1987 there was little 
medical genetics work happening. There was only one cytogenetics lab which was 
staffed with around four or five scientists, which Ferguson-Smith deemed to be ‘really 
inadequate’ for the running of a regional service.167 Whilst keen to implement such a 
regional service for the area, he found the experience differed greatly from his work to 
achieve the same outcome in Scotland. Many of the obstetricians in the towns which 
surrounded Cambridge were reluctant to get involved, mainly, he felt, because he was a 
‘new guy coming to Cambridge from Scotland trying to impose this programme’.168 He 
recalled how he tried to get his colleagues ‘to think in terms of a network of regional 
centres in England to share out the load of tests. This was how we got the system to 
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work in Scotland. We established a consortium of labs in which each of the four centres 
provided tests for an agreed number of different conditions and posted the patient 
samples to each other. Each received enough samples to develop sufficient expertise in 
a particular condition. It worked well in Scotland, but it took a long time before the 
individual groups in England worked together as a network.’169 Despite these setbacks 
the regional service did become established and grew greatly over the years which 
followed, becoming instrumental in offering prenatal diagnostic testing and screening 
for a variety of conditions.  
 
In addition to the diagnostic work, Ferguson-Smith and his colleagues were also 
involved in a wide range of research, including gene mapping, comparative genomics 
and research to improve prenatal testing methods. Whilst working in Cambridge 
Ferguson-Smith was asked by the Government to be the scientist on the inquiry into 
bovine spongiform encephalopathy (BSE). This began in late 1997 and it was expected 
to take up one day a week of Ferguson-Smith’s time for a year, but instead was almost a 
full-time job which lasted for three years.170 At the beginning of the inquiry Ferguson-
Smith was still the Chair of Pathology, and so was required to train up the other 
members of the inquiry to give them the required knowledge about BSE. He organised 
lectures in the Department of Pathology for them, and despite retiring from his chair in 
pathology in 1998 he maintained his involvement with the inquiry, seeing it through to 
completion.171  
 
When retiring from the Chair of Pathology post he remained active in research, and 
moved to the Veterinary School in Cambridge to work on comparative genomics in 
greater detail. He took the members of his research team who were working on flow 
cytometry in pathology to the Veterinary School to assist in this work,172 and the group 
formed the Cambridge Resource Centre for Comparative Genomics. Their current work 
in the Centre involves comparative analysis of chromosomes from a variety of species, 
and the group also provide chromosome specific DNA from over 150 species to 
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researchers around the world.  This work is enabling studies on comparative genetics 
and evolutionary biology, and it has the potential to provide an insight into which genes 
are essential for life and have been conserved amongst species.  
 
VIII. Conclusion 
It is clear that Ferguson-Smith was a critical figure in the development of medical 
genetics in the West of Scotland. Beginning with his interest in chromosomes at the 
early stage of his career, through to the move to Johns Hopkins to further develop his 
skills, medical genetics remained a key focus of his priorities throughout. The 
expansion of the medical genetics department in Glasgow was aligned with the wider 
developments which were occurring in the prenatal field, such as the use of 
amniocentesis, CVS and ultrasound, combined with the increased demand for testing 
from pregnant women. The department grew from one room within the University of 
Glasgow to an entire Institute for medical genetics, in the form of the Duncan Guthrie 
Institute. The details of the running of the department highlight the collaborative nature 
of the work which was going on, with many staff members listing ease of 
communication as central to departmental functioning. Whilst Ferguson-Smith’s move 
to Cambridge may have been a surprise for his staff members, it shows his continuing 
commitment to expand medical genetics and make it more accessible to the public. That 
the department continued to thrive under the leadership of Professor Connor is 
reflective of the nature of the staff who worked there, who were keen to continue 
developing and expanding medical genetics further.  
 
Thus, it can be seen that whilst there was change which took place with the move from 
Ferguson-Smith to Connor running the department, much of this followed on from 
earlier work implemented by Ferguson-Smith. Both the clinical service and the MSc 
work were established by Ferguson-Smith, but expanded and continued to develop 
under Connor’s management. In addition, the molecular genetics work which was 
mainly at the research stage in Glasgow when Ferguson-Smith left, became entrenched 
in the molecular genetics’ consortium for Scotland, with the clinical molecular service 
flourishing with Connor running the department. Whilst some members of the 
department, including Ferguson-Smith himself, felt that the research culture stagnated 
132 
 
after Ferguson-Smith’s departure, this can perhaps be seen in a wider movement 
towards becoming more service focused over time. Ferguson-Smith himself has 
continued to leave a legacy in this area in Glasgow, with his contribution to the early 
days of medical genetics still recognised. This was shown in 2004, when the new 
clinical genetics centre opened in the West of Scotland, and was called the ‘Ferguson-
Smith Centre for Clinical Genetics’.  
 
By using the case study of Ferguson-Smith to explore how medical genetics advanced 
in the specific region of the West of Scotland, it is possible to build up a comprehensive 
understanding of the staff and facilities which were involved. Examining the 
development of medical genetics in Glasgow in this manner allows for a detailed picture 
to emerge of how the department was structured, both in terms of physical space and 
under the leadership of Ferguson-Smith. Having an understanding of these features will 
enable an in-depth analysis of how the prenatal testing programmes were run within the 
department. Two of these key programmes, namely testing for chromosome disorders 
and neural tube defects, will be the focus of chapters three and four. In both of these 
chapters the material presented here on the development of medical genetics in Glasgow 
will combine with the information from chapter one on prenatal testing techniques, to 
enable detailed examination of these prenatal services in the West of Scotland. 
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Chapter Three – Prenatal Diagnosis of Chromosome Anomalies: 
Development, Implementation, and Uptake 
 
I. Introduction 
At the First International Congress of Human Genetics held in 1956 in Copenhagen, 
data was presented by Tjio of Sweden, and by Ford and Hamerton of London, showing 
that the chromosome number in humans was 46, and not 48 as had been previously 
theorised.1 This discovery opened up the field of chromosome research to the detection 
of many chromosome anomalies, and a number of associated chromosome disorders 
would be identified over the following years. An editorial published in The Lancet in 
April 1959 highlighted that the ‘chromosomes of man, as of other mammals, are very 
hard to study’, but that strides were being made in the detection of chromosome 
disorders, exemplified by findings such as those by Lejeune, Gauthier and Turpin that 
47 chromosomes were present in cases of Down’s syndrome.2 These discoveries, when 
situated amongst those made by others such as Steele and Breg, would go on to make 
prenatal testing feasible. As highlighted in previous chapters, one of the key focus areas 
for those working in the prenatal testing field was the detection of fetal chromosome 
anomalies. This chapter will examine how the detection of chromosome disorders in the 
fetus evolved, giving consideration to both the work carried out in the West of Scotland 
by Ferguson-Smith and his colleagues, and also other research teams throughout the rest 
of the world. 
 
The first section of this chapter will consider the early research work into chromosome 
anomalies, which was focused not on antenatal detection of these conditions, but instead 
centred on trying to understand hereditary patterns. Discussion will then highlight how 
the timing of the work by Steele and Breg alongside the implementation of more 
permissive abortion legislation would combine to provide women with the option to 
terminate affected pregnancies after a diagnosis of fetal anomaly, thus opening up the 
whole field of prenatal testing. Early attempts at diagnosis of chromosome anomalies in 
                                                          
1 Author Unknown, ‘Conferences and Congresses – International Congress of Human Genetics’, The 
Lancet, 268:6938 (1956), p. 350. 
2 Author Unknown ‘Leading Article – The Chromosomes of Man’, The Lancet, 273:7075 (1959), p. 716. 
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the fetus by Ferguson-Smith and his colleagues at Glasgow will be considered, followed 
by a detailed description of the expansion of prenatal testing in the region. The running 
of prenatal testing programmes by other research groups will also be examined, as will 
key technical issues associated with prenatal testing. 
 
A major area of interest for Ferguson-Smith was the link between maternal age and 
chromosome anomalies, and the debates surrounding the discrepancies between prenatal 
and live-born rates of chromosome disorders will be discussed in detail. The uptake 
rates of prenatal testing programmes for chromosome disorders will also be considered, 
with the differing numbers experienced by various research groups discussed. Finally, 
the attempts to develop screening programmes for Down’s syndrome using maternal 
serum AFP levels will be examined, exemplifying the continued drive by researchers to 
move towards less invasive testing methods. 
 
II. Early Chromosome Research to Predict Patterns of Heredity 
Despite the key publication in 1960 by Fuchs and Riis, which showed that 
amniocentesis could be used for fetal sexing, the main focus of chromosome research in 
the early 1960s was not on developing chromosome work to be used in prenatal testing. 
Those involved in studying chromosomes were instead keen to understand more about 
the different types of chromosome anomalies, and how these could be inherited. They 
were hopeful that this information could then be used to predict the likelihood of 
recurrence of conditions in families who were seeking genetic advice. By 1961 it had 
been identified that ‘the recently described human chromosome abnormalities are of 2 
main types’, with the first group comprising ‘individuals who have an irregular number 
of chromosomes, a situation called aneuploidy’ and the second group comprised of 
individuals where the ‘chromosome anomaly involves the structure of the individual 
chromosomes’.3 These structural aberrations can include deletions, where a section of 
the chromosome is missing which results in the loss of genetic material, and 
translocations, where part of one chromosome becomes attached to another 
                                                          
3 Malcolm A. Ferguson-Smith, ‘Chromosome Abnormalities with Congenital Disease’, Modern Medicine, 
29:5 (1961), p. 80. 
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chromosome.4 These structural aberrations are shown in Figure 3.1, alongside an 
inversion and a duplication of a section of a chromosome: 
 
 
Figure 3.1 – Showing a variety of alterations which can occur, which impact 
chromosome structure.5 
 
In March 1961 the Royal College of Physicians of London held a conference on the 
‘Clinical Aspects of Genetics’, where topics included the description of human 
chromosomes and the methods available to identify them. Discussions also focused on 
the sex chromosome anomalies, and trisomic conditions such as Down’s syndrome.6 
Work was also presented on new trisomy syndromes which were in the process of being 
identified – these would later go on to be classified as trisomy 13 and trisomy 18.7 A 
conference held in November 1961 in Glasgow on ‘Diseases of Genetic Aetiology’ 
covered similar subjects, with sex chromosome disorders, Down’s syndrome and other 
                                                          
4 ‘Chromosomal Abnormalities – Structural Rearrangements’, Virtual Genetics Education Centre 
University of Leicester <http://www2.le.ac.uk/projects/vgec/healthprof/topics/patterns-of-
inheritance/chromosomal-abnormalities#structural-aberrations> [accessed 17th August 2017]. 
5 Neil A. Campbell and Jane B. Reece, Biology, 7th Edition, (San Francisco: Pearson Education, Inc., 
publishing as Benjamin Cummings, 2005), p. 286. 
6 Author Unknown, ‘Conferences – Clinical Aspects of Genetics’, The Lancet, 277:7178 (1961), pp. 663-
664. 
7 Ibid., p. 664. 
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trisomy syndromes discussed.8 Whilst there was a brief discussion on the ‘present 
knowledge and future prospects in the field of human cytology’, there is no recorded 
mention of hoping to develop these techniques for prenatal testing – instead the speaker 
‘looked forward to the day when he could map genes on human chromosomes’.9  
 
A key aim of understanding how chromosomes worked was to utilise this knowledge to 
provide genetic advice to families. In October 1961 several papers were published in 
The Lancet which assessed the possible increased chance of having a second child with 
Down’s syndrome subsequent to having had an affected child. As described by Carter 
and Evans: 
 
Three questions are very important for genetic counselling in relation to 
Down’s syndrome. First, if parents have had one child with the syndrome, 
is there an increased risk of their having a second child similarly affected, 
and is the increase dependent on maternal age? Secondly, if the answer is 
Yes, is the increase limited to a minority of the parents? Thirdly, if the 
answer is again Yes, can these parents be identified cytologically?10 
 
This quote highlights the many questions which still remained unanswered about 
chromosome disorders in the early 1960s.11 Whilst researchers were becoming aware 
that recurrence rates of chromosome conditions could be higher in families who had an 
affected child, there was still uncertainty surrounding whether these conditions could be 
identified in families prior to future pregnancies. By December 1962 it seemed that 
advances had been made. The British Medical Journal stated that ‘the value of the new 
techniques of studying chromosomes is now firmly established’, and that an ‘important 
practical application in relation to Down’s syndrome is in predicting the chances of the 
                                                          
8 Author Unknown, ‘Conferences – Diseases of Genetic Aetiology Conference at Glasgow’, British 
Medical Journal, 2:5266 (1961), pp. 1559-1560. 
9 Ibid., p. 1560. 
10 C.O. Carter and K.A. Evans, ‘Risk of Parents Who Have Had One Child with Down’s Syndrome 
(Mongolism) Having Another Child Similarly Affected’, The Lancet, 278:7206 (1961), p. 785. 
11 It should be noted here that the term ‘mongolism’ was still commonly used in the early 1960s to 
describe Down’s syndrome. I strongly oppose the use of this terminology, however to retain historical 
accuracy the term ‘mongolism’ will be used in this thesis in direct quotes. 
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parents’ having a second similarly affected child’.12 It was thought to be ‘advisable to 
test the parents and child before offering advice on the risk of recurrence of mongolism 
in later pregnancies’.13 This could be achieved by testing the chromosomes of the 
parents to see if they had a chromosome translocation which could lead to future 
children having an increased chance of inheriting the condition.14 By 1963 this seemed 
to be becoming a more common testing practice, with a report published in the British 
Medical Journal from the ‘Second Symposium on Mental Subnormality’, held at the 
University of Birmingham, stating that ‘chromosomal investigation should now be part 
of the routine laboratory service of a children’s teaching hospital’.15 This was the case 
in the Birmingham region, where ‘all cases of mongols born to mothers under the age of 
30, both parents, and when convenient the child, were seen immediately’.16 In Glasgow, 
the medical genetics unit also accepted cases of parents ‘who have had more than one 
mongol child’, young mothers ‘who have had one mongol child and contemplate a 
further pregnancy (possibly 20% of such cases carry a chromosome translocation)’ and 
parents ‘who have had one mongol child and have a history of mongolism in other 
members of the family’.17 
 
III. The Emerging Possibility of Prenatal Testing 
Although it was becoming possible to determine the recurrence of Down’s syndrome, it 
seemed doubtful to some that there would ever be the possibility of detecting this and 
other chromosomal conditions in the fetus early enough during pregnancy to enable 
termination prior to birth. The samples which were being tested were from children and 
adults, with no attempts being made to characterise fetal chromosomes. Ferguson-Smith 
himself wrote in 1964 of it being ‘doubtful if foetal chromosome analysis from 
                                                          
12 Author Unknown, ‘Leading Article – Chromosomes in Medicine’, British Medical Journal, 2:5317 
(1962), p. 1453. 
13 Ibid. 
14 Translocation Down’s syndrome is rare, and involves the breaking off of the long arm of chromosome 
21 and its re-attachment to the long arm of another chromosome – for example chromosome 14. A 
parent can have a translocation but be unaware because of a complete lack of Down’s syndrome 
characteristics. If a child receives the typical two copies of chromosome 21 (one from each parent) along 
with the copy of chromosome 14 with the added long arm of chromosome 21, then they will have three 
copies of the long arm of chromosome 21, leading to Down’s syndrome. 
15 Author Unknown, ‘Special Report – Mongolism’, British Medical Journal, 1:5325 (1963), p. 248. 
16 Ibid. 
17 University of Glasgow Archives, Papers of Malcolm Andrew Ferguson-Smith, UGC 188/3/2/3/7, 
Ferguson-Smith Correspondence Da-Du, pp. 19-20 (letter dated May 30th 1963). 
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embryonic cell cultures could be completed early enough in pregnancy to make 
therapeutic abortion possible’.18 However, the publication of the previously discussed 
key paper by Steele and Breg in 1966 would go on to refute these doubts. They showed 
that cells taken from human amniotic fluid were not only viable, but could be grown in 
culture and also karyotyped. They concluded that ‘chromosome analysis of the fetus in 
utero is therefore feasible’.19 This would prove to be correct, with the discovery acting 
as the stimulus to develop the field of prenatal testing.  
 
To enable these discoveries surrounding chromosome knowledge to become clinically 
applicable, however, would require changes to abortion legislation. This would occur in 
1967, with the passing of the Abortion Act, which specifically detailed that termination 
of pregnancy could be carried out after a diagnosis of fetal anomaly. Prior to the 
implementation of the Abortion Act 1967, there had been a number of legal prohibitions 
on abortion, but these did not cover Scotland and England together. Whilst in England 
there was specific legislation in place prohibiting termination of pregnancy, in Scotland 
abortion was a ‘common law offence without strictly defined limits’ which meant that 
‘it was possible to interpret it more elastically than English statute law’.20,21 Whilst 
abortion was defined in Scottish legal textbooks as being illegal, it was stated that it 
could be carried out when ‘certain medical criteria relating to the life and health of the 
                                                          
18 M.A. Ferguson-Smith, ‘Avoiding Serious Birth Defects by Prenatal Diagnosis: Current Effects on Birth 
Incidence’, in Changing Patterns of Conception and Fertility, ed. by D.F. Roberts and R. Chester, (London: 
Academic Press Inc. (London) Ltd., 1981), p. 121. 
19 Mark W. Steele and W. Roy Breg Jr., ‘Chromosome Analysis of Human Amniotic-Fluid Cells’, The 
Lancet, 287:7434 (1966), p. 385. 
20 Gayle Davis and Roger Davidson, ‘“A Fifth Freedom” or “Hideous Atheistic Expediency”? The Medical 
Community and Abortion Law Reform in Scotland, c.1960-1975’, Medical History, 50:1 (2006), p. 31. 
21 In England legislation such as the Offences Against the Person Act of 1837 prohibited abortion 
entirely, but this was succeeded in 1929 by the Infant Life Preservation Act (ILPA). The ILPA made 
termination of pregnancy legal when the abortion was carried out for the purpose of preserving the life 
of the pregnant woman. (See Stephen Brooke, ‘Abortion Law Reform 1929-68’, in Witness Seminar The 
Abortion Act 1967, ed. by Michael D. Kandiah and Gillian Staerck, Institute of Contemporary British 
History, 2002, p. 15.) Despite the ILPA, it was not clear from a legal perspective when it would be 
deemed suitable for a medical practitioner to carry out an abortion. The legal position at that time was 
put to the test in 1938 by Alec Bourne, a London-based gynaecologist who carried out an abortion on a 
14 year old girl who had become pregnant after being raped by several soldiers. Bourne’s case went to 
trial but he was acquitted, and the ruling set the precedent for a belief that abortions could be carried 
out under certain circumstances to preserve the life of the pregnant woman. See James Owen Drife, 
‘Historical Perspective on Induced Abortion Through the Ages and its Links with Maternal Mortality’, 
Best Practice & Research Clinical Obstetrics and Gynaecology, 24:4 (2010), p. 437 and John Keown, 
Abortion, Doctors and the Law. Some Aspects of the Legal Regulation of Abortion in England from 1803 
to 1982, (Cambridge: Cambridge University Press, 1988), p. 51. 
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mother were satisfied’.22 Thus a doctor could carry out a termination of pregnancy if 
they had assessed the case of the patient, and felt that an abortion would be the best 
outcome to maintain their health or welfare. The advances made in chromosome 
knowledge in the 1960s, combined with the implementation of the Abortion Act 1967, 
made it possible to not only detect fetal anomalies prior to birth, but to provide women 
with the option to terminate affected pregnancies if they chose to do so. For Marie 
Ferguson-Smith these two developments were inextricably linked in the development of 
practical prenatal decision-making: 
 
And in 1967, debate started about updating the 1921 abortion law. The 
amendment to the law was being looked at and it was introduced in 
Parliament by David Steel. And that was to allow women selective 
termination in certain circumstances with the signature of two doctors and 
so on. That was passed. And at the same time, scientists in United States 
were discovering that they could grow amniotic fluid cells. So putting the 
two things together suddenly you had the potential to give a practical 
choice in genetics. Because until then, until prenatal diagnosis, clinical 
genetics was consultative and there was nothing tangible on offer. You 
gave patients risks but you couldn’t do a bloody thing about it. There was 
little choice.23  
 
This lack of choice would change swiftly after the Abortion Act 1967 was officially 
implemented in April 1968.24 Only a few months after this the medical genetics unit in 
Glasgow was attempting to culture amniotic fluid cells, with Malcolm Ferguson-Smith 
stating that he was ‘particularly interested in the application of these cultures for the 
antenatal diagnosis of chromosome aberrations’ as he had ‘recently seen two pregnant 
women who are both translocation carriers’ and was therefore keen ‘to establish a 
reliable technique as soon as possible’.25 Ferguson-Smith wrote to colleagues in 
Wisconsin and Boston to seek their advice on how best to develop the technique, 
                                                          
22 Davis and Davidson, ‘“A Fifth Freedom”’, p. 31. 
23 MEFS Interview, Transcript 2, p. 4. 
24 Stephen Brooke, ‘Abortion Law Reform 1929-68’, in Witness Seminar The Abortion Act 1967, ed. by 
Michael D. Kandiah and Gillian Staerck, Institute of Contemporary British History, 2002, p. 19. 
25 UGC 188/3/3/15/6, Ferguson-Smith Correspondence Na-Ne, p. 2 (letter dated October 21st 1968). 
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updating them on their progress and setbacks, highlighting the knowledge sharing 
network which was widespread amongst those working in medical genetics.26  
 
A key reason that the group in Glasgow were able to start working on culturing 
amniotic fluid cells so soon after Steele and Breg’s publication was that they were 
already involved in working with samples of placenta, culturing these for chromosome 
analysis. This was to help understand the cause of multiple miscarriages or stillbirths, 
which was a research focus for the department as early as 1963.27 As the group had a 
laboratory in the Queen Mother’s Hospital in Glasgow, they were working closely with 
the obstetrics and paediatrics teams, and Marie Ferguson-Smith has recalled how these 
experiences helped her to develop skills for tissue culture: 
 
Our lab was based in a maternity hospital with neonatal paediatrics ward. 
Ian Donald was Professor of Midwifery,28 and he and the paediatricians 
wanted some chromosome analysis done on stillbirths and spontaneous 
abortions. I found that I could actually do it and I was quite good, 
successful at it. I could basically grow any tissue that was given to me. Our 
local paediatric pathologist Angus Gibson tutored me on selecting the 
correct placental tissues, a totally neglected but genetically informative 
material, and I started to develop tissue culture techniques to get 
chromosome preparations for clinical diagnosis. I started working very 
closely with the firms that were producing media, and the two firms that 
worked in Scotland were Gibco Bio-cult, and Flow, to improve tissue 
culture methods.29 
 
Whilst the group were working with placental tissues prior to the publication by Steele 
and Breg, after 1966 they began to consider how they could utilise their existing 
knowledge and skills to develop tissues cultures from amniotic fluid. Malcolm 
Ferguson-Smith has recalled the steps which led to these advances, which interestingly 
derived from receiving amniotic fluid samples from pregnant women whose fetus had 
                                                          
26 Letters to Wisconsin – UGC 188/3/3/19/14, Ferguson-Smith Correspondence Sa, pp. 9-10 (letters 
dated October 21st 1968 and November 13th 1968). 
Letters to Boston – UGC 188/3/3/12/12, Ferguson-Smith Correspondence Li-Lo, pp. 12-13 (letters dated 
October 21st 1968 and November 19th 1968). 
27 UGC 188/3/2/3/7, Ferguson-Smith Correspondence Da-Du, pp. 19-20 (letter dated May 30th 1963). 
28 This title given to Donald was a particular one in Scotland, with the Professor of Midwifery essentially 
a Professor in Obstetrics and Gynaecology. Donald himself was an obstetrician. 
29 MEFS Interview, Transcript 2, p. 3. 
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haemolytic disease due to Rhesus incompatibility. Haemolytic disease of the fetus and 
newborn is also known as Rhesus disease, and as shown in Figure 3.2, occurs in women 
who have Rhesus negative blood, if their fetus has Rhesus positive blood: 
 
 
Figure 3.2 – Showing the Rhesus interaction between a Rhesus negative woman, and 
her Rhesus positive fetus. The pregnant woman must have already been exposed to 
Rhesus positive blood (most usually in a previous pregnancy), and her body goes on to 
produce antibodies against the Rhesus antigen. If her immune system encounters the 
Rhesus antigen again (for example in a subsequent pregnancy) then the antibodies it had 
produced will cross the placenta and attack and destroy the red blood cells of the fetus. 
It can continue to attack these red blood cells even after birth. The condition is now 
fairly uncommon due to injections which can be given to the pregnant woman, which 
help to remove the fetal blood cells which are Rhesus positive before the mother 
becomes sensitised.30  
 
                                                          
30 ‘Hypersensitivities’, Lumen Microbiology 
<https://courses.lumenlearning.com/microbiology/chapter/hypersensitivities/> [accessed 7th August 
2018] (section titled Rh Factors). 
For more information on Rhesus, see ‘Rhesus Disease – Overview’, NHS Choices  
<http://www.nhs.uk/conditions/Rhesus-disease/Pages/Introduction.aspx> [accessed 16th August 2017]. 
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Marie Ferguson-Smith ‘was growing up placental cells at the time and of course that’s 
where the amnion comes from. So we thought about what material we needed to get 
practice for making amniotic cell cultures. We got samples of amniotic fluid from 
patients who had had their amniotic fluid tested because the fetus had haemolytic 
disease due to Rhesus incompatibility’.31 This was the material which would form the 
basis of much of the testing: 
 
In these cases the obstetricians were taking samples of amniotic fluid to 
test for bilirubin32 in the amniotic fluid and I wanted the amniotic cells that 
were being discarded. So these were some of the samples that we got to 
practice with. We got another lot of samples from pregnant patients that 
had to have their uterus removed because of obstetric problems. The whole 
pregnancy was removed in those cases, it’s called a hysterotomy. Ian 
Donald and his team told us when they had such cases and gave us the 
samples so that we could collect the amniotic fluid and grow the cells. 
That’s what Marie started working on.33 
 
This prior experience in tissue culture would go on to benefit the medical genetics unit 
over the following years. In November 1968 Malcolm Ferguson-Smith wrote to a 
colleague in Boston in the United States updating him on their progress, declaring that 
they were ‘nearly at the stage of making chromosomes’ and that this was partly due to 
the fact they were now getting amniotic fluid samples from much earlier in pregnancy, 
in cases of therapeutic abortion. The group had discovered that trying to culture cells 
from the amniotic fluid of pregnancies at a more advanced gestation was not as 
successful, such as in cases of Rhesus incompatibility.34 As mentioned in chapter two, 
the group first began offering amniocentesis for the purposes of prenatal diagnosis in 
1969. Some of the first people to undergo the testing were people that Ferguson-Smith 
                                                          
31 MAFS Interview, DS300117, p. 2. 
32 Rhesus disease causes a build-up of excessive amounts of bilirubin, which can lead to neurological 
damage. 
‘Rhesus Disease – Complications’, NHS Choices 
<http://www.nhs.uk/Conditions/Rhesus-disease/Pages/Complications.aspx> [accessed 16th August 
2017]. 
33 MAFS Interview, DS300117, p. 2. 
34 UGC 188/3/3/12/12, Ferguson-Smith Correspondence Li-Lo, p. 13 (letter dated 19th November 1968). 
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knew, such as friends and wives of colleagues with an understanding of the tests, but it 
was quickly made available to the general public.35  
 
After testing several individuals, by 1971 the Glasgow medical genetics unit were 
publishing results of their work in the area. In the British Medical Journal in October of 
that year, they highlighted the importance of the Abortion Act 1967 in giving ‘mothers 
with a substantial risk of bearing a seriously handicapped child the choice of having the 
pregnancy terminated’, and described that ‘as chromosome aberrations are numerically 
the most important indication for antenatal diagnosis our efforts have been directed 
particularly at the chromosome analysis of cultured amniotic fluid cells’.36 They carried 
out amniocentesis on 30 pregnant women who had been referred for genetic 
counselling, and they successfully determined the chromosome constitution in all but 
one of the fetuses, resulting in 29 fetal karyotypes for analysis. A second amniotic 
sample was required in 5 of the patients, bringing the success rate of the procedure to 
83%.37 Of the 29 fetuses that had their karyotype successfully determined, one was 
subsequently terminated. This was due to the finding that the fetus was male, in a 
pregnancy which was at risk of X-linked granulomatous disease, a condition which 
impairs the immune system and is passed from mother to son.38 
 
Over the following years the demand for prenatal chromosome analysis increased in the 
West of Scotland, with the majority of patients being referred through Malcolm 
Ferguson-Smith’s genetics clinics. He recalled that the group did not advertise the 
prenatal service at this stage as they were so busy with the work they had, and that they 
‘wanted to go carefully to know what we are doing, are we causing abortions or causing 
difficulties for the fetus. I mean was there a danger to the fetus in any kind of way.’39 
These concerns were reasonable, especially as awareness was growing amongst 
clinicians of the link between amniocentesis and miscarriage.40 However, referrals did 
                                                          
35 MAFS Interview, DS300117, p. 3. 
36 M.E. Ferguson-Smith, M.A. Ferguson-Smith, N.C. Nevin and M. Stone, ‘Chromosome Analysis Before 
Birth and its Value in Genetic Counselling’, British Medical Journal, 4:5779 (1971), p. 69. 
37 Ibid., p. 70. 
38 Ibid. 
39 Abortions in this context is referring to miscarriages. MAFS Interview, DS300117, p. 4. 
40 These risks are discussed in detail in chapter one on the history of prenatal testing. 
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increase, and the main indications for testing were ‘parental chromosomal translocation 
or mosaicism where the risk of fetal chromosome abnormality is about 20%, 
pregnancies in mothers over the age of 40 years where there is a 2.6% risk of Down’s 
syndrome, and pregnancies in mothers who have had a previous child affected with 
Down’s syndrome’.41  
 
134 cases were referred to the Glasgow and West of Scotland Genetic Counselling 
Service for chromosome analysis between 1969 and 1973, and 90% of these cases were 
successfully analysed.42 There was one false negative in this testing group; the cell 
culture showed an unaffected female karyotype, maternal cells having been cultured in 
error, and a chromosome anomaly was not predicted.43 Ferguson-Smith noted the details 
of this case in 1976 when completing a questionnaire about the prenatal testing service 
in Glasgow. He stated that the ‘trisomy-21 fetus was missed early on in our series. A 
normal female karyotype was diagnosed from our culture dish of fibroblast-like cells. A 
female infant with Down’s syndrome was born at term. Clearly maternal cells and not 
fetal cells were grown.’44 The group were aware of the problems that maternal cell 
contamination could cause, referring to it as ‘undoubtedly the major hazard in fetal 
chromosome analysis’.45 The group were keen to minimise this risk, and worked on 
several techniques to reduce the chance of diagnostic error. They noted that it was most 
likely that the maternal cells were ‘included in the sample either during insertion of the 
needle or during withdrawal when negative pressure is applied to the syringe. It is 
therefore essential to use a stiletto with the needle and to discard the first and last few 
drops of amniotic fluid withdrawn into the needle.’46 Marie Ferguson-Smith also 
recalled working with John Paul, an eminent research scientist based at the Beatson 
                                                          
41 M.A. Ferguson-Smith, ‘Prenatal Diagnosis of Chromosome Anomalies’, Proceedings of the Royal 
Society of Medicine, 67:12 Pt. 1 (1974), p. 1256 
42 Ibid. 
43 Ibid. 
44 UGC 188/3/4/57/2, Ferguson-Smith Correspondence M, pp. 11-15 (letter accompanying questionnaire 
dated 8th November 1976). 
45 M.A. Ferguson-Smith and M.E. Ferguson-Smith, ‘Screening for Fetal Chromosome Aberrations in Early 
Pregnancy’, Journal of Clinical Pathology, 29:Suppl. 10 (1976), p. 175. 
46 Ibid. 
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Institute in Glasgow,47 to learn how to identify different cell types and ensure they were 
growing fetal and not maternal cells: 
 
I learned a lot from John Paul, who was in Beatson and the guru in tissue 
culture. He was exceedingly helpful because the other technical difficulty 
was to make absolutely sure that we were growing fetal cells and not 
maternal cells. So very early on we had to be very aware of what type of 
cell line became established. Now this is where people like John Paul were 
fantastic, because I took my specimens to him. At one point he actually 
came to our lab and held my hand so to speak while we identified the 
different cell lines. So then we knew that if we had a fibroblast cell line 
from amniotic fluid it had to be skin and not fetal. We were able to 
differentiate between epithelial cells which were fetal and fibroblast which 
were suspect … Every step of the process was recorded. Each sample had a 
case note, each culture dish had its own identifying letter and each step of 
growing was recorded in detail. We could go over our notes, analyse each 
step, learn from it and get better results.48 
 
This focus on improving laboratory techniques to ensure correct results was of great 
importance, especially as the number of women undergoing prenatal testing increased 
dramatically over the following years. By 1975, 353 pregnant women had been tested, 
because of an increased chance of chromosomal anomaly in the fetus. A further 363 
women were tested to exclude a chromosomal disorder, despite their initial referral to 
the genetic counsellor being for a non-chromosomal factor, such as a previous 
pregnancy affected by a neural tube defect.49 One of the main reasons for referral for 
chromosome analysis was pregnancies with a maternal age of over 40, as a number of 
chromosome disorders in the fetus become more frequent with advanced maternal age. 
121 women underwent amniocentesis as they were over 40 years of age, and 8 of these 
pregnancies were diagnosed with chromosomal anomaly, giving a high anomaly rate of 
6.6%. The aberrations included seven cases of Down’s syndrome and one of XXY 
Klinefelter’s syndrome.50 In addition, 1 of 72 cases tested in women aged 35-39 had a 
                                                          
47 The Beatson was originally a cancer hospital which opened in 1890, with a research department 
formed at the facility in 1912. Under the directorship of Dr John Paul, the distinguished scientist noted 
above, in 1967 the department became the Beatson Institute for Cancer Research. See ‘History’, Cancer 
Research UK Beatson Institute <http://www.beatson.gla.ac.uk/About/history.html> [accessed 7th August 
2018]. 
48 MEFS Interview, Transcript 4, p. 2. 
49 M.A. Ferguson-Smith and M.E. Ferguson-Smith, ‘Screening for Fetal Chromosome Aberrations’, p. 166. 
50 Ibid., p. 167. 
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chromosome anomaly (rate of 1.4%).51 Among 363 women offered amniocentesis for 
reasons other than a potential chromosomal disorder, two cases of chromosome 
aberration were diagnosed, one of Down’s syndrome, and one in which a female fetus 
had an extra X chromosome (triple X syndrome).52 All 11 of these diagnoses led to 
termination of the affected fetus. 1 case of Down’s syndrome was missed throughout 
the testing period (the above-mentioned case due to maternal cell contamination).53 
 
The number of amniotic fluid samples being tested continued to grow, as shown in 
Figure 3.3 (relevant column highlighted with a blue arrow).  
 
 
Figure 3.3 – Detailing the number of amniotic fluid samples tested per year.54 
 
                                                          
51 Ibid. 
52 Ibid., pp. 170-171.  
53 Ibid., p. 166. 
54 UGC 188/3/4/2/1, Ferguson-Smith Correspondence with G C Arneil, p. 9. 
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In 1976 there were 530 amniotic fluid samples tested, but by November 1977 around 
100 amniotic fluid samples were being received for testing each month.55 Despite these 
increasing numbers, Ferguson-Smith felt that they did not represent the actual need for 
the testing in the region, which he estimated to be ‘at least four times the number 
received’.56 
 
As prenatal testing for fetal chromosome anomalies was becoming well established in 
Glasgow, reports of successful attempts at chromosome analysis from amniotic fluid 
were also being described from other groups around the world. Ebbin and colleagues in 
California reported their experience in 1973 of diagnosing a translocation between 
chromosomes 9 and 18 in a fetus at 17 weeks gestation. The pregnancy was terminated 
and the fetus was found upon pathological examination to have several anomalies.57 In 
1974 Gordon and colleagues in Edinburgh reported their experience of diagnosing a 
case of trisomy 18 in the fetus of a forty-one year old woman. They took an initial 
amniotic fluid sample by amniocentesis at 16 weeks but the cells failed to grow in 
culture, so the procedure was repeated at 19 weeks gestation. The second sample of 
cells grew and showed trisomy 18, and the pregnancy was subsequently terminated.58 
The group commented that they felt the case illustrated ‘the value of antenatal diagnosis 
of fetal abnormality when this can be followed by abortion’.59 Results from larger scale 
trials were also starting to emerge, with Wahlstrӧm and colleagues reporting their 
findings from a study of prenatal chromosome analysis carried out on 219 women. 
Overall 97.8% of women in their study received chromosome information about the 
fetus, and the frequency of miscarriage after the procedure was 2.3%.60 Three cases of 
fetal chromosome anomaly were diagnosed, all of which led to termination of the 
pregnancies.61 The group concluded that ‘prenatal chromosome determination is a 
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57 Allan J. Ebbin, Miriam G. Wilson, Joseph W. Towner and James P. Slaughter, ‘Prenatal Diagnosis of an 
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59 Ibid., p. 111. 
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reliable and safe method, allowing as it does, the diagnosis of invalidating diseases 
during pregnancy’.62  
 
IV. The Technical Issue of Mosaicism Associated with Prenatal Testing 
Whilst prenatal testing programmes were becoming established in various centres 
throughout the world, it was perhaps inevitable that potential concerns would arise. One 
such issue was mosaicism, where a mixture of cells would be encountered after 
amniocentesis, with some of the cells having 46 chromosomes, whilst other cells 
showed a different chromosome count. These cases presented difficulties for 
counselling, as clinicians were unsure of the impact such a cell mixture could have on 
fetal development. Expectant parents were therefore placed in a very difficult situation, 
whereby they were unsure of what the outcome of mosaicism would be, and were 
having to make decisions to terminate or continue with their pregnancies based on very 
limited information. For example, some cases of fetal mosaicism which were detected 
prenatally led to the birth of children with an unaffected karyotype, displaying no 
physical signs of any chromosome anomaly. Such a case was reported by Atkins, 
Milunsky and Shahood in 1974. Following amniocentesis one cell line showed a male 
karyotype, 46,XY, and the other cell line had 47 chromosomes, including two abnormal 
X chromosomes and a normal Y chromosome. The pregnancy continued, and studies 
after birth showed a 46,XY male karyotype.63  
 
Reports were also emerging of cases where terminations of pregnancy occurred as a 
result of a diagnosis of mosaicism, only for the fetus to be found not to have the 
expected anomalies upon pathological examination. Kardon and colleagues reported a 
case where a 45,X fetus was diagnosed as a result of amniocentesis, but the terminated 
fetus was found to be male, with a 46,XY chromosome complement.64 It was thought 
that this was a case of 45,X/46,XY mosaicism. As the authors highlighted, if the 46,XY 
chromosome complement had been discovered initially then the mosaicism would not 
                                                          
62 Ibid., p. 190. 
63 Leonard Atkins, Aubrey Milunsky and Jacqueline M. Shahood, ‘Prenatal Diagnosis: Detailed 
Chromosomal Analysis in 500 Cases’, Clinical Genetics, 6:4 (1974), p. 318. 
64 N.B. Kardon, P.R. Chernay, L.Y.F. Hsu, J.L. Martin and K. Hirschhorn, ‘Problems in Prenatal Diagnosis 
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149 
 
have been diagnosed. It is therefore unlikely that a termination of pregnancy would 
have taken place. Another case of 45,X/46,XY mosaicism was reported by the same 
laboratory in 1976. A prenatal diagnosis of 45,X/46,XY mosaicism was made at 22 and 
a half weeks gestation, and the mosaic cell line was found from two different cultured 
flasks of amniotic fluid cells. The parents were counselled about the range of physical 
manifestations which could occur as a result of this mosaicism, ranging from ‘relative 
normality to sexual maldevelopment’ and they opted to continue with the pregnancy. 
The infant was born phenotypically male, and by the time the paper had gone to print 
was still developing normally, however the mosaic cell line was confirmed postnatally 
in both blood and skin cultures.65 These cases highlight one of the many difficult 
decisions faced by pregnant women undergoing prenatal diagnosis. Whilst the testing 
could offer an insight into the chromosome constitution of a fetus, it could not 
necessarily predict the effect this would have on the mental and physical development 
of the fetus if the pregnancy continued.  
 
Trisomy 20 mosaicism was also diagnosed relatively frequently following 
amniocentesis. In these cases, a mixture of cells would be found, some of which had 46 
chromosomes, and others which had 47 chromosomes, due to an extra copy of 
chromosome 20. Recognising that postnatal outcome of this condition was unknown, in 
1978 Rodriguez commented that ‘confronted with a situation of undetermined 
significance and risk, counselors and parents alike have so far considered termination of 
pregnancy as the only acceptable solution’.66 In the cases reported by Rodriguez and 
colleagues, two observations of trisomy 20 mosaicism were made; one couple opted to 
terminate their pregnancy, whilst the other chose to continue ‘in spite of the uncertainty 
associated with the prenatal finding’.67 In the terminated fetus ‘no external or internal 
abnormalities of any organ or tissue’ were found upon pathological examination, and 
tissue cultures of skin showed no evidence of extra copies of chromosome 20.68 
Similarly, in the case of the couple who opted to continue with their pregnancy, no 
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physical anomalies were found when the baby was born. By 2 months of age all 
‘physical and developmental landmarks were completely normal’, and analysis of the 
tissues of the infant after birth ruled out mosaicism for trisomy 20.69 The authors in the 
discussion section of their paper pondered whether it would turn out that trisomy 20 
‘might yet reflect just another peculiarity of amniotic fluid cells in culture’.70 
 
Several other groups also published similar findings. Kardon and colleagues reported 
three instances where trisomy 20 mosaicism was detected prenatally. Two couples 
opted to continue with their pregnancies and phenotypically unaffected infants were 
born, both of whom had 46 chromosomes.71 The third couple opted to terminate their 
pregnancy and upon pathological examination the fetus was found to be a 
phenotypically unaffected female. In this instance, cells from the aborted fetus failed to 
grow in culture, so it was not possible to confirm or refute a diagnosis of mosaicism.72 
Nevin and colleagues reported a similar case where a 25 year old woman was referred 
for amniocentesis due to a history of neural tube defects in her husband’s family.73 After 
undergoing amniocentesis three separate chromosome cultures were set up from the 
amniotic fluid, and a total of 41 cells were analysed from these. 22 cells had a 46,XX 
chromosome constitution, and 19 cells had a 47,XX+20 constitution. Although ‘the 
difficulty of interpreting the mosaicism were explained to the parents’ they opted to 
terminate the pregnancy. The aborted fetus was found to be physically unaffected, and 
post-abortion chromosome analyses from several tissues were all found to be 46,XX.74 
 
In the cases listed above it is clear that terminations took place in a number of 
pregnancies where the fetus was found after abortion to be phenotypically and 
chromosomally unaffected. Mosaicism therefore presented a real difficulty for genetic 
counselling – what advice should be given to pregnant women when such anomalies 
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were found? In most of the cases quoted above, women and couples were given the 
information that there could be a potential anomaly but that the outcome of this was 
unknown. It is perhaps not surprising that several women in this situation opted to 
terminate their pregnancies. However, the impact of this upon finding out the fetus was 
physically and chromosomally unaffected after abortion must have been great, if the 
women were told of these findings. These cases raise wider questions of whether having 
more knowledge of the condition of a fetus prenatally is actually beneficial to a woman 
and/or couple, especially in cases where medical professionals are unable to offer a 
great deal of insight into the impact this may have on fetal and child development. 
 
V. Debate Surrounding Maternal Age Effect 
The above section highlights some of the main issues linked to decision making 
following prenatal testing. For some pregnant women, such as those faced with the 
possibility of mosaicism in the fetus, they had only limited information upon which they 
had to make decisions about continuing or ending their pregnancy. Uncertainties about 
how prenatal findings would influence postnatal development were a real concern for 
researchers, as they were aware of the impact such information could have on decisions 
surrounding termination of pregnancy. However, mosaicism was not the only area 
where discrepancies between prenatal and postnatal data were beginning to emerge. 
One of the key debates centered on the inconsistency of pre- and post-natal risk 
estimates of chromosomal anomalies at varying maternal ages. 75 This was an area in 
which Ferguson-Smith had a keen interest, and he was involved in a number of 
discussions on this subject. The group he led were keen to provide ‘accurate estimates 
of the risks associated with increased maternal age’ to enable patients to make 
‘informed decisions about whether or not to have amniocentesis’.76  
 
                                                          
75 ‘Risk’ was the term commonly used to describe the likelihood of pregnancies having certain 
chromosomal or other anomalies. There is a current movement amongst parents, advocates, and 
individuals with Down’s syndrome to change the use of the term ‘risk’ to that of ‘chance’, due to the 
negative connotations that the word ‘risk’ entails. Where possible in this thesis I have used the term 
‘chance’, however in this particular section the word ‘risk’ will be used to be maintain historical 
accuracy, as many descriptions are quoted or paraphrased from publications which use ‘risk’. 
76 M.A. Ferguson-Smith, ‘Letters – Prospective Data on Risk of Down Syndrome in Relation to Maternal 
Age’, The Lancet, 308:7979 (1976), p. 252. 
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However, this area of research was not without controversy, as a number of research 
groups disagreed on what the correct risk estimates for Down’s syndrome should be. In 
The Lancet in 1976 Ferguson-Smith presented the case for Down’s syndrome rates 
being a great deal higher than previously thought. Most patients at this time were 
counselled based on risks from retrospective studies of live births, which gave much 
lower risk rates of Down’s syndrome than amniocentesis did. For example, in a 
retrospective study carried out by Dr Ernest Hook in New York, the risk of having a 
child with Down’s syndrome was 0.4% in mothers aged 35-39, and 1.3% in mothers 
aged 40-44.77 In contrast, the study presented by Ferguson-Smith of 283 pregnancies 
tested by amniocentesis found the risk of carrying a fetus with Down’s syndrome to be 
0.8% in women aged 35-39 years, and 4.6% in women 40 years or over.78 Ferguson-
Smith argued that the ‘differences between the risk calculated from the prospective and 
retrospective data appear to be too great to be accounted for solely by the loss (through 
spontaneous abortion and stillbirth) of Down syndrome pregnancies between the time of 
amniocentesis and delivery’. He concluded that ‘the risks associated with increased 
maternal age … have been substantially underestimated in the past’, and that ‘the most 
important consideration is to ensure that patients and their obstetricians take account of 
the prospective data so that they may make informed decisions about whether or not to 
have amniocentesis’.79 Other researchers based in Edinburgh wrote to The Lancet 
supporting Ferguson-Smith’s letter. Their own data had shown that women aged 35-39 
had a 1.3% risk of having a fetus with Down’s syndrome, and that in women aged 40 
years and over this was 3.4%.80 The Edinburgh group concluded that they wished to add 
‘our support to Professor Ferguson-Smith’s opinion that amniocentesis results provide 
the preferred basis for clinical and actuarial judgements regarding prenatal screening’.81 
 
However, these opinions sparked a debate amongst the scientific and medical 
community. In a reply to Ferguson-Smith’s paper Hook described his opinion as being 
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‘erroneous on several counts’.82 Hook believed that there were ‘no grounds’ for 
Ferguson-Smith’s claim ‘that my study or the other retrospective studies cited have 
grossly underestimated the true rates’. He argued that the discrepancies in the rates 
could be explained partly by the high rate of fetal loss which occurs late in pregnancies 
with fetal anomalies, and partly by the fact that Ferguson-Smith had grouped ages 
together (such as 35-39 and 40 and over) when the age estimates, in Hook’s opinion, 
should be analysed by each individual year.83 Hook concluded that ‘data derived from 
studies of amniotic fluid obtained in the second trimester cannot be used to estimate 
rates of cytogenetic abnormalities among live births’ and that ‘those doing genetic 
counselling should carefully distinguish the risk of an abnormality in a live birth from 
the risk of an abnormality detectable in mid-pregnancy’.84  
 
The Paediatric Research Unit at Guy’s Hospital in London also wrote to The Lancet 
with their thoughts on the matter. Whilst they found that their amniocentesis figures 
‘show a similar increase in the frequency of chromosomally abnormal offspring in 
women of 35 years and older, and the risk for Down syndrome specifically is about 
double that usually indicated by postnatal studies’, they thought that it ‘should not be 
assumed that the amniocentesis figures necessarily represent the true risk figures which 
should be applied to the population as a whole’.85 Previous research by their department 
had shown that of fetuses with Down’s syndrome roughly 13.6% aborted, 6.4% were 
stillborn, and 80% were liveborn, leading them to conclude that the discrepancy 
between the prenatal and liveborn figures was unlikely to be wholly accounted for by 
‘fetal wastage’. The group suggested that one reason for the discrepancies could be that 
women referred for amniocentesis have a known poor obstetric or family history, and so 
represent a group who were already high-risk. The group believed that instead of 
assuming that ‘the data gathered prenatally are correct and the postnatal incorrect, we 
believe that the discrepancy between the two could stimulate a fruitful search for 
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information which might allow the definition of further risk factors, so that 
appropriately weighted counselling could be given to individuals’.86  
 
As different groups were publishing a variety of findings in quick succession, the 
research community had the difficult task of trying to reach a consensus on which were 
the correct figures for a number of conditions, to allow this information to be translated 
into clinical practice. An editorial in The Lancet in 1978 suggested that perhaps the 
‘correct course of action is to advise the older mother of the unresolved discrepancies 
between liveborn and amniocentesis rates of Down’s syndrome, to acquaint them with 
the possible complications of amniocentesis itself, and to allow them to use their own 
judgement of which risks pose the greater threat’.87 This would allow women to weigh 
up the chance of miscarriage associated with amniocentesis versus the chance of the 
fetus having a chromosomal anomaly, and make their own decision about whether to 
undergo testing. However, the reality was not quite as simple as this, with many women 
unable to access prenatal testing facilities due to their age. Different centres throughout 
the world had varying age cut-off points at which they would offer amniocentesis, with 
some centres offering the testing from 35 onwards, whilst others would only make it 
available to women over the age of 40.  
 
In Edinburgh the policy was to ‘offer amniocentesis to patients of 38 years or over and 
to make the procedure available on request to those aged 35-37’.88 Data presented by 
the Edinburgh group showed that between 1975 and 1977, of the 404 pregnancies 
tested, with a maternal age between 35 and 39, 1.98% of these pregnancies were found 
to have chromosomal anomalies. 195 pregnancies were tested with a maternal age over 
40, and 6.15% of these were found to have chromosome anomalies. This ‘relatively 
high’ prevalence of chromosome anomalies in the younger age bracket led the group to 
conclude that their results ‘highlight the necessity for more widespread application of 
amniocentesis in the 35 and over age group’. However they felt that ‘the ultimate 
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decision should rest with the parents and the availability of clinical and laboratory 
expertise’.89  
 
Research into maternal age effects became a key focus for Ferguson-Smith, and for 
several years he worked on furthering his knowledge in this area. He was certain that if 
those working in the field wanted to reduce the number of babies born with Down’s 
syndrome, then amniocentesis would have to be offered to younger women, in his 
opinion those aged 35 and over. In July 1978 he wrote to The Lancet, again querying 
the discrepancies between live-birth and prenatal rates of Down’s syndrome, and the 
impact these would have on younger women. Data presented at the 3rd European 
Prenatal Diagnosis Conference had shown that the expected rate of Down’s syndrome 
in pregnancies in the 35-39 year age group was 0.84%, which was 37% above the 
expected rate from live born studies.90 Ferguson-Smith felt that it seemed likely that 
‘many obstetricians are deterred from offering amniocentesis to their patients in the 35-
39 years age group because they use obsolete and incomplete information and believe 
the risk of a fetal chromosome abnormality may not be sufficiently different from the 
risk of fetal loss after amniocentesis to justify the procedure’.91 By November 1980 he 
was working to convince his own obstetrics colleagues in Glasgow that offering women 
amniocentesis from the age of 35 would reduce the number of Down’s syndrome births 
further. He wrote to Doctor Rob Chatfield of the Department of Obstetrics and 
Gynaecology in the Queen Mother’s Hospital outlining that ‘about 50% of mothers 40 
years of age and over are being tested in Glasgow, but, although the risk to these 
mothers is high, the numbers of affected births avoided are small. If all such 
pregnancies were tested the reduction in Down’s syndrome would be 10%, whereas the 
reduction would be 37% if all mothers 35 years of age and over were tested.’92 He 
presented data showing that, in 1979, different health board regions were varying a 
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great deal in the number of pregnancies in women over the age of 35 who were tested, 
as shown in Figure 3.4 (relevant columns designated with a blue arrow): 
 
 
Figure 3.4 – Showing the varying numbers of pregnancies in women aged 35 and over 
which were tested by amniocentesis in different health boards.93 
 
Some of the health boards which tested the highest number of pregnancies were those 
associated with the Edinburgh screening centre (38.8%), the Dundee screening centre 
(26.8%) and the Glasgow screening centre (22.6%). In stark contrast, the Western Isles 
health board tested no pregnancies, highlighting the huge variety in access to services 
dependent upon geographical location. A potential reason for these discrepancies could 
be a lack of suitable facilities and trained staff in the more remote geographical region 
of the Western Isles, as even in Glasgow there were concerns being raised about the 
possible burden on staff involved in carrying out amniocentesis if the age was dropped 
to 35 years. In November 1980, Professor Whitfield, Head of the Department of 
Obstetrics at the Queen Mother’s Hospital wrote of his concerns that the ‘ultrasonically 
trained staff are overstretched at the moment’ and that work was now having to be done 
after normal working hours and at the weekend. Whilst he confirmed that he would 
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‘discuss with the ultrasounders the (at present) hypothetical implications of reducing the 
age for Down’s syndrome screening to 35 years’ he felt that ‘my own view remains that 
37 years is the right age to begin offering this screening to mothers, and I base this on 
my own balancing of relative risks rather than on logistic or staffing factors’.94 
 
By December 1980 it had been confirmed by the Executive Committee of the Division 
of Obstetrics that, in fact, the policy of the Queen Mother’s Hospital was ‘to offer 
amniocentesis to all women of 35 years of age or over, and while this may not be the 
practice in the rest of the West of Scotland it has been the policy of the Hospital since 
the innovation of amniocentesis’.95 It is noteworthy that an important member of staff, 
Professor Whitfield, if sticking to his view that amniocentesis should be offered from 
the age of 37 onwards, would not have been following official hospital policy on this 
matter. A group led by Hamerton and Boué seemed to have similar reservations to 
Whitfield, concluding that a ‘centre’s decision to set a lower limit at which it will 
recommend amniocentesis for maternal age will depend on the balance between a 
number of factors’ including, amongst others, the resources available to the centre. The 
group recommended that ‘highest priority for this service should be given to mothers 
aged 40 and above. Furthermore all mothers aged 40 and over should be informed about 
the test and offered this service if they so wish. High priority for amniocentesis should 
be given to mothers between ages 37 and 39 who have a moderately high risk. If 
sufficient resources are available, all mothers in this age group should be informed 
about the test and offered the service. Mothers in the 35-36 age group may enter this 
programme if facilities are available.’96 
 
These concerns about staffing commitments, resources, and risk of miscarriage 
continued to cause discrepancies between policy and practice for a number of years. In 
1985, Ferguson-Smith wrote to Professor Beard, who was based in the Department of 
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Obstetrics and Gynaecology, Saint Mary’s Hospital Medical School in London, 
highlighting that, although the policy in Glasgow was to offer amniocentesis to women 
aged 35 and over, his ‘obstetric colleagues show no uniformity in their policy’. He 
believed that ‘the majority now adopt the lower age of 35 years, although some of my 
older colleagues still use 37. In the past, many were influenced by the rather high fetal 
loss rate obtained in the MRC Study into the hazards of amniocentesis’.97 These hazards 
were of course of importance, as obstetricians had to weigh up the potential risk of 
miscarriage associated with amniocentesis against the chance that a fetus would have a 
chromosome anomaly. With the miscarriage risk not known in the early days of prenatal 
testing it is understandable that the teams would have proceeded with caution, however 
it seems that some obstetricians continued with this viewpoint even once the testing was 
safer and well established.  
 
Research into the referring practices of 173 Western New York State obstetricians 
found that between 1974 and 1978, 47.4% of this group did not refer a single patient for 
amniocentesis.98 Of those obstetricians who did refer patients for the testing procedure, 
their demographic showed that they were younger, worked in rural areas, were 
associated with university hospitals and tended to be non-Catholic.99 A study in Canada 
found that women expected that the testing would be offered to them if their physician 
thought it was necessary, however women were frequently not offered any testing. This 
led the authors to conclude that ‘professional reticence has the practical effect of 
blocking access to prenatal diagnosis, especially for the youngest eligible age group 
(35-38 years)’.100 These studies highlight that the obstetrician could play a central role 
in limiting access to prenatal testing, and the impact of the views of key clinicians in 
Scotland will be discussed in chapter five of this thesis.101 
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Ferguson-Smith remained focused on researching the impact of maternal age on 
chromosome anomalies, and one of his key contributions to the field was a study with 
John Yates, who was also based at the Duncan Guthrie Institute, of 52,965 
amniocenteses from across Europe. The study was the largest of its kind, and aimed to 
analyse the influence of maternal age for a number of chromosome disorders including 
trisomies 13, 18 and 21, Turner’s syndrome and Klinefelter’s syndrome. Of the 52,965 
pregnancies tested, 1200 chromosome aberrations were found, and an analysis of their 
frequency carried out.102 Trisomy 21 (Down’s syndrome) was responsible for 51.1% of 
the aberrations, trisomy 18 (Edward’s syndrome) for 10.1%, XXY (Klinefelter’s 
syndrome) for 7.2%, triple X syndrome for 5.4%, trisomy 13 (Patau’s syndrome) for 
3.2%, 45,X (Turner’s syndrome) for 2.0%, and XYY syndrome for 1.5%.103  
 
The data from this study strengthened the hypothesis that trisomy 21 was increased in 
older mothers, but interestingly it showed that the condition rose ‘exponentially from 
age 35’.104 This finding supported Ferguson-Smith’s argument that testing for the 
condition via amniocentesis should be offered to women from the age of 35 onwards if 
a decline in Down’s syndrome births was the desired outcome of the testing 
programmes. The research also showed that the rise in cases of trisomy 21 was not 
sustained past the age of 46 years; Ferguson-Smith and Yates hypothesised that this was 
due to the inability of older mothers to maintain a fetus with a chromosome anomaly in 
utero, which would result in an increased miscarriage rate prior to amniocentesis.105 
Similar figures were observed for both trisomy 18 and 13, although the incidence rate 
for both conditions was lower than for trisomy 21. In trisomy 18 the rates rose 
exponentially up to age 43, and in trisomy 13 up to age 42, but then declined in both;106 
it was hypothesised that rates were lower for both of these conditions than for trisomy 
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21 due to their lower viability, which resulted in greater difficulty in maintaining the 
fetus in an older mother.107   
 
In contrast, slightly different findings were noted in the majority of the sex chromosome 
anomalies. For both triple X and XXY Klinefelter’s syndromes there was an increase 
above a maternal age of 38, but this level did not decrease with advancing maternal age. 
This was thought to be due to the lesser impact these conditions would have on the 
viability of a fetus.108 In the case of 45,X Turner’s syndrome, the mean maternal age for 
the chromosome anomaly was 38 years, notably lower than for triple X syndrome (40.8 
years) and Klinefelter’s syndrome (41.1 years).109 Turner’s syndrome showed an 
inverse relationship with increasing maternal age, and again this was thought to be due 
to the decreased viability of the fetus, which would lead to earlier miscarriages in older 
mothers.110 The findings of this study were clinically significant, as they presented a 
case for lowering the age at which prenatal testing was offered to 35. They were also 
important for providing data to prospective mothers which highlighted the increasing 
chance of having a child with a fetal anomaly as maternal age progressed, potentially 
influencing the decision of whether or not to accept the risk of miscarriage associated 
with amniocentesis.   
 
VI. Uptake Rates of Prenatal Testing 
Whilst testing for chromosomal disorders had the potential to drastically reduce the 
number of babies born with chromosome anomalies, the testing was not as popular as 
would perhaps have been expected. This could have been for several reasons, including 
concerns about the safety of the procedure, objections to termination of pregnancy, and 
a lack of clinicians who were willing to refer patients for the testing, amongst others. 
The safety issues were discussed in chapter one, and the issues surrounding clinician 
referrals and social reasons for objecting to the testing will be discussed in detail in 
chapters five and six. Much of the data which follows focuses on detection and 
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termination rates for Down’s syndrome, but other chromosome anomalies were also 
being tested for. However, at the time much of this data was being published, it was 
thought that the prevention of Down’s syndrome was the most important in terms of 
public health initiatives and funding. Cases of Down’s syndrome were numerically the 
highest, and people with Down’s syndrome can have a number of other health concerns 
linked to the condition, such as heart problems, which require medical attention. Due to 
medical advances many individuals with Down’s syndrome were starting to live into 
adulthood and progressing through education systems, and social support systems were 
needed to support these individuals through each of these life stages. By way of 
contrast, at this time the majority of individuals with trisomy 13 and trisomy 18 were 
not expected to live past their first year, and so the financial and longer-term health 
implications were perhaps not seen as being quite as important.111  
 
The longer-term health implications of sex chromosome anomalies were also not seen 
as being of the same severity as those associated with Down’s syndrome by some 
clinicians and pregnant women. As described by Holmes-Siedle and colleagues, ‘Sex 
chromosome abnormality is far less damaging to the phenotype; most types are 
compatible with a normal life expectancy, and are often undiagnosed.’112 This is 
reflected in the lower termination rates for pregnancies with sex chromosome anomalies 
when compared to pregnancies with Down’s syndrome, as shown in a study by Verp et 
al. published in 1988. 87.5% of pregnancies with autosomal aneuploidy ended with 
termination (this group was composed of cases of trisomy 21, trisomy 18 and trisomy 
13), but only 41.2% of cases of sex chromosome anomaly resulted in elective 
termination of the pregnancy.113 
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Between 1976 and 1981, 2700 women aged 35 or over were tested for chromosome 
aberrations in the West of Scotland; these women were offered the testing due to their 
advanced maternal age.114 This represented only 20.8% of women over 35 who were 
pregnant during this period. Down’s syndrome births in the West of Scotland were 
reduced by 8.8% during this period. However, this figure did not take into account the 
30% of Down’s syndrome fetuses which were thought to be lost between amniocentesis 
and birth, so the real impact of the testing was thought to be as low as 5.8%. Ferguson-
Smith felt that this ‘must be regarded as disappointing when it is considered that an 
estimated 35% reduction might be achieved in the region if all women 35 years of age 
or over had amniocentesis’.115 There were several reasons that women did not attend for 
amniocentesis in this age range; whilst 16% of women refused amniocentesis as they 
objected to termination on religious or moral grounds, the majority (50%) did not have 
amniocentesis because their obstetrician did not offer them the procedure, believing the 
risks outweighed the benefits.116 These attitudes are reflected in a survey carried out in 
1976 by the Clinical Genetics Society, who found that ten regional health authorities 
tested less than 1% of all their pregnancies.117  
 
Several other centres also reported lower than expected uptake of their prenatal 
diagnosis programmes. Bell and colleagues found that in women aged over 35 years in 
Queensland, Australia, the uptake of prenatal diagnostic testing was only on average 
15.5% between 1981 and 1983.118 This was despite women in the region having access 
to amniocentesis since 1974.119 Youings, Gregson and Jacobs found that in Wessex the 
uptake of prenatal diagnosis amongst eligible women was 36% (mean proportion) with 
figures ranging from only 16% uptake in women aged 35, to 50% uptake in women 
aged 37 and over.120 With these uptake rates, corrected for the expected 30% loss of 
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fetuses with Down’s syndrome between prenatal diagnosis and birth, the group 
surmised that they had detected around 53% of cases of Down’s syndrome using 
prenatal testing. However, they thought it was likely that this figure would be an 
overestimate, as they could not ascertain all the livebirths of babies with Down’s 
syndrome which had occurred in the region.121 Data from the Mersey Region and North 
Wales showed a higher uptake of testing in women over the age of 35, with the 
percentage of women tested increasing steadily, rising from 26.65% in 1978, to 44.13% 
in 1983.122 The detection rate for Down’s syndrome between 1978 and 1984 was 
15.06% (taking into account the expected 30% loss of Down’s syndrome fetuses).123 
Whilst the number of pregnancies being tested in this region was higher than in the 
West of Scotland, less than a quarter of Down’s syndrome cases were detected.  
 
VII. The Development of Maternal Serum Screening Programmes 
A potential means to test the pregnancies of more women was however being developed 
during this time period, as a result once again of alpha-fetoprotein (AFP). As previously 
described, this protein was found in increased quantities in pregnancies in which the 
fetus had a neural tube defect. It migrated across the placenta and was detectable at low 
levels in blood taken from pregnant women. This discovery opened up the entire field of 
screening for neural tube defects, enabling a maternal blood test to determine whether 
the likelihood of the fetus having a neural tube defect was increased. A similar 
discovery would change the process of testing for chromosome disorders, as Merkatz et 
al. noted in 1984 that there was an association between low maternal serum alpha-
fetoprotein (msAFP) levels and autosomal trisomies, such as Down’s syndrome.124  
 
This work by Merkatz prompted others to begin investigating the use of msAFP as a 
marker for Down’s syndrome and other chromosome anomalies, with one of the first 
papers being published by Cuckle, Wald and Lindenbaum in April 1984. They analysed 
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records from their AFP screening service (which had been running since 1975 to test for 
neural tube defects) and found 61 pregnancies in which the fetus had Down’s syndrome 
and msAFP results were available. Overall they found that msAFP levels were 
significantly lower for pregnancies where the fetus had Down’s syndrome, compared to 
normal pregnancies.125 Although this data was retrospective, they concluded that 
‘Maternal serum AFP levels are significantly lower in pregnancies associated with 
Down syndrome than in unaffected pregnancies and sufficiently so to form the basis of 
a screening test.’126 Noting that msAFP levels and maternal age were independent 
measures of the chance of Down’s syndrome, they proposed that the use of both of 
these parameters together would result in more successful screening.127 They postulated 
that an effective screening policy would be to offer amniocentesis to all women above a 
certain age (suggested age 38) and then to those of younger maternal ages, whose 
msAFP levels were low enough to suggest Down’s syndrome. Implementing a 
screening policy such as this would result in 40% of Down’s syndrome pregnancies and 
6.8% of unaffected pregnancies being selected for further testing by amniocentesis.128  
 
Their paper was not however met with overwhelming support, with several authors 
writing in to The Lancet shortly after its publication to voice their concerns. Houlsby, 
based in the Department of Paediatrics in Sheffield, calculated that Cuckle and 
colleagues estimate of 6.8% of unaffected pregnancies being selected for amniocentesis 
would result in 44,404 unaffected pregnancies undergoing amniocentesis in one year in 
England and Wales. Houlsby wrote that this ‘alarming number of false positives with 
consequent parental distress, taken in conjunction with the number of miscarriages that 
would result from the amniocenteses performed’ led them to conclude that it was ‘not 
acceptable to offer amniocentesis to over 6% of pregnant women on the basis of this 
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proposed screening policy’.129 Others such as Seller raised concerns about the potential 
emotional cost to pregnant women, especially as, when their data was analysed, 
between 400 and 500 amniocenteses would have had to have been carried out to detect 
1 case of Down’s syndrome. Seller emphasised that screening programmes caused a 
greater level of anxiety for women who had no reason to suspect a chromosome 
anomaly in their fetus, than for women who expect their pregnancy may have a higher 
chance of a chromosome disorder, possibly due to family history or advanced maternal 
age. She concluded that ‘It is possible that, with a yield of around 1 in 450, the price 
could be too high in emotional terms, even if the test were proved to be cost-effective’ 
and that more counselling facilities would need to be provided to support women 
through the screening process.130 Others, such as Cowchock and Ruch, reported that, 
although there seemed to be a link between decreased levels of msAFP and Down’s 
syndrome, the difference was not great enough when compared to pregnancies where 
the fetus did not have the condition for them to confirm the findings by Cuckle and 
others. They concluded that ‘At this time the suggestion that low maternal serum AFP 
levels could be used as a screening test for fetal trisomies or Down syndrome may be 
premature.’131 
 
There were however some groups who found similar results to Cuckle, including 
Fuhrmann and colleagues who were based in Germany. By analysing retrospective data 
from their msAFP screening programme (which was in place to detect neural tube 
defects), they found that they would have had to carry out 1361 amniocenteses to detect 
9 of the cases of Down’s syndrome in their study, giving a rate of 150 amniocenteses 
carried out for every 1 case of Down’s syndrome detected.132 A prospective study was 
started in July 1984 in the State of Connecticut in the United States, and detected a 
number of cases of Down’s syndrome which would have otherwise been missed, 
particularly in women who were not of advanced maternal age. They looked at msAFP 
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levels, maternal age, and maternal weight to create a formula to calculate the likelihood 
of the fetus having Down’s syndrome, and offered amniocentesis testing to women 
where the chance was at least 1 in 250.133 Their initial screening programme (carried out 
for a year) ‘has yielded 4.9% of women less than 35 years of age at increased risk for 
trisomy. To date, 7 cases of trisomy have been found in the screened population.’ This 
led them to conclude that these ‘initial results strongly support a continued evaluation of 
prospective screening for trisomy in women who, by reason of their age, would not 
ordinarily have been considered for amniocentesis’.134 Another large scale prospective 
study was carried out in an eight-centre New England collaborative project, limited to 
women under the age of 35, and data was published in 1986 of the results gathered 
between January and August 1986. 51,141 women were screened and 1050 (2.1%) were 
offered amniocentesis, of which 807 accepted. After amniocentesis 10 cases of Down’s 
syndrome and 4 cases of trisomy 18 were detected, leading the group to conclude that 
21% of estimated cases of Down’s syndrome were detected (48 cases were predicted in 
the age group of women screened). They felt that their experience indicated that msAFP 
screening for Down’s syndrome on a larger scale was feasible.135  
 
The Glasgow group led by Ferguson-Smith were also one of the teams exploring the use 
of msAFP in the detection of chromosome anomalies.136 Ferguson-Smith and colleagues 
began a retrospective study of pregnancies diagnosed with Down’s syndrome or other 
trisomies between April 1982 and May 1987.137 They investigated the possibility of 
combining maternal age and maternal serum alpha-fetoprotein levels as risk estimates 
for fetal autosomal trisomies, as this combination detected more at risk pregnancies.138 
This increased detection rate would allow for more targeted testing using amniocentesis 
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and CVS in those higher risk individuals. msAFP levels were available for 142 
pregnancies with chromosomal anomalies – 114 with trisomy 21, 19 with trisomy 18, 
and 9 with trisomy 13, whilst msAFP levels from 113,045 unaffected pregnancies tested 
during the same time period were used as the control group.139 The results showed that 
msAFP levels were significantly lower in pregnancies which had a chromosomal 
anomaly when compared to unaffected pregnancies, with 79.6% of the msAFP levels 
below the median of the general population of pregnant women in affected 
pregnancies.140  
 
It was estimated that the use of both maternal age and msAFP combined would detect 
37% of autosomal trisomies, compared to only 30% when using the risk factor of 
maternal age over 35 alone.141 The inclusion of msAFP levels decreased the screening 
age to 25, and the percentage of trisomies detected varied greatly between age groups, 
with only 12% of autosomal trisomies detected in the age group 25-29 years, compared 
to 100% detection in those aged over 40 years.142 Whilst these figures are low for the 
younger age groups, if risk estimates were based purely on maternal age alone, it is 
likely that none of these cases would have been detected. These results led the group to 
conclude that ‘significantly improved detection of aneuploid pregnancies can be 
achieved for no increase in the amniocentesis rate by utilising the existing information 
available from MSAFP screening programmes’.143  
 
Screening using msAFP for Down’s syndrome was implemented in Glasgow in 1987. 
The process was recalled by a scientist working in the group as being one of the major 
changes that occurred in the laboratory in the late 1980s: 
 
But the biggest change was the shift with low serum being found for 
women with Down syndrome … and effectively what it did was it brought 
the age range down a bit so it meant some younger mothers were included 
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… so you got a better pick up rate. And so we started to, we were still 
doing the raised serum for the neural tubes but we were also starting to 
look at low serum. And still looking quite a lot at maternal age patients but 
also younger patients, younger mothers were being included in the Down’s 
risk group … I think the cut off at the time was taken at about 1 in 220 or 1 
in 250 risk of Down syndrome. So if you were given a risk in that figure 
you would then go and have, be offered an amniocentesis or a CVS.144 
 
Whilst from the scientific perspective the implementation of the test seemed a straight-
forward progression, for the midwife who worked closely with both the obstetricians 
and medical genetics department, this was not entirely the case. She had seen the initial 
difficulties involved in ensuring all wider staff members and patients had an 
understanding of the testing process and the interpretation of the results:   
 
My impression of that at the time was that there could have been more 
discussion between the medical genetics department and the obstetricians 
in general about the introduction of Down’s syndrome screening because 
many of the obstetricians and many of the midwives in the antenatal clinic 
started to get reports that said there was a higher risk of a baby having 
Down’s syndrome but really didn’t fully understand how this information 
had come about, what it meant and I think that there was a period where 
there was, confusion is maybe too strong a word but just a bit of anxiety 
about how to  convey this information, what the options are.145 
 
This insight into the initial implementation of screening procedures highlights the 
difficulties that several groups of staff can face when new protocols are implemented. It 
is interesting to note that the midwife recalled the testing being implemented in March 
1987, which was the same month that Ferguson-Smith accepted the Chair of Pathology 
post in Cambridge, and that may have contributed to the initial difficulties encountered. 
Another key area where difficulties were noted was amongst the parents undergoing 
screening and testing, who experienced anxiety upon finding out test results: 
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And you can imagine also the impact it had on parents. I think today not all 
but most parents are aware of the option of screening, of prenatal 
diagnosis, not all but it is certainly more out there and known about. But 
you can imagine then, “what do you mean the blood test is saying that my 
baby has Down’s syndrome”, well no that’s not actually what it’s saying, 
but the anxiety that it caused was huge until it kind of settled down and we 
managed it much better. So for parents it caused a lot of anxiety.146 
 
This corresponds to the concerns that were raised by others, such as Seller, when the 
screening was first being discussed in The Lancet.147 The problems with implementation 
were however resolved relatively quickly, due to the role that the midwife played in the 
department: 
 
As the midwife at that time I took a lot of that on board so in fact it came 
to pass reasonably quickly I think that the higher chance results came back 
to me, I would then contact the patient to let them know that they had a 
higher chance result, they would come back and speak to me about that, I 
would give them the option of amniocentesis so again you know sort of 
starting at the very beginning and following them through.148 
 
This highlights the importance of having proper communication when new screening 
and testing programmes were being implemented, and also of having dedicated staff 
members who played key roles in supporting parents through these new procedures. 
Ensuring that staff were up to date with changing techniques would also be significant 
over the years which followed, as other markers would be identified which made the 
testing more specific. In 1988 Wald and colleagues published a detailed study on the 
use of maternal serum unconjugated oestriol as a screening test for Down’s syndrome, 
which they found in significantly lower levels in pregnancies where the fetus was 
affected, compared to pregnancies where the fetus was not.149 Using a combined 
screening test involving maternal age, msAFP and unconjugated oestriol levels was 
more effective at detecting pregnancies with an increased chance of the fetus having 
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Down’s syndrome, than using any of the measures alone.150 Further work confirmed 
these results.151 Another marker, human chorionic gonadotrophin, was also found to be 
associated with pregnancies where the fetus had a chromosome anomaly, although in 
this case it was found in raised, rather than decreased, concentrations in the maternal 
serum.152  
 
The new ‘triple test’ as it would become known, involving the measurement of maternal 
serum levels of AFP, unconjugated oestriol, and human chorionic gonadotrophin, 
alongside maternal age, was found to be more reliable than testing using maternal age 
alone. Researchers based in Denmark found that using what became known as the 
‘triple test’ – combined measurements of msAFP, unconjugated oestriol and human 
chorionic gonadotrophin – together with maternal age would result in the detection of 
57.6% of pregnancies with Down’s syndrome with a 7.3% false positive rate, whilst 
only using msAFP and maternal age would detect 53% of Down’s syndrome 
pregnancies for a false positive rate of 9.4%.153 A research group in Italy also found that 
combining the triple test with maternal age gave the highest detection rate and lowest 
false-positive rate. They concluded that their results, when considered alongside the 
other reported cases in the literature, ‘provide sufficient evidence that DS screening 
using maternal serum markers is an effective complementary strategy’, which they were 
offering to women through their genetic counselling clinics.154  
 
First and second trimester screening programmes are now firmly established in the 
prenatal field in the National Health Service, with all women being offered access to 
such programmes. First trimester screening is now being refined further, with the 
development of non-invasive prenatal testing (NIPT). NIPT involves taking a blood 
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sample from the pregnant woman to analyse DNA fragments present in the maternal 
plasma during pregnancy, known as cell-free DNA. Whilst the majority of the cell-free 
DNA comes from the mother, around 10-20% of it is fetal. If there are a greater number 
of fetal DNA sequences which map to chromosome 21 than would be expected in the 
sample, then the woman is likely to be at a higher chance of carrying a fetus which has 
Down’s syndrome. Whilst research has shown that this testing can detect around 98% of 
fetuses with Down’s syndrome, the test only provides a chance factor and does not 
provide a definitive diagnosis. A woman who received a high chance result would still 
be required to have the diagnosis confirmed by an invasive test, such as 
amniocentesis.155 
 
VIII. Conclusion 
The move towards NIPT highlights the continued interest which has now existed for 
several decades in detecting a number of chromosome disorders prior to birth. Although 
technology has advanced to enable the analysis of fetal DNA, all screening programmes 
still rely on the diagnostic testing methods of amniocentesis and CVS. The work carried 
out by groups such as that led by Ferguson-Smith to increase the detection rates of 
chromosome anomalies and decrease the number of incorrect results was therefore of 
central importance to such programmes becoming established.  
 
As can be seen at the beginning of this chapter, for researchers studying chromosomes 
in the early 1960s, the priority was on detecting patterns of heredity. There was 
uncertainty that analysis of chromosomes would ever be available early enough in 
pregnancy to enable termination, with Ferguson-Smith himself skeptical of such 
possibilities. However, the work of scientists and clinicians throughout the 1950s and 
1960s which showed that amniotic fluid cells could be cultured and their chromosome 
constitution analysed, combined with the implementation of the Abortion Act 1967, 
paved the way for prenatal testing to become a central component of antenatal care.  
                                                          
155 All information on NIPT from: 
‘NIPT for Down Syndrome A Guide For Patients and Healthcare Professionals’, The NHS Rapid Project 
<http://www.rapid.nhs.uk/guides-to-nipd-nipt/nipt-for-down-syndrome/> [accessed 29th August 2017].   
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By analysing the developments which were occurring at both local and 
national/international perspectives, it is possible to build up a detailed picture of how 
chromosome analysis in prenatal testing developed. The early testing was broadly 
successful in being able to correctly detect chromosome anomalies, and in the case of 
the group run by Ferguson-Smith, enough women were coming forward for such tests to 
enable the staff to refine their skills. However, as can be seen by the discussion on 
mosaicism, the testing was not without technical difficulties, some of which would have 
life-long consequences for the women involved. The debates surrounding what 
information should be given to pregnant women were exemplified in the discussion on 
maternal age effects, whereby different research groups struggled to reach a consensus. 
Whilst academic debate continued, women were making decisions on whether or not to 
undergo invasive testing based on the information being supplied to them by their 
clinicians. The risks associated with invasive testing for chromosome anomalies 
resulted in some obstetricians showing an unwillingness to refer women for the testing, 
and some women themselves opting out due to the miscarriage risk. It is perhaps not 
surprising that when faced with these issues, researchers were keen to develop less 
invasive screening programmes. 
 
The main screening programme for chromosome anomalies used msAFP, which was 
also linked to the detection of neural tube defects. The next chapter will consider the 
development of testing for neural tube defects, which followed a similar path to that of 
chromosome anomalies – invasive testing followed by the development of large-scale 
screening programmes.   
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Chapter Four – Research into Neural Tube Defects: Alpha-fetoprotein, 
Screening Programmes, and the Impact of Vitamins 
 
I. Introduction 
With the advent of prenatal diagnosis in the 1960s, it became clear that testing for a 
variety of chromosome disorders was feasible, and could provide women with the 
option to terminate affected pregnancies. However, there was an awareness amongst 
researchers and clinicians that prenatal testing might be developed to assist in detecting 
other conditions before birth, such as anencephaly and spina bifida, both neural tube 
defects (NTDs). Anencephaly results in a lack of formation of the cranial vault; skin 
also fails to develop, resulting in exposure of the nervous tissue to the amniotic fluid, 
which causes degeneration. The outcome of this condition is either stillbirth or post-
partum death.1 In spina bifida, part of the spinal column remains open, and the condition 
varies in severity dependent upon the location of the lesion and whether or not it is 
covered by skin. Symptoms range from leg weakness through to full paralysis, 
neurological difficulties, and a short life span in severe cases.2 Both of these NTDs are 
often associated with poor clinical prognosis due to their severity, and the possibility of 
reducing the number of children born with these conditions through the utilisation of 
prenatal testing was viewed positively by the majority of geneticists.3 
 
This chapter will consider the development of testing programmes for neural tube 
defects, both in the West of Scotland and wider afield. The central role that alpha-
fetoprotein (AFP) played as a marker for neural tube defects in the fetus during 
pregnancy will be examined, and the limitations of testing using AFP alone will be 
discussed. As with chapter three on chromosome research, researchers were keen to 
move to less invasive screening methods for NTDs. The move towards screening using 
                                                          
1 Michael Connor and Malcolm Ferguson-Smith, Essential Medical Genetics, 5th Edition, (Oxford: 
Blackwell Science Ltd, 1997), p. 180. 
2 Lachlan de Crespigny and Rhonda Dredge, Which Tests for My Unborn Baby?, (Australia: Oxford 
University Press, 1991), pp. 95-96. 
3 This is shown in the high number of geneticists who were working on tests to detect these conditions. 
The work of various individuals and groups developing these tests will be discussed in detail throughout 
this chapter. 
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maternal serum AFP (msAFP) will be discussed, with the experiences of different 
research and clinical groups considered. The regional variations which existed within 
these screening programmes will be analysed, and the debate surrounding the suitability 
of msAFP will be examined. The final section of this chapter will look at the attempts to 
elucidate the role that vitamin supplementation could play in preventing the formation 
of neural tube defects in the fetus. The issues associated with trying to assess the impact 
that vitamins could play will be considered, alongside the key role that pregnant women 
played in taking part in clinical trials. By considering all of these aspects, the timeline of 
testing for NTDs will become apparent, with the focus for researchers moving from 
invasive testing to prevention attempts over a short period of time. 
 
II. The Role of Alpha-fetoprotein 
Throughout the time period of this study, 1950 to 1990, the rate of NTDs varied across 
the United Kingdom. In the high prevalence area of the West of Scotland, NTDs 
occurred in approximately six per thousand births.4 Prior to the discovery of the role 
that AFP could play in detecting NTDs, a leading clinician in this region, Professor 
Malcolm MacNaughton, expressed his hopes that it would be possible in the future to 
‘detect conditions like spina bifida by some similar technical method’ as was currently 
being used to detect chromosome anomalies, as the condition was becoming ‘quite a 
problem’.5 It was only four months after MacNaughton wrote this letter to Ferguson-
Smith that Brock and Sutcliffe published their now renowned paper in The Lancet titled 
‘Alpha-fetoprotein in the Antenatal Diagnosis of Anencephaly and Spina Bifida’. They 
described the measurement of AFP in the amniotic fluid of a number of pregnancies 
which had led to anencephaly, spina bifida or hydrocephaly,6 and found that the level of 
AFP was raised in cases of anencephaly and spina bifida. They concluded that the 
                                                          
4 M.A. Ferguson-Smith, H.A. Rawlinson, H.M. May, P.N.C. Gent and J.G. Ratcliffe, ‘Maternal Serum 
Alphafetoprotein in Prenatal Screening for Open Neural Tube Defects’, in The Diagnosis and 
Management of Neural Tube Defects A Scientific Meeting of the Royal College of Obstetricians and 
Gynaecologists, ed. by J.A. Jordan and E.M. Symonds (London: The Royal College of Obstetricians and 
Gynaecologists, 1978), p. 55. 
5 University of Glasgow Archives, Papers of Malcolm Andrew Ferguson-Smith, UGC 188/3/3/13/6, 
Ferguson-Smith Correspondence with M Callum MacNaughton, p. 2 (letter dated 1st March 1972). 
6 Hydrocephalus is a build-up of fluid on the brain, which can lead to brain damage due to the pressure 
caused by the excess fluid. 
‘Hydrocephalus’, NHS Choices <http://www.nhs.uk/conditions/hydrocephalus/Pages/Introduction.aspx> 
[accessed 26th April 2017] (para. 1). 
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results suggested that ‘amniotic-fluid AFP measurements will be valuable in the early 
antenatal diagnosis of anencephaly and spina bifida’ and that the prenatal detection of 
these conditions would ‘enable termination of these pregnancies’.7  
 
Sandy Raeburn, a clinician who began working in the same department as Brock shortly 
after this discovery, has described how the finding that AFP was raised in pregnancies 
with NTDs was both a ‘brilliant bit of planning’ by Brock, but also a bit of a ‘fishing 
trip’.8 Raeburn described how a recurrence rate of roughly 1 in 20 was known for 
women who had previously had a child with a NTD, but it was not yet possible to detect 
those subsequent affected pregnancies. For many of the women a 1 in 20 recurrence rate 
was too high for them to consider continuing with the pregnancy, and so they opted to 
have a termination. Prior to or during the termination a sample of amniotic fluid would 
be taken, and the outcome of these pregnancies could therefore be monitored. The fetus 
was examined pathologically for the presence of a neural tube defect, and the amniotic 
fluid studied to detect if certain proteins were raised in these pregnancies. As Raeburn 
recalls, around 25 proteins were examined but it was ‘alpha-fetoprotein that did it’, 
highlighting that this was not just a fortuitous finding, but the result of a study of several 
potentially relevant proteins.9  
 
The publication of Brock and Sutcliffe’s findings led others in the medical genetics field 
to begin examining the possibility that AFP could be used as a diagnostic marker. Brock 
reported another case, this time along with Scrimgeour, of raised AFP in an 
anencephalic fetus,10 and Lorber and colleagues also found greatly increased AFP levels 
in the amniotic fluid of a woman who was pregnant with an anencephalic fetus.11 
Ferguson-Smith and his colleagues were some of the first to begin analysing 
                                                          
7 D.J.H. Brock and R.G. Sutcliffe, ‘Alpha-fetoprotein in the Antenatal Diagnosis of Anencephaly and Spina 
Bifida’, The Lancet, 300:7770 (1972), p. 197. 
8 SR and AR interview, DS300150, p. 13. Interview with Sandy and Arlene Raeburn, 13th April 2016. 
Sandy Raeburn completed a medical degree, and was appointed a Senior Lecturer in Medical Genetics in 
Edinburgh in May 1973. He worked in several medical genetics roles throughout his career, and spent six 
months on sabbatical at the Duncan Guthrie Institute in Glasgow.  
9 Ibid. 
10 D.J.H. Brock and J.B. Scrimgeour, ‘Letters – Early Prenatal Diagnosis of Anencephaly’, The Lancet, 
300:7789 (1972), pp. 1252-1253. 
11 J. Lorber, C.R. Stewart and A. Milford Ward, ‘Letters – Alpha-fetoprotein in Antenatal Diagnosis of 
Anencephaly and Spina Bifida’, The Lancet, 301:7813 (1973), p. 1187. 
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retrospective samples of amniotic fluid, which had been stored from previous 
pregnancies after chromosome analysis was carried out on the samples, to measure AFP 
levels. That the amniotic fluid samples were stored and not discarded highlights the 
forward-thinking nature of the department, and it was this initiative which enabled them 
to offer the testing to relevant patients shortly after Brock and Sutcliffe’s work was 
published. Records of this are detailed in several correspondence documents in the 
Ferguson-Smith archive, which shows the initial caution expressed about the reliability 
of the testing, followed by its rapid diffusion from research into clinical practice.  
 
In February 1973 Jack Insley, a Consultant Paediatrician in Birmingham, wrote to 
Ferguson-Smith to enquire if the department in Glasgow would be willing to test 
samples of amniotic fluid for increased AFP levels in patients from Birmingham.12 
Ferguson-Smith replied that he would be happy to test samples, but only if the patients 
were aware that the results could not be guaranteed, as the reliability of the test ‘had by 
no means been proved and must await the results of a large series’. At this point in time, 
March 1973, the department in Glasgow had tested 125 retrospective amniotic fluid 
samples, and found raised levels of AFP in three abortus specimens, all of which had 
central nervous system malformations.13 In April 1973 Rodney Harris, Director of the 
Department of Medical Genetics in Manchester, wrote to Ferguson-Smith asking for 
details of the AFP work going on in Glasgow, as he had heard from a student that 
Ferguson-Smith had found raised levels of AFP in a fetus with spina bifida.14 Ferguson-
Smith replied detailing the current situation in Glasgow, where they were offering the 
testing as a clinical service to patients who had previously had one or more children 
with major central nervous system malformations, with the aim of detecting fetal 
anomalies. Ferguson-Smith was keen to stress that the testing was not offered until they 
had carried out AFP analysis on 150 retrospective amniotic fluid samples, and had 
found no false positive or false negative results.15 By May 1973 they had carried out 
amniocentesis on 14 women; of these only 1 exhibited markedly raised levels of alpha-
                                                          
12 UGC/188/3/3/9/1, Ferguson-Smith Correspondence with Jack Insley, p. 15 (letter dated 28th February 
1973). 
13 Ibid., p. 14 (letter dated 15th March 1973). 
14 UGC 188/3/3/8/6, Ferguson-Smith Correspondence with Rodney Harris, p. 12 (letter dated 13th April 
1973). 
15 Ibid., p. 13 (letter dated 17th May 1973). 
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fetoprotein at both 15 and 18 weeks gestation, but the department were ‘very concerned 
by this case as ultrasound showed a normal sized head’.16 After an X-ray at 18 weeks 
showed a short trunk the woman opted for a termination and those involved in the 
testing were ‘very relieved’ when the patient delivered a fetus with physical 
anomalies.17 This termination was the first to be carried out in ten years at the Queen 
Mother’s Hospital,18 and was a major milestone as the head obstetrician at the time was 
Ian Donald, who as previously discussed, was morally opposed to the majority of 
terminations.19 Harris replied in June 1973 that he now knew of three spina bifida 
fetuses which had raised AFP levels, and concluded that it ‘rather looks as though there 
is something in it!’20 
 
This prediction by Harris would prove to be true, and in September 1973 the Glasgow 
group published the findings of the case of spina bifida reported to Harris. The paper 
was an investigation into the use of amniotic fluid alpha-fetoprotein in the diagnosis of 
NTDs, and was one of the first studies of this kind in the United Kingdom.21 They used 
AFP values from 140 samples from unaffected pregnancies, which helped to form their 
control group for the experiments,22 and also undertook amniocentesis on 20 patients 
who had an increased chance of having a fetus affected by a NTD.23 18 of the 20 
patients had normal alpha-fetoprotein levels, and by the time the paper went to print, six 
of these had delivered healthy children. Of the two who had high levels of AFP, both 
chose to terminate their pregnancies, and both had a fetus with anomalies.24 As both 
                                                          
16 Ibid. 
17 Ibid. 
18 Ibid. 
19 Malcolm Nicolson and John E.E. Fleming, Imaging and Imagining the Fetus: The Development of 
Obstetric Ultrasound, (Baltimore: The Johns Hopkins University Press, 2013), pp. 238-239. As discussed 
in the introduction, the views of Ian Donald and others will be discussed in detail in chapter five, which 
examines the social response to prenatal testing. 
20 UGC 188/3/3/8/6, Ferguson-Smith Correspondence with Rodney Harris, p. 15 (letter dated 5th June 
1973). 
21 It should be emphasised here that although the work published by Ferguson-Smith was one of the 
earliest publications showing the clinical applicability of the alpha-fetoprotein test, the original work 
which showed the link between neural tube defects and alpha-fetoprotein was carried out by Brock and 
Sutcliffe in Edinburgh. 
22 10 samples were excluded from the main analysis as they came from ‘spontaneous abortions’, and 
were found to have very high levels of AFP. 
23 Lindsey D. Allan, M.A. Ferguson-Smith, Ian Donald, Elizabeth M. Sweet and A.A.M. Gibson, ‘Amniotic-
fluid Alpha-fetoprotein in the Antenatal Diagnosis of Spina Bifida’, The Lancet, 302:7828 (1973), p. 524. 
24 Ibid., pp. 523-524. 
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cases of NTDs were detected and there were no false positive readings, the group 
concluded that ‘A.F.P. estimation in amniotic fluid may be used to detect open neural-
tube defects early enough in pregnancy to allow termination’ and that their results were 
‘sufficiently promising to justify a more widespread screening of pregnancies in women 
who have had one or more children with a neural-tube defect’.25 These results were of 
importance as they not only confirmed the use of AFP as a marker for NTDs, but they 
also enabled women to receive the diagnosis early enough to terminate the affected 
pregnancy.  
 
Other reports from around the United Kingdom and further afield began to surface in 
the early 1970s, supporting the association between raised AFP and NTDs. Seller and 
colleagues diagnosed a case of anencephaly on the basis of increased AFP, which was 
confirmed by ultrasound. This diagnosis occurred at 18 weeks gestation, which was 
early enough to enable termination. The group linked their findings with that of Brock 
and Scrimgeour, and concluded in their paper, published in July 1973, that, to their 
knowledge, ‘this is the first report of its practical application’.26 In October 1973, Field 
and colleagues from Australia reported another case of raised AFP in a pregnancy 
where the fetus was anencephalic. Neither ultrasound nor X-ray could confirm the 
presence or absence of a fetal head, so the decision to terminate the pregnancy was 
based on the raised AFP level. Although they felt that ‘more experience’ was required 
to confirm the validity of the technique, they were confident that the present research 
‘suggests that a very high amniotic alpha-fetoprotein is diagnostic of anencephaly to the 
extent of influencing a decision to terminate’.27 Connon also used AFP measurement 
alongside ultrasound to rule out a recurrence of spina bifida in 12 patients, and noted 
that the relief for these women ‘once the fear of another spina bifida baby has been 
removed has been impressive and has made the second halves of their pregnancies a 
time of happy expectancy’.28 
                                                          
25 Ibid., pp. 524-525. 
26 Mary J. Seller, Stuart Campbell, T.M. Coltart and J.D. Singer, ‘Early Termination of Anencephalic 
Pregnancy After Detection by Raised Alpha-fetoprotein Levels’, The Lancet, 302:7820 (1973), p. 73. 
27 Barbara Field, Gillian Mitchell, W. Garrett and Charles Kerr, ‘Letters – Amniotic Alpha-fetoprotein 
Levels and Anencephaly’, The Lancet, 302:7832 (1973), p. 798. 
28 Aileen F. Connon, ‘Antenatal Diagnosis of Spina Bifida’, The Journal of Obstetrics and Gynaecology of 
the British Commonwealth, 81:10 (1974), p. 754 and p. 756. 
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III. Problems Associated with Closed Lesions 
It was becoming clear that increased levels of AFP were linked to anencephaly in the 
fetus, and some cases of increased AFP in cases of open spina bifida were also being 
reported. However, data began to emerge which showed that closed spina bifida lesions 
might not be associated with an increased level of AFP, and would therefore potentially 
remain undetected. Closed spina bifida lesions are usually characterised by skin 
covering the affected area – the most common form is known as Occulta, with the 
name, derived from the Latin ‘hidden’, reflective of the closed lesion. The symptoms 
associated with a closed spina bifida lesion vary greatly – whilst some people show no 
symptoms, others are affected by paralysis, and/or bowel and urinary problems.29 
Laurence and colleagues reported a case in 1973, where AFP levels tested by 
amniocentesis at 16 weeks of pregnancy were within the normal range, but when the 
baby was stillborn later in the pregnancy it was found to have a closed spinal lesion. 
They concluded that their case ‘confirms that some affected children will be missed 
even though they may have disabling neural-tube defects compatible with survival’, and 
speculated that this missed diagnosis could be due to the AFP not diffusing as easily 
into the amniotic fluid when the lesion is closed.30 A similar case was reported by 
Stewart and colleagues who tested several hundred pregnancies and had one false 
negative result, whereby a closed spinal lesion was not associated with raised levels of 
AFP, which they felt added ‘further confirmation to the thesis that this technique will 
not be of value in the diagnosis of “closed” lesions’.31  
 
These results were also being found in the West of Scotland, where two closed lesions 
had been missed by the middle of 1974. Correspondence between the Director of the 
Birth Defects Treatment Center in Johns Hopkins University in Baltimore and 
Ferguson-Smith provides more information on these cases. Asked to provide an update 
                                                          
29 ‘What Are the Different Types of Spina Bifida?’, My Child Without Limits 
<http://www.mychildwithoutlimits.org/understand/spina-bifida/how-is-spina-bifida-diagnosed/types-
of-spina-bifida/> [accessed 9th August 2018]. 
30 K.M. Laurence, A.C. Turnbull, R. Harris, R.F. Jennison, E. Ruoslahti and M. Seppӓlӓ, ‘Letters – Antenatal 
Diagnosis of Spina Bifida’, The Lancet, 302:7833 (1973), p. 860. 
31 C.R. Stewart, A. Milford Ward and J. Lorber, ‘Amniotic Fluid α1fetoprotein in the Diagnosis of Neural 
Tract Malformations’, British Journal of Obstetrics and Gynaecology, 82:4 (1975), p. 261. 
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on the AFP testing programme,32 Ferguson-Smith described the testing of 71 women 
who had previously had one or more children with a NTD. Of the 33 women who had 
presented with normal AFP levels during pregnancy, two had delivered babies with 
closed defects. Although both babies were treated surgically, one had mild signs of 
neurological damage.33 This case highlights the fallible nature of prenatal testing; whilst 
correct in the majority of cases, an incorrect diagnosis could have a major impact on the 
family of an affected child. Many of the women undergoing the testing could not 
contemplate another pregnancy after having an affected child, and only began 
conceiving again once a test for NTDs was in use. For a woman to experience the relief 
of a negative diagnosis when she was extremely concerned about the recurrence of a 
condition, to then give birth and find the baby was subsequently affected, would be 
difficult to process. Whilst those involved in the testing stressed the imperfect nature of 
prenatal diagnosis, it would not have made an incorrect diagnosis any easier on those 
involved.  
 
Whilst cases of ‘false negative’ diagnoses were beginning to disseminate in the 
literature, concerns were also being raised about the possibility of ‘false positive’ 
diagnoses, whereby an unaffected fetus would be terminated as a result of an incorrect 
AFP reading. Campbell and colleagues reported such a case in The Lancet in May 1975. 
A woman who had previously had an anencephalic baby was tested by amniocentesis, 
and very high levels of AFP were found, but ultrasound examination could show no 
anomalies in either the fetal head or spine. When further AFP tests continued to show 
raised levels, a termination of pregnancy was decided upon. Pathological examination 
of the fetus revealed no anomalies.34 This case highlights the key role that ultrasound 
could play in detecting structural fetal anomalies, as if the ultrasound findings had been 
relied upon then a termination of pregnancy could have been avoided, which would 
have presumably resulted in the birth of an unaffected baby. A similar case was reported 
by Field and Kerr from Australia, who found raised levels of AFP in a woman who had 
spina bifida herself, and had previously given birth to a baby with anencephaly. Raised 
                                                          
32 UGC/188/3/3/6/8, Ferguson-Smith Correspondence Fr, p. 33 (letter dated 15th April 1974). 
33 Ibid., p. 34 (letter dated 23rd May 1974). 
34 S. Campbell, J. Pryse-Davies, T.M. Coltart, Mary J. Seller and Jack D. Singer, ‘Ultrasound in the 
Diagnosis of Spina Bifida’, The Lancet, 305:7915 (1975), p. 1066-1067. 
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AFP levels were found in the amniotic fluid, but similar to the Campbell case, no 
anomalies were noted on the ultrasound scan. In this case the parents elected not to 
terminate the pregnancy, and a healthy baby girl was born with no spinal 
malformations.35  
 
In 1976 Ferguson-Smith responded to a questionnaire from Dr Milunsky which 
requested information on various aspects of the prenatal diagnosis service in Glasgow 
and the West of Scotland. He emphasised that in the 1030 amniotic fluid AFP samples 
that the department had tested they had only had one false positive result. A raised AFP 
level was found after amniocentesis at 18 weeks gestation, and another sample taken 
one week later was similarly increased. However, after termination of the pregnancy the 
fetus was ‘apparently normal’, highlighting that even in experienced departments, 
incorrect diagnoses could still occur.36  
 
Explanations were sought about causes of raised AFP levels in unaffected pregnancies, 
and it was noted by the Ferguson-Smith group that, when more than one amniotic fluid 
sample was submitted after amniocentesis, and one was more blood-stained than the 
other, the blood-stained sample had higher levels of AFP.37 Similar findings were 
reported by Brock, who noted that even a small amount of fetal blood in the amniotic 
fluid sample could result in a ‘grossly elevated A.F.P. value’.38 By discarding any 
samples in which there was a substantial amount of fetal blood present, they were able 
to achieve a 0% false positive rate in their own AFP diagnostic procedure.39 In addition, 
the discovery in 1979 that another marker, acetylcholinesterase (AChE), could be found 
in the amniotic fluid of pregnancies affected by NTDs was also increasing the 
                                                          
35 Barbara Field and Charles Kerr, ‘Letters – Antenatal Diagnosis of Neural-Tube Defects’, The Lancet, 
306:7929 (1975), pp. 324-325. 
36 UGC 188/3/4/57/2, Ferguson-Smith Correspondence M, p. 15 (letter to Dr Milunsky dated 8th 
November 1976). 
37 Allan, Ferguson-Smith, Donald, Sweet and Gibson, ‘Amniotic Fluid Alpha-fetoprotein’, p. 525. 
38 D.J.H. Brock, ‘Letters – Antenatal Misdiagnosis of Neural-Tube Defects’, The Lancet, 306:7933 (1975), 
p. 495. 
39 Theirs was a study of 997 cases; AFP values were raised in 45 cases. In 12 cases the AFP levels were 
raised due to blood contamination and were therefore discarded, a variety of NTDs were diagnosed in 
the remaining 33 cases.  
See D.J.H. Brock and J.B. Scrimgeour, ‘Letters – Alphafetoprotein Assay in All Amniocentesis Samples’, 
The Lancet, 307:7974 (1976), p. 1404. 
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specificity of testing. When inhibited by a specific reagent, AChE would show up as a 
distinct band on an electrophoresis gel, making it possible to distinguish between 
pregnancies in which the fetus was affected or unaffected. These distinct bands are 
shown in Figure 4.1:   
 
 
Figure 4.1 – Showing the bands associated with a NTD pregnancy on an electrophoresis 
gel. When amniotic fluid samples were run through an electrophoresis gel, two bands 
would appear in the gel in pregnancies associated with a NTD, whilst only one band 
would appear in pregnancies where the fetus did not have a NTD. This is exemplified in 
the photograph – lane A shows the two bands associated with a NTD pregnancy, in this 
instance a case of spina bifida, compared to lane C which shows only one band, and was 
a sample from an unaffected pregnancy.40 
 
A collaborative group was set up to analyse the usefulness of AChE as an adjunct to 
testing AFP in amniotic fluid, and they published their results in August 1981. The 
Collaborative Acetylcholinesterase Study pooled data from 15 centres to examine the 
impact testing amniotic fluid samples could have on the specificity of results. 99.6% of 
                                                          
40 A.D. Smith, N.J. Wald, H.S. Cuckle, G.M. Stirrat, M. Bobrow and H. Lagercrantz, ‘Amniotic-Fluid 
Acetylcholinesterase as a Possible Diagnostic Test for Neural-Tube Defects in Early Pregnancy’, The 
Lancet, 313:8118 (1979), p. 687. 
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pregnancies affected by anencephaly had positive AChE results, as did 99.4% of 
pregnancies with open spina bifida.41 The test could therefore be useful if used in 
addition to traditional AFP testing. A raised level of AFP in the amniotic fluid 
combined with two bands on an AChE gel would be a more reliable indicator of a NTD 
in the fetus than a raised AFP level alone. It would be particularly useful in cases where 
the AFP level was borderline between a raised and normal level – a borderline result 
combined with one band on an AChE gel was a likely indicator that the fetus did not 
have a NTD.  
 
Utilising knowledge such as this, alongside implementing other methods of prenatal 
diagnosis including ultrasound, to confirm a diagnosis of neural tube defect, could 
decrease the false positive rates in testing programmes. However, despite these 
improvements, amniocentesis was still required to provide a diagnosis, and as it was 
associated with a 1% increased miscarriage rate the testing was only offered to those 
who had an increased chance of having a fetus with a NTD. As described previously, 
the discovery by Brock that AFP could also be found in the maternal serum, albeit in 
much lower quantities, would entirely change the target group of women for prenatal 
examination, and would pave the way for mass prenatal screening for NTDs. 
 
IV. The Move Toward Less Invasive Screening Using Maternal Serum Alpha-
fetoprotein 
The majority of cases of NTD occur in women with no prior history, and so only testing 
those known to have a higher chance of NTD in their pregnancy would therefore not 
diagnose a number of affected fetuses. However, the ability to detect AFP in maternal 
serum opened up the possibility of screening the pregnant population to uncover those 
pregnancies where the fetus had a higher chance of a NTD, and referring these women 
on for further diagnostic testing. Brock and colleagues published the findings of their 
research on the maternal serum levels of AFP in The Lancet in October 1973, presenting 
details of a case of anencephaly. The woman in their study had previously given birth to 
                                                          
41 Report of the Collaborative Acetylcholinesterase Study, ‘Amniotic Fluid Acetylcholinesterase 
Electrophoresis as a Secondary Test in the Diagnosis of Anencephaly and Open Spina Bifida in Early 
Pregnancy’, The Lancet, 318:8242 (1981), pp. 322-323. 
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a baby with anencephaly, and during the subsequent pregnancy she had blood taken at 
16 and 21 weeks gestation to test the maternal serum alpha-fetoprotein (msAFP) levels. 
These were found to be greatly increased at both gestation periods when compared with 
controls. Amniocentesis was carried out and the amniotic fluid AFP level was also 
raised; further examination by ultrasound and X-ray showed that the woman was 
carrying another fetus with anencephaly, and the pregnancy was terminated.42 Whilst 
the group were aware that this result ‘raises the possibility of screening pregnancies 
through a determination made on a small amount of maternal blood’, they felt that it 
would be ‘unwise to suggest that maternal serum A.F.P. alone could be used to diagnose 
anencephaly or spina bifida early in pregnancy’.43 They were concerned about the 
potential number of false positive or false negative results, and were aware that as more 
samples were tested the level at which msAFP levels would be deemed as normal or 
raised might change. 
 
In a similar manner to the discovery of raised AFP in amniotic fluid, after the report by 
Brock on msAFP, others working in the prenatal field began to explore the potential 
uses and drawbacks of the technique. Seller and colleagues in London examined levels 
of msAFP in women who had an increased chance of having a fetus with a NTD, and 
found that in those pregnancies where the fetus had a NTD the msAFP levels were 
raised. In some cases the rise was noticeable, for example, at 19-24 weeks gestation an 
msAFP level of 450ng. per ml. was found in a woman carrying a fetus with a NTD, the 
highest level in the control group being around 90ng. per ml. However, in other cases, 
such as one recorded in the group at 13-18 weeks gestation, the msAFP level was 
actually lower in a pregnant woman carrying a fetus with a NTD than the highest levels 
recorded in the controls (350ng. per ml. in the control, versus 300ng. per ml. in the 
woman carrying the affected fetus).44 It was concluded that, whilst msAFP testing could 
potentially lead to the detection of NTDs in affected fetuses, there was a risk of ‘error’ 
and the test was not as clear-cut as it was for the detection of raised AFP in amniotic 
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fluid.45 Harris and colleagues reported far less promising results, with eight of the nine 
pregnancies affected by a NTD that they tested showing msAFP values in the normal 
range, leading them to conclude that msAFP screening of the wider pregnant population 
was not advisable.46 However, Wald and Bonnar in Oxford, working collaboratively 
with Brock in Edinburgh, published details of seven cases of NTD (five of spina bifida 
and two of anencephaly) where the msAFP levels were raised when compared to control 
pregnancies.47  
 
Debate continued throughout the following months on the usefulness of msAFP 
screening, with the need for a pilot study to test this on a large scale becoming apparent. 
The UK Collaborative Study on Alpha-fetoprotein in Relation to Neural-Tube Defects 
was set up in January 1975, with the aim of determining the efficiency of msAFP 
screening to select members of the pregnant population for further diagnostic testing. 
Nineteen centres provided data for the study and the results were published in 1977, 
with 18,684 non-NTD pregnancies acting as the control group, and 301 NTD 
pregnancies forming the study cohort.48 The study was mainly retrospective, with many 
samples tested after the outcome of the pregnancy was already known. However, the 
results showed that, if serum samples were taken at 16-18 weeks of pregnancy, then 
88% of cases of anencephaly and 79% of open spina bifida cases could be detected 
using the msAFP screening assay.49  
 
Whilst the results showed that a high number of cases of NTD could be detected, 
several other factors would impact the outcome rates of such a screening programme, 
including having adequate laboratory facilities such as space and equipment to run such 
a large project, and ensuring that women presented early enough in pregnancy to be 
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screened. Levels of msAFP rise from 13 weeks’ gestation and peak at around 32 weeks, 
changing on a weekly basis.50 Ensuring that the correct gestational date is being 
compared against the equivalent control level is therefore of vital importance in msAFP 
screening. However, many women who presented with a pregnancy were unsure when 
they had conceived. The UK Collaborative Study felt that 16-18 weeks was the 
optimum time for blood samples to be taken for screening, however in practice many 
groups increased this time limit to include from 16 to 20 weeks’ gestation. This would 
ensure that higher numbers of women would be able to participate in the screening 
programmes, whilst still allowing time for repeat samples to be taken and amniocentesis 
and ultrasound examinations to be carried out if required. This was the case in the West 
of Scotland screening programme, where samples were screened between these time 
periods; testing any earlier than 16 weeks could lead to incorrect diagnoses, as even an 
anencephalic fetus could have normal msAFP levels at 15 weeks gestation, and it was 
thought that beginning the screening procedure after 20 weeks would lead to 
termination very late in the pregnancy which would cause additional distress for the 
women involved.51 It was therefore of vital importance that ultrasound technology was 
developing throughout the same time period that prenatal screening programmes were 
expanding. Ultrasound scanning was now capable of accurately determining gestational 
age, and well-trained staff were involved in the screening programmes, who were 
competent and confident in using such technology. Ultrasound was also of key 
importance in the direct visualisation of the fetus. Structural anomalies such as 
anencephaly could be detected, in addition to several of the other reasons for raised 
msAFP levels which could lead to false positive results, such as multiple pregnancies 
and missed abortions.52 
 
Since ultrasound was to be of key importance, it is perhaps not surprising that Glasgow 
contributed a great deal to the development of msAFP screening, as ultrasound facilities 
were well developed in the city. Ian Donald had pioneered the technology and 
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implemented it in Glasgow, and many of the clinicians and researchers working within 
this region therefore had an awareness of the uses of ultrasound. In addition, Donald 
worked with Ferguson-Smith in a clinical and research capacity, and knew him 
personally as both a neighbour and friend.53 Glasgow contributed the highest number of 
NTD pregnancies to the UK Collaborative Study, and under the leadership of Ferguson-
Smith, would go on to run one of the largest prenatal screening studies for NTD over 
the following years. Perhaps the particular set of circumstances which was occurring in 
the West of Scotland at that time played a key role in this contribution. The high rate of 
NTD in the region in addition to the work of Ian Donald ensured that the patients and 
technology were in place. Combined with Ferguson-Smith’s drive to offer relevant 
testing to any women who wished to utilise it, and the growing laboratory facilities and 
expertise under his leadership, the elements required for further study of msAFP 
screening were in place. Ferguson-Smith commented in 1975 that Scotland seemed to 
be particularly well placed to carry out such studies. As much of the original research 
on the subject had stemmed from Scotland, there were a number of experienced 
personnel working in the field, and there was a real interest from many others in the 
profession.54 Indeed, as early as June 1974 Ferguson-Smith was in discussion with the 
Scottish Spina Bifida Association about the pilot study the department had begun.55 
This work involved determining the normal range of AFP in the maternal serum. 
Several of the reagents were supplied by other researchers to assist with the project, 
including Nishi in Japan and Leek in London, highlighting the many collaborations 
which were required in the early stages of such a project to develop a workable 
technique.  
 
In November 1974 Ferguson-Smith wrote to Nishi to thank him for providing reagents 
and to update him on the progress of the research in Glasgow. At this stage the group 
had not had any false positive results, as all raised msAFP levels could be linked to 
either intrauterine fetal death, multiple pregnancies, or NTDs.56 These initial results 
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were encouraging and the department became involved in another larger pilot study to 
test the impact of msAFP screening for NTDs in the West of Scotland. The first two 
phases of the study ran from 20th May 1975 to 30th June 1977, and screened a total of 
17,707 women who were 15-20 weeks pregnant.57 In phase one, which ran until 30th 
June 1976, a total of 6122 pregnancies were tested between 15 and 20 weeks gestation 
to measure their msAFP levels. The levels were checked against the normal distribution 
of msAFP levels, which had been measured in a control group composed of 948 
samples from pregnancies which had resulted in the delivery of a healthy baby.58 The 
intervention point which was used as a cut-off score for increased msAFP levels was the 
99th percentile of the levels estimated from the control samples. The msAFP levels were 
found to be increased above the intervention point in 87.5% of pregnancies with an 
anencephalic fetus, and in 71.4% with an open spina bifida fetus.59 If a pregnancy was 
found to have increased msAFP levels, another sample was taken and the test repeated. 
If the result still showed increased levels then clinical examination by ultrasound was 
carried out. If ultrasound did not reveal a reason for the increased msAFP level then the 
next step was amniocentesis to confirm a clinical diagnosis. A number of women whose 
increased alpha-fetoprotein levels were detected during the screening programme opted 
to undergo terminations as a result of a positive diagnosis; the overall impact of the 
programme in phase one was thus ‘to reduce the birth frequency of open neural-tube 
defects in 6122 pregnancies by 63.3%’.60  
 
Whilst these results looked promising to the researchers involved, a small number of 
anomalies which should have been detected were missed during phase one. False-
negative msAFP results were given in six pregnancies, two of which were anencephalic 
fetuses, and four of which were fetuses with open spina bifida.61 In both of the 
anencephalic and two of the open spina bifida cases, the serum levels had been 
measured at 15 weeks gestation. This fell outside the 16-20 weeks gestation screening 
period which the group determined later in this study as being the ideal time period for 
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screening.62 In the remaining two cases of open spina bifida the serum levels were taken 
at 18 weeks, but the intervention threshold which had been used for this stage of 
pregnancy was too high, and the cases were therefore not identified.63 In another five 
pregnancies high msAFP levels were detected, but further testing did not consistently 
confirm these results, which led to continuation of the pregnancy through to the birth of 
an affected baby. In one of these cases the woman was pregnant with an undiagnosed 
twin pregnancy, which was discordant for anencephaly, with one fetus affected by the 
condition and the other fetus unaffected.64 After a high msAFP level was detected 
during screening, the woman proceeded to amniocentesis. As the twin pregnancy had 
not been diagnosed, amniotic fluid was only taken from one fetus. By chance, the 
amniotic fluid sampled was that of the unaffected fetus, giving a false negative result.65 
One other patient did not return for any further testing after the initial elevated msAFP 
level was detected, and continued on to have a fetus with spina bifida. In another case a 
diagnosis of open spina bifida was missed as the gestation was overestimated by four 
weeks.66 Two further pregnancies with spina bifida were missed as, despite having 
initial raised levels of msAFP, their second msAFP test showed levels which were 
thought to be within the normal range. These samples were taken at 18 weeks, and as 
previously mentioned, the intervention threshold used for this stage was too high, which 
resulted in the misinterpretation of the samples as having normal levels of msAFP.67 
These results show that the testing was not without problems, and that incorrect 
diagnoses could be made which affected the outcome of pregnancies. They also 
highlight once again the importance of ultrasound for correctly dating pregnancies and 
visualising multiple pregnancies and structural anomalies. 
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Phase two of the study ran from 1st July 1976 until 30th June 1977, during which 11,585 
pregnancies were screened between 16-20 weeks gestation.68 As the laboratory had, by 
this time, developed facilities for the testing of a higher number of specimens, and due 
to a number of missed detections when the intervention point was the 99th percentile, the 
intervention point was now dropped to the 97th percentile. Whilst this increased the 
number of amniocentesis tests required, it also improved the detection rate for NTDs – 
100% of anencephalic and 81.2% of open spina bifida fetuses were detected by 
checking msAFP levels.69 As in phase one, a number of women chose to undergo 
terminations after further clinical examination and a positive diagnosis, and the result 
was a reduction in the ‘birth incidence of open neural tube defects in 11,585 
pregnancies by 81.4%’.70 In phase two, seven cases of open spina bifida were not 
detected; in three of these cases the msAFP levels were below the intervention point, 
and in the other four cases levels were above the intervention point but were not 
detected for a number of reasons.71 In one case the msAFP level was incorrectly 
interpreted as being normal, whilst in another, amniocentesis gave a false negative 
result.72 Another case was incorrectly diagnosed as being a twin pregnancy and this was 
thought to explain the raised alpha-fetoprotein levels. No further checks took place, and 
the woman delivered a single child with spina bifida. In the remaining case 
amniocentesis was not repeated after a first unsuccessful attempt, so a prenatal 
diagnosis was not possible.73  
 
The screening test detected a high number of anomalies overall. The group therefore 
believed that their work strongly supported ‘the case for the introduction of a voluntary 
national screening programme for neural-tube defects along the general strategy 
outlined in phase II of this study’.74 Ferguson-Smith was keen to highlight that 
screening programmes should be introduced gradually, with high cut-off rates for 
increased levels of msAFP used initially. This would enable screening programmes to 
be developed in conjunction with obstetric departments to ensure that the resources to 
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meet the demand for the increased number of ultrasound examinations and 
amniocentesis tests that would be required would be available. As confidence grew in 
using these techniques, the intervention point for raised msAFP could be lowered, 
increasing the detection rates for NTDs.75 These pilot studies showed that implementing 
a screening programme for msAFP levels could greatly reduce the number of babies 
born with NTDs. Brock and Gosden, writing to the British Medical Journal, commented 
on the ‘dramatic decrease in the birth incidence of both spina bifida and anencephaly 
since the introduction of screening into the Strathclyde region’, which they felt justified 
‘the hopes that many of us have held out for a real reduction in incidence of these 
appalling disorders as soon as anyone had courage to apply the AFP test on the scale for 
which it was designed’.76  
 
V. Regional Variations in Maternal Serum Alpha-fetoprotein Screening Programmes 
The results of programmes run by other groups were also emerging, with Clarke and 
colleagues screening 5539 pregnant women at three maternity units in London. Whilst 
Clarke found that the screening led to diagnosis of NTDs in a number of women who 
had no previous history for the conditions, only a quarter of the women presented to 
their medical practitioner during the ideal time period for the blood test to be taken, and 
there were a number of issues with false positive and false negative results during the 
programme. 300 women who booked before 23 weeks gestation had a raised msAFP 
level, however in 204 of these women no explanation could be found for the elevation.77 
Not all of these women progressed on to amniocentesis, but if they had then this could 
have resulted in a number of miscarriages as a result of the procedure. A number of 
diagnoses were also missed due to women booking too late for the test to be reliable, or 
because gestational age was incorrectly estimated.78 This illustrates the differing 
detection rates in varying regional areas, and emphasises the importance of having the 
infrastructure in place to run such a screening programme. Changing patterns in 
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antenatal attendance were needed for such tests, with women being referred at 
appropriate weeks of their pregnancy. This required publicity to encourage women to 
inform their own doctors about their pregnancy at an early stage, and also for clinicians 
to ensure that blood samples were being taken at appropriate time periods. In addition, 
developed ultrasound technology and instruments, and the ability to use them, were 
required for accurate dating of gestational age; as seen in this study, inaccurate 
gestational dating led to a number of false results.  
 
Bennett and colleagues also found that their experience with false negative and false 
positive results made them ‘cautious’ about implementing a screening programme using 
msAFP. They measured msAFP levels in over 6000 women and had a detection rate of 
74.5%.79 One case of open spina bifida was missed as the msAFP level was not raised, 
and one ‘morphologically normal’ fetus was terminated after two serum samples and an 
amniotic fluid sample all showed raised levels of msAFP and AFP respectively.80 
Bennett raised an important issue in the paper, highlighting the impact that false 
negative diagnoses can have on women. Whilst a lack of false positive results is often 
detailed in these studies as it entailed that there were no unnecessary terminations of 
pregnancy, the impact of false negative diagnoses is often not discussed. However, 
Bennett comments on the case of one woman who had several tests including msAFP 
screening followed by ultrasound and amniocentesis, which all showed no increased 
chance of NTD, but the woman then went on to deliver an affected baby. The effect on 
the woman is described as ‘disastrous’, with the parents rejecting the baby after the 
birth, and continuing to do so four months later.81 In contrast, a screening programme 
carried out in Edinburgh on 6377 women had a detection rate for open NTDs of 83%.82 
Although eight fetuses with spina bifida (four open and four closed) were missed in the 
study, this high detection rate led Brock and colleagues to conclude that ‘facilities and 
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finance should be found to provide an antenatal maternal plasma AFP screening 
service’.83 
 
The experience of different departments in several regions was clearly variable, and 
there was uncertainty about whether or not screening programmes should be 
implemented. To this end, the Working Group on Screening for Neural Tube Defects 
was set up by the Standing Medical Advisory Committee in 1978, with the aim of 
advising on ‘what guidance might be given to health authorities on the introduction into 
routine antenatal care of a service to detect neural tube defects’.84 The report covered a 
number of areas including the balance between benefits and risks of a screening 
programme, and the financial and staffing implications. At the beginning of the report, 
the group outlined four ‘strategic options’. These were: 
 
(i) Discourage, or at most fail to encourage, development of the screening 
programme. This might be dangerous, leading to the establishment of a 
large number of local centres, many of which might fall below acceptable 
standards. 
(ii) Encourage the development, including the monitoring, of existing 
centres. 
(iii) Support the development, including the monitoring, of screening 
facilities in areas which at present do not have them. 
(iv) Make the service generally available as soon as resources permit.85  
 
Of these four, the Working Group felt that ‘Option (i) is probably untenable, and rapid 
progress towards Option (iv) may be unwise, in view of some remaining uncertainties 
on the merits of the programme and the costs entailed in implementing it rapidly. 
Options (ii) and (iii) are not mutually exclusive, and in the longer term might in fact 
lead to Option (iv).’86 It is of interest to note that the Working Group had concerns 
around the quality of the service provided by local centres, but were also keen to avoid 
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wider rapid implementation without adequate resources. That the Working Group 
specifically mention monitoring of programmes in options ii and iii seems to suggest 
that they wished to proceed cautiously, with monitoring being a key feature of any 
screening programmes being implemented. 
 
The Working Group set out twelve recommendations at the end of their report, the first 
of which was that ‘There should be co-ordination and planning of screening for neural 
tube defects at all levels of the service, locally, regionally and nationally, using the 
existing committee structure. No screening programme should be established without 
extensive discussion with all staff involved.’87 This recommendation shows the need for 
widespread involvement in screening programmes, and seems to link to the first 
strategic outcome that the Working Group discussed at the start of the report, regarding 
the development of centres on a local basis. Several other recommendations were made, 
including the need for women to be encouraged to attend antenatal appointments as 
early as possible to enable screening to take place, the requirement for ultrasound 
facilities to be available, that screening should be organised to minimise unnecessary 
amniocenteses, and that laboratories should take part in the National Quality Control 
Scheme to ensure that measurements of maternal serum alpha-fetoprotein were precise 
and within an acceptable standard.88 The Working Group also stressed the importance 
of patients being given sufficient information to ensure that they could make a decision 
about whether or not to take part in a screening programme.89  
 
Overall, the report carefully weighed up the potential areas of concern surrounding 
implementing screening programmes, but also considered that screening programmes 
could work with careful planning and monitoring. Despite the Working Group 
expressing concerns that local services could fall below recommended standards, and 
that there should be co-ordination and planning at a national level, regional variations 
did develop, and continued to exist for a number of years after the publication of the 
report. A key example is the experience of Standing and colleagues, who carried out a 
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screening programme for two years in the King’s Lynn Health District, which had a low 
incidence of NTD. They screened 3479 pregnant women, and eight of these women had 
pregnancies affected by NTDs.90 Four of these fetuses had anencephaly, and four had 
other forms of open NTDs. Of the four with other forms, one was detected by msAFP 
screening and the finding of raised AFP confirmed in amniotic fluid, one had raised 
msAFP levels but had normal AFP levels upon amniocentesis, and two cases were 
missed entirely.91 The outcome of the anencephalic pregnancies is not described, 
however it is likely that they were terminated; this was the most common decision made 
by pregnant women in this situation, as no treatment was available for anencephaly. The 
screening programme had been implemented ‘with the expectation that it would prevent 
the birth of most live babies with open neural tube defects’, but after just two years the 
group felt that ‘these expectations had not been fulfilled and, with the agreement of all 
those connected with the maternity service, the screening programme was 
discontinued’.92  
 
A number of clinicians and researchers questioned the decision to end the King’s Lynn 
screening programme after only two years, with many feeling that Standing’s 
conclusion that ‘the correlation between concentrations of maternal serum alpha-
fetoprotein and fetal open neural tube defect, anencephaly apart, is insufficiently close 
to justify this type of screening’ was very different from their own findings.93 The South 
Wales Anencephaly and Spina Bifida Screening Group thought that the conclusions of 
their own study were ‘not likely to be so pessimistic’,94 and Wald and colleagues felt 
that there was ‘no sound basis for the screening programme to be abandoned’ as 
Standing’s results were based on small numbers.95 Others working in low-incidence 
areas in London expressed similar concerns, with Enticknap and colleagues reporting 
their screening results of over 6000 women, where no non-NTD pregnancies were 
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terminated, and only one case of closed spina bifida was missed.96 Seller, also based in 
London, reported their own ‘disappointments’ as a result of a screening programme, in 
which several cases of NTD were missed, but felt that two years was far too short a time 
period to truly test the applicability of such programmes.97 A report by Ward and 
colleagues on their four years’ experience of running a msAFP screening service at 
University College Hospital in London, from the initial stages of research through to 
providing it as a routine service, detailed that it took them two and a half years to 
establish a normal range for serum AFP levels, and that the majority of their undetected 
cases happened early in the study.98 This highlights the initial difficulties associated 
with screening programmes of this kind, which measure ‘amounts’ of something, and 
often require adjustments in the first few years, as was the case in the studies led by 
Ferguson-Smith. 
 
Perhaps the study by Standing could have benefitted from longer term analysis and 
adjustments, instead of being stopped after such a comparatively short time period. 
Screening programmes can take time to develop, as can be seen in the case of the West 
of Scotland, where the uptake of screening increased over time, from 34.1% of pregnant 
women undergoing screening in 1977 to 77.4% in 1982.99 By the end of 1982, 238 
pregnancies in which the fetus had anencephaly, and 157 pregnancies where the fetus 
had spina bifida, had been terminated as a result of being initially identified by the 
screening programme. Despite seven pregnancies being terminated as a result of a false 
positive diagnosis, it was felt that the screening programme was important enough to 
maintain. As previously discussed in chapter one, the increased participation of women 
in the screening process contributed to a notable decrease in the total birth rate for 
neural tube defects, which declined from 4.3 per 1000 in 1976 to 1.7 per 1000 in 1981 
in the West of Scotland.100 By 1985 220,000 pregnancies had been screened, and the 
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programme was linked to a 72% reduction in the birth incidence of NTDs in the West of 
Scotland.101 Brock commented that this was the largest screening programme attempted, 
and that ‘no other prenatal screening programme can claim figures anywhere near 
this’.102  
 
Regional differences were therefore apparent, with some health districts offering 
screening programmes whilst others did not, and great variations were occurring in the 
detection rates of NTDs. Whilst it was clear that screening programmes could play a 
role in decreasing the number of babies born with NTDs, there were clear benefits to 
preventing the occurrence of NTDs, rather than only terminating affected pregnancies. 
At the same time as work was going on to implement screening programmes, other 
clinicians and researchers were investigating the underlying causes of NTDs, in the 
hope that this knowledge could be used to prevent the occurrence of affected fetuses in 
the future. 
 
VI. Vitamin Studies and Folic Acid in the Prevention of Neural Tube Defects 
For several years prior to the finding that AFP could be used in the detection of NTDs, 
there was an understanding that vitamins could impact the development of the embryo, 
and that a lack of vitamins within the pregnant woman could negatively affect fetal 
growth. In 1956 Woollam and Millen wrote of how ‘the effect of a vitamin deficiency 
during the first stage (corresponding to the first three months of pregnancy in the 
human) will be to interfere with the development of vital organs, such as the heart and 
brain, which are then in a critical stage of their development. The result will be the birth 
of a foetus with a congenital malformation which represents a form of arrested or 
abnormal growth.’103 Despite this awareness, the specific factors leading to conditions 
such as anencephaly and spina bifida were unknown; however both conditions had been 
induced in animal models by causing a deficiency of folic acid during the affected 
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pregnancies, suggesting that dietary factors could influence their occurrence.104 Work in 
the late 1960s and early 1970s did consider the role of vitamins, but research findings 
were mixed. In 1969 Emery and colleagues reported their study in which they measured 
serum folate levels in parents who had children with either anencephaly and/or spina 
bifida, and found no difference between these parents and controls. They concluded that 
‘the results suggest that, in man, a deficiency of folic acid may not be directly related to 
the pathogenesis of spina bifida and anencephaly’.105  
 
Research continued into the potential causes of NTDs and a complex picture began to 
emerge, showing that a number of factors such as genetic susceptibility, environmental 
influences, and social class could play a role in their incidence. Renwick’s potato blight 
hypothesis was proposed in 1972, suggesting that ‘a teratogenic substance in potatoes 
afflicted by the potato blight fungus, Phytophthora infestans’ was responsible for 
causing NTDs.106 Despite Renwick’s insistence that this could be the causative factor, 
little evidence was found by others to confirm this, with groups in Edinburgh107 and the 
United States108 finding no correlation. Folic acid continued to be investigated as a 
possible factor, and whilst studies from Aberdeen109 and Edinburgh110 continued to 
question the role it played, larger studies by Hibbard and Smithells showed that there 
might be a correlation. Hibbard examined 805 women early in their pregnancies and 
found that the rate of fetal malformation was four times greater in women who had red-
cell folate concentrations of less than 130ng/ml, compared to women who had levels 
greater than 130ng/ml.111 Smithells examined 900 women in the first trimester of 
pregnancy and found that the mean red-cell folate levels of the women who went on to 
give birth to a child with a NTD were 141ng/ml, compared to 228ng/ml in the control 
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group.112 It was suggested that the next logical step would be to determine the causality 
directly by supplementing mothers who had an increased chance of having children 
with NTDs prior to conception. 
 
Smithells and colleagues duly initiated a study of pre-conception supplementation, and 
in February 1980 they reported their results. A number of different departments 
contributed patients to the study, including Leeds, London, Belfast, Manchester and 
Chester; women were recruited both through genetic counselling clinics and by 
obstetricians, and all women who had previously had a child with a NTD and who were 
not already pregnant were invited to join the study. Those women who were already 
pregnant or declined to join the study formed the control group.113 Women in the study 
group were given one multivitamin and iron preparation tablet (Pregnavite Forte F) 
three times a day ‘for not less than 28 days before conception and continuing at least 
until the date of the second missed period – i.e., until well after the time of neural-tube 
closure’.114 Overall the provisional recurrence rate115 in the supplemented group was 
0.6%, compared to 5.0% in the non-supplemented control group.116 Whilst these results 
seemed to suggest that supplementation prior to pregnancy could impact recurrence 
rates of NTDs, the authors were keen to stress that this was not a definite conclusion, 
and that other factors could have affected the results. However, they hoped that their 
data would encourage others to carry out similar studies to gain further insight into this 
possible link.117  
 
Almost immediately after the publication by Smithells and colleagues, criticisms were 
voiced regarding the design of the study. As previously mentioned, NTD rates varied 
throughout the country and concerns were raised about bias in the study and control 
groups. David Stone, at the University of Glasgow, wrote in to The Lancet expressing 
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his view that it was ‘clear’ that the supplemented group lived mainly in low-incidence 
areas, whereas the control group were formed of those living in high-incidence regions. 
He found it ‘hardly surprising’ that the recurrence rate was higher in the control group 
than in the supplemented group.118 Stone also raised further concerns about the design 
of the study, querying why Smithells and his colleagues did not ‘evaluate their 
interesting hypothesis by means of a randomised controlled trial, which would have 
been eminently practicable, would have minimised selection bias, and would have been 
more likely to convince the sceptics’.119 This question would go on to cause an intense 
debate in the scientific and medical community, as Smithells replied to Stone stating 
that their intention has been to carry out a ‘double-blind controlled study for which 
placebo tablets had already been prepared, but that the protocol was rejected by three 
separate hospital research ethics committees, and we had to resort to a less satisfactory 
design’.120  
 
An editorial in May 1980 in The Lancet framed the situation well, questioning if it 
would be ethical for clinicians to ignore the result of Smithells’ study because it was not 
based on random selection criteria, knowing that this could potentially lead to more 
NTD births, or if, on the other hand, it would be ethical to prescribe vitamins when their 
exact impact was unknown.121,122 The editorial also argued that ethics committees 
should have to answer questions about their decision to decline permission for a 
randomised trial. Clearly the best way to test the data presented by Smithells and 
colleagues would be in a large randomised trial, but as Smithells’ work had shown a 
potential correlation between supplementation and NTDs, it was even less likely that 
ethics committees, knowing this, would now approve such a study.123 Criticism of the 
ethics committees was fierce amongst some readers, with Kirke likening the decision of 
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the ethics committees to ‘sanctioning what amounts to a situation of uncontrolled 
experimentation on mothers and their babies’,124 and Freed commenting that the ‘sorry 
situation’ had resulted in risks being undertaken without the end result of any real 
answers.125  
 
Throughout 1981 and 1982 debate continued on the subject, with further work by 
Laurence and colleagues corroborating the impact of folic acid supplementation on 
recurrence rates of NTDs. Among the 44 women in their trial who received folate 
supplementation there were no recurrences of NTDs, compared to 6 recurrences in the 
67 women who did not receive supplements.126 Smithells and colleagues discussed the 
sense of urgency which now surrounded the study of folic acid, as due to the publicity 
accorded to their findings, it could not be guaranteed for much longer that women who 
were in control groups in trials were not self-supplementing with vitamin preparations 
bought over the counter, which could skew results.127 The study by Laurence prompted 
further discussion of whether it was ethically justifiable to continue randomised trials 
when more data seemed to be pointing to a beneficial effect of folic acid 
supplementation.128 Some commentators went so far as to state that it was ‘clear that all 
women who have an affected child should receive supplementation for further 
pregnancies’.129 In the United States the American Spina Bifida Association would not 
endorse a trial for NTDs if it involved a placebo drug, as they felt it was unethical.130 
However, not all clinicians and researchers were convinced, with Stirrat expressing 
concerns that women’s hopes could be raised unnecessarily if supplementation did not 
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prove to be effective,131 and Meier questioning if other avenues of research would be 
shelved in favour of supplementation programmes which might prove to be 
ineffective.132  
 
In the end it was the side of caution which was firmly erred on, with the Medical 
Research Council (MRC) in the United Kingdom announcing in 1982 that they would 
carry out a long-term study to analyse the effects of vitamin and folic acid 
supplementation. The study proposed four separate ‘categories’ into which women 
would be placed – one group would receive minerals and multivitamins, another would 
receive minerals, vitamins and folate, a third group would receive minerals and folate, 
and a final group would receive minerals alone; this fourth group who would only 
receive minerals would act as the placebo group within the study.133 The Steering 
Committee of the trial wrote to The Lancet in 1983 stating that the trial was being 
carried out because many doctors remained uncertain about what they should be 
advising their patients, and that there remained doubts about the impact vitamin 
supplementation had on recurrence rates of NTDs.134 The response to the proposed 
study by the wider medical population was mixed, with some strongly in favour of the 
trial. Wald and Polani, two key figures in medical genetics based, respectively, at St 
Bartholemew’s Hospital and Guy’s Medical School in London, felt that ‘though 
suggestive, the evidence is so inconclusive that it does not justify offering extra 
vitamins to all women who are at risk’.135 They felt that the potential harmful effects of 
prescribing supplementation had to be considered alongside the benefit of providing 
these vitamins, and that a large, randomised trial would be the most appropriate method 
of truly examining the safety and efficacy of such preparations. However, it should be 
noted that they were both members of the Steering Committee for the trial, and so were 
evidently in favour of the trial being carried out. Interestingly, in contrast to the United 
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States, in the United Kingdom the Association for Spina Bifida and Hydrocephalus was 
in favour of the MRC trial.136  
 
Others working in medical genetics, such as Harris and Read in Manchester, were in 
favour of the trial but raised concerns about how it could be proved that self-
supplementation did not take place. In their region around three quarters of obstetricians 
offered some kind of vitamin supplementation to women with a previous child with 
NTDs, and for this reason Harris and Read decided not to take part in the study. 
However, they did not have concerns about the ethics of a randomised trial.137 Lorber in 
Sheffield thought the whole trial was ‘regrettable’ and questioned how it could be 
ethical at that time, when it had not been deemed so when Smithells and colleagues 
were carrying out their original work.138 Similar sentiments were echoed by Leck, who 
theorised that many women would decline to participate when fully informed that 
vitamin supplementation may reduce the chance of recurrence of NTDs, and that it was 
likely that their family doctor would support their decision.139 
 
Whilst the debate about the ethics of the MRC trial continued, more research was 
published which corroborated the relation between vitamin supplementation and NTDs. 
Smithells and colleagues looked at another cohort of women, and found there were 
recurrences of NTDs in 0.9% of supplemented women, compared to a 5.1% recurrence 
rate in un-supplemented mothers.140 Seller and Nevin looked at the impact of vitamin 
supplementation in two areas which varied greatly in their incidence of NTDs – the 
south-east of England, which was a low-incidence area, and Northern Ireland, a high 
incidence area. They found that vitamin supplementation produced a slightly less than 
two-fold reduction in the recurrence rate in south-east England, and a greater than three-
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fold reduction in Northern Ireland.141 These findings indicated that vitamin 
supplementation might have varying impacts depending on the incidence status of the 
region in which it is being trialled. Other cases provided more information specifically 
about folic acid, with Blank and colleagues reporting a case where a woman took a 
vitamin supplementation which lacked folic acid, and had a recurrence of NTD. 
Although they were keen to stress that one case could not provide a definitive answer 
about the role of folic acid, they thought it might suggest that folic acid is indeed of 
importance.142 A study into the effects of folic acid in Cuba examined a larger number 
of women, and found no recurrences of NTDs in the 81 women who had been fully 
supplemented with folic acid, or the 20 women who had only been partially 
supplemented, but reported 4 recurrences of NTDs in the 114 women who became 
pregnant without taking any form of folic acid supplementation.143 
 
Despite reservations by some that women would not wish to take part in the MRC trial, 
the number of women recruited increased steadily over several years, and the results of 
the study were published in July, 1991. It had initially been envisaged that 2000 
subjects would be required for the trial, but it was stopped after the results of 1195 
pregnancies were determined, as it became clear that folic acid was having an impact in 
preventing NTDs. In the groups given folic acid there were only 6 recurrences of NTD, 
compared to 21 recurrences in the groups which did not take folic acid.144 The relative 
risk estimate for the folic acid group was 0.28 compared to the control groups, linking 
folic acid to the prevention of 72% of NTDs.145 The study comprised data from 33 
centres around the world, the greatest number of participants being drawn Glasgow.146  
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As the West of Scotland had such a high rate of NTDs Ferguson-Smith and others were 
keen to participate in trials from the earliest possible stage, with correspondence on a 
proposed trial covering several geographical regions as far back as 1980. Dr Michael 
Hill, Chairman of the Division of Obstetrics in the Forth Park Maternity Hospital, 
Kirkcaldy, had written to Professor Whitfield in Glasgow informing him that the Fife 
region had hoped to begin a study on the role of vitamin supplementation, but had been 
advised that the geographical area was too small to sustain a meaningful study. The 
hospital in Kirkcaldy was located around 60 miles away from Glasgow and was in a 
separate council area, however Hill asked if Glasgow would be interested in joining 
such a trial together with Fife to ensure sufficient numbers of women could be 
enrolled.147 In a letter written to Dr Chatfield, based in the Division of Obstetrics in the 
Queen Mother’s Hospital in Glasgow, Ferguson-Smith detailed that he would be keen to 
take part in such a trial, highlighting the ‘considerable concern’ surrounding the design 
of the initial trial by Smithells and colleagues. Ferguson-Smith felt that Glasgow would 
be excellently placed to contribute patients to a multi-vitamin trial in the region, as the 
success of the msAFP screening programme had brought suitable subjects to the 
attention of the medical genetics department. Ferguson-Smith proposed that the fairest 
way to carry out a randomised trial was to contact half the women known to the 
department who had previously had one or more children with NTDs, and ask them to 
take part in the trial. Those who agreed would be given vitamin supplements and would 
form the subject group, and those who were not contacted would have any future 
pregnancies followed up as a control group. Ferguson-Smith felt that this was ‘perhaps 
the only ethical way’ that such a trial could be carried out, given the ‘major uncertainty 
that vitamin deficiency plays any role whatsoever in the aetiology of N.T.D.’148  
 
However, it was decided that the department would participate in the large-scale MRC 
trial, which had a different design from that outlined above by Ferguson-Smith. The role 
that folic acid played in the prevention of NTDs became a main focus for the medical 
genetics department in Glasgow, with one staff member describing it as ‘one of the 
single biggest research and development programmes’ occurring in the mid-1980s in the 
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department.149 He recalled how ‘huge’ the scheme was, and that Glasgow were playing 
an important role as they were ‘supplying patients and tests and staff over the course of 
about 6 or 7 years’.150 The department hired a co-ordinator specifically for the 
programme, Margaretha van Mourik, who began working in the department in 1982. 
Van Mourik recalled seeing the advertisement for a Research Assistant post in the 
Department of Medical Genetics led by Ferguson-Smith, and being told about the MRC 
Vitamin Trial during her interview in June of 1982. She was involved in the trial, 
covering the West of Scotland, from the beginning of her employment, which she 
described as a ‘well defined’ project.151 The trial was double-blind, so neither van 
Mourik nor the patients knew if the patients were receiving vitamin or folic acid 
supplements, which were handed out as dark red capsules.  
 
Van Mourik recalled in detail visiting the patients in their homes to discuss the research 
project to ensure the women had an informed understanding of what it would entail. 
Participation in the study was entirely voluntary, and van Mourik recalled informing the 
women that they were able to obtain the vitamin supplements from their own doctors if 
they did not feel they could participate in the trial. Despite many of the women 
struggling with ‘enormous sadness’ and ‘raw’ emotions as a result of previously 
terminating a pregnancy following a diagnosis of NTD, the majority she visited were 
keen to take part in the trial. This level of participation was contradictory to what many 
expected when the MRC trial was announced. However, several of the women involved 
in the study run by the Glasgow centre emphasised that they would take part as they did 
not want another woman to go through what they had – an attitude that made van 
Mourik ‘fiercely loyal’ to these women.152 Patients enrolled in the trial were visited 
every three months and urine and blood samples were taken for analysis. At each visit 
any tablets the patients had not used were collected and taken back to the laboratory, to 
monitor rates of non-compliance. The Glasgow centre contributed information on 287 
                                                          
149 GG interview, DS300134, p. 11. 
150 Ibid. 
151 MvM interview, DS300167, p. 1. Interview with Margaretha van Mourik, 14th June 2016. Margaretha 
van Mourik undertook her nursing and midwifery qualifications in the Netherlands. She joined the 
Department of Medical Genetics in Glasgow in 1982, where she has remained for 36 years, and she was 
the first Consultant Genetic Counsellor in Scotland. 
152 Ibid. 
207 
 
‘informative’ pregnancies to the MRC study, where the outcome of the birth was 
known.153  
 
As previously mentioned the MRC study was stopped in the early 1990s. Van Mourik 
recalled the ‘enormous difference’ folic acid supplementation made in decreasing NTD 
births.154 She stressed that the people researchers should be most grateful to were the 
women who opted to take part in a double-blind trial to aid scientific discovery, and 
whose contribution is often underestimated, as their names do not appear on scientific 
papers.155 More than a decade on from the original research by Smithells, the MRC trial 
showed that folic acid supplementation could reduce the chance of NTDs, and 
supplementation is still recommended by the NHS. Women not known to be at an 
increased chance for NTDs are advised to take a 400 microgram tablet per day prior to 
conception and up until 12 weeks of pregnancy, and those with a high chance are 
advised to take a 5 milligram tablet per day for the same time period.156 This illustrates 
the lasting impact that this research has had, and is indicative of the move from 
termination of affected fetuses to the prevention of the condition in the wider 
population.  
 
VII. Conclusion 
In many ways the development of prenatal tests for NTDs followed the same path of 
prenatal testing for chromosome disorders, moving from invasive testing to large scale 
screening programmes. Testing for NTDs began after it became possible to detect 
conditions such as anencephaly and spina bifida prenatally using AFP, which had been 
shown to be a useful marker by Brock and Sutcliffe. This discovery would go on to be 
utilised by research groups throughout the world, including the team led by Ferguson-
Smith. As highlighted in this chapter, they were one of the first groups to analyse 
amniotic fluid samples for a retrospective link between AFP and NTDs, as they had 
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amniotic fluid samples stored from prior pregnancies of a number of women. Whilst a 
link between AFP and NTDs was established fairly quickly by the research community, 
the testing was not without issue, and there were a number of false negative and false 
positive results reported. It was also found that closed lesions could not be detected, 
meaning that AFP was only a reliable marker for open NTDs. The introduction of 
AChE helped to reduce the chance of an incorrect diagnosis, but there was still a focus 
amongst researchers and clinicians on moving towards less invasive testing. This was 
achieved in the form of a screening programme, which measured the levels of AFP in 
the maternal serum of pregnant women. Whilst the group led by Ferguson-Smith ran a 
large scale trial which seemed to show a link between increased levels of msAFP and 
NTDs, many other research groups were not convinced of the suitability of such 
screening programmes. As Lӧwy has summarised, these large scale prenatal screening 
programmes could not ‘guarantee the absence of false negatives and false positives’, 
and they could also be responsible for generating ‘false reassurance for some people’ 
and ‘an unnecessary, costly, and distressing diagnostic odyssey for others’.157 In 
addition to the issues associated with false positive and false negative results, data also 
began to emerge that showed regional variations in the detection rates of NTDs using 
msAFP, and in some geographical areas the screening programmes were stopped 
altogether. This illustrates the impact that the views of certain individuals in different 
locations could have on availability of prenatal testing resources. 
 
Perhaps the area where testing for NTDs differs most from that of detection of 
chromosome disorders, was the discovery that folic acid could play a role in preventing 
NTDs forming in the fetus. Instead of being able to detect conditions prenatally and 
then offer a termination of pregnancy, it became possible to prevent the formation of 
NTDs in around 70% of women by offering them folic acid supplementation. Despite 
the various debates and controversies which surrounded this discovery, the overall 
result was that over time these findings would be incorporated into antenatal care. This 
reduced the number of terminations which would take place for fetuses with NTDs, and 
was seen as an acceptable antenatal intervention by the majority of women. The option 
to prevent NTD formation as opposed to terminating an affected pregnancy would be 
                                                          
157 Ilana Lӧwy, Imperfect Pregnancies: A History of Birth Defects and Prenatal Diagnosis, (Baltimore: 
Johns Hopkins University Press, 2017), p. 181. 
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particularly welcome for those women who disagreed with termination. The next two 
chapters of this thesis will consider the perspective of the various groups who were 
opposed to termination of pregnancy, for a variety of reasons such as moral or religious 
beliefs. 
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Chapter Five – The Abortion Act 1967: Development, Discussion, and the 
Views of the Medical Profession 
 
I. Introduction 
The previous chapters of this thesis have examined the scientific and clinical 
developments which were occurring in the field of prenatal testing between 1950 and 
1990. However, it is also important to consider the social time period and circumstances 
that these developments were situated amongst, particularly the 1960s, which was a 
decade of major social and cultural change. Whilst prenatal testing offered the diagnosis 
of fetal anomaly during pregnancy, without permissive abortion legislation this 
information could not be legally acted upon. The implementation of the Abortion Act 
1967, with its specific clause for fetal anomaly, would change this situation entirely, 
providing a clear legal basis for carrying out terminations after a diagnosis by prenatal 
testing.  
 
The Abortion Act of 1967 was the culmination of a great number of debates on the 
subject which had spanned several decades, but found a footing amongst the many 
social changes which were occurring in Britain in the 1960s. Stephen Brooke has 
suggested that since its implementation the Act has ‘accrued profound symbolic 
meaning’, which alongside the abolishment of the death penalty and the 
decriminalisation of homosexuality, ‘signalled a more liberal approach to moral and 
sexual questions’ in Britain.1 The nature of research into the detection of conditions 
such as chromosome disorders and neural tube defects, enabling elective termination of 
affected pregnancies, raised a number of ethical issues for society to contemplate. 
Running throughout this chapter will be a consideration of the way in which fetal 
anomaly was considered within the changing abortion legislation, which links the work 
in medical genetics in Glasgow with the wider social context in which it was occurring. 
 
                                                          
1 Stephen Brooke, ‘Abortion Law Reform 1929-68’, in Witness Seminar The Abortion Act 1967, ed. by 
Michael D. Kandiah and Gillian Staerck, Institute of Contemporary British History, 2002, p. 15. 
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This chapter will examine the debates surrounding the Abortion Act 1967, and the 
response of those within various medical professions to the new legislation. It will begin 
by examining the legal situation in Scotland surrounding termination of pregnancy, 
prior to the implementation of the Abortion Act 1967. It will then consider the 
movement towards the development of new legislation, which would permit termination 
of pregnancy under specific circumstances, analysing the role that groups such as the 
Abortion Law Reform Association (ALRA) played in this campaign. It will go on to 
argue that one of the most crucial areas of the debate focused on the permissibility of 
abortion for fetal anomaly, and will emphasise that for many of those involved in 
campaigning both for and against abortion, fetal anomaly was a central topic for 
discussion. The argument here will be that fetal anomaly was often viewed as different 
to abortions which were taking place for other reasons, and that despite objections to a 
fetal anomaly clause in the early 1960s, by the time of Steel’s Bill, this clause had 
become less contentious and was not the subject of a great deal of debate, with broad 
acceptance of its provisions. 
 
This chapter will also consider the views of the medical profession towards the 
legislation, and the divisions that existed on the subject. The opinions of some of the 
key professional medical bodies will be discussed, including their views on fetal 
anomaly, and the role they played in trying to influence the content of the legislation 
will be examined. To analyse the impact that the views of medical figures could have on 
access to abortion services, the case of two key figures in Scotland will be considered, 
Dugald Baird and Ian Donald. The opinions and actions of Donald are particularly 
important, as he was based in Glasgow and had both a working relationship and 
personal friendship with Malcolm Ferguson-Smith. Analysing their perspectives will 
give an insight into how those in positions of medical power could impact abortion 
services in the regions in which they worked. Specifically, for Donald, the way in which 
he viewed terminations for fetal anomaly, as opposed to abortion more broadly, will be 
considered.  
 
The passing of the Abortion Act 1967 did not result in unanimous acceptance of the 
new legislation, and this chapter will therefore consider the response to the Report of 
212 
 
the Lane Committee, which was set up in 1971, to examine the working of the 1967 
abortion legislation in practice. This will provide an insight into the implementation of 
the new legislation, and highlight the differing viewpoints which remained on the 
subject after the Act was in place, with a particular focus on Scotland. Some of the 
groups who will be considered within this section will be religious and associated 
organisations, who are the central focus of chapter six. This chapter therefore plays an 
important role in providing background knowledge of the changing abortion landscape, 
which is essential for understanding the perspectives of the religious groups who will be 
considered in the next chapter. 
 
II. Early Legislation and the Development of the Abortion Act 1967 
There is a wealth of published literature available on the development of abortion 
legislation, much of which was discussed within the literature review. It is important, 
however, to examine some of this literature here, to help provide a detailed overview of 
the development of the Abortion Act. This will provide a framework on which to place 
section three of this chapter, which will examine the specific views which existed 
towards termination for fetal anomaly, analysing primary sources to build up a 
comprehensive picture of these circumstances.  
 
As discussed in chapter three, before the development of the Abortion Act 1967, there 
had been a number of legal prohibitions on abortion, but these varied between Scotland 
and England. Whilst in England termination of pregnancy was prohibited by specific 
legislation, in Scotland abortion was a common law offence, which meant that it could 
be interpreted in a more flexible manner than English legislation on the subject. In 
addition to the legal ambiguities surrounding abortion in Scotland, Nicolson has 
described how the Scottish police were reluctant to become involved in investigating 
abortion cases in hospitals. This meant that ‘as far as the performance of abortion by 
qualified medical practitioners was concerned, the matter was left to the conscience of 
individual doctors’.2 In Scotland proof was also required that the woman had been 
                                                          
2 Malcolm Nicolson, ‘Letters – Abortion Shouldn’t Become a Postcode Lottery’, The Guardian  
<https://www.theguardian.com/world/2017/oct/29/abortion-shouldnt-become-a-postcode-lottery> 
[accessed 22nd May 2018]. 
213 
 
pregnant before any conviction could be made; the victim in Scots law was ‘the 
potential child … if there was no potential child there was no crime’.3 As Davis and 
Davidson have discussed, gathering enough proof to secure a conviction was difficult in 
Scotland. There would have to be evidence that the woman had been pregnant, and 
usually the pregnant woman and her family would be keen to conceal the pregnancy, as 
would the person who had carried out the abortion. These factors are reflected in the 
prosecution rates; between 1945 and 1966 there was not one prosecution in Scotland 
against a registered medical practitioner when it had been argued that the abortion was 
carried out to perhaps save the life or benefit the health of the pregnant woman.4 
 
Whilst abortion may have been a common law offence in Scotland with a low 
prosecution rate, many in the medical profession were still wary of aborting pregnancies 
without clear legal guidelines. It would take until 1967 before updated legislation was 
produced in the form of the Abortion Act, which was a culmination of the efforts of the 
M.P. David Steel, and numerous pro- and anti-abortion campaigners who worked to 
influence the exact wording of the Act. One of the key groups involved were the ALRA, 
who campaigned strongly for women to have access to abortion services. Founded by 
feminist figures and members of the legal profession, the group’s aim was the removal 
of restrictions on abortion. They felt that women should have access to abortions for a 
variety of social, economic and psychological reasons; these included risk to the 
physical or mental health of the woman, in cases of pregnancy following rape, if a 
woman’s ability to act as a mother was in question, or if the baby was likely to be born 
with severe disabilities.5 The ALRA campaigned initially outside of Parliament, but 
frustrated with the lack of progress they were making, began looking at ways to change 
the laws on abortion in the House of Commons.6 It is perhaps unsurprising that no 
political party was keen to take on the contentious subject of abortion as a main party 
issue. However, the ALRA got round this by working with a number of individual 
parliamentarians who were keen to see abortion laws liberalised, including Renee Short 
                                                          
3 Gayle Davis and Roger Davidson, ‘“A Fifth Freedom” or “Hideous Atheistic Expediency”? The Medical 
Community and Abortion Law Reform in Scotland, c.1960-1975’, Medical History, 50:1 (2006), p. 32. 
4 Ibid. 
5 Sylvie Pomies-Marechal and Matthew Leggett, ‘The Abortion Act 1967 A Fundamental Change?’, in 
Preserving the Sixties Britain and the Decade of Protest, ed. by Monia Carla O’Brien Castro and Trevor 
Harris (Basingstoke: Palgrave Macmillan, 2014) p. 52. 
6 Brooke, ‘Abortion Law Reform 1929-68’, p. 16. 
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and Lord Silkin.7 Short and Silkin both introduced Bills with a view to liberalisation in 
1965, and although neither were passed, they were discussed in much greater detail than 
any legislation on the subject had been previously, leading some to argue that ‘the 
climate at Westminster was warming to the liberalisation of abortion law’.8  
 
Perhaps contributing to this more liberal climate was the fact that a number of young 
M.P.s from various political parties were elected in 1966, whom Pomies-Marechal and 
Leggett have stated were ‘open-minded’ and ‘more attuned to the expectation of 1960s 
Britain’.9 Amongst these M.P.s was David Steel, a 28 year old lawyer, who came third 
in the ballot for Private Members Bills for 1966-67. He was approached by a number of 
pressure groups to take forward their campaigns, including the ALRA, and he decided 
to act on the issue of abortion. A key reason for this was his strong disagreement with 
the situation that financial status affected access to abortion services. Women who were 
financially well off could access medically safer terminations when compared to those 
who were poorer, who were having to resort to ‘back-street abortions’ and all the risks 
these carried.10 After consultation with the ALRA, Lord Silkin, Renee Short, and 
Dugald Baird, amongst others, Steel published his ‘Medical Termination of Pregnancy 
Bill’ on the 15th of June 1966. It proposed four criteria under which legal abortions 
could be carried out, if they had been agreed upon by two doctors. These included a risk 
to the life or mental or physical health of the mother; if the baby was likely to be born 
with ‘abnormalities’; if the pregnant woman’s capability as a mother would be severely 
overstretched by the care of this child; or if the pregnant woman was a ‘defective’, had 
been raped, or was under the age of 16.11  
 
III. The Importance of Fetal Anomaly in Impacting Abortion Legislation 
Whilst there have been a great number of reasons suggested for the successful passing 
of the Abortion Act in 1967 when a number of previous attempts at similar legislation 
                                                          
7 Madeleine Simms, ‘Abortion Law and Medical Freedom’, British Journal of Criminology, 14:2 (1974), p. 
121. 
8 Brooke, ‘Abortion Law Reform 1929-68’, p. 16. 
9 Pomies-Marechal and Leggett, ‘The Abortion Act 1967’, p. 55. 
10 Ibid., p. 56. 
11 Brooke, ‘Abortion Law Reform 1929-68’, p. 18. 
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failed, it is widely believed that the fetal anomaly clause played a key role. Indeed, a 
number of those writing on the subject of the Act, including Gleeson, and Davis and 
Davidson, place it as a central factor around which the legislation was designed.12 As 
this thesis is concerned with prenatal testing, the impact of fetal anomaly in influencing 
legislative change will be examined in detail, looking particularly at the influence of 
Thalidomide and rubella. Lӧwy has argued that these ‘widely publicized events – the 
thalidomide scandal of 1961 and the German measles epidemic of 1962-1964 – brought 
to the fore the role of environmental teratogens (agents that produce fetal 
malformations) and contributed to an important shift in the perception of abortion’.13 
 
In her article ‘Persuading Parliament: Abortion Law Reform in the UK’, Gleeson 
outlines how in the 1940s Australian scientists had shown that the viral infection rubella 
was responsible for babies being born with congenital anomalies,14 including hearing 
loss, brain damage and heart problems.15 Gleeson describes how, despite the effects of 
rubella being well known, an attempt to introduce an abortion Bill into the British 
Parliament in 1954 failed. The Bill had been drafted by Glanville Williams of the 
ALRA (who was a leading academic expert on English criminal law), and would have 
allowed termination on grounds of anomaly. Gleeson describes how Williams had 
persuaded Lord Amulree to introduce the Bill, but that the Bill ‘was not debated, 
however, because Lord Amulree was so ‘alarmed’ by the clause that at the last hour he 
declined to introduce the entire Bill’.16 Gleeson’s example illustrates that it was not a 
straightforward trajectory between recognising the impact of fetal anomaly and 
implementing legislation which would enable termination on these grounds. However, 
by 1964 attitudes towards termination for anomaly seemed to have relaxed, and it was 
claimed by Williams that it had become ‘quite standard practice in a number of 
hospitals to terminate pregnancy on eugenic grounds where the woman has caught 
German Measles (rubella) during the first trimester’, despite it being technically illegal 
                                                          
12 See Kate Gleeson, ‘Persuading Parliament: Abortion Law Reform in the UK’, Australasian 
Parliamentary Review, 22:2 (2007), p. 30, and Davis and Davidson, ‘“A Fifth Freedom”’, pp. 35-36. 
13 Ilana Lӧwy, Imperfect Pregnancies: A History of Birth Defects and Prenatal Diagnosis, (Baltimore: Johns 
Hopkins University Press, 2017), p. 75. 
14 Gleeson, ‘Persuading Parliament’, p. 29. 
15 ‘Rubella’, NHS Choices Website <http://www.nhs.uk/chq/Pages/1104.aspx?CategoryID=54> [accessed 
23rd March 2018] (section titled Rubella and Pregnancy). 
16 Gleeson, ‘Persuading Parliament’, p. 29. 
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in England and Wales.17 In 1964, the editor of the British Medical Journal (BMJ), 
responding to a letter querying the ethics of aborting a fetus after a maternal rubella 
infection, stated that ‘It is difficult to justify risking the birth of a deformed baby where 
this is preventable and where it seems certain that the mother can subsequently give 
birth to a normal baby.’18 That the editor of such a prominent medical journal was 
speaking out in favour of abortion in cases of fetal anomaly highlights the seemingly 
more widespread acceptability of terminations for women who found themselves in this 
situation.  
 
It is also of interest to consider the statements which were being made by various 
professional bodies on the subject of abortion for fetal anomaly, to gain further insight 
into the views of the medical profession. As early as 1938 a report by the British 
Medical Association (BMA) stated that abortion was permissible if there was a 
reasonable certainty that ‘serious hereditary risk’ would be transferred to the child.19 
They had also favoured clarification of the law of the position of a doctor who carried 
out a termination ‘due to “handicap”’.20 By the time the BMA released a subsequent 
report in 1966, they had strengthened this argument further, stating that: 
 
In the intervening period a considerable amount of knowledge has 
accumulated about foetal abnormalities. Prediction can now be made with 
some certainty in the case of certain genetically determined disease, 
chromosomal anomalies, and maternal rubella. Furthermore, the possibility 
of damage to the health of the mother and environmental factors may need 
to be considered in reaching a medical opinion on the desirability of 
termination. Accordingly it is important that the law should not attempt to 
define too precisely the circumstances in which pregnancy may be 
terminated in such cases. We recommend that the law be amended to 
provide that the risk of serious foetal abnormality may be taken into 
account in deciding whether or not to recommend termination of 
pregnancy.21 
                                                          
17 Glanville Williams, ‘Legal and Illegal Abortion’, The British Journal of Criminology, 4:6 (1964), p. 563. 
18 Author Unknown. Editorial reply to original letter by Eugene G. Laforet, ‘Letters – Embryo, Foetus, or 
Child?’, British Medical Journal, 2:5413 (1964), p. 878. 
19 Sheelagh McGuinness, ‘Law, Reproduction, and Disability: Fatally ‘Handicapped’?’, Medical Law 
Review, 21:2 (2013), p. 221. 
20 Gleeson, ‘Persuading Parliament’, p. 31. 
21 Report by B.M.A. Special Committee, ‘Therapeutic Abortion’, British Medical Journal, 2:5504 (1966), p. 
40. 
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Another of the professional groups in favour of legalising abortion for fetal anomaly 
was the Royal Medico-Psychological Association (RMPA), which dedicated four 
paragraphs of an eleven-paragraph memorandum to the subject. They provided a 
number of examples to support their view that legislation on this subject could be 
beneficial to society, including the increased likelihood that women would go on to 
have further children if they terminated a pregnancy likely to result in fetal anomaly, 
whilst the converse was true if they continued with the pregnancy.22 As has been shown 
earlier in this thesis, there were women who agreed with this sentiment, and who would 
not contemplate another pregnancy until prenatal detection of the condition which 
affected their family was possible. In a similar manner to the RMPA, the Royal College 
of Obstetricians and Gynaecologists (RCOG) published a report in 1966 in which they 
stated that it was ‘the view of Council that the great majority of gynaecologists would 
find it possible to work to an Abortion Act which contained the following provisions’, 
one of which was where the pregnancy would ‘involve substantial risk that the child if 
born would suffer from such physical or mental abnormalities as to deprive it of any 
prospect of reasonable enjoyment of life’.23 
 
Several medical professionals also wrote to journals such as The Lancet and the British 
Medical Journal on the subject. Views put forward by those who were in favour of 
termination on the grounds of fetal anomaly included that it would ‘surely be tyrannical 
to hold that the law forces a woman against her strong revulsion to give birth to a child 
that will probably be born seriously deformed or mentally subnormal’.24 Likewise, a 
study of NHS doctors carried out in the London area in 1964 found that ‘70% approved 
the liberalising of the abortion law to make statutory the termination of pregnancy, not 
only when the woman’s mental or physical health is at stake, but also when “there is a 
serious risk of a defective child being born”’.25 
                                                          
22 The Royal Medico-Psychological Association, ‘The Royal Medico-Psychological Association’s 
Memorandum on Therapeutic Abortion’, British Journal of Psychiatry, 112:491 (1966), p. 1072. 
23 Council of the Royal College of Obstetricians and Gynaecologists, ‘Legalized Abortion: Report by the 
Council of the Royal College of Obstetricians and Gynaecologists’, British Medical Journal, 1:5491 (1966), 
p. 853. 
24 Williams, ‘Legal and Illegal Abortion’, p. 564. 
25 Evelyn Fisher, ‘Letters – Legalising Abortion’, The Lancet, 288:7472 (1966), p. 1077. 
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However, objections to legislation on the grounds of anomaly were also voiced. 
Stacpoole-Ryding wrote to the BMJ in 1963 stating his belief that ‘The taking of 
innocent human life is opposed because it is wrong’ and queried why ‘If it is moral to 
destroy children with congenital defects, why is it immoral to destroy adults with 
acquired defects?’26 Concerns were also raised in an editorial in the BMJ in 1965 about 
how easy it would be to reliably predict the impact exposure of agents such as maternal 
rubella might have on the fetus, and that ‘Evidence of the date of conception and of the 
actual risk which the foetus had run might not be easy to obtain in some cases.’27 Others 
queried how difficult it would become to justify preserving the life of premature babies, 
or carrying out surgery on ‘deformed newborn babies which will still leave them 
permanently crippled’. The same correspondent felt that, if the abortion laws were to be 
liberalised, it would ‘spell the end of the code of ethics on which Western medicine has 
been built’ and that doctors would have to ‘find a new code which will include the right 
to decide on who lives and who dies’.28 The Medical Women’s Federation published 
their memorandum on the subject of ‘Abortion Law Reform’ in December 1966, where 
they stated that, despite agreeing that the present abortion law needed revising, the 
committee did not consider ‘that the risk of an abnormal child being born should be 
listed as a categorical indication’.29   
 
Whilst the problems associated with rubella ignited some level of support for abortion 
in cases of fetal anomaly, it was not strong enough to lead to legislative change. 
However, it has been argued that the impact of Thalidomide, a drug which was given to 
pregnant women in the 1950s and early 1960s to help with morning sickness, but which 
resulted in the birth of babies with shortened limbs, ‘contributed to the climate of public 
and medical sympathy for women seeking abortion’.30 Indeed, Gleeson goes as far as to 
say that ‘Law reform might have stagnated entirely had it not been for Thalidomide.’31 
                                                          
26 F. Stacpoole-Ryding, ‘Letters – Abortion Law Reform’, British Medical Journal, 2:5354 (1963), p. 444. 
27 Author Unknown, ‘Leading Article – Abortion Law’, British Medical Journal, 1:5441 (1965), p. 1010. 
28 H.J. Liebeschuetz, ‘Letters – Abortion Law Reform’, British Medical Journal, 1:5499 (1966), p. 1359. 
29 Medical Women’s Federation, ‘Abortion Law Reform. Memorandum Prepared by a Subcommittee of 
the Medical Women’s Federation’, British Medical Journal, 2:5528 (1966), p. 1512. 
30 Davis and Davidson, ‘“A Fifth Freedom”’, p. 35. 
31 Gleeson, ‘Persuading Parliament’, p. 30. 
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An international rubella epidemic in 1964-65 coincided with the Thalidomide scandal 
becoming well publicised, and the combination is thought to have ‘secured heightened 
sympathy’ for women seeking abortion due to fetal anomaly.32 Many members of the 
ALRA have directly linked their involvement in the campaign for the Abortion Act to 
the ‘thalidomide tragedy’,33 and Hindell and Simms have described it as ‘the motor that 
reinvigorated the Abortion Law Reform Association and which paved the way for 
reform’.34 Likewise, in her book Heredity and Hope, Ruth Schwartz Cowan links 
Thalidomide and rubella as key catalysts for change in the abortion movement. Cowan 
argues that ‘All successful social movements – and abortion reform was indeed very 
successful – are galvanized by one or two crucial events, the kind that recruit more 
activists to the cause at the same time as they alter the receptivity of people with the 
power to make the desired reform.’35  
 
This is reflected in the stories of some of the key campaigners for changes to abortion 
legislation. In his book Abortion Freedom: A Worldwide Movement, Francome 
described how Diane Munday, a leading figure in the ALRA, recounted that she had 
been given a prescription for Thalidomide from her doctor.36 Her realisation that ‘if I 
had taken that drug, and had developed a handicapped fetus, I would have wanted an 
abortion’ was key in her decision to join the ALRA and work for a change in the law.37 
Others had stronger views, including Madeleine Simms, a key campaigner within the 
ALRA, who thought it was ‘so appalling that there were people around who were 
actually prepared to compel women to have handicapped babies when this could be 
avoided’.38 She had a family friend who had a brain-damaged son, and in her opinion it 
‘devastated’ the life of the mother, and she believed that people ‘do not always 
understand what the implications are for the mother and the whole family’.39 She went 
                                                          
32 Gleeson, ‘Persuading Parliament’, p. 30. 
33 Interview with Madeleine Simms, ‘Abortion Law Reformers: Pioneers of Change’, ed. by Ann Furedi 
and Mick Hume, British Pregnancy Advisory Service, 2007, p. 15. 
34 Keith Hindell and Madeleine Simms, Abortion Law Reformed, (London: Peter Owen Ltd., 1971), p. 108. 
35 Ruth Schwartz Cowan, Heredity and Hope: The Case for Genetic Screening, (Massachusetts: Harvard 
University Press, 2008), p. 108. 
36 Colin Francome, Abortion Freedom: A Worldwide Movement, (London: George Allan & Unwin, 1984),  
pp. 81-82. 
37 Interview with Diane Munday, ‘Abortion Law Reformers: Pioneers of Change’, ed. by Ann Furedi and 
Mick Hume, British Pregnancy Advisory Service, 2007, p. 8. 
38 Interview with Madeleine Simms, ‘Abortion Law Reformers’, p. 15. 
39 Ibid. 
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as far as to dedicate her book Abortion Law Reformed, co-written with Keith Hindell, 
‘To the thalidomide mothers for whom reform came too late’.40 
 
These views were not limited to those directly involved in the ALRA. Lӧwy discusses 
the case of a ‘white, middle-class, educated, devoted mother of four children and the 
animator of a popular children’s TV show’ from Arizona, Sherri Finkbine, who had 
taken Thalidomide early in her pregnancy and was subsequently granted an abortion on 
medical grounds. However, when she took her story to the general public to warn other 
women about the dangers of Thalidomide, the hospital which had been scheduled to 
carry out her abortion cancelled the procedure as they were afraid of negative reactions. 
Finkbine was eventually forced to travel to Sweden to have a termination. Lӧwy argues 
that Finkbine’s case ‘was an ideal vehicle for the claim that abortion may be justified in 
certain cases’, and that she was ‘very different from the stereotypical image of an 
immoral and irresponsible lower-class woman who seeks an illegal abortion’. 41  
 
Whilst this case happened in the United States, there also seemed to be a move within 
the United Kingdom towards viewing termination for fetal anomaly as a separate 
category. Ferguson-Smith himself made this distinction. Despite being one of the main 
advocates for prenatal testing, he disagreed with abortion for social reasons, which 
shows that these circumstances were often viewed differently, even by those involved in 
the medical field.42 Cowan has argued that ‘Public opinion polls have revealed, over and 
over again, that the majority of people, even some who have their doubts about the 
wisdom of abortion for other indications, believe that it is better to terminate a 
pregnancy than to bring someone who is doomed to suffer with a serious disease or 
disability into the world.’43 This view was reflected in a national opinion poll carried 
out by the Daily Mail newspaper in 1962 which showed that 73% of the British public 
                                                          
40 Hindell and Simms, Abortion Law Reformed, dedication page. 
41 Lӧwy, Imperfect Pregnancies, pp. 75-76. 
42 History of Modern Biomedicine Research Group (Interview Questions by Ms Emma M. Jones, 
transcribed by Mrs Debra Gee, and edited by Professor Tilli Tansey and Mr Alan Yabsley), ‘Ferguson 
Smith, Malcolm 06 Scotland, Genetic Counselling, Religious Objections’, YouTube 
<https://www.youtube.com/watch?v=DzH-Mrh9Lrw> [accessed 20th July 2018]. 4 minutes 30 seconds to 
4 minutes 44 seconds. 
43 Cowan, Heredity and Hope, p. 6. 
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were in favour of abortion where a child might be born ‘deformed’,44 and by 1966-67 
this figure had risen to 91%.45 As the Daily Mail has traditionally been seen as a right-
wing, conservative newspaper, these findings are perhaps quite surprising, but provide 
an insight into the wider cultural shift happening within the United Kingdom 
surrounding abortion attitudes. The Report of the Committee on the Working of the 
Abortion Act, also noted that, when the general public were asked if they agreed with 
abortion in women who had contracted rubella in the first trimester or who were at 
‘risk’ of having a ‘deformed baby’, support increased over time – from 58% in 1965 to 
91% in 1966.46 It also appears that the prosecuting authorities were not keen to be 
involved in cases involving licensed doctors who had carried out terminations on the 
grounds of fetal anomaly in good faith. As Gleeson has pointed out, there is ‘no record 
of prosecution of a doctor for performing an abortion on a woman who had taken 
Thalidomide’, despite concern within the medical profession about the legality of these 
procedures.47 
 
As this chapter has shown, for many, termination of pregnancy as a result of fetal 
anomaly was viewed differently from termination for social reasons. The following 
section will consider how a fetal anomaly clause was discussed when attempts to alter 
abortion legislation were being considered. One of the areas of discussion that are most 
prominent when examining attitudes towards termination for fetal anomaly before the 
advent of prenatal testing, is that of diagnostic certainty. While fetal anomaly was being 
specifically considered within changing abortion legislation in the early 1960s, much of 
the discussion focused around the uncertainty of the diagnosis of conditions prenatally. 
Indeed, in a discussion of his draft Bill in the House of Commons in February 1961, 
Kenneth Robinson specifically mentioned rubella infection as a situation which it may 
be suitable for termination to take place under. However, Mr Renton, also participating 
in the discussion, voiced his concerns regarding the surety of diagnosis. He stated that 
‘although medical science has made considerable strides since 1938, when the 
Departmental Committee sat, it is still not possible to predict with any confidence in any 
                                                          
44 Davis and Davidson, ‘“A Fifth Freedom”’, p. 36. 
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Volume II Statistical Volume, (London: Her Majesty’s Stationery Office, 1974), p. 30. 
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particular case whether a child will exhibit some form of abnormality or how severe that 
abnormality will be’.48 That diagnosis of fetal anomaly, or its severity, could not be 
made definitively during pregnancy was also raised by several other commentators. In a 
draft version of a note in response to Robinson’s Bill, it was stated that additional 
criteria such as fetal anomaly were ‘open to strong objection’ and that a diagnosis could 
not be made with ‘sufficient certainty’.49 Others commented that ‘Congenital deformity 
is so unpredictable that the only related justification for medical termination of 
pregnancy springs not from the ascertainable degree of risk but from the mother’s state 
of apprehension’, leading to the conclusion that there was no need for a separate fetal 
anomaly clause, as a medical professional could proceed to termination in this instance 
under existing legislation.50 These examples indicate that the concerns surrounding a 
fetal anomaly clause in the early 1960s, prior to Steel’s Bill, focused on how one could 
be sure that fetal anomaly was present. 
 
However, by the time Steel’s Bill was put forward, there seemed to be clear support for 
a fetal anomaly clause. It was reported that Steel himself felt that any ‘revised’ wording 
of his abortion Bill which ‘did not contain an express reference to abnormality’ would 
be ‘unacceptable’.51 Support was also voiced more widely, including by individuals 
who were happy to make their views known. David Primrose, a consultant working with 
‘mental deficiency’, wrote to the Minister of Health, expressing his approval of the 
abortion Bill overall, but specifically emphasising his support for termination where 
there was ‘the possibility of serious physical or mental abnormality in the foetus’.52 A 
survey carried out by the National Opinion Poll on behalf of the ALRA showed the high 
levels of acceptability for terminations as a result of fetal anomaly. 80.5% of 
respondents answered positively when asked the question ‘Do you think abortion should 
also be legal if there is serious risk that the child would be born deformed?’, which was 
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the same percentage who agreed that abortion should be legal in cases where the woman 
had become pregnant as a result of rape.53 These high levels of acceptability seem to 
reflect that, in general, there was widespread support for abortion in cases of fetal 
anomaly. Even some individuals who were campaigning against abortion law reform 
more broadly, such as Norman Wylie, M.P.,54 were willing to allow an exception in 
such circumstances. Wylie commented that ‘“There might be arguments in favour of 
abortion to avoid the birth of a seriously handicapped child, but the rest of the Bill is 
thoroughly bad”’.55 
 
However, not all of those who were politically involved in the discussion of the 
proposed abortion legislation were supportive of the fetal anomaly clause. There were 
those who supported attempts to change the language within the clause, and those who 
wanted its removal altogether. With regards to the language, discussion focused a great 
deal around the wording which dealt with the likelihood of fetal anomaly, including 
terms such as ‘substantial risk’. The Bill proposed that abortion would be allowed ‘on 
the ground that there is a substantial risk that if the child were born it would suffer from 
such physical or mental abnormalities as to be seriously handicapped’. The Viscount 
Dilhorne proposed an amendment to the Bill to leave out the phrase (“there is a 
substantial risk”) and insert (“it is more likely than not”) in its place. He also wanted to 
leave out the term (“seriously handicapped”) and insert (“deprived of reasonable 
enjoyment of life”) as its substitution.56 However, opposition was raised to both of these 
suggestions. The idea that a clinician should be responsible for determining what would 
constitute ‘reasonable enjoyment of life’ was not seen as viable. It was pointed out that 
many different factors combine to influence enjoyment of life ‘which may be 
independent of any physical or mental abnormality’, including personality, ‘which it 
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would be impossible for the doctor to assess or even form an opinion on in the case of 
an unborn child’.57 
 
If the proposed phrase ‘more likely than not’ was introduced, it would require certainty 
by the medical profession that there was a greater than 50 per cent chance that anomaly 
would be present. However, critics of this suggested wording change, argued that ‘it is 
evident that the degree of risk demanded by the amendment can rarely be identified’.58 
It was highlighted that ‘developments in medical research may in the years to come 
make more accurate prognostication of abnormality possible, but it is doubtful whether 
it is right to legislate now for this eventuality’.59 The amendments were proposed prior 
to the more widespread use of prenatal testing for conditions such as chromosome 
anomalies, where a diagnosis could be made with greater confidence, and thus there was 
resistance to limiting the clause to grounds which would make it too specific to be 
utilised in clinical practice.  
 
Whilst there were some concerns raised over the fetal anomaly clause being made too 
restrictive by proposed wording changes, others were arguing for further restrictions to 
be put in place, or for the clause to be removed altogether. Two of the key figures 
involved were the M.P.s Jill Knight and Norman St. John-Stevas. St. John-Stevas’s 
campaign against the Abortion Act 1967 will be discussed in chapter six in the context 
of opposition on religious grounds. However, his attempts to limit fetal anomaly 
legislation will be described briefly here. Both Knight and St. John-Stevas proposed 
amendments which would have required both the ‘mother’ and the ‘father’ to provide 
‘written consent’ before a termination for fetal anomaly could be carried out, with a 
statement that ‘the degree of risk and the seriousness of the handicap have been fully 
explained … by a registered medical practitioner’.60 Opponents of the amendment 
expressed concern that difficulties would arise from such a requirement, including that 
the precise estimate of risk for anomaly might not be available for the doctor to provide, 
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and that conflict could arise between the pregnant woman and the male involved, with 
the male potentially refusing to provide consent for the termination.61 
 
Amendments were also proposed to remove the fetal anomaly clause as a whole. These 
were put forward by various groups of individuals, but were defeated each time. One of 
these groups was composed of the Earl of Dundee, the Baroness Emmet of Amberley, 
and the Lord Bishop of Exeter. Another group consisted of Jill Knight, Norman St. 
John-Stevas, James Dunn and William Wells.62 The main line of argument presented 
against inclusion of the fetal anomaly clause was that the ‘unborn child is a member of 
the human race … and that it is wrong to deprive it of life solely because it may be 
seriously handicapped’, a standpoint which was viewed as being ‘Roman Catholic’.63 
These ideas will be discussed further in chapter six, when considering the Catholic view 
towards prenatal testing and termination for fetal anomaly. Another reason given for the 
removal of the fetal anomaly clause related to the previously discussed concept of 
uncertainty, with it being contested that ‘with present medical knowledge it is 
impossible to forecast with any certainty whether there will be serious disability or 
abnormality in a particular case’.64 In the consideration of both of these proposed 
amendments, however, other members noted that there was ‘a good deal of public 
sympathy’ for abortion in cases of fetal anomaly, and that people ‘who support this 
reform do not see themselves as passing judgement on a child’s fitness to live but as 
exercising compassion for the potential child and its parents’.65 
 
                                                          
61 National Records of Scotland, AD63/759/11, Medical Termination of Pregnancy Bill Commons Report 
1/1/20 (24), p. 3. 
62 Information on the amendments proposed by the group consisting of the Earl of Dundee, the 
Baroness Emmet of Amberley, and the Lord Bishop of Exeter, can be found in National Records of 
Scotland, AD63/759/10, Medical Termination of Pregnancy Bill Lords Committee 1/1/17 (11). 
Information on the amendments proposed by the group consisting of Jill Knight, Norman St. John-
Stevas, James Dunn and William Wells can be found in National Records of Scotland, AD63/759/11, 
Medical Termination of Pregnancy Bill Commons Report 1/1/18 (18). 
63 National Records of Scotland, AD63/759/10, Medical Termination of Pregnancy Bill Lords Committee 
1/1/17 (11), p. 1. 
64 Ibid. 
65 National Records of Scotland, AD63/759/11, Medical Termination of Pregnancy Bill Commons Report 
1/1/18 (18), p. 2. 
226 
 
Whilst issues relating to fetal anomaly did feature in discussions surrounding abortion 
legislation, there was widespread acceptance of the inclusion of this clause within 
Steel’s Bill. Whilst clauses such as allowing abortions for social reasons were subject to 
fierce debate, and ended up being removed prior to the legislation being passed as the 
Abortion Act 1967, the clause relating to fetal anomaly remained, despite a small 
number of individuals opposing it. It is of interest to note that much of the debate 
surrounded a lack of certainty over a positive diagnosis of anomaly during pregnancy, a 
situation which would decrease with the implementation of prenatal diagnosis. Despite 
this uncertainty, most people were still willing to support abortion on these grounds, and 
accept that some pregnancies which were unaffected by fetal anomaly, could be 
terminated as a result. 
 
IV. The Perspectives of the Professional Medical Bodies 
As we have seen, Steel’s Bill aimed to make abortion available for a number of 
different reasons, including to preserve a woman’s physical or mental health. The 
medical profession, who would shoulder the responsibility for the implementation of the 
law, were heavily involved in debating the potential changes. Abortion law reform was 
a very contentious issue within the profession, with conflicting views existing amongst 
many of the key professional bodies, including the RCOG, the BMA and the RMPA. 
Prior to the implementation of the Abortion Act 1967 the RCOG and the BMA had 
expressed the view that the current law did not need changing. As late as 1966, in the 
middle of many ongoing debates on the subject, the BMA ‘noted that there “remains a 
body of medical opinion which takes the view that the law does not need amendment in 
that all the accepted medical indications for therapeutic abortion are covered by the 
law”’.66 In the same year, a report by the RCOG stated that ‘The present situation 
commends itself to most gynaecologists … in that it leaves them free to act in what they 
consider to be the best interests of each individual patient.’67 This contrasts strongly 
with the view put forward by the RMPA that many in the medical profession ‘are 
inhibited in advising on, or carrying out, termination of pregnancy for fear that they 
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might have to face legal consequences or because their professional reputation might be 
endangered’.68 
 
However, as MacIntyre has argued, each of the professional bodies were acting in such 
a way as to protect their own interests. In the case of the RMPA they had a vested 
interest in health being viewed as a combination of physical and mental wellbeing; 
otherwise, MacIntyre argues, ‘to put it crudely, they would be out of business if the 
concept of health were restricted to that of absence of biological pathology’.69 Those 
involved in the psychology and psychiatry fields were generally held to have more 
liberal views towards abortion, and in a survey carried out of members of the Society of 
Clinical Psychiatrists in 1967, 80% were found to be in favour of progressive 
legislation.70 However, those with a more conservative attitude towards termination 
dissented from the views of the psychiatrists, and some went as far as to state their 
belief that there was no such thing as psychiatric indications for pregnancy 
termination.71 By way of contrast, the RCOG were in favour of clarification of the law, 
but wanted to restrict reform as much as possible. Once they realised that legal changes 
were going to occur despite their objections, they became closely involved in trying to 
influence the Act, in conjunction with the BMA. The RCOG recommended that 
termination should only be carried out under the supervision of a consultant 
gynaecologist. There were 460 of these consultants in Britain at this time, and so there 
would be a major problem with the supply and demand balance for the procedure.72 The 
RCOG were also against specific indications being included in any legislation, arguing 
instead that it should be the general health of the mother which was taken into account, 
and the gynaecologist should be the one to make a decision on her health. These 
combined clauses were designed, MacIntyre argues, to ensure that the RCOG 
maintained authority in this medical sphere.73 In the end, the BMA persuaded the 
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RCOG that it was impractical to only have consultants carrying out the operation. 
However, both the BMA and RCOG combined to argue strongly that two or more 
doctors should be required to decide upon a termination.74 The BMA were similarly 
disposed to the RCOG as regards to specific indications being excluded from the 
legislation, and argued that doctors should be able to maintain their professional 
autonomy and decide for themselves whether or not a termination should take place. 
Both the BMA and RCOG emphasised that their organisations would not put any 
pressure on doctors to terminate a pregnancy, including if it had occurred as the result 
of a sexual assault.75 
 
Whilst a number of issues in the legislation were debated during the various stages of 
the Bill, the possibility of the inclusion of a social clause proved to be the most 
contentious and highly debated subject. A clause which would permit women to have 
abortions based on social, rather than strictly medical, grounds, was one that the ALRA 
had campaigned strongly for. The RMPA also favoured that social circumstances 
should be taken into account,76 whilst both the RCOG and BMA were strongly opposed 
to their inclusion.77 The RMPA released a memorandum on therapeutic abortion in 
1966, stating that ‘The Royal Medico-Psychological Association approaches the 
problem of therapeutic abortion with the firm view that, in addition to traditionally 
accepted medical and psychiatric criteria, all social circumstances should be taken into 
account. If, after considering all these factors, a psychiatrist should form the opinion 
that the mental health of the mother and the whole family would be promoted by 
termination, then it should be lawful for him to recommend it.’78 As Keown has 
discussed, the RCOG and BMA objected to a social clause as they felt that these 
indications were not medical, and they were concerned that it would lead to an 
‘excessive demand for termination on social grounds, and this would be unacceptable to 
the medical profession’.79 
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The views of the medical profession impacted the legislation for the Abortion Act 1967. 
Steel was aware that support of the medical organisations was essential for the Bill to be 
passed, and it became clear to him that in order to secure the agreement of the medical 
profession, the social clause would have to be removed. In December 1966, Steel 
withdrew the clauses relating to the woman’s capability as a mother, and the criteria of 
being a ‘defective’, having been raped, or being under sixteen.80 Instead, medical 
practitioners were able to take into account the physical and mental health of the 
pregnant woman, and her current and foreseeable future environment. The specific 
clause for fetal anomaly remained within Steel’s Bill. A conscience clause was also 
inserted into the Bill, ensuring that medical practitioners were able to opt out of taking 
part in abortions. After the committee stages the Bill passed its third reading in the 
House of Commons on the 14th of July 1967, with 262 to 181 votes.81 After being 
passed by the House of Lords on the 24th of October 1967, the Bill received the Royal 
Assent on the 27th of October 1967, and was officially implemented on the 27th of April 
1968.82 It was the first time that abortion legislation had covered Great Britain, rather 
than Scotland and England and Wales separately.83 
 
V. The Views of Senior Obstetricians/Gynaecologists – The Case of Dugald Baird and 
Ian Donald 
Although abortion legislation changed with the passing of the Abortion Act 1967, there 
continued to be disagreements amongst various groups on the subject. Vast regional 
differences existed for both the availability of, and access to, abortion services, and it 
has been argued that in a number of cases, this was down to the beliefs of the senior 
obstetricians/gynaecologists who were working in these regions. This was particularly 
prominent in Scotland, where two main figures, Dugald Baird and Ian Donald, held 
hugely different views on abortion. This section will consider each of their viewpoints 
in turn, with a particular focus on Donald as he was based in Glasgow. It will also 
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analyse how these views impacted on the services which were available in their 
respective regions, Aberdeen and Glasgow, building on concepts discussed in Davis and 
Davidson’s article ‘‘Big White Chief’, ‘Pontius Pilate’, and the ‘Plumber’: The Impact 
of the 1967 Abortion Act on the Scottish Medical Community, c.1967-1980’. As was 
discussed in the literature review, Davis and Davidson are two of the leading 
commentators on the views of Baird and Donald. The following sections of this chapter 
will therefore consider their work in detail, but will explore further evidence regarding 
Donald in his relations with Ferguson-Smith. This will include primary source material 
from the Ian Donald and Malcolm Ferguson-Smith archives, in addition to oral history 
testimony by a clinician, Bill Hannay, who worked under the leadership of Ian Donald.  
 
As described by Davis and Davidson, Sir Dugald Baird was a key medical proponent 
for the liberalisation of abortion provision. Baird was a registrar in gynaecology in 
Glasgow before becoming Regius Chair of Midwifery at the University of Aberdeen in 
1936.84 Born in Greenock in 1899, it was the time Baird spent working in Glasgow 
which helped to shape his strong views on abortion. As Davis describes, he began to 
‘recognise the various influences that social and economic factors could have upon 
maternal health and female physiology’.85 Many women in Glasgow had large families, 
and Baird found that in the early 1930s, ‘one third of all maternal deaths in the Glasgow 
Royal Maternity Hospital were in women who had six or more children’.86 In addition, 
two women were dying each week in the Maternity Hospital from complications of 
childbirth.87 Despite this, Baird noted, no contraceptive advice was given to these 
women, and it was ‘scarcely surprising therefore that one third of all maternal deaths in 
Scotland at that time were due to septic abortion’.88 Davis has outlined how Baird came 
to move from Glasgow to Aberdeen, and the impact this had on his clinical practice. 
She highlights that working with the women described above led Baird to develop a 
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permissive view towards abortion, and he decided to make his views public around 
1936, after a conflict with a Roman Catholic priest.89 Davis describes how Baird found 
that his liberal leanings would not be supported in Glasgow, which had a large Roman 
Catholic population, and this was one of the factors which influenced his decision to 
move to Aberdeen, where the influence of the Catholic Church was much less.90 Indeed, 
the varying rates of Roman Catholicism are still evident between Aberdeen and 
Glasgow today; the 2011 census showed that 27.3% of the population in Glasgow 
classed themselves as Roman Catholic, compared to only 8.9% in Aberdeen. The 
overall percentage of people identifying as Roman Catholic in Scotland was 15.9%, 
indicating that Glasgow has a higher than average number of Roman Catholic residents, 
whilst Aberdeen has a lower than average number.91 The views of the Roman Catholic 
population in the city of Glasgow and surrounding areas will be a key focus of chapter 
six, where their outspoken views against abortion will be considered in detail. 
 
By way of contrast to Glasgow, Davis outlines, the community of Aberdeen was 
receptive to Baird’s views, and the city became one of the few places in Britain where 
terminations were carried out in significant numbers prior to the Abortion Act 1967. 
Baird had consulted the Professor of Law at the University of Aberdeen for clarification 
on abortion legislation in the late 1930s, and he was informed that it was unlikely 
prosecutions would be brought against him, unless it could be proven that there was 
criminal intent.92 Baird utilised this flexibility in the law to extend abortion provision, 
with two out of every hundred pregnancies being terminated in Aberdeen under his 
leadership. As a result, Baird argued that fewer women died in childbirth in Aberdeen, 
and that fewer women accessed unqualified abortionists, as these women knew their 
‘difficulties [would] receive sympathetic and unprejudiced consideration from the 
medical profession in Aberdeen’.93 Baird remained an ardent supporter of abortion 
provision and wider family planning. In 1965 he published one of his most famous 
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articles on the subject, entitled ‘A Fifth Freedom?’. Baird added one freedom of his own 
to the four proposed by Franklin Roosevelt: 
 
You will recollect that Franklin Roosevelt in a speech on 6 January 1941 
said: "In the future days, which we seek to make secure, we look forward 
to a world founded upon four essential freedoms." The first is freedom of 
speech and expression. The second is freedom of every person to worship 
God in his own way. The third is freedom from want. The fourth is 
freedom from fear." And I would suggest that it is time to consider a fifth 
freedom – freedom from the tyranny of excessive fertility.94 
 
That women and men should be able to control their family size was of central 
importance to Baird, and whilst he believed that abortion should not be used as a 
method of contraception, he did believe it ‘should be available in the last resort’.95 
Viewing obstetrics as social medicine, he advocated sterilisation if a woman had 
completed her family. Whilst Baird was confident in his own views, he was one of a 
small minority in the medical profession who were willing to carry out abortions in 
anything approaching substantial numbers prior to the Abortion Act 1967. The attitudes 
of others in the medical profession had not followed the same path as Baird, and Davis 
and Davidson have suggested that by 1966 Baird felt a ‘sense of frustration that the law 
had to be changed at all, and that his fellow doctors were not following his lead’.96 
Despite this frustration, Baird was a supporter of the Abortion Act 1967, and 
campaigned strongly in its favour. He spoke of his own experience of carrying out 
terminations for social reasons which had ‘striking benefit to the health of the mother 
and to the whole family’.97 Baird was one of twelve signatories to a statement on Steel’s 
Bill which expressed their unequivocal support for a Bill which they believed would 
give doctors ‘the freedom to make the best choice for the mother, her established 
family, and the embryo within her’.98 Baird maintained this view after the legislation 
was passed, and in 1975 when commenting on the Act he called it ‘one of the most 
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important and beneficial pieces of social legislation enacted in Britain in the last 100 
years’.99 
 
Baird’s liberal views on abortion were not unchallenged, and many within the medical 
community in Scotland were strongly opposed to the idea of termination of pregnancy. 
One such opposing figure was Ian Donald, the pioneer of ultrasound. Donald was born 
in Cornwall in 1910 and studied at Saint Thomas’s in London; he then undertook a 
number of medical roles before becoming Regius Professor of Midwifery at the 
University of Glasgow in 1954.100 This section will examine Donald’s views in detail, 
as he was a figure of central importance in Glasgow. Donald was a deeply religious man 
and an active member of the Scottish Episcopal Church, and as Nicolson describes, ‘He 
was fairly High Church and while, as far as I am aware, he never actually described 
himself as Anglo-Catholic, that was broadly his doctrinal position.’101 Donald was 
morally opposed to terminations in the vast majority of circumstances, and was 
particularly opposed to abortions for social reasons.102 As vocal as Baird was in favour 
of abortion, Donald was equally outspoken in his opposition to it, and he claimed that 
only one pregnancy in 3750 was terminated in Glasgow, a sharp contrast to 
Aberdeen.103  
 
Donald argued specifically against Baird’s view of the ‘tyranny’ concept of excessive 
fertility and motherhood, which he believed ‘contrasts sharply with the mother-and-
child concept which has been glorified by the art of centuries’.104 He strongly disagreed 
with Baird’s views that ending a pregnancy for social reasons could improve the overall 
health and well-being of the pregnant woman, and wrote to the British Medical Journal 
protesting against the ideas put forward by Baird in his article ‘A Fifth Freedom?’. The 
letter was written by Donald, and after some amendments his colleagues John McBride, 
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Wallace Barr and James Willocks also agreed to sign it. Their letter was rejected for 
publication, but its text has been reproduced in the book Ian Donald: A Memoir by 
Willocks and Barr.105 Donald and his colleagues began by acknowledging Baird’s ‘great 
authority and unquestioned sincerity’, but argued that despite Baird’s arguments being 
‘well-intentioned’, they were also ‘dangerous’.106 They argued that there was a major 
difference between pregnancies which if continued would directly threaten the life of 
the woman (such as a patient with cervical cancer during pregnancy), and situations 
where the baby is ‘unwanted because of inconvenience, expense or nuisance value’.107 
It was emphasised that there were other ways to help women involved in this situation, 
including using social services to help women in poverty.108 Whilst this was advocated 
as a possible solution, those writing the letter did not expand on the situation which 
would face women if they did continue with a pregnancy in the hope of gaining social 
support, only for this to not be provided. 
 
Whilst Donald was strongly against abortion for social reasons, he did carry out a small 
number of terminations for reasons of fetal anomaly, which was important for the 
medical genetics field in Glasgow. Donald himself spoke of his cut off point being 
‘when it was scientifically certain that the baby would be incapable of mental and 
spiritual development’.109 Anencephaly was an example of such a medical 
circumstance. Donald’s views have been investigated by other authors, including Davis 
and Davidson, and Nicolson and Fleming, but what has not been covered in the 
published literature is the possibility that the development of medical genetics in 
Glasgow, led by Ferguson-Smith, had an influence on his position. Despite their work 
potentially placing them in conflict, Ferguson-Smith described Donald as a ‘neighbour 
and a friend’, who he had worked with for many years, and spoke highly of him during 
his interview for this project.110 Ferguson-Smith mentioned how he might have had an 
influence on Donald with regards to terminations for fetal anomaly, after getting him to 
speak to one of his patients who was undergoing prenatal diagnosis. The woman had 
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one living child who was affected by a metabolic disease, and had had a second 
pregnancy terminated because of the same condition. She then had another termination 
as during her third pregnancy she was found to be carrying an anencephalic fetus, and 
her fourth pregnancy which was being tested by amniocentesis was also found to have a 
fetus which had the same metabolic disease.111 Ferguson-Smith recalled how the 
woman was articulate and was able to tell Donald how she felt. Donald ‘was of course 
extraordinarily sympathetic and kind, and realised what a burden this had been for her. 
And he appreciated how impossible it was for this woman, without any kind of health 
service support, to look after these children and how difficult it would be for her to have 
another one.’112 Whilst Donald did not have to terminate that woman’s pregnancy, he 
did in the future go on to terminate the pregnancies of two women who had undergone 
prenatal testing in Ferguson-Smith’s department in the early 1970’s. The paper 
describing the cases was published in 1973 in The Lancet with Donald’s name on it, 
which was an important step in linking Donald to terminations carried out for reasons of 
fetal anomaly.113 Ferguson-Smith was aware of the significance of this decision, as 
when writing to a colleague in Manchester about one such case, he emphasised that this 
was the first termination to take place in the Queen Mother’s Hospital in ten years.114 
This is of key importance when considering Donald’s views towards termination of 
pregnancy. In some of the published literature Donald is portrayed as wholly opposing 
termination, and even amongst those who do highlight that he would terminate in cases 
of fetal anomaly, no mention is made of Ferguson-Smith. 
 
When Donald was asked by the newly formed Society for the Protection of Unborn 
Children (SPUC) group at the University of Glasgow to take part in a debate on 
‘Congenital defects and abortion’, he was entirely unimpressed with the idea, despite 
being a member of SPUC. He wrote back to the organiser stating that he thought the 
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subject was ‘tasteless’ as a ‘debating stunt’,115 and that the matter of the debate was 
‘distressingly serious and not one for frivolity’.116 Donald also stated that he would 
‘support the proposed motion in favour of aborting a malformed child since this is my 
current practice’,117 and highlighted his connection with Ferguson-Smith by stating that 
he had been working with him ‘for some time and it is only fair to let you know that in 
the face of incontrovertible scientific evidence of gross fetal handicap I have no 
hesitation in terminating pregnancy. These are rare occasions, nevertheless 
important.’118 This quote illustrates the direct working relationship between Ferguson-
Smith and Donald, and emphasises Donald’s willingness to terminate a pregnancy in the 
rare circumstances he approved of doing so. That Donald was in discordance with 
SPUC on this issue is not well-known. Donald is usually presented in the literature as a 
founding member of SPUC with sustained and vigorous opposition to abortion, with no 
discussion of his willingness to terminate a pregnancy in certain cases of severe fetal 
anomaly.119  
 
Donald did indeed see these as rare cases, but he argued in favour of having the 
resources available to make these diagnoses. Whilst giving a lecture in Dublin, Donald 
argued that Irish obstetricians should be performing more terminations as a result of 
fetal anomaly diagnosis, emphasising that ‘One cannot have at one’s disposal highly 
accurate scientific information as is now available by modern techniques of prenatal 
diagnosis of fetal abnormality and not take the responsibility of making intelligent use 
of it.’120 However, Donald maintained concerns about the numbers of terminations 
which were happening for fetal anomaly which did not sit well with his own moral 
code. Despite advocating for selective terminations to be allowed for fetal anomaly, he 
was keen to emphasise that by maintaining a strict selection criteria he was able to 
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‘count on his fingers and toes the number of abortions he had done’.121 He also spoke in 
1975 about how the whole subject of prenatal testing followed by termination of the 
pregnancy was becoming ‘an increasing feature of obstetric practice in our country’,122 
and that he often felt it was a ‘joyless and morbid subject’.123  
 
Donald had concerns that his own ultrasound technology was being used for such 
purposes, as it was a central feature both in increasing the safety of amniocentesis, and 
also in the direct diagnosis of structural anomalies during fetal development. As 
discussed in previous chapters, ultrasound was also involved in dating gestational age, 
which was essential for correct estimations of alpha-fetoprotein in neural tube defect 
screening programmes. Donald was a keen advocate of furthering research into the 
causes of the conditions which were being terminated, and stated in a letter to a Mrs 
Barnes in 1981 that he shared her ‘view that research should be directed towards 
preventing fetal handicap, by mitigating its consequences when it occurs and by 
avoiding the present practice of liquidating the victims by a policy of indiscriminate 
abortion’.124 Hoping that ‘I myself would not like to feel that I had contributed to a 
Huxleyian Brave New World Society’,125 in a letter written in September 1977 Donald 
commented that with his involvement he ‘may in the end have been contributing to 
therapeutic nihilism’, a statement which was much to the dismay of the Ferguson-
Smiths, who were attending the same meeting where he made the comment.126 This 
section of this thesis shows the complex circumstances which surrounded Donald’s 
views towards termination of pregnancy for fetal anomaly. Whilst for some, no mention 
is made of this perspective at all when discussing his views, others do note that he was 
willing to terminate pregnancies as a result of fetal anomaly under limited 
circumstances. What this presentation of the working relationship between Donald and 
Ferguson-Smith reveals is that the two men influenced each other’s clinical practice. 
This link has not been described elsewhere in the published literature.  
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However, it should be noted that Donald, whilst willing to consider terminations under 
limited circumstances for fetal anomaly, was a strong anti-abortion advocate more 
broadly. Donald had concerns that ultrasound was assisting with terminations following 
prenatal testing, and he utilised the technology to strengthen his arguments against 
abortion on many occasions. Nicolson has described how Donald would show 
ultrasound images of the fetus to a woman who was seeking an abortion in the hopes of 
changing her mind.127 Donald believed that ultrasound ‘killed that dirty lie that the 
foetus is just a nondescript meaningless jelly, disposable at will, something to be got rid 
of’,128 and often showed ultrasound footage at public meetings and discussions to 
strengthen his anti-abortion message. He made a six minute film of a 12 week old fetus 
in the womb ‘jumping around like a youngster on a trampoline’, where it could be seen 
‘kicking, moving its arms, even moving its hands to its face from time to time’.129 Pope 
John Paul II heard about the film and was so enthralled by it that he arranged a meeting 
with Donald at the Vatican. After the Pope had watched the film it was shown to around 
20 million Italians on their main TV news bulletin, and Donald commented that he 
wanted the Italian public ‘to judge for themselves whether this early scrap of humanity 
was a meaningless jelly or real life’.130 His description of abortion as ‘‘legalised 
murder’ performed on ‘flimsy reasons’’ and his declaration that he would ‘never, never 
destroy a healthy baby unless there are very serious reasons to do so’ emphasise quite 
how strong his views were on this subject.131  
 
VI. The Impact of Baird and Donald’s Views on Abortion Service Provision 
Throughout the years after the Abortion Act 1967 both Baird and Donald remained 
vocal on their views regarding abortion. Whilst Donald lamented the ‘disheartening 
paradox’ of improvements in fetal medicine coinciding with a ‘rising tide of deliberate 
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wastage of healthy unborn life’,132 Baird had moved even further in his liberal leanings, 
from the belief that abortion should be freely available but its suitability for individual 
women decided by the medical profession, to ‘come round to the view that abortion on 
request is the most realistic attitude to adopt in the present state of society’.133 As has 
been discussed within the literature review, Davis and Davidson are two key scholars 
who have written about Donald and Baird. This section of the thesis will consider some 
of their work on how Baird and Donald impacted the availability of abortion within 
their regions, and will provide oral history testimony from a clinician who was 
interviewed for this thesis, Bill Hannay, to further examine how Donald’s views 
influenced clinical practice in Glasgow. It is important to examine Davis and 
Davidson’s work here, as it provides an overview of how inequalities developed 
throughout Scotland with regards to access to abortion services. These inequalities 
would greatly impact hospital services, which was a key focus for the Lane Committee, 
whose report will be examined in detail in the next section of this chapter. This section 
therefore provides an overview of how abortion service provision would develop, of 
which it is essential to have an understanding in order to place the responses to the Lane 
Committee report in Scotland in context. 
 
Utilising Ingram’s article in The Lancet on ‘Abortion Games: An Inquiry into the 
Working of the Act’, Davis and Davidson have discussed how the views of Donald and 
Baird affected access to abortion services in their regions after 1967. Ingram’s article is 
based around the book Games People Play by Berne, which used a ‘game model to 
analyse interpersonal manoeuvres or transactions which have both an apparent, manifest 
motive and a concealed one, which is hidden even from those involved’.134 One 
category of medical professionals Ingram looked at was general practitioners (GPs), 
who, he believed, had many options available to them regarding abortion. One was to 
refer patients to a specialist who agreed with their belief system. If a GP did not agree 
with abortion then they could refer their patient to a consultant they knew held similar 
views, knowing a termination would be refused; Ingram classed this as a ‘bounced 
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cheque’.135 As Davis and Davidson have discussed, in Glasgow this would involve 
referral to Donald, who felt that the abortion requests he received were from doctors 
who were looking for a termination to be refused.136 Donald himself confirmed this to 
be the case, in a publication in 1974 titled ‘Life – Death – And Modern Medicine’: 
 
Because of the strict line which my own unit has taken, many of our 
requests come from doctors who are really seeking support in their view 
that the request for termination of pregnancy should be refused. The 
number of our requests has not risen at all over the years since the Act was 
passed, and has remained fairly static at approximately one a week. You 
may attribute our attitude as you like – moral rectitude or sheer bloody-
mindedness – we are nevertheless unrepentant.137 
 
Ingram discussed the impact that specialist gynaecologists who were advanced in their 
field could have, for example by imposing on their staff a certain policy on termination. 
This ‘Big White Chief’, as classified by Ingram, would have a great deal of power, and 
their opinions would usually tend to spread ‘from patients, staff, and hospital to whole 
cities and regions’, which Davis and Davidson argued happened in Scotland.138 Thus 
these specialists, such as Donald and Baird, would over time have become known for 
their stance on abortion, and it is likely that they would have hired staff with similar 
views to their own. Staff and hospitals would therefore have been linked with liberal or 
restrictive abortion policies, enabling GPs to identify the specialists whose views were 
closest to their own. Thus, as noted above, the number of termination requests that 
Donald’s unit received, did not greatly increase in the years following the 1967 Act.  
 
The hugely different belief systems of Baird and Donald clearly had a major impact on 
women living in the regions they were responsible for providing clinical care to. For 
Baird and Donald, the Abortion Act 1967 had little impact on their clinical practice, 
with both continuing to treat abortion in the same manner as they did before the 
legislation was passed. In the case of Baird, that meant offering abortions to women 
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who he deemed as in need of the service, whilst for Donald this meant refusing to 
provide abortions, except in a very limited number of cases, including where the fetus 
had no chance of spiritual development. Thus, each region became involved in a self-
perpetuating cycle, whereby the numbers of abortion referrals and procedures were 
directly linked to the belief systems of the clinicians running the areas.  
 
The cases of Baird and Donald highlight the control the medical profession had over the 
provision of abortion services; for them it was about their individual beliefs, but behind 
every abortion request was a woman who felt she could not cope with the continuation 
of her pregnancy. These belief systems are clearly reflected in the abortion rates for the 
different regions. In 1969 the abortion rate for the North-eastern Region of Scotland 
(comprising Aberdeenshire) was 3.9 per thousand women, compared to 1.6 per 
thousand women for the Western Hospital Board Region (comprising Glasgow).139 The 
figure for the city of Aberdeen was 6.2 per thousand; no comparable figure exists for 
the city of Glasgow alone at this time, but it is reasonable to conclude that abortion rates 
in Aberdeen were almost four times as high as in the Western region of Scotland.140 
Hugh McLaren, an obstetrician and an opponent of permissive abortion legislation, 
commented on the differing rates. He remarked on how ‘two cities, each offering a high 
standard of medical ethics and obstetrical care, may differ widely. For example, 
Aberdeen carries out abortion or abdominal hysterotomy in one in 50 pregnancies. In 
Glasgow the rate is one in 3,750, and without doubt social and economic pressures in 
the slum areas of Glasgow overshadow Aberdeen.’141 
 
Baird argued that the social and economic pressures facing Glasgow were being 
exacerbated by the high birth and low abortion rates in the city. He attributed the lower 
abortion rate in Scotland when compared to England and Wales to the fact that ‘58 per 
cent of all births in Scotland take place in the Western Region’. He went on to single 
out Glasgow as the source for many of these figures: 
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In Glasgow, the centre of the Western Region, the birth rate (per 1000 
women aged 15-44) is 20 per cent above that of the combined rate for the 
other three Scottish cities and the illegitimacy rate per 1000 unmarried 
women is twice as high. The perinatal mortality rate in Glasgow is 20 per 
cent higher than the rate in other cities. These very high rates, especially 
the high illegitimacy rate, are important contributory factors to the 
notoriously high incidence of disease, delinquency and crime in 
Glasgow.142 
 
That the birth rate was so much higher in Glasgow than in other Scottish cities led Baird 
to conclude that ‘in four of the five Scottish regions there seems to be close agreement 
on the need for a liberal abortion policy amongst the leading obstetricians and 
gynaecologists and the family doctors with whom they work’, but that the situation in 
Glasgow ‘is due partly to the existence of a large Roman Catholic minority but basically 
to the anti-abortion views of several of the leading obstetricians in the region’.143 It is 
not difficult to imagine that Donald, with his strongly outspoken and uncompromising 
views on abortions, was one of those Baird had in mind with this statement. For Baird 
and Donald, the situation may have involved their own moral decisions, but for the 
women living in these regions it resulted in a postcode lottery, where the decision to 
allow them to undergo a termination of pregnancy may not have been based on the 
merits of their case. As more hospitals restricted terminations to those who lived within 
their catchment areas, the impact of the ‘Big White Chief’ would be felt more keenly by 
those women attempting to access abortion services. Although areas such as Aberdeen 
were seen to have a more liberal abortion policy, they would only accept women who 
lived within their area, meaning women from Glasgow were unable to go there to have 
an abortion. To obtain a termination which was unavailable to them on the NHS, many 
women from Glasgow resorted to travelling to England to pay for an abortion privately. 
This was a common enough occurrence that the Glasgow to Liverpool train was 
nicknamed ‘the Abortion Express’.144 
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These inequalities in access to abortion services did not exist solely between Glasgow 
and Aberdeen, but were also evident within the city of Glasgow itself. This is 
exemplified when comparing the experiences of Donald, with those of his more liberal 
colleague across the city, Professor Malcolm MacNaughton, who Donald was known to 
refer to as ‘the abortionist in the East’.145 MacNaughton had been a lecturer in Dugald 
Baird’s department between 1957 and 1961, which is likely to have impacted his liberal 
views on abortion.146 When working in Glasgow, MacNaughton was under rising 
pressure to perform more abortions, and as demand increased, he had to turn down the 
abortion requests of women who did not live within the catchment area of the 
hospital.147 Even though MacNaughton was willing to assist the women that Donald 
would have refused to terminate, he was restricted in doing so due to time and resource 
constraints.  
 
Evidence from an oral history interview carried out for this thesis has shown that these 
generalisations about Donald’s stance were consistent with the realities of working with 
him. A clinician, Bill Hannay, who worked with Donald, confirmed that this divide in 
hospital abortion policy occurred not just in theory but also in practice in Glasgow, 
when recalling the case of a woman who had somehow been referred to the Queen 
Mother’s Hospital for a termination of pregnancy, stating ‘how she got to our clinic I 
don’t know because it was well known that it wasn’t done, it all went to the other side 
of town’.148 He went on to describe how Rottenrow,149 the maternity hospital located on 
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the other side of Glasgow, had MacNaughton as a staff member, and ‘they had more 
liberal views on termination on that side of the city and GPs knew this and abortions 
went, termination requests went there. It’s not that we didn’t deal with spontaneous 
abortion of course we did you know, but the team on the other side they did all the 
terminations.’150 As MacNaughton was working at Rottenrow, his clinical premises 
were physically distinct from those of Donald, as shown in Figure 5.1, giving him 
freedom to exercise these more liberal views.  
© Crown Copyright and Landmark Information Group Limited (2018). All rights 
reserved. (1960s). 
Figure 5.1 – Showing the physically distinct location of the Queen Mother’s Hospital, 
where Ian Donald was based, and the Glasgow Royal Maternity Hospital, where 
Malcolm MacNaughton worked. The Queen Mother’s Hospital is marked by the blue 
circle, and the Glasgow Royal Maternity Hospital by the red pin.151 
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Whilst it is possible that a particular stance towards abortion would become 
synonymous with a hospital, as shown in the examples of Donald and MacNaughton 
above, there would, of course, have been members of staff who worked with them who 
did not totally align themselves with their views. One such individual is the consultant 
quoted above, Bill Hannay. Hannay had worked under Ian Donald as a senior registrar 
in 1975, and managed to convince him that a woman who presented at the hospital had 
a worthy case for a termination. Donald eventually agreed that the termination could 
take place, and Hannay commented that this showed that Donald ‘wasn’t totally 
intransigent in that way’.152 However, Hannay clearly had to convince Donald of the 
need for the abortion, and Donald came to watch the termination and take photographs, 
although Hannay never found out what these photographs were to be used for.153 That 
Hannay could still recall the event more than forty years after it had taken place 
suggests this was a rare occurrence which stood out in his memory. This example 
emphasises the impact that personal relationships can have on decision making, and the 
importance of considering these relationships where possible.  
 
VII. The Lane Committee Report – Responses in Scotland 
The above discussion on the disparities which emerged within and between regions for 
abortion services highlights the volume of terminations which were being requested. 
This high demand for abortion services did not go unnoticed by those who had raised 
concerns about the possible impact of more permissive abortion legislation. Calls for an 
investigation into the working of the Act began almost as soon as it came into force, 
with medical professionals and religious groups at the forefront of the disquiet. 
However, since its implementation in 1968 there has only been one large scale review 
of the Act carried out, that of the Lane Committee, published in 1974.154 The Lane 
Committee sought the views of a variety of groups and individuals regarding the 
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working of the Abortion Act, but crucially, their terms of reference did not entail an 
examination of the underlying principles of the abortion legislation. The Lane 
Committee were commissioned rather to investigate the working of the Abortion Act 
1967 in practice, and the impacts it was having.  
 
Much to the surprise of many people, the Committee voiced its full support for the 
working of the legislation, raising only a few concerns.155 The Report of the Committee 
stated that they were ‘unanimous in supporting the Act and its provisions’ and had ‘no 
doubt that the gains facilitated by the Act have much outweighed any disadvantages for 
which it has been criticised’.156 However, they did highlight issues with the strain the 
new Act had put on medical staff who had little time to adapt, the inequality which 
existed in accessing abortion services on the NHS throughout the United Kingdom, and 
the ‘instances of gross irresponsibility’ amongst some doctors working in private 
practice, who were using the Act to terminate pregnancies on ‘comparatively trivial 
grounds’ in order to make money.157 It is interesting to note that the main concerns 
which the Lane Committee raised do not seem to relate to termination for reasons of 
fetal anomaly. Perhaps this could be related to the distinct way in which abortion for 
these reasons was viewed, both by the wider public and by those who had played a role 
in moving abortion legislation through the legal system. That terminations for fetal 
anomaly did not seem to be a cause for concern could also be related to the small 
number of which were carried out each year in comparison to abortions for other 
reasons – the figure given for Scotland was only 1.6% for the year 1970 for fetal 
anomaly, compared to 89.6% on the grounds of ‘Risk of injury’ to the ‘physical or 
mental health’ of the woman’.158 
 
In a number of publications, Davis and Davidson have considered the working of the 
Abortion Act in Scotland, including the specific role of Scottish clinicians and religious 
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groups with regards to the Lane Committee recommendations. These areas of study of 
concern in Scotland by Davis and Davidson will be considered here, alongside an 
examination of primary source material in the National Records of Scotland.  
 
For the most part, the response to the Lane Committee Report was positive, with many 
key medical groups voicing their support for it. Two of the groups who gave their 
general support for the recommendations within the Lane Committee were the BMA 
and the RCOG. The BMA ‘congratulated the Committee on “the publication of such an 
exhaustive and informative report which is yet so lucidly and pleasantly written” and go 
on to state that “the Council would not, in general, defer with the recommendations of 
the report”’.159 The RCOG made similar comments about agreeing with the general 
themes of the Report, stating ‘that “the majority of members of the Council welcome 
the recommendations of the report as a whole”’, as did The Royal College of 
Psychiatrists.160 It is interesting that the BMA, RCOG and Royal College of 
Psychiatrists all found themselves able to broadly support the conclusions of the Lane 
Committee Report, as when the changing abortion legislation was being debated, such 
parity between the BMA and RCOG with the Royal College of Psychiatrists was not in 
place. The Scottish Division of the Royal College of Psychiatrists ‘made no substantial 
criticisms or comments on the report except to praise it for its comprehensiveness’. 
However, they did highlight that ‘psychiatrists are less and less frequently involved in 
recommendation for termination as family doctors have now identified those 
gynaecologists who are willing to carry out the operation’.161 This was certainly the 
case in Glasgow, where, as discussed earlier in this chapter, doctors could choose to 
send a woman to a liberal or restrictive professional in the city, with MacNaughton and 
Donald filling these respective roles. This unity within professional groups was not 
universal however, with specific comments from the Scottish Executive Committee of 
the RCOG highlighting the difference in opinion which still existed amongst its own 
members. Whilst accepting and having ‘no comments on the statistical data in the 
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report’, they also stated that ‘The majority of members of Council welcome the 
recommendations of the Report as a whole, but a minority of members who are opposed 
to terminations of pregnancy on socio-economic grounds regret that the terms of 
reference of the Committee excluded consideration of subsections 1 to 4 of Section 1 of 
the Act.’162  
 
Other medical groups also broadly came out in support of the Lane Committee Report 
and its recommendations, with the University of Edinburgh Medical School expressing 
‘its approval of the report and the conclusions and recommendations it had come to’, 
and the Royal College of Physicians of Edinburgh holding the report as ‘very 
satisfactory’ and in line with their own views.163 The views amongst two midwifery 
groups were also broadly supportive of the Lane Report, with the Central Midwives 
Board for Scotland wanting to ‘convey their congratulations to the Committee on the 
production of an excellent Report on an obviously emotive subject’, and the Scottish 
Board of the Royal College of Midwives approving of its main recommendations, and 
complimenting the Lane Committee ‘for producing such a comprehensive and humane 
report’.164 The Scottish Board of the Royal College of Midwives did, however, express 
the wish to limit the upper time restriction for abortion to 20 weeks, but perhaps in 
contrast with this, recommended ‘that facilities for genetic study of cells, particularly 
for women over 40, should be extended so that any woman who desires it may have this 
investigation performed’.165 Thus, while they wished to extend prenatal testing for 
women over the age of 40, a 20 week upper time limit could be restrictive, as women 
often would not find out the results of prenatal tests until around this time period. A 20 
week time limit was also supported by the Scottish District Nursing Association, but in 
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contrast to the midwifery groups discussed above, they were not as complimentary of 
the Lane Report, describing the ‘Committee’s deliberations’ as ‘somewhat 
superficial’.166 They did, however, support the recommendations in general. The Lane 
Committee looked at lowering the time limit at which abortions could be carried out, 
and recommended an upper time limit of 24 weeks gestation. It has been argued that 
their reasoning for choosing this limit was ‘based mainly on the wish not to prejudice 
the use of diagnostic amniocentesis … as in some circumstances the final outcome of 
this procedure may not be available until about the 22nd week of gestational age’.167 
This would suggest that the Lane Committee were deliberately providing support for 
terminations to be available on the grounds of fetal anomaly.  
 
Whilst there seemed to be broad support within the medical profession for the Lane 
Committee Report, some of the concerns which had been raised by the Committee were 
reflective of the criticisms of the Abortion Act in general. Within England some of the 
key issues were ‘the role of the private sector, access by foreign women to British 
abortion services, and the advertising of British abortion services abroad’.168 As 
Davidson and Davis highlight, these issues were not seen as being particularly 
important within the Scottish medical profession. However, other concerns were shared 
across the border, including ‘the pressure on gynaecological services imposed by 
abortion work, the impact on staff resourcing of the conscience clause and of 
professional differences over the appropriateness of abortion procedures within normal 
maternity care, geographical variations in the interpretation of the act, and issues 
surrounding the statutory time limit for terminations.’169 
 
As can be seen in the above quote, pressure on gynaecological services was raised as a 
key area of concern by medical professionals, when considering the impact of the 
Abortion Act 1967. It was clear that after the implementation of the new legislation, 
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many more women became aware that they could seek a termination of pregnancy, and 
numbers subsequently increased. Whilst David Steel welcomed these increasing 
numbers as a reflection that fewer women would be accessing back-street abortion 
services, Davis and Davidson have presented specific examples of medical 
professionals who showed their displeasure at the impact these increasing numbers of 
terminations had on their gynaecological services.170 One such group was Lothian and 
Peebles Executive Council, who, Davis has highlighted, ‘lamented, due to the limited 
number of consultants and because terminations required to be carried out as early as 
possible, many other gynaecological cases had to be deferred for unreasonable 
periods’.171 This unhappiness at the impact on other services was articulated more 
fiercely by the Matron of Bellshill Maternity Hospital, who expressed unhappiness as 
the maternity hospital’s ‘commitments to our ordinary patients are barely met, standards 
of nursing care are falling, and yet we have to spread our professional skills still further 
to cope with this additional category of patient’.172  
 
The Matron defines women seeking abortions as an ‘additional category’, suggesting 
that she views these cases as distinctively different from other gynaecological patients. 
This was true of many in the medical profession, and Davis and Davidson have 
presented evidence of nurses and midwives in particular feeling uncomfortable with 
being involved in abortion procedures. For instance, the Principal Nursing Officer for 
the Aberdeen Special Hospitals, commented that, in the opinion of many nurses, 
maternity hospitals were not, in general, the best place for abortions to be carried out.173 
The conscience clause was in place to ensure that those who were not comfortable being 
involved in terminations could opt out from doing so, but the situation was more 
complex than this. As Davis and Davidson have highlighted, utilising the conscience 
clause could cause distress for the individuals involved, particularly nursing staff. By 
‘having to refuse support to doctors for whom they had affection and respect, many 
nurses were said to be caused distress’, and they were all too aware that by refusing to 
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participate in abortion work, they were ‘placing the burden of the patient’s care on to 
one of their nursing colleagues’.174 
 
In reality, what the utilisation of the conscience clause did was to lead to vast regional 
differences developing, or in some cases continuing, much the way they had prior to the 
implementation of the Abortion Act 1967. This regional variation was discussed 
repeatedly by the Lane Committee, who stated their unhappiness with the situation. 
Suggestions following the Lane Committee Report were for staff appointments to be 
made which would enable abortions to be carried out in all regions; this will be 
specifically discussed for Glasgow below. Many of those who provided evidence to the 
Lane Committee emphasised the impact these regional variations were having on their 
own medical practices, with the Board of Management for Glasgow Royal Infirmary 
‘where an unusually liberal ideology prevailed’ presenting their evidence to the Lane 
Committee that it was the need for women to try and source an abortion by ‘‘shopping 
around’ that was responsible for their gynaecological waiting list having doubled in just 
one year’.175 
 
Particularly relevant to this thesis is the response of the Faculty of Medicine at the 
University of Glasgow to the Lane Committee Report. Professor McGirr, the Muirhead 
Chair of Medicine, composed the reply to the Scottish Home and Health Department 
(SHHD) who were seeking responses to the Report. McGirr consulted the Regius 
Professor of Midwifery (Ian Donald) and the Muirhead Professor of Obstetrics and 
Gynaecology (Malcolm MacNaughton) for their views. As discussed above, the views 
of Donald and MacNaughton towards abortion varied drastically, which could perhaps 
have led to difficulties in forming a unified response. Indeed, McGirr himself highlights 
in his letter to the SHHD that it was ‘virtually impossible to present a Faculty view’ on 
the subject, and comments that on the subject of abortion there are wide-ranging views, 
which vary ‘from the view that the implied assumption of the utter disposability of life 
must entitle the Report to the distinction of being one of the most pagan in British 
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parliamentary history to full agreement with the views expressed by the Committee’.176 
McGirr went on to discuss matters such as the importance of contraception education, 
and concluded that ‘From the statistics given, it is evident that the services are 
inadequate in fact in the Western Region of Scotland.’177 A few possible solutions to the 
development of more adequate provision are suggested, including enlargements of 
departments with the addition of more staff members, or that ‘when university 
representatives are taking part in selection of gynaecologists to work in this area that 
they should be aware of this deficiency so that appropriate staff can be appointed’.178 
Appropriate staff, in this context, mean those who would be willing to carry out 
terminations. As has been shown within this chapter, however, those in a position of 
authority within the clinical sphere, such as Ian Donald, tended to surround themselves 
with individuals who shared their views on abortion. It is difficult to imagine this 
practice changing, and someone such as Donald, with his particularly stringent views on 
abortion, hiring a new member of staff with outspoken pro-abortion views.  
 
A number of religious and lay organisations were also consulted for their views on the 
Lane Report. Whilst chapter six will focus on the views of the Catholic Church and the 
Church of Scotland to abortion more generally, the responses of a few religious and 
related groups to the Lane Committee will be outlined here, due to the relevance in this 
section. The Society for the Protection of Unborn Children, SPUC, who will be 
discussed throughout chapter six, held strong anti-abortion views, and were vocal about 
their desire to tighten up abortion legislation. Their response to the Lane Committee 
included a line-by-line critique of the Report, detailing their unhappiness. SPUC 
questioned what the Lane Committee’s proposals were to deal with the ‘abuse of the 
law’ surrounding terminations of pregnancy in the private sector. They also maintained 
that the Lane Committee’s comments that abortion must remain an individual decision 
‘can only be interpreted as a recommendation to permit, in practice, abortion on 
request’.179 SPUC felt that the composition of the Lane Committee was not 
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representative of wider society, due to the Committee’s comments that they 
unanimously supported the Abortion Act, with SPUC highlighting that the Committee 
members ‘cannot have been representative of the views of the population as a whole, 
since a large majority of electors are opposed to abortion on request’.180  
 
Another group who responded critically to the Report was the Society of the Innocents, 
a Glasgow-based organisation, set up in 1977 by a priest based in Lanarkshire. The 
society aimed to provide a ‘caring alternative to abortion’, in line with their belief that 
‘all human life is precious from the moments of conception and that abortion is the 
taking of a human life’.181 As might be expected, they were not in favour of the findings 
of the Lane Report. They queried the statistical data presented, particularly relating to 
illegal abortions, and opposed the Lane Committee’s advocacy of contraception, which 
the Society believed did not decrease abortion numbers.182 In addition to the Report 
itself, the Society of the Innocents were strongly critical of the composition of the Lane 
Committee, stating that ‘Surely it is not the norm to have Government Committees so 
badly balanced in opinion’.183 This view was also held by the Catholic Child Care 
Office, who also commented that ‘The fact that there were no anti-abortionist members 
meant that no balanced or worthwhile report would be forthcoming since there was no 
possibility of a minority viewpoint which might have contributed to a fuller 
understanding of the problem.’184  
 
Groups associated with the Catholic faith were not, however, the only religious 
organisations putting forward criticism of the Lane Committee findings. The Free 
Church of Scotland were unhappy with the numbers of abortions taking place, and 
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especially those which were occurring for social reasons.185 This is a key point to 
consider; the Lane Committee was not looking at the terms of the Act, but this did not 
stop several commentators explicitly mentioning the category of terminations for social 
reasons. Davis and Davidson have highlighted that particularly strong resistance to 
abortions for social reasons came from obstetricians, nurses and midwives, with the 
Scottish Council of the Royal College of Midwives stating in their submission to the 
Lane Committee that abortion seemed to be ‘to many nurses ‘the antithesis of 
Midwifery’’.186  
 
The Church of Scotland were a key group who also provided comments on the Report. 
They led the opening of their own submission to the Scottish Home and Health 
Department with the words ‘The findings of the Lane Committee must cause concern’, 
and emphasised that ‘the principles on which the Committee base their judgment are not 
necessarily those on which the Act is based’.187 One of the key areas which the Church 
of Scotland disagreed with the Lane Committee on was their perception that the Lane 
Committee based its findings ‘on the Principle of the “Quality of Life”, usually that of 
the mother … a whole report written with this as the criterion is bound to reach very 
different findings on particular aspects of the working of the Act from those which the 
Church proposed’.188 The Church of Scotland raised points in their report about the 
need for all women to receive counselling prior to an abortion taking place, and voiced 
their support for an upper time limit for abortion of 20 weeks. They expressed particular 
anxiety around the Committee’s findings that abortion services would need to be 
expanded, and found the discussion by the Committee around staff appointments 
‘disturbing’, as they believed it could undermine the conscience clause within the Act, if 
it was made an essential requirement that prospective recruits to obstetric departments 
would have to be willing to carry out terminations.189 As can be seen in the discussion 
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from the University of Glasgow above, such a policy was considered necessary to 
ensure adequate provision of services in any region.  
 
From the evidence presented, it seems that there was not unanimous support for the 
findings of the Lane Committee, with several medical groups generally accepting the 
contents of the Report, whilst many religious organisations felt strongly that it was not 
representative of the general public’s views on abortion. Despite raising these concerns, 
there have been no further in-depth analyses of how the Act is working since the 
publication of the Lane Committee’s findings. There has been one major change to the 
legislation since its inception, which is the lowering of the legal time limit for abortion 
from 28 to 24 weeks. However, there are exceptions to this time limit when the 
immediate life of the mother is at risk, or if the baby is likely to be born with severe 
disabilities.190 There continue to be a number of different pro- and anti-abortion 
perspectives, with people on both sides of the debate continuing to campaign for 
changes to the legislation. Whilst some individuals believe that the legislation is too 
restrictive, removing the choice of terminating a pregnancy away from women and into 
the hands of the medical profession, others feel that it is too lenient, allowing women 
access to abortion services when the rights of the fetus should be protected. 
 
VIII. Conclusion 
With the implementation of the Abortion Act 1967, terminations can be carried out 
under defined circumstances, enabling many women to access medically safe abortions. 
This legislation greatly influenced the field of prenatal testing, making it possible for 
women to terminate pregnancies suspected to be affected by fetal anomaly, if they 
chose to do so. However, the development and implementation of the Abortion Act 
1967 was a source of great debate for society in general, and the medical profession in 
particular. This chapter has highlighted some of the campaigning which occurred by 
groups such as the ALRA to push for more permissive legislation, and has emphasised 
the importance of fetal anomaly for their cause. Many of those involved in the fight to 
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have abortion legislation implemented described how their views on fetal anomaly 
influenced their stance on abortion more generally, and surveys showed that many 
members of the public were in favour of termination for fetal anomaly, even if they 
disagreed with abortion for other reasons. It can also be seen that the fetal anomaly 
clause was generally accepted by those who were debating abortion legislation more 
broadly, with few challenges to alter or remove the clause from Steel’s Bill. Indeed, 
even amongst those who were fighting against more permissive abortion legislation, 
there were some who agreed with the fetal anomaly clause. 
 
Whilst the ALRA and other campaigners were working to have more liberal abortion 
legislation passed, one of the key groups involved in discussions on the subject were the 
professional medical bodies. As was highlighted in this chapter, it can be seen that each 
of these were responding in a way that would ensure their professional autonomy would 
be maintained. Whilst the RMPA were in favour of more progressive legislation, the 
RCOG and BMA were arguing strongly against some of the clauses in Steel’s Bill, and 
they were keen for abortion to remain under the control of the medical sphere. As was 
seen in the discussions of Dugald Baird and Ian Donald, this control could have a major 
impact on the women living in the regions served by individual consultants, with the 
ease and difficulty of accessing abortion services greatly influenced by where the 
women lived, and which medical professional the women were referred to for an 
appointment. The case of Donald and Baird highlights how a number of factors such as 
moral, ethical and religious beliefs can all impact decision making surrounding 
termination of pregnancy. Personal relationships also play a key role, as highlighted in 
the interactions of Ferguson-Smith and Donald, who were able to work together and 
maintain respect for each other, despite holding different views on a number of areas 
surrounding termination of pregnancy. Archival and oral history testimony presented 
within this chapter has also shown that Donald was not inflexible on his views towards 
abortion, being willing to carry out terminations in limited circumstances, including in 
certain cases of fetal anomaly. 
 
These inequalities in abortion provision, and the impact the legislation had on hospital 
services, were two of the key themes which emerged in the Report produced by the 
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Lane Committee which examined the working of the Act. Within this chapter the 
response of various medical and religious groups to the Lane Report is considered, 
which emphasises the differences in opinion which existed several years after the 
legislation was in place. It was noted within this section, that terminations for fetal 
anomaly were not an area of key concern for the Lane Committee. It is thought that they 
supported abortions in these cases, due to recommending an upper time limit of 24 
weeks gestation for terminations. This time scale would enable women to undergo 
prenatal testing followed by an abortion if requested.  
 
It was not only those within the medical profession who worked to gain control over 
abortion legislation, and some of the key figures involved in discussions on the subject 
were from religious organisations. The work presented in this chapter provides an 
overview of much of the changing landscape on abortion legislation, against which the 
responses of religious groups to these changes can be set. The next chapter will 
therefore consider the views of two of the main religious groups in Scotland – the 
Roman Catholic Church and the Church of Scotland – to abortion legislation, including 
their attempts to influence legislation prior to and after the implementation of the 
Abortion Act 1967. 
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Chapter Six – The Views of Religious Organisations on Abortion, Focusing 
on the Roman Catholic Church and the Church of Scotland 
 
I. Introduction 
The previous chapter considered the development of legislation which became the 
Abortion Act 1967, and emphasised the importance that the belief systems of local 
clinicians could have on availability of abortion services. However, there were other 
groups with strong feelings on the subject of abortion, with religious organisations 
particularly keen to voice their opinions. The main perspectives which will be 
considered in this chapter are those of the Roman Catholic Church and the Church of 
Scotland, who held different views on abortion. Two of the key sources which were 
used to gather information have been the Scottish Catholic Observer (SCO), a Scottish 
Catholic weekly newspaper, and Life and Work, a monthly Church of Scotland 
magazine publication.1 However, the lack of direct discussion on prenatal diagnosis in 
either publication is noteworthy. Whilst letters and articles on abortion fill pages of both 
the SCO and Life and Work, there are few direct references to prenatal testing. The only 
real exception to this is a flurry of articles and letters in the SCO in 1981, which is 
probably linked specifically to this year, having been designated the International Year 
of the Disabled by the United Nations. The lack of discussion is unexpected, as the only 
available ‘treatment’ for a diagnosis made by prenatal testing during the time period of 
this research was a termination of pregnancy, which would be presumed to conflict with 
certain religious teachings on both abortion and disability.2  
 
The time period of this study was one characterised by many social changes, including 
the passing and implementation of the Abortion Act 1967. As discussed in the previous 
chapter, this drastically changed the accessibility of abortions, and resulted in many 
women seeking to terminate their pregnancies legally under the clauses of the Act. For 
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examining the Scottish religious perspective, the decision was made to concentrate on the material 
gathered from the Scottish Catholic Observer (SCO) and Life and Work, from the years 1966 to 1987. 
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both the Church of Scotland and the Roman Catholic Church, the Abortion Act 1967 
resulted in a number of moral and theological questions which had to be dealt with over 
the years which followed. Within the Roman Catholic Church abortion was a highly 
emotive subject which was frequently discussed. Termination of pregnancy was strictly 
prohibited, and this viewpoint has remained until the present day. Within the Church of 
Scotland, abortion was a more nuanced matter, with Kirk discussions on the subject 
changing a great deal between the mid-1960s and late-1980s. At certain times abortion 
was seen as acceptable to the Kirk in a limited set of circumstances, whilst at other 
points it was condemned unequivocally, except to save the life of the pregnant woman. 
Thus, a complex situation was emerging for both the Church of Scotland and the Roman 
Catholic Church, where many members of society were in favour of legalised abortion, 
but religious organisations were grappling with their own views on the subject, which 
often did not align with those of wider society.  
 
The SCO and Life and Work will be used as sources to gain an insight into how strongly 
each organisation fought in favour of or against abortion legislation, with fetal anomaly 
specifically mentioned when relevant. This chapter will begin by providing a broad 
overview of the perspective of the Roman Catholic Church to abortion, and will also 
examine the Church of England and Church of Scotland perspectives. It will argue that 
the Church of England’s publication, Abortion An Ethical Discussion, was of central 
importance in influencing the Church of Scotland’s perspective on the subject, and also 
played a key role in the development of attitudes to abortion more broadly.3 The roles 
that the Catholic Church and Church of Scotland played in trying to influence 
legislative change will be considered, with the strategies and discussions taking place 
within both organisations analysed in detail. The formation of the Society for the 
Protection of Unborn Children (SPUC) and its impact on Steel’s Bill will also be 
examined. 
 
The Church of Scotland response to the abortion legislation will be considered, 
alongside the discussions which continued to take place for two decades after Steel’s 
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Bill was passed, both at the General Assembly and in Life and Work. With regards to 
the Catholic Church, the various ways in which their opposition was voiced will be 
discussed. Finally, this chapter will investigate if there was a link between religion and 
prenatal decision making, by examining publications which look at prenatal testing 
choices and the link with religious identity and observation. It will argue that the 
process of decision making surrounding prenatal testing is a complex one, which takes 
into account more than just religious beliefs. The experiences of individuals working in 
Glasgow will also be considered in this section, including clinicians and a midwife, with 
their oral testimonies further highlighting the complex nature of the interaction between 
prenatal testing and religion. 
 
II. Broad Overview of Religious Perspectives 
Within most of Christianity abortion has been viewed as a grave moral sin, even when 
society permitted termination of pregnancies.4 Christian teaching argued that it was 
wrong to take an innocent life, and the current Catholic and Protestant perspectives on 
abortion reflect this belief. Catholic teaching emphasised that each child was a gift from 
God – thus to terminate a pregnancy was to ‘destroy’ such a gift, and to ‘reject the 
honour and dignity of motherhood’.5  The Catholic Church taught that direct abortion 
under any circumstances was morally wrong. There were no exceptions to this rule – a 
pregnancy should not be terminated if it occurred as a result of rape, or if an abortion 
was to save the life of the pregnant woman.6 The only circumstances under which a 
termination of pregnancy would be carried out would be if the death of the fetus was an 
‘indirect’ consequence of a medical intervention intended to prevent the death of the 
pregnant woman. There are very few examples given in Catholic Church teaching of 
relevant medical situations which would fit this category, but one such case would be if 
the pregnant woman was found to have cancer of the womb and a hysterectomy was 
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urgently required. Catholicism would have permitted the hysterectomy to take place, the 
loss of the fetus being considered a foreseen but unintended consequence of this act.7   
 
The situation in the Protestant churches was slightly different, as there was no one 
doctrinal position on the subject. As discussed by Callum Brown, the views on abortion 
of both the Church of England and the Church of Scotland changed a great deal in the 
1960s. He outlines how in 1964 ‘none of the main churches had a policy in place of 
positive support for terminations and most had standing policies of opposition’.8 
Despite this, several Anglican clergy wrote to the Abortion Law Reform Association 
(ALRA) throughout 1964 and 1967 asking for information on abortion, many of whom 
were supportive of abortion reform. 9 The ALRA were also approached by the Church 
of England in 1965 to provide them with information on abortion, for a report which 
was being written by the Church of England Assembly Board for Social Responsibility. 
The ALRA provided written material, and arranged for representatives to discuss the 
subject with the Board.10 The report was published in 1965, under the title Abortion An 
Ethical Discussion, and was broadly in favour of abortion reform, under limited 
circumstances. The Church of Scotland produced a similar document in 1966, which 
Brown considers was ‘strongly influenced by that of the Anglican Church’.11  
 
In Abortion An Ethical Discussion, the Church of England Assembly Board for Social 
Responsibility concluded that the fetus should be viewed as having a ‘significance 
which must not be overlooked, minimized or denied’ as it was ‘potentially a human 
life’. However, they stated that under limited circumstances abortions could be 
acceptable.12 The Church of Scotland expressed similar sentiments, such as ‘that the 
inviolability of the fetus is one of the fundamentals and its right to life must be strongly 
safeguarded’. However, they also recognised that ‘this general right is, in certain 
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circumstances, in conflict with other rights’, including those of the pregnant woman.13 
As a result of this conflict of interests the view has been formed over time by the 
Church of England and the Church of Scotland that whilst abortion is morally wrong, 
there are limited circumstances under which the termination of pregnancy is acceptable, 
to preserve the life, health, or well-being of the pregnant woman.14 These views have 
led to the two churches being seen by some as readier than the Catholic Church ‘to 
support abortion when the pregnancy has resulted from a clear act of injustice (eg rape, 
criminal assault, incest), when it gravely threatens the physical or mental health of the 
mother, or when the fetus is seriously abnormal’.15 Brown argues that through their 
publications ‘these key Protestant churches provided important general support’ to the 
Abortion Act.16 Both of these churches had no policy in favour of abortion in 1964, but 
only a few years later gave qualified support for reform. However, it would be wrong to 
assume that all members of the Church of Scotland were in favour of these changing 
views towards abortion. Indeed, as Brown has emphasised, ‘because their churches 
were so divided on the issue, neither their members nor their churches as a whole were 
voluble campaigners for the Bill’.17 This illustrates the more complex situation of 
varying opinions within the Church of England and the Church of Scotland, as a result 
of there being no consensus as to an appropriate doctrinal position. 
 
III. Church of Scotland Response to Proposed Legislative Changes 
The positions of the Church of Scotland and the Roman Catholic Church to abortion 
prior to the 1967 Act will now be discussed in detail. As highlighted above, the Church 
of Scotland published a key document in 1966 which gave an insight into their views on 
abortion. This was published after their 1966 General Assembly, and strongly supported 
the views put forward in Abortion An Ethical Discussion.18 Although Abortion An 
Ethical Discussion had, as its authors emphasised, ‘no authority beyond that of the 
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group which has created it’,19 it was designed to encourage Christians to think about 
abortion on a deeper level. This was the main text containing an Anglican view on the 
subject of abortion, and the information contained within it is frequently cited. Indeed 
David Steel, in his foreword for Hindell and Simms book Abortion Law Reformed, cited 
the publication as ‘the best summary of the ethics of abortion yet published’.20 As the 
Church of Scotland was heavily influenced by the report, it is important to consider the 
views presented within it in more detail.  
 
For the Assembly Board for Social Responsibility of the Church of England who 
compiled the report, the crux of the abortion matter was summarised as ‘the problem of 
weighing the claims of the mother against the claims of the foetus and vice versa, when 
they conflict’.21 The Board came to the conclusion that: 
 
After surveying the matter afresh in the light both of traditional discussions 
and of present proposals, our broad conclusion is that in certain 
circumstances abortion can be justified. This would be when, at the request 
of the mother and after the kind of consultation which we have envisaged 
in this report, it could be reasonably established that there was a threat to 
the mother’s life or well-being, and hence inescapably to her health, if she 
were obliged to carry the child to term and give it birth.22  
 
With regards more specifically to fetal anomaly, they highlighted the anxieties which 
might be experienced by a pregnant woman when a diagnosis of fetal anomaly is made, 
including that the woman may be so worried about giving birth to a ‘defective child’ 
that her health may suffer, and/or that she and her partner may be so affected by raising 
such a child that it might impact adversely upon their current children if they have any, 
or stop them having any more in the future.23 They also considered whether it is right to 
allow a baby who has a very high chance of having a ‘deformity’ to be born. 
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The Assembly Board came to the conclusion that in certain instances there could be 
justification for a woman to have an abortion as a result of fetal anomaly. In this case 
the group concluded that these circumstances include an ‘assessable risk of a defective 
or deformed child’.24 Although this view is more liberal than the Catholic standpoint, 
the Board were adamant that abortion should not be available on demand, and that the 
decision to terminate a pregnancy could only be made when there was a real threat to 
the woman’s health or well-being. The decision would have to be the result of a 
consultation with a licensed medical practitioner who viewed this as essential, and could 
not be made solely by the woman herself. Termination of pregnancy would not be 
permitted on the basis of fetal anomaly alone, and the decision would have to be based 
firmly on the prognosis of the pregnant woman and her specific circumstances.25  
 
The Church of Scotland was involved in monitoring and participating in abortion 
discussions throughout the course of 1966 and 1967, and engaged with David Steel 
about the clauses within his Bill. In September 1966 an article was published in Life and 
Work in which the author, having met Steel, described his decision to proceed with the 
Medical Termination of Pregnancy Bill as a ‘courageous choice’.26 However, by 
January 1967 concerns were being raised by the Rev. L. David Levison that Steel’s Bill 
was going ‘much further’ than their report had, and that within the Bill there were 
clauses that the Church could not validate.27 Levison expressed the Church’s ‘sincere 
hope that when Mr Steel’s Bill reappears from Committee that it will have been 
considerably amended, as he himself anticipates, and will in the end approach the 
Church’s own considered view, which it certainly does not at the moment’.28 It seems 
that in many ways this hope was met, as after the 1967 General Assembly the Social 
and Moral Welfare Board published further thoughts on the Bill, including that Steel 
‘had made much reference to our report and used a theological reference from it for the 
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lines of his speech in presenting the Bill’.29 The Working Group convened by the 
Church of Scotland on the matter of abortion was pleased to see that amongst the 
proposed amendments to Steel’s Bill were ‘proposals to drop clause (c) the 
controversial “social clause” and clause (d) the clause specifying several categories such 
as the deficiency of the mother, cases of rape and of the mother being under the age of 
sixteen, the categories that the Assembly had already found unacceptable’.30 The 
Working Group felt that the Church should be ‘grateful’ that the proposed amendments 
brought the Bill more in line with their own report, and that people should ‘pray that 
this will be the final outcome’.31 The Church of Scotland played an active role in trying 
to ensure the legislation agreed with the views they held, by meeting with Steel to 
discuss the subject, and by publishing various documents on the matter. Overall, the 
Church of Scotland was in favour of abortion reform, but only to allow abortions to take 
place under rare circumstances, with the worth of the fetus still being carefully 
considered.  
 
IV. The Catholic Fight Against Steel’s Bill, and the Formation of the Society for the 
Protection of Unborn Children 
By way of contrast, in the decades prior to the implementation of the Abortion Act 
1967, the Catholic Church was already speaking out against abortion. In the encyclical 
Casti Connubii, issued in 1930 by Pope Pius XI, the ‘grave sin’ of abortion was 
discussed, in which it was stated that ‘however much we may pity the mother whose 
health and even life is gravely imperilled in the performance of the duty allotted to her 
by nature, nevertheless what could ever be a sufficient reason for excusing in any way 
the direct murder of the innocent? This is precisely what we are dealing with here.’32 
More specifically on the subject of fetal anomaly, Pope Pius XII in a similar manner 
stated in 1951 that ‘there is no man, no human authority, no science, no medical, 
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eugenic, social, economic or moral “indication” which can establish or grant a valid 
juridical ground for a direct deliberate disposition of an innocent human life’.33  
 
However, when it came to campaigning against Steel’s Bill, the impression gathered 
from studying the Scottish Catholic Observer is that the Catholic Church were 
unexpectedly quiet on the subject, with only twenty-three articles/letters on the subject 
printed for 1966 and 1967, several of which criticised the lack of response to the Bill. In 
1966 one of the first articles to address the issue of abortion was by Cardinal Heenan, 
who commented that ‘Until recently the accepted view of Christians and, so far as I 
know, of all believers, has been that direct killing of the child-to-be is immoral. It is 
only because of what is called the liberalising of the law against abortion that the 
Catholic attitude has begun to appear eccentric’.34  
 
Another article in the Observer condemned abortion unequivocally as ‘plain murder’.35 
Nevertheless, when the House of Commons voted on the first reading of the Bill, only 
14 of 32 Catholic M.P.s turned up, and it passed by, what Norman St. John-Stevas 
described as, a ‘grotesquely large majority of 194 votes’.36 One of the most outspoken 
voices in the fight against the Bill, St. John-Stevas condemned the absence of Catholic 
M.P.s from the vote as ‘shockingly bad’. He was concerned that the longer-term effects 
of this lack of support would be ‘all the more serious as the very small vote against the 
Bill will make it much more difficult to amend at the committee stage and get some of 
its worst features removed’.37 
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These figures suggest that the Catholic Church was not as prominent as would have 
been expected in the fight which was mounting against Steel’s Bill. In general it seems 
that the Catholic Church was caught off guard. As Francome has argued, the Catholic 
Church ‘was not ready for this particular battle’, and he has spoken of how Lord 
Craigmyle, the leader of the Catholic Union, said that the vote ‘was a shock to us’ and 
talked of the ‘appalling weight of the abortion lobby’.38 In the years after the Abortion 
Act had come into force, many Catholics echoed such sentiments. Kathleen Morton, the 
president of the pro-life group Cell, commented that there was ‘no doubt we were 
caught napping in 1967 with the Abortion Act’,39 whilst another reader of the Scottish 
Catholic Observer stated ‘Virtually nothing was said or done when the Abortion Bill 
was being debated and when it finally became law we held up our hands in horror and 
wondered why this “licence to kill” ever reached the Statute Book, as if it had crept up 
on us un-noticed.’40 
 
Indeed it seemed that if anyone was leading the fight against Steel’s Bill it was the lay 
people of the Catholic Church, a move which was viewed with ‘satisfaction and 
approval’ by some members of the clergy.41 Lay involvement in Scotland included the 
printing of twenty thousand copies of a pamphlet against abortion, designed by the 
Catholic Young Men’s Society and the Knights of Saint Columba. Within this pamphlet 
strong religious language was used to stir up the fight against Steel’s Bill, with the 
pamphlet claiming that ‘If the Abortion Bill goes through Herod will laugh in Hell. 
There will be perpetrated in one name a Massacre of the Innocents more dreadful in its 
scope than any Herod could have imagined.’42 Use of phrases such as ‘massacre’ and 
‘innocents’, and the direct mention of Hell, makes it clear that there was a strong 
revulsion felt about the Abortion Bill. Nevertheless, the advice it gave was somewhat 
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mild, with readers urged to write to their M.P. to let them know their views, and to sign 
petitions.43 
 
Petitions and rallies formed a central part of the Catholic fight against Steel’s Bill, with 
a petition of 4000 signatures handed to Tom Fraser, the M.P. for Hamilton in Scotland. 
After a long discussion with a ‘deputation’ led by a local priest, Fraser assured the 
group that ‘if the Bill were returned to Parliament unchanged he would have no 
hesitation in voting against it’.44 A meeting in Greenock town hall in the West of 
Scotland attracted ‘more than 1200 Catholics and non-Catholics’ who came to listen to 
the views of three doctors about abortion. One of those speaking, Dr O’Reilly, a senior 
obstetrician at St Francis Maternity Home in Glasgow, stated his belief that ‘there was 
no such thing as a therapeutic abortion’ and that ‘no woman’s health has ever been 
improved by a direct attack on her unborn child’.45 Such a statement is clearly in direct 
opposition to the beliefs of those campaigning for abortion reform, who felt very 
strongly that a woman’s life could benefit from a termination of pregnancy under 
certain circumstances.  
 
Whilst petitions and rallies were happening towards the end of 1966, no formal group 
against abortion was formed until the Society for the Protection of Unborn Children 
(SPUC) was launched at a ‘well-publicised press conference at the House of Commons’ 
in January 1967.46 Given that the Abortion Act received the Royal Assent in October 
1967, it is clear that the formation of SPUC happened very late in the abortion 
campaign. Members of the committee included Hugh McLaren, Professor of Obstetrics 
and Gynaecology at the University of Birmingham. McLaren said he was ‘shocked into 
action … when the Bill was given the go ahead by an overwhelming vote in 
Parliament’.47 As previously highlighted, other committee members included Ian 
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Donald. Interestingly, although this group was non-denominational, Catholic members 
had been specifically excluded from joining the council of the organisation. According 
to Hindell and Simms, this exclusion ‘was repeatedly stressed at every press conference 
and public meeting, although as an Irish paper remarked, this was “more a tactical move 
than anything else”, to prevent SPUC being identified as merely a vehicle of the 
Catholic Church. There was, however, no bar against Catholics joining the rank and file 
of the organization’.48 Francome argues that pressure coming from the Catholic Church 
was easier to dismiss than pressure from other sources. He considers that the Catholic 
Church ‘was not particularly astute in putting forward its views’ and that, due to their 
opposition to contraception, they lacked ‘credibility’.49 While contraception was gaining 
more acceptability with the general public, the official Catholic Church statements were 
unflinching in their condemnation of any artificial methods of preventing pregnancy, 
leaving many churchgoers feeling isolated from the official Catholic Church 
standpoint.50 Brown has argued that due to their views on contraception and abortion, 
the Catholic Church was ‘at odds with British government policy and the general 
acquiescence in that policy that had evolved during the sixties amongst the main 
Protestant churches in Britain’, leading to ‘the isolation of the Catholic Church from an 
increasingly-liberal swerve of mainstream Christianity in Britain’.51 Thus, the Catholic 
view on abortion could also be seen as inapplicable to the real lived experience of many 
individuals requesting abortions, and easier to dismiss as a lack of compassionate 
understanding by those in favour of reforming the abortion laws.  
 
Despite the lack of Catholic members on the official committee, Lovenduski has 
commented that SPUC was ‘unable, despite a large membership, to overcome its image 
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of a narrowly-based, Catholic-inspired group and proved ill-equipped to prevent 
passage of the Act’.52 The reason it could not shake this perception was that many of its 
most outspoken members were Catholic. One of SPUC’s first acts was to petition the 
Prime Minister to set up a Royal Commission to investigate all the facts relating to 
abortion before any legislative changes were made. The two members of SPUC 
responsible for establishing the petition were both Catholic M.P.s – Norman St. John-
Stevas and James Dunn.53 They had hoped to gain one million signatures on the 
petition, but in the end gathered 530,000. Hindell and Simms have commented that 
‘With no Church structure to call on, it is doubtful whether the reformers could have 
collected so many in the same time’, highlighting both the impression that SPUC was 
seen as a largely Christian organisation, and the potential it had to become a formidable 
opponent of abortion law reform.54 Despite the large number of signatures on the 
petition, what was notable were the signatures which were missing, namely a great 
many Anglican vicars. The petition was distributed to 10,000 of them, but it seemed that 
‘most were not sympathetic’, and when the British Council of Churches met in April 
1967 they concluded that regarding abortion, ‘Christian compassion in the face of 
human suffering did require a measure of reform.’55 Thus while SPUC might have kept 
Catholic members off their committee, they could not prevent Catholic attitudes to 
abortion becoming the prevailing source of their fight. 
 
Although they managed to secure over half a million signatures on their petition, Hugh 
McLaren, speaking in February 1967, emphasised that the protest should have come 
earlier.56 Paula Davies, writing in the Scottish Catholic Observer, also in February, 
described SPUC as ‘hastily formed’ and was not optimistic about their chances of 
defeating the Bill.57 However, the campaign against abortion continued to be waged, 
with Norman St. John-Stevas publishing an article in the Scottish Catholic Observer on 
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the 24th February calling for ‘the cooperation of all men of goodwill who see the 
dangers of the Bill’. He also called upon the hierarchy and the ‘leaders of lay Catholic 
opinion’ to ‘take the initiative at once’ as ‘There are times to keep silent, but this is not 
one of them.’58 Readers wrote letters to the Scottish Catholic Observer urging others to 
sign the petition by SPUC, and criticised the lack of opposition to the Bill as ‘too 
feeble’, querying why if there were ‘7 million Catholics in this country … only 300,000 
names have been collected against the Bill’.59 In the end, despite the petitions and 
rallies, Steel’s Bill was passed, changing the availability of abortion services in an 
unprecedented manner. For those who had opposed the Bill, this decision in no way led 
to acceptance of the outcome. In March of 1968 Norman St. John-Stevas published 
another article in the Scottish Catholic Observer, this time titled ‘Abortion – the 
struggle is just beginning’ and for many individuals this was exactly the case.60 The 
next section will focus on the aftermath of the Abortion Act, and the reaction to the new 
abortion legislation by religious organisations. 
 
V. The Church of Scotland Perspective on Abortion from 1967 to 1987 
After taking an active role in trying to influence abortion legislation, the Church of 
Scotland went quiet on the subject once the Abortion Act 1967 was in place. In 1968 
and 1969 there were no relevant articles on abortion published in Life and Work, and in 
1970 the only contribution of note on the subject was a letter from a reader who was 
pregnant with her fifth child and who refused to have an abortion as she believed God 
wanted her to have the baby.61 The subject of abortion did not feature prominently in 
discussions occurring at the General Assembly either, with very few mentions of it by 
the Social and Moral Welfare Board. In 1968 their only comment was to remind readers 
that although the recent legislation on abortion had been ‘in the direction of showing 
greater humanity and compassion’, there were still those who ‘consider such changes to 
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be but a half-way house to unbridled “freedom”’.62 It would seem that, in the immediate 
years following the Abortion Act, the Church of Scotland did not have strong opinions 
on the functioning of the Act. However, by 1971 concerns were beginning to emerge, 
with a report by the Committee on Moral Welfare stating that ‘the Act must have the 
Church’s continued scrutiny while awaiting further evidence regarding its working’. 
Although it provided no evidence to back up the claims, the report concluded that it was 
‘doubtful’ if the Act had done anything to stop ‘back-street’ abortions in any significant 
way, and that there was ‘unease among many doctors, nurses and psychiatrists over the 
interpretation and operation of the Act’.63 In the 1972 General Assembly the subject of 
abortion featured prominently in the Committee on Moral Welfare report, with five 
pages dedicated to the Abortion Act. The committee felt that the high numbers of 
abortions being carried out should give ‘cause for concern’, and that as ‘Christians, we 
must reassert the sanctity of human life as the gift of God, which cannot be taken away 
lightly’.64  
 
Interestingly, the report seemed to suggest that abortions carried out for reasons of fetal 
anomaly were to be viewed separately – they put forward the figures that in 1970 only 
0.1% of terminations were carried out to save the mother’s life, in addition to 1.6% of 
terminations ‘because there may have been the risk of abnormal or mentally defective 
babies’. They concluded that ‘These figures betray a disturbing attitude to human life, 
as the operation in 98% of cases involves the destruction of a potentially normal 
child.’65 This viewpoint would seems to be representative of Church of Scotland 
members, as a Gallup poll carried out in 1966 found that only 26% of Church members 
opposed abortion being legalised in cases where the ‘child may be born deformed’.66 
Whilst giving their support for terminations in these circumstances, the Committee 
spoke out strongly against ‘the “social grounds” for abortion’, stating that ‘The only 
possible grounds acceptable to the Committee for the termination of a pregnancy are 
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that there is a real conflict of interest between the health of the mother and the life of the 
child’.67 They also raised concerns about the suitability of the conscience clause for 
providing the required protection to staff wishing to refrain from being involved in 
terminations, and suggested that the time limit for abortions should be lowered to 20 
weeks gestation.68 
 
The 1973 and 1974 General Assembly reports only briefly mentioned abortion, stating 
that the Church were still waiting on the findings of the Lane Committee, and were 
continuing to monitor the situation. As described in the previous chapter, the Lane 
Committee had been set up in 1971 to report on the working of the Abortion Act, under 
the leadership of Mrs Justice Lane. The committee was prohibited from examining the 
moral and ethical dimensions of abortion, and was instead to focus on how the Act was 
working in practice. However, within Life and Work correspondence on abortion began 
to increase from 1972 onwards, with many readers writing to express their unease about 
the current situation in the United Kingdom. Several correspondents emphasised their 
unhappiness at the number of abortions being carried out in Scotland, which they felt 
were too high. Geoffrey Allan was convinced that the medical profession was ‘damned’ 
if they could not hold ‘strongly to the belief in the preservation of human life’,69 and 
Stewart MacPherson cited the number of abortions as one of the reasons he believed 
society was ‘sick’.70 Following on from these letters were several from Dr Jane 
Darroch, encouraging anyone who had concerns about the working of the Abortion Act 
to join SPUC.71 She claimed that the majority of the abortions being carried out were 
‘because the shady end of the medical profession is willing to sacrifice human lives in 
order to gratify selfish women’, and that nurses were particularly distressed at having to 
inspect ‘the mangled pieces of a baby aborted by suction’ and watch ‘a breathing, 
crying baby die in a dish’.72 This emotive language was typical of that used by SPUC, 
with the description of women who had undergone an abortion as ‘selfish’ being 
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reflective of their attitudes. The somewhat gruesome images conjured up by their 
description of ‘mangled’ babies dying ‘in a dish’ was also a common shock tactic used, 
with the aim of spurring individuals to join the organisation. 
 
However, this approach used by SPUC did not seem to be particularly successful in 
recruiting members from the Church of Scotland. In December 1973 Dr Jane Darroch 
was once again writing in to Life and Work, this time to lament the lack of support from 
their members. She queried why if the Church of Scotland has a million members only 
8 of them are members of SPUC, questioning ‘Where are the 999,992?’.73 Several of 
those 999,992 members replied explaining why they were not part of SPUC, including 
the Rev. E.J. Brain, who had been a member of the group along with his wife. They 
subsequently quit the organisation because of its ‘absolute and uncompromising nature’ 
and ‘because nowhere in their reasoning is there a place for compassion for the potential 
mother’.74 Ann Gregory found it ‘totally wrong’ of Jane Darroch ‘to assume that others 
should support her particular attitude either as Christians or as members of the Church 
of Scotland’, stating that she found it ‘utterly repugnant that this kind of appeal for mass 
support can be made on any basis for such a complex and sensitive issue’.75 Gregory 
argued that she felt her own convictions to be ‘equally Christian’ when advocating for 
abortion services to be made easier to access for women living in poverty who were 
‘downtrodden and hopelessly exploited … crammed into our cities’ housing schemes’.76 
Margaret MacKay wrote in to highlight that unless someone has experience with an 
unwanted pregnancy they cannot appreciate the situation, likening the ‘horror’ to ‘being 
caught like a rat in a trap’.77 These contrasting views highlight the complexities of the 
Church of Scotland position on abortion. As the Church did not have a doctrinal view 
on the subject matter (in contrast to the Catholic Church) then members were freer to 
follow their individual Christian conscience in matters, leading to debates on these 
differing viewpoints. The interactions happening in the correspondence columns of Life 
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and Work also seemed to support the evidence put forward earlier that SPUC struggled 
to lose its Catholic ‘label’, and that many Church of Scotland members found it too 
strong a position for them to support.  
 
The subject of abortion was discussed very infrequently over the next decade at the 
General Assembly, and no major changes were made to policy until 1985. At this 
General Assembly it was agreed, much to the surprise of many Church of Scotland 
members, that abortion could only be carried out ‘in the case of risk to maternal life and 
after the exhaustion of all alternatives’.78 In a controversial move, this ruled out abortion 
in cases of rape and fetal anomaly. When the specific subject of abortion in cases of 
rape was discussed, it was concluded that the ‘unborn child’ was ‘an innocent party, and 
its destruction cannot undo the evil which has already been done’.79 For fetal anomaly, 
the new stance was that ‘abortion does not prevent handicap, it merely destroys those 
who are already its victims’.80 The Church also committed itself to securing a review of 
the 1967 Abortion Act.81  
 
Given that the Church of Scotland had traditionally taken a wider view on the 
circumstances in which abortion was acceptable, the response from those in the Church 
community was one mainly of disbelief. The pages of Life and Work were filled with 
readers writing in on the subject, mainly to voice their shock at the General Assembly 
decision. For many, it was the rejection of allowing abortions in cases of rape that 
caused the most anger. Even the Editor of Life and Work stated that it was ‘very 
unfortunate’ that the Church of Scotland had gone on record ‘as rejecting the option of 
abortion in rape cases’ and that ‘many good Christians disagree with the Social 
Responsibility study group on the point’.82 Comments from readers were also strongly-
worded in their condemnation of the General Assembly decision. One reader 
commented that they were ‘saddened, disgusted and appalled’ by the decision which 
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they felt ‘shows a crass insensitivity towards the tragic plight of any woman who finds 
herself pregnant after rape’.83 Another commented that ‘To condemn a victim of such a 
horrific experience to relive that experience every hour of every day is cruelty of the 
worst kind.’84 The main themes of women’s suffering being perpetuated were repeated 
several times over the following months, with many readers clearly identifying 
terminations in cases of rape or for fetal anomaly as beneficial for a woman’s mental 
health. These comments suggest that the majority of Church of Scotland members were 
uncomfortable with a hard-line stance being taken on abortion, with one reader even 
suggesting that the decision was influenced by the Catholic Church.85 Whilst there were 
some readers who were in favour of the decision, including one who stated that she was 
‘delighted’ and believed that the Church was ‘going back to biblical teaching on the 
sanctity of life’,86 their comments were in the minority of those writing in to Life and 
Work.  
 
The realisation that the Church had taken a new view on abortion seemed to propel 
those who disagreed into action to change the 1985 General Assembly ruling. In 
February 1986 it was reported in an editorial in Life and Work that parishes were 
working to influence the Presbytery of Edinburgh, amongst other Presbyteries, to ‘ask 
the General Assembly to instruct the Board of Social Responsibility to reconsider and 
revise their policy with fuller research and wider consultation with a view to meeting 
the needs of the Church’s pastoral care’.87 The anger felt at the 1985 ruling seemed to 
have the desired effect, as at the 1986 General Assembly it was agreed to remove the 
criteria from the previous year, and instead ‘reaffirm the position held since 1966, that 
the criteria for abortion should be that the continuance of the pregnancy would involve 
serious risk to the life or grave injury to the health whether physical or mental, of the 
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pregnant woman’.88 The 1985 decision was described by Rev. Ogston as a ‘mistake 
which was made with the best possible motives’, but which had left a lot of people 
feeling that ‘common sense had departed the Church and that compassion had 
disappeared’. He warned against the Church entering an ‘ice age’ where decisions 
forgot emotional factors, and ‘pleaded with the Assembly to blot out the unfortunate 
impression given last year that “we care neither for women who have been assaulted nor 
for women told they might be pregnant with a handicapped child”’.89 
 
As with the 1985 ruling, this change in stance caused a great deal of communication in 
Life and Work, with debate once again occurring. It was noted by the editor that the 
1986 outcome was ‘much more popular with media and public opinion outside the 
Church’ but that a deep division remained within the Church itself, and that reversing 
the previous year’s decision may turn out to be a mistake if it did not allow for ‘seeking 
a major revision of the present law’.90 Some readers strongly disagreed with the 
decision, which they felt was only done to please the public. The Rev. George Fiddes 
argued that the Church was ‘starting from the wrong place if it is seeking to make 
policy in deference to the popular opinion of the people, rather than starting from a 
sound biblical and theological position’,91 and L.E. Bell disliked that ‘biblical 
considerations’ were being ‘set aside in favour of popular will’.92 For many others 
however the decision was a positive one, including a Christian staff nurse who believed 
that it was not enough to ‘quote Scripture passages to a rape victim’, and who herself 
assisted at terminations where it would benefit the woman’s wellbeing.93 The Rev. 
Graham Monteith, who was disabled, spoke at the Assembly advocating that ‘parents 
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should be allowed freedom of choice which comes from God in coming to a decision 
about an abortion when a woman is told she is expecting a handicapped child’.94 
 
The debates surrounding the response of the Church of Scotland to the subject of 
abortion were clearly multi-faceted, with ordinary Church members voicing their 
opinions in the hope of changing official viewpoints on the matter. The Church was 
aware of the lack of uniformity on the subject matter, and in 1987 published the book 
Abortion in Debate on behalf of the Church of Scotland’s Board of Social 
Responsibility. As previously described, this book enabled several different contributors 
to put forward their views on various aspects of the abortion debate, with two 
contrasting viewpoints presented in each chapter. Authors with opposing views were 
then able to reply to the work written by each other to further advance the debating 
process. In the foreword for the book it was outlined that ‘No issue has been discussed 
by the Church in recent years with more vigour and strength of feeling than that of 
abortion’, highlighting the awareness the Church had of the divisions running through it 
on the subject.95  
 
VI. The Catholic Church Continues the Abortion Fight, After the Implementation of the 
Abortion Act 1967 
By way of contrast, the next section will examine the response of the Catholic Church, 
who continued to maintain their view that abortion was not permissible under any 
circumstances. As mentioned earlier, over the decades that followed the passing of the 
Abortion Act, the Catholic Church stuck steadily to this belief, and this is still their 
teaching up to the present day. As this viewpoint has not changed, this section will 
focus on highlighting some of the events protesting against abortion that were being led 
by the Catholic Church in Glasgow and the West of Scotland, which were reported in 
the Scottish Catholic Observer. It will also examine the Catholic viewpoint surrounding 
termination of pregnancy for fetal anomaly, as this started to be discussed in more detail 
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in the Observer in 1981, which was the United Nations International Year of the 
Disabled. It will then go on to consider whether religion impacted decision making in 
the prenatal testing setting, examining both oral testimonies and published papers on the 
subject. 
 
As previously discussed, petitions and rallies formed some of the main forms of protest 
against abortion led by those of a Catholic faith, and this was also true of specific events 
occurring in Glasgow after abortion legislation had been passed. One of the first events 
which displays the strength of interest surrounding the issue in the region was the ‘1000 
strong audience’ at a public debate, organised by the Scottish Catholic Renewal 
Movement in 1970.96 On the political side Norman St. John-Stevas and David Steel 
were two of the speakers, and from the medical profession both Ian Donald and Dugald 
Baird participated in the event. As would be expected, St. John-Stevas and Donald both 
spoke out against the Abortion Act, and Steel and Baird were arguing in favour of it. 
The number of attendees indicates the strength of feeling in Glasgow on the subject, 
three years after the passing of the Act. The issues which arose in the debate included 
the high numbers of terminations being carried out (the figures being perceived as high 
by those against abortion), and the profiteering which was occurring in some areas, 
where gynaecologists were able to make large sums of money for carrying out abortions 
privately.97  
 
In addition to meetings and debates, public protests formed a large part of the Catholic 
campaign, and some of these managed to attract high numbers of participants, with 
attendance at a rally in Glasgow numbering 12,000 in April 1974. The rally began with 
speeches in Glasgow Green, followed by a march to Glasgow Cathedral, where seven 
white wreaths were laid at the baptismal font, one for every 1000 abortions which had 
been carried out in Scotland in the previous year.98 A key speaker was Thomas 
Winning, then Auxiliary Bishop of Glasgow, and a prominent spokesperson for the anti-
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abortion point of view.99 He spoke out frequently against abortion, including at an event 
organised by the Glasgow Catholic Nurses’ Guild, where he ‘launched a strong attack’ 
on what he described as the ‘destroyers of life’, concluding that nothing ‘can justify the 
killing or maiming of innocent people’.100 
 
There is also evidence in the Scottish Catholic Observer that Catholic schools in the 
West of Scotland played a role in these protests. As reported in January 1971, a group 
of pupils from St. Aloysius in Glasgow spent a day carrying a crib around five churches 
in the city, praying before it in each.101 A large march was also organised in April of the 
same year, when 500 school pupils from Coatbridge went on a march against abortion, 
carried banners and handed out leaflets. The leaflets included pictures ‘showing an 
aborted baby lying in a stainless steel bucket’, and the banners displayed messages such 
as ‘“Abortion – Legalised Murder” and “Respect Life – Kill Abortion”’.102 Around 
sixty teachers joined the students on the march. Canon Duddy, a parish priest, helped to 
lead the walk, which ended with a church service, during which he denounced the Act 
as ‘obnoxious, evil and unjust’ and said the purpose of the walk was to ‘express our 
abhorrence against the Abortion Act and those women who want abortion on 
demand’.103 That teenagers were being exposed to images of fetuses lying in steel trays 
highlights the shock tactics that were used by some Catholic members to try and get the 
message across that abortion was wrong.  
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In addition to organising rallies and petitions, many members of the Catholic faith 
supported attempts to alter the abortion legislation, or remove it altogether. One of the 
campaigns they supported most strongly was that of James White, M.P. for Glasgow 
Pollok, who proposed a Bill which would tighten abortion legislation. Despite not being 
Catholic himself, White faced pressure from his Catholic constituents to make abortion 
the subject of his Private Member’s Bill, and was inundated with letters to this effect. 
Catholics ‘in many parishes in Glasgow were encouraged to write to Mr White to 
persuade him to make reform of the 1967 Act the subject of his Private Member’s Bill’. 
It seemed this encouragement certainly worked.104 By January 1975 it was reported that 
he had received over 8000 letters in support of his proposed Abortion Amendment 
Bill,105 and at an event in Glasgow to discuss the proposed changes to the legislation, 
Archbishop Winning was one of the marchers in the crowd.106 Some of the main clauses 
of White’s Bill were that it would prohibit abortions on social grounds, reduce the upper 
time limit for abortions from 28 weeks to 20 weeks, and would prohibit experiments on 
live fetuses.107 8000 people attended an anti-abortion rally in Glasgow in September 
1975, where support for White’s Bill was voiced,108 and in January 1976 White was 
presented with a petition signed by 30,000 women in Glasgow in support of his Bill. He 
stated that the petition ‘overwhelmingly showed that Glasgow women had rejected the 
abortion promoting attempts of “trendy social engineers and manipulators”’.109 White’s 
Bill was withdrawn as the Government decided to establish a Select Committee to look 
into the subject of abortion. However, when the recommendations of the Select 
Committee were not put in place, other abortion amendment bills were devised. These 
included the Benyon Bill, which again had many Catholic supporters as it proposed 
restrictions to abortion legislation, and the Corrie Bill, which aimed to severely restrict 
abortion services. The Corrie Bill was proposed in 1979, and the terms included 
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decreasing the gestational age at which terminations could take place to 20 weeks, 
making abortion permissible in only very limited circumstances, ensuring doctors did 
not receive financial gain from carrying out terminations, and strengthening the 
conscience clause.110 The Bill received a great deal of support from Catholics in 
Scotland, and a debate on the Bill held at Glasgow University Union in October 1979 
‘produced an overwhelming vote in favour of the Bill’.111 
 
While the above examples highlight some of the ways in which members of the 
Catholic Church in Scotland were involved in campaigning against abortion, many of 
those writing in to the Scottish Catholic Observer were unhappy with what they 
perceived as apathy on the subject from others. Writing in to the newspaper, one reader 
commented on how ‘In recent years Catholics have stood as silent onlookers and 
watched the moral code of this country being torn asunder’ and had ‘made only the 
merest whisper in protest’. A mass held in Saint Mary’s Cathedral in Edinburgh to pray 
for the success in lobbying M.P.s to repeal the Abortion Act 1967 was poorly attended, 
with the ceremony taking place in a ‘near-empty’ cathedral.112 A motorcade event 
planned for Edinburgh also had to be cancelled on the day, when only five cars and 
fifteen pedestrians showed up to it, with the event being labelled a ‘disaster’ by one of 
the organisers.113 The lack of enthusiasm for the anti-abortion events led one reader of 
the Scottish Catholic Observer to conclude that many members of the Church had 
‘contributed by the sin of omission, to the 170,000 innocents’ deaths by abortion carried 
out in our hospitals in the past year’. This particular reader was unhappy that a great 
many Catholics were not members of SPUC, that few Catholic nurses had opted to use 
the conscience clause, and that around 9.9% of women having terminations identified as 
Catholic.114  
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There was also little discussion on the subject of prenatal testing, with few 
communications detailing the concerns which could arise between the testing and links 
with abortion. The issue of abortion for fetal anomaly was, however, raised in a letter to 
the Scottish Catholic Observer in December 1977. The reader, Denis Ferguson, was the 
father of a disabled child, and he described how Malcolm Ferguson-Smith and Ian 
Donald were ‘equally eminent colleagues in Glasgow … who are opposed to the 
abortion of healthy unborn children but advocate the abortion of unborn children who 
suffer from congenital malformation’. He argued that Ferguson-Smith and Donald 
believed that ‘in the case of the handicapped, death is the lesser of two evils’. However, 
Ferguson disagreed with this position, highlighting that the quality of life for children 
such as his had improved greatly over the last ten years.115 There was, evidently, some 
wider awareness of the work being carried out in the prenatal field in Glasgow, and not 
everyone was in agreement with it. There is no published reply to this letter from either 
Ferguson-Smith or Donald, and it is not known if they were aware of it. Ferguson-Smith 
did, however, receive private correspondence expressing disapproval of his work. A 
letter written to him in 1978 maintained that he and his team must be ‘very satisfied 
with your work considering your success rate in the murder of innocent babies’. The 
same author expressed their wishes that Ferguson-Smith would ‘put the intelligence that 
God gave you to the fight to preserve life and not destroy it’ as ‘If God had meant these 
babies not to be born, then he could have ended their lives.’ They concluded ‘Do not 
fall into the false impression that you can play God. Remember, “What you do unto the 
least of my brethren, you do unto me.”’116 This quote places emphasis on the idea that 
how society treats those who are seen as more vulnerable is a reflection of society 
overall, and links to the idea put forward by Meilaender that an important aspect of 
Christianity is to ‘value and protect – for Christians, to see Christ in – those who are 
“least” among us’.117 
 
Whilst these communications are strong in their disapproval of Ferguson-Smith’s work, 
their number were few, and there did not seem to be a great deal of discussion 
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surrounding prenatal testing and abortion until 1981. 1981 was classified as the 
International Year of the Disabled by the United Nations, and it would seem that this 
prompted an awakening of the collective Catholic conscience to begin speaking out 
against termination for fetal anomaly. People with disabilities expressed similar 
sentiments to the parent, Denis Ferguson, quoted above. Peter McCann, a former Lord 
Provost of Glasgow who was himself disabled, queried ‘How dare anyone tell any 
disabled person that their life is not a full life.’118 Mrs Marilyn Gillies Carr, who was 
born without any arms, questioned if the doctors who promoted the testing stopped to 
consider how their comments would make people with disabilities feel. She highlighted 
that many people with disabilities found the current situation ‘frightening’, and 
described the BMA as being ‘more fitting to a British Master-race Association than to a 
British Medical Association’.119 Other voices were also beginning to speak out against 
prenatal testing, linking it to eugenics, including Archbishop Winning, who expressed 
his unhappiness about the developments which were occurring. In 1978 he likened 
prenatal screening to the efforts by the Nazis to sterilise ‘those who were not able to 
contribute to pure healthy Aryan stock’, questioning ‘Is the screening of the unborn to 
detect deformity and eliminate it merely a more refined more euphemistic way of 
achieving the same end?’120 Marilyn Gillies Carr also commented on ‘the treatment 
meted out to the handicapped – which all too often seems more in accordance with the 
philosophy prevalent in Hitler’s Germany that only what is useful is good, than the 
standards one would expect in a civilised society’.121 Malcolm Ferguson-Smith himself 
has also recounted the story of being called a Nazi by an Archbishop in Glasgow, a 
claim that Marie Ferguson-Smith strongly objected to, as she had spent time in a Nazi 
concentration camp during the Second World War.122  
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A key message which began to emerge from these communications was that people 
with disabilities should be treated as individuals, and that their worth should not be 
defined by what they could and could not do. Bishop Mario Conti of Aberdeen 
commented that there was a ‘mentality that reduces situations and individuals to an 
assessment based on spurious categories of usefulness, of economic worth, of a so-
called ‘quality of life’ which has more to do with physical integrity than with personal 
growth and spiritual fulfilment’, but that this was unacceptable, as the ‘real test of a 
caring society is the value it places on the individual’.123 Bishop Conti maintained that 
‘Catholics stood beside the disabled and counted it a privilege to serve them’ and 
emphasised that they would ‘defend their right to be born … and to be protected from 
every misguided busybody who thinks they would be better dead’.124  
 
VII. The Impact of Religion on Prenatal Testing Decisions 
It therefore seems that a conflict should exist between Catholicism and prenatal testing, 
as the testing would lead to a termination of pregnancy in the majority of confirmed 
cases, which was strictly prohibited by the Catholic Church. This sequence of diagnosis 
followed by termination led Anthony Fisher, in Catholic Bioethics for a New 
Millennium, to describe prenatal tests as ‘heat-seeking missiles to ensure that those 
babies who have certain genetic disorders never see the light of day’.125 However, an 
interesting point raised in an interview with a clinician who had worked in the genetics 
clinics in Glasgow since 1982, was that religion of attendees at the clinic was initially 
recorded, but that this was stopped when it was found it did not have a direct association 
with decision making.126 In a similar manner, the statistics reported by the Lane 
Committee found a lack of correlation between religion and abortion decisions, with the 
data suggesting that ‘Catholics are probably not much (if at all) less likely than other 
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women to opt for an abortion.’127 Rayna Rapp, in Testing Women, Testing the Fetus, 
also notes that the genetic counsellors she interviewed stated that Catholic women opt 
for amniocentesis as frequently as non-Catholic women.128 This raises the question of 
whether or not the conflict between religion and prenatal testing existed in practice, or 
mainly in theory.  
 
Interviews with researchers and clinicians who worked in areas associated with prenatal 
testing can provide an insight into whether or not conflict occurred which affected the 
work going on in the field. When one obstetrician was asked if there were many 
members of staff working in obstetrics who objected to terminations, he commented:  
 
There weren’t a lot actually, there obviously were and I mean I’ve worked 
with Roman Catholic doctors who really, they didn’t voice their objections, 
they just didn’t get involved you know. On the whole I found that the 
people I was working with didn’t make a song or dance about it if they 
didn’t like to do it they just kept quiet. There must have been some around 
the place who created a fuss I suppose. There was you know occasionally 
there would be a nurse maybe, and senior nurses would identify that and 
just say you’re not involved in this case. These were generally on religious 
grounds.129 
 
Another clinician commented that it was a ‘very difficult time in the early days of 
prenatal diagnosis. Although the majority of obstetricians were happy to refer their 
patients to clinical genetics, a small number would not.’130 When asked why this was 
the case, he replied: 
 
That was to do with termination of pregnancy and that was particularly 
noticeable in some areas of Glasgow and Lanarkshire. And of course that’s 
very bad for the families who lived there, who may have had different 
views to their doctors. In those days it was seen as a Roman Catholic issue 
but we found people's views on abortion depended on a whole lot of 
factors and religion was only one of them and probably not even the main 
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one. However, often the GP would refer at risk, expecting families for 
genetic advice, even if their obstetrician did not.131 
 
Both of these interviewees were of the opinion that it was a small minority who had 
concerns about termination of pregnancy, and both mention the Roman Catholic faith as 
being a potential factor. Their recollections of how much religion impacted the 
profession are slightly different, with one feeling that the small numbers who did not 
want to be involved did not affect clinical arrangements greatly, whilst the other felt it 
made for a ‘very difficult time’ initially. 
 
In discussions with the second clinician quoted here the question was raised of why 
some women might have chosen not to undergo prenatal testing when it became 
available, and religion was mentioned as a factor: 
 
There were some people who said that they wouldn’t consider it for 
religious reasons, yes, but they were actually very few and not limited to 
Roman Catholics. In all the years that I did genetics I can think of probably 
fewer than 5 people who said they didn’t want to have a termination for 
religious reasons. But you know other people may have felt that but just 
been embarrassed to say that.132 
 
A conflict between religion and prenatal testing may have been less apparent, if women 
were uncomfortable expressing their religion as a reason for not being willing to 
undergo the testing. However, a qualified midwife working in the department has 
commented from her perspective on religion being quite an important factor: 
 
Religion was a big thing and there were many parents who would not 
proceed with prenatal diagnosis because their religious beliefs were such 
that that was not right for them to do. I met a reasonable amount of parents 
who found themselves in the situation of being told that the baby had an 
abnormality and they made the decision to end their pregnancy but really 
struggled with it because of their religious beliefs.133  
                                                          
131 Ibid. 
132 Ibid., p. 19. 
133 KM Interview, Transcript 1, p. 8.  
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She went on to explain that: 
 
So parents would sometimes find themselves in the situation of being 
given the information that their baby had an abnormality, making the 
decision to terminate the pregnancy because that was right for them, but 
had strong religious beliefs and the guilt associated with that was huge. 
The guilt associated with terminating a pregnancy for fetal abnormality is 
huge for any parent that has to make that decision, I think religion has an 
impact on that as many other factors do but if their religious or cultural 
beliefs were against termination of pregnancy then they struggled more 
with that decision.134 
 
Even among those working in the field there were different perspectives about the role 
that religion played. Perhaps this could be due to the strength of religious beliefs 
amongst the specific patients they were encountering, but the relationship dynamic 
between patient and midwife versus patient and clinician could also play a role. In some 
situations, a female patient may feel more comfortable disclosing such information to a 
female midwife. However, the male clinician quoted here had built up very close 
relationships with the families he was working with over many years, so perhaps this 
would not have been a concern for his patients. What starts to emerge is a picture that is 
far more complex than would perhaps be expected from traditional religious teachings 
on the subject. For some women their religion was such a strong influence in their life 
that they refused prenatal testing, but for others, although their religious identity was 
strong, they still decided upon having the tests. 
 
Examples of both of these situations can be found in the wider literature. Bennett found 
that 25 of 49 women who turned down prenatal screening did so for religious reasons.135 
Of the 44 women in Bundey’s study who refused amniocentesis, the majority were 
actively practising Christians (66%).136 Interviews carried out by Rapp for Testing 
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Women, Testing the Fetus also show this on a more personal level, with one woman 
refusing a termination after a diagnosis of anencephaly. This woman was devoutly 
religious, and she wanted to ‘carry the fetus to term and accept God’s mercy in taking 
the baby quickly to Him’; additionally, she ‘saw her own suffering and the suffering of 
the baby as a test of God’s mysteries’.137 In The Tentative Pregnancy, Rothman quotes a 
letter received from a woman who strongly links her pro-life views to her religious 
beliefs, stating that ‘I am a Christian. Every person has the right to live – no one has the 
right to decide for someone else that their life is not worth living.’138  
 
From the descriptions above it seems that in some cases there is a link between religious 
identity and prenatal decision making. However, what becomes apparent when looking 
further into the literature, is that it is often not merely religious identification, but 
religious adherence which impacts decision making. Berne-Fromell and colleagues 
found a link between ‘active participation in the life of various religious congregations’ 
and refusal of prenatal testing,139 and Cao and colleagues reported ‘strict adherence to 
the Catholic religion’ as a reason for women in their study turning down testing.140 In 
addition, Tymstra and colleagues noted that fewer women would make use of a variety 
of prenatal tests if they were members of a church (36% of church members, compared 
to 46% of non-church members).141 Singer and colleagues found a direct correlation 
between religious attendance and abortion attitudes, when considering the percentage of 
women who would ‘want abortion in case of serious defect’. 56.3% of women who 
never went to church would want an abortion, compared to 45.9% who went several 
times a year, 42.4% who went monthly to almost weekly, and 25.5% who went weekly 
or more.142 Beth and Donald Granberg reported similar findings amongst Protestants 
and Catholics, whereby ‘approval of abortion decreases as religiousness increases’ and 
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this is particularly strong in the Catholic population, as ‘it is Catholics who attend 
church once a week or more who are distinctly low in their level of approval’.143 
 
The testimony from the midwife, however, highlights that even though having a 
termination of pregnancy went against their religious beliefs and resulted in guilt for the 
women involved, some still chose to proceed with the termination. It could be that for 
those of a strong religious faith, some women find that their concerns about being able 
to raise a child with a disability outweigh their religious beliefs and they decide to 
terminate. Pressure by society, family members and friends, and perhaps even the 
medical profession, combined with factors such as financial constraints, may of course 
all influence such a decision. McCoyd undertook a qualitative study of thirty women 
who chose to terminate their pregnancies after receiving a diagnosis of fetal anomaly. 
Many of these women gave similar reasons for choosing termination. One was thankful 
for the technology which she believed ‘saved my life’ as she felt that had she given 
birth ‘life as I know it would be over. There would have been no more children, 
possibly a break up of my relationship, no financial security of a job, no quality of life 
for my son.’144 For another woman the choice she made was not just for herself – she 
felt that whilst she ‘did it for me’ she also ‘did it for my marriage. I did it for my other 
child. I did it for my home and job and way of life.’145 For these women, although their 
decisions were multi-faceted, they felt that terminating the pregnancy would be the best 
thing to do in their individual circumstances at that time. 
 
Despite many women feeling that they had made the correct decision, guilt associated 
with religious beliefs is also a pervasive theme in the testimonies in Testing Women, 
Testing the Fetus. Rapp’s impression from the genetic counsellors that she interviewed 
was that whilst Catholic women use amniocentesis as frequently as non-Catholic 
women, they are ‘more troubled’ by it than Protestant women, who see ‘reproductive 
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145 Judith L.M. McCoyd, ‘“I’m not a saint”: Burden Assessment as an Unrecognized Factor in Prenatal 
Decision Making’, Qualitative Health Research, 18:11 (2008), p. 1494. 
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technology as occupying a space apart from their spiritual practices, for they saw both 
faith and reproductive medicine as private matters’.146 Several of the counsellors ‘were 
explicit in their statements concerning Catholic women’s guilt and the need to provide 
sympathetic clerical references’, and felt that the Catholic women ‘seemed to carry an 
additional burden of guilt’.147 One of her patient interviewees, Nivia, was described as 
‘guilt-wracked by having chosen abortion after the prenatal diagnosis of Turner’s 
syndrome. Nonetheless, she believed that she had made the right decision.’148 Another 
interviewee decided to terminate her pregnancy, but as it was Easter she decided to 
wait, stating that she just ‘“couldn’t do it; I just couldn’t do it until after His suffering 
was ended. Then my child could cease to suffer as well”’.149 Of thirteen women who 
were Catholic and who had chosen termination after a diagnosis of fetal anomaly, ten 
‘believed that their Catholic backgrounds had made it harder to recover from abortion 
than they imagined to be the case for non-Catholic women’.150 
 
If Rapp’s study is representative of wider decision making, then those who categorise 
themselves as belonging to a religion, but who choose to terminate, could lead to a 
skewing of the data surrounding religion and prenatal decision making. A woman may 
record herself as belonging to a religious organisation, but still decide to terminate even 
though it goes against religious teachings, and is left dealing with the guilt associated 
with this decision after the procedure. More examples of the tension between religious 
identification and prenatal decision making can be found in the wider literature. Green, 
Snowdon and Statham found that ‘47% of women ‘completely’ influenced by their 
religion and 82% of those influenced ‘quite a lot’ indicated at least one situation in 
which they themselves might consider abortion’.151 The same study concluded that 
‘many women who terminate for fetal abnormality may be acting against their own 
moral convictions. This may, for some, still be the less undesirable of two undesirable 
options.’152 Robinson and colleagues interviewed 22 women who had undergone 
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amniocentesis and then continued with their pregnancies, carrying out the interviews 
when the children were a year old. They found that ‘Many of the mothers had religious 
backgrounds consonant with the general antiabortion attitudes which they expressed. 
Fifteen women expressed a general opposition to abortion and 7 were generally in 
favour of it. Despite the disapproval of abortion and despite how badly they wanted 
their babies, most women were prepared to go ahead with abortion in the event of 
positive findings. Seventeen had no doubt that they would do so although some of these 
imagined that it would be difficult or that they would feel some remorse.’153 The reason 
behind the decision for some of those interviewed was that ‘they could not accept such a 
burden’.154 Whilst viewing themselves as religious, and holding religious beliefs which 
are against abortion, most women in this study were willing to set aside religious 
teaching on the subject when it directly impacted them. 
 
Another possible reason for the discrepancies between the expected conflicts could be 
that for many people religion is a fluid concept, and people do not always fit into a neat 
box of belonging to a religion and following every aspect of it. Voas has argued that 
whilst a number of people will identify as being either religious or non-religious, there 
will be a large population of people somewhere in the middle. These people, described 
by Voas as the ‘fuzzy group’ are neither regular churchgoers, nor are they against 
religion – they may retain some loyalties to traditional religious beliefs, but this is 
usually in an uncommitted way.155 The ‘fuzzy group’ have been analysed by Storm, and 
split into four groups – those of moderate religious beliefs, those of passive religious 
beliefs, those who belong without believing, and those who believe without 
belonging.156 Whilst these four groupings are useful, some people may fall into different 
categories at different times. The group that belong without believing could be 
particularly important in impacting statistics, as their religious label may not correlate 
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with their own belief systems. Thus, they may choose to make decisions which seem to 
conflict with the beliefs of their religious label.  
 
This is reflected in a study by Davies and Doran, who analysed the decision making of 
women of advanced maternal age, of whether to undergo or decline amniocentesis. 36 
women in their study were Catholic and/or had a Catholic spouse, but only 11 of these 
women said that their religion had impacted their decision making. They found that 
‘One third of the Catholic families were not practicing their religion and two-thirds did 
not agree with the church’s teaching on abortion.’157 Thus, whilst still identifying as 
Catholic, these families were not likely to follow church teaching on the subject. A 
number of other studies have also shown that those who identify as Catholic agree with 
abortion for fetal anomaly. Green, Snowdon and Statham reported that 75% of 
Catholics thought that abortion should be available if there was a strong chance of fetal 
handicap,158 and Kyle and colleagues found that 74% of Catholic women in their study 
definitely intended to undergo prenatal screening for neural tube defects.159 In addition, 
Breslau reported that 55% of Catholics agreed with termination where ‘There is strong 
chance of serious deformity in the baby.’160  
 
Another factor which could have impacted decision making is that despite the Catholic 
Church being strongly opposed to abortion, no official statement was made by a Pope 
on prenatal diagnosis until the late 1980s. Donum Vitae, published by Pope John Paul II 
in 1987, outlined more specifically the position of the Church on the matter of prenatal 
diagnosis. He stated that prenatal testing could be ‘morally licit’ when it was used to 
protect the life and health of the fetus, for example by enabling the diagnosis of a 
medical condition which could be treated in the fetus prior to or just after birth. Thus the 
vast majority of prenatal testing, which is carried out with the potential of choosing to 
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have an abortion based on the results, is ‘gravely opposed to the moral law’ of the 
Catholic Church.161 The women who would ask for prenatal testing on the basis of 
terminating the pregnancy if an anomaly was found would therefore be acting in a 
strictly discordant way with official teaching; Pope John Paul II stated that not only 
would she be committing a ‘gravely illicit act’, but that her spouse and relatives would 
also be doing so, along with the specialists who recommended the testing.162 However, 
as this statement was not released until 1987 it is possible that many women had already 
entered into prenatal screening and testing programmes, and were using their own 
conscience to guide them on these matters. Rapp has characterised this situation as ‘a 
precipitate of liberal, individualistic Catholicism separating out of official doctrine’, 
whereby the women involved ‘uphold a general ethical worldview which is deeply 
Catholic, and personally accept its emotional consequences. Nonetheless, they reserve 
the right (and accord it to others) to choose abortion under certain circumstances.’163 
 
Thus, a situation seems to be occurring where decision making and beliefs vary 
amongst those who identify as belonging to a religious faith. Whilst the Church of 
Scotland sanctioned terminations for fetal anomaly in certain circumstances, the Kirk 
was divided on the subject of abortion more generally. As shown from the discussion of 
the Kirk’s views towards abortion throughout this chapter, several years went by with 
no mention of the subject at all, and it is possible that women were not fully aware of 
what the Kirk’s views were. In addition, the changing attitudes at the 1985 and 1986 
General Assembly could have caused confusion for women who were looking to the 
Church of Scotland for guidance, and could have led to them relying more on their own 
moral beliefs for decision making. By way of contrast, it is unlikely that Catholic 
women would be unaware of the position of the Catholic Church on abortion, as it was 
such an important topic. The Catholic Church spoke out strongly against termination of 
pregnancy, and several Papal declarations made it clear that to have an abortion for any 
reason was sinful. However, the situation is far more complex than linking religion 
directly to prenatal testing, as several other factors are clearly influencing women’s 
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decision making. From the data above it seems that it is a personal choice for each 
woman, who will take into account religious, moral and personal beliefs and situations 
before deciding on the best course of action for herself and her family. This is 
summarised well by Rapp, who as a result of her research concluded that: 
 
Religion provides one resource in the complex and often contradictory 
repertoire of possible identities a pregnant woman brings to her decision to 
use or reject amniocentesis. There is no definitive “Catholic,” “Jewish,” or 
“Protestant” position on reproductive technology, when viewed from the 
pregnant woman’s point of view. Rather, each concrete, embedded 
pregnancy is assessed in light of the competing claims on maternity the 
individual acknowledges and to which she responds.164 
 
It is certainly the case that, in the genetics clinics run by Ferguson-Smith, decision 
making did not correlate strongly with religion. Despite Glasgow being known for its 
religious population, prenatal screening services were highly utilised, and few women 
seemed to explicitly state their religion as a reason for turning down such services. 
However, as can be seen throughout this chapter, those who strongly supported the anti-
abortion cause seemed unwavering in their views, and it is possible that they would not 
attend for any prenatal testing, causing their data to go unrecorded. It would therefore 
be very difficult to trace these women to find out more about their decisions, as they 
would be unlikely to have come into contact with genetic services. Whilst their reasons 
for turning down testing would possibly be recorded by midwives at their antenatal 
appointments, it seems unlikely that their details would be made easily available to 
researchers in the subject area due to patient confidentiality issues.  
 
VIII. Conclusion 
What can be determined from the data presented in this chapter is that abortion is a 
highly emotive and subjective topic, with wide-ranging views held by a variety of 
individuals. Religious organisations have played a key role in attempting to influence 
abortion legislation since the development of Steel’s Bill, whether arguing in favour of 
or against the Bill. For the Church of Scotland, the subject of abortion has been a well-
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debated but also divisive matter. Initially supporting Steel’s Bill and aligning 
themselves with the Anglican publication Abortion An Ethical Discussion, they were 
seen to hold less restrictive views on abortion than the Catholic Church. However, 
within the Church of Scotland there were many who did not agree with this stance, and 
this can clearly be seen in the 1985 General Assembly, which voted that abortion would 
only be permitted to save the life of the pregnant woman. This decision caused 
backlash, and was subsequently reversed at the 1986 General Assembly.  
 
The situation within the Catholic Church has remained steadier over time, as they have 
continued to stick to the viewpoint that they have held for centuries which is that 
abortion is morally wrong. The Catholic Church was surprisingly quiet in leading the 
fight against Steel’s Bill, however since the passing of the Abortion Act 1967 they have 
been among its most vocal opponents. With such staunch views on abortion, it would be 
expected that there would have been a strong opposition from the Catholic Church to 
prenatal testing, as the outcome of a diagnosis of fetal anomaly tended to be termination 
of the pregnancy. However, this opposition seems to be surprisingly missing, with no 
official statement made on prenatal testing by a Pope until 1987.  
 
Whatever the reasoning behind this lack of discussion, it is unclear whether the 
pronouncements of the Catholic Church would have had a direct impact on many 
women who were undergoing prenatal testing, as highlighted by the discussions of the 
complex nature of the influence of religion on prenatal decision making. Whilst there 
were some women who were unwilling to take part in prenatal testing, or act upon its 
results, due to their religious beliefs, for many their religion was only one part of a 
complex web of ethical and moral beliefs which impacted their decision making. It is 
hoped that this chapter has highlighted the key role played by the Church of Scotland 
and the Catholic Church in the abortion debate, particularly as it relates to the issue of 
fetal anomaly, and has shown the complex nature of interactions which exist between 
religion and prenatal testing that can impact decision making. 
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Conclusion 
 
I. Introduction 
This thesis set out to examine the development of prenatal diagnosis between 1950 and 
1990, using the West of Scotland as a case study. As was highlighted in the 
introduction, this is an important original contribution as little scholarly attention has 
been paid to the history of prenatal testing in Scotland. Focusing analysis on the city of 
Glasgow was particularly significant, given the interesting circumstances under which 
prenatal testing was devised and applied. There are many benefits to using a local study 
to gain an insight into the medical innovations and social implications of the field of 
prenatal testing. Under the leadership of Malcolm Ferguson-Smith, Glasgow was at the 
forefront of the implementation of many of the prenatal testing and screening 
programmes. Concurrently, anti-abortion attitudes were held by many religious figures 
in the region. Glasgow therefore provided a unique opportunity to explore how 
scientific and social factors combined to impact the development of prenatal testing. 
 
It has been shown that the role of certain individuals can greatly impact service 
expansion and availability in a region, as highlighted through the work of Malcolm 
Ferguson-Smith and his colleagues. Throughout this thesis it can be seen that the 
scientists and clinicians who worked in the prenatal testing field were driven to make 
these services available to the public. By analysing the role that Malcolm Ferguson-
Smith and his colleagues played in bringing prenatal testing to Glasgow and the 
surrounding areas, a detailed picture emerges of the relevant scientific innovations 
which occurred in this region. It was possible to analyse the specific details of testing 
and screening programmes, particularly for chromosome anomalies and neural tube 
defects, and the administrative hurdles faced when creating a new specialty could also 
be revealed. It was, however, also essential to place these developments in a national 
context, which was achieved through the analysis of medical and scientific journals, 
newspapers and magazines.  
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Whilst the scientific and technical developments which were occurring in prenatal 
testing were a key focus of this thesis, these did not evolve in isolation from the social 
time period in which they occurred. As was highlighted throughout the introduction, the 
importance of considering the social context was paramount to gaining a fuller 
understanding of the development of the prenatal testing field, which was particularly 
important for Glasgow. Thus, an analysis of the role of abortion legislation in the form 
of the Abortion Act 1967 was undertaken, with a focus on the impact that the ability to 
diagnose fetal anomaly had on altering views surrounding termination of pregnancy. 
This analysis helps to show that the majority of the public supported abortion being 
available for reasons of fetal anomaly.  
 
As the legislation kept abortion strictly under the control of the medical profession, their 
views were important for gaining an insight into how this affected access to abortion 
services, with the role of two influential clinicians in Scotland, Dugald Baird and Ian 
Donald, considered in detail. The examination of the views of Ian Donald provided a 
further insight into the effect that an individual could play on the availability of prenatal 
services. Despite holding strong anti-abortion views in the majority of circumstances, 
Donald was willing to carry out a termination of pregnancy if the fetus had, in his view, 
no chance of spiritual development, due to severe fetal anomaly. This thesis examines 
Donald’s friendship with Ferguson-Smith, highlighting the importance of personal 
connections in influencing decision making. The importance of individuals is brought to 
the forefront, and the complex nature of decision making in prenatal testing highlighted.  
 
As the West of Scotland had a highly religious population the views of two of the main 
Christian denominations, the Church of Scotland and the Catholic Church, towards 
abortion were considered. This work is particularly significant, as little attention has 
previously been given to the attitude of the churches towards abortion for fetal anomaly. 
Throughout this thesis it becomes apparent that Glasgow was a highly religious city, 
where the Catholic Church frequently promoted anti-abortion messages. Large protests, 
marches, and rallies were well attended by local people, and this general atmosphere 
could have caused difficulties for those involved in prenatal testing. However, such 
conflicts did not materialise between the groups involved, at least not on the scale that 
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might have been predicted. There were only a few direct attacks on prenatal testing by 
religious organisations, and equally few official proclamations on its moral 
acceptability. This lack of conflict is also apparent when decision making following 
prenatal testing is considered.  
 
Thus, by using a local case study, what emerges are the stories of several individuals 
and groups, who all played a role in impacting the field of prenatal testing. Through the 
investigation of scientific technologies and laboratory tests, the campaign for more 
permissive abortion legislation, and the strongly held views regarding the rightfulness 
of prenatal testing, this thesis has drawn out the stories of the people involved. Linking 
these stories into a narrative emphasises the importance of treating both the technical 
and social aspects with equal importance, as outlined in the introduction of this thesis. 
This work makes an important contribution to the current literature on the development 
of prenatal testing, by detailing how the scientific and medical discoveries evolved over 
time, and how they were received by society. Specifically, for Glasgow, it becomes 
clear that prenatal testing became a routine aspect of antenatal care, despite broader 
opposition to abortion by certain groups within the city. 
 
The work which was undertaken in Glasgow also contributed to the overall expansion 
of the field of prenatal testing in a national and international context. For example, work 
confirming the link, first shown by Brock and Sutcliffe, between alpha-fetoprotein and 
neural tube defects, and the ability to screen pregnant women for these conditions using 
maternal serum, would change the field of prenatal diagnosis entirely. In addition, by 
contributing a number of patients to research studies such as that examining the link 
between folic acid and neural tube defects, the medical genetics department in Glasgow 
directly contributed to the revision of international protocols of pregnancy management. 
Debates between Ferguson-Smith and Ernest Hook on the specifics of the maternal age 
effect on chromosome disorders exemplifies the international span of the community of 
clinicians and scientists who were investigating various aspects of the prenatal diagnosis 
field, as did Ferguson-Smith and Yates’ work on the significance of maternal age. For 
Ferguson-Smith specifically, his role as the first Editor of the journal Prenatal 
Diagnosis increased his international profile. Ferguson-Smith also communicated with 
300 
 
researchers and clinicians from around the world about prenatal diagnosis projects, 
including obtaining reagents from Nishi in Japan to assist with the maternal serum 
alpha-fetoprotein screening programme.1  
 
One of the most important international links that Ferguson-Smith maintained 
throughout his career was with the department of medical genetics at Johns Hopkins 
University in Baltimore, led by Victor McKusick. McKusick played a central role in the 
development of the field of medical genetics. He was responsible for establishing the 
first medical genetics clinic at Johns Hopkins in 1957, and was centrally involved in 
many key research projects throughout his career, including the Human Genome 
Project. McKusick also created Mendelian Inheritance in Man, a catalogue of human 
phenotypes which is updated on an annual basis (initially published as a text, and now 
available online).2  
 
Ferguson-Smith contributed a chapter to a book written about Victor McKusick and the 
history of medical genetics, within which he described McKusick as having earned ‘the 
title of “founding father” of medical genetics’.3 Ferguson-Smith speaks of McKusick in 
an almost biblical sense in this chapter, describing the trainees that McKusick had 
‘gathered around him’ at the Moore Clinic, as his ‘disciples’, many of whom would go 
on to ‘spread the word and create clinical genetics centers around the world’.4 
Ferguson-Smith remained in correspondence with McKusick throughout his career, and 
McKusick was invited to open the Duncan Guthrie Institute when it was established.5 
This highlights the continued impact that training in McKusick’s department had on 
Malcolm Ferguson-Smith, and the high regard in which he held McKusick. Through his 
connection with McKusick and the department in Johns Hopkins, Ferguson-Smith had 
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Victor McKusick and the History of Medical Genetics, ed. by Krishna Dronamraju and Clair Francomano 
(New York: Springer, 2012), p. 53. 
4 Ibid. 
5 Ibid., p. 62. 
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strong international links in the medical genetics community in North America and 
beyond. 
 
This reputation of medical genetics in Glasgow can be seen in the number of students 
who would travel from abroad to learn from those working in the department. One of 
the key ways in which Glasgow contributed to the expansion of medical genetics 
internationally, was through the MSc course which was set up under the leadership of 
Malcolm Ferguson-Smith, and expanded by Douglas Wilcox. This course has been 
described as disseminating widely the basic principles of genetics. At a more advanced 
level, researchers and clinicians came to study and learn the techniques at the Duncan 
Guthrie Institute, before taking up key positions in genetics departments elsewhere. One 
example is Maria Guida Boavida, who came from Portugal to gain experience in 
Glasgow. 6 As described in chapter two, one interviewee commented that there couldn’t 
have been many places in the United Kingdom that didn’t have a staff member who had 
spent time at the Duncan Guthrie institute.7 Many of the staff of the Glasgow Institute 
had also spent time studying elsewhere, including Elizabeth Boyd, who worked in a 
laboratory in Paris, David Aitken, who spent time in Holland, and Mike Connor, who 
worked with McKusick at Johns Hopkins University.8  
 
II. Chapter Findings 
The main focus of chapter one was to detail the technical developments which made 
prenatal diagnosis feasible. These technologies formed the central component of testing 
and screening programmes, both in the West of Scotland, and throughout the rest of 
Europe and North America. A key feature of this chapter was the description of the 
elucidation of the correct chromosome number in humans. It is argued that this 
discovery was the foundation upon which much of prenatal diagnosis was based, 
enabling it to become feasible and clinically relevant. By establishing the human 
                                                          
6 EB Interview, DS300139, p. 4. 
7 JL Interview, DS300179, p. 9. 
8 For information on each of these, see the relevant pages of their interview transcripts: 
EB Interview, DS300135, p. 3.  
DA and JC Interview, DS300190, p. 1.  
MC Interview, DS300143, pp. 1-2. 
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chromosome count as 46, it became possible to identify chromosome conditions which 
differed from this number, thus enabling the detection of chromosome anomalies.  
 
This information became particularly relevant to prenatal testing when combined with 
amniocentesis. The development of this procedure in the 1950s, which entailed the 
extraction of amniotic fluid for analysis, was complimented by the discovery that cells 
obtained from amniotic fluid could be cultured in the laboratory. In 1966 Steele and 
Breg showed that the chromosome constitution of the cells found in amniotic fluid 
could be determined. This was a fundamental turning point for prenatal testing. 
Amniocentesis went on to become an integral part of antenatal care, despite being 
associated with an increased miscarriage risk. Amniocentesis was also used to analyse 
the biochemical properties of the amniotic fluid, particularly with regards to alpha-
fetoprotein, which was found to be a useful diagnostic marker for neural tube defects 
and Down’s syndrome. The discovery that alpha-fetoprotein could cross the placental 
barrier, and be detected in the maternal serum, transformed prenatal testing. Increased 
levels of alpha-fetoprotein in the serum were linked with neural tube defects, whilst 
decreased levels were associated with Down’s syndrome. It thus became possible to 
take a simple blood sample from a pregnant woman, identify the likelihood of her fetus 
having these conditions, and if necessary, refer her on for further diagnostic testing. 
This innovation, it has been argued, opened up the prenatal field to all pregnant women, 
resulting in prenatal screening becoming a routine aspect of antenatal care. 
 
Despite these developments, throughout the 1960s and 1970s, a number of medical 
professionals were concerned that the testing could only take place in the second 
trimester of pregnancy. This would result in terminations of pregnancy usually taking 
place after 20 weeks gestation, which was more medically challenging and thought to 
be more emotionally upsetting for the women who faced this situation. Several attempts 
were therefore made to develop methods which would enable a diagnosis to be made in 
the first trimester of pregnancy. This was realised with the development of chorionic 
villus sampling (CVS). However, despite the high hopes that many had for CVS, the 
test did not prove to be as popular as expected. The procedure was associated with a 
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higher miscarriage rate than amniocentesis, and women who were not identified as 
being at increased chance of anomaly generally opted for amniocentesis. 
 
As women were becoming more aware of the increased miscarriage risks associated 
with invasive procedures, ultrasound was beginning to play a role in the direct diagnosis 
of structural anomalies of the fetus. Pioneered in the 1950s by Ian Donald and his 
colleagues, ultrasound made the fetus visible, and was not associated with any increased 
risk of miscarriage, as it was an entirely non-invasive technique. Ultrasound was able to 
visualise conditions such as anencephaly, and was also centrally involved in improving 
the safety of invasive prenatal testing methods, such as amniocentesis. Thus, a 
combination of invasive and non-invasive prenatal testing techniques became available, 
which made it possible to detect an increased number of fetal anomalies. 
 
However, in order for these technologies to be clinically significant, they had to be 
developed for use in a clinical setting, and then accepted by pregnant women. The 
clinical and advisory services of the Glasgow Department of Medical Genetics 
facilitated this transition. As outlined in the introduction, this thesis aimed to use the 
case study of Ferguson-Smith to examine the development of prenatal testing in detail, 
and Ferguson-Smith’s career was therefore the focus of chapter two. Ferguson-Smith’s 
education and early job roles were examined. During his school and university studies, 
he already had an interest in the subject of genetics. His movement into the field of 
chromosome studies occurred as a result of a chance meeting with the pathologist 
Bernard Lennox, who was looking for someone to assist him with a nuclear sexing 
project. This study, examining males with Klinefelter’s syndrome, piqued Ferguson-
Smith’s interest, and convinced him of the importance of studying human chromosomes 
in more detail. This interest was, however, not shared by others working in Glasgow at 
this time, and Ferguson-Smith moved to Johns Hopkins University in Baltimore, to 
further his skills.  
 
The time Ferguson-Smith spent at Johns Hopkins structured his future career, and he 
returned a few years later as the first Lecturer in Medical Genetics at the University of 
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Glasgow. He then spent a number of years setting up a chromosome diagnostic service 
within the West of Scotland region. As chromosome studies advanced and 
amniocentesis became feasible, he then turned to establishing a range of prenatal testing 
services. As was highlighted in chapter two, the work using amniocentesis in prenatal 
testing in Glasgow was first begun with the aim of enabling women to continue on with 
pregnancies, which would otherwise have been terminated on the basis of possible fetal 
anomaly. From Ferguson-Smith’s perspective, the development of prenatal testing in 
Glasgow was carried out with the aim of enabling women to consider further 
pregnancies, who had previously been impacted by fetal anomaly during a previous 
pregnancy. This is important to note, as questions are often raised in the literature about 
the link between prenatal testing and eugenics. This was seen in the discussion in 
chapter six, when figures such as Archbishop Winning and Marilyn Gillies Carr 
publicly condemned what they saw as the link between prenatal testing and eugenics.  
 
The department became exceptionally busy with the advent of prenatal testing, and 
initially did not even advertise their services, as they had a great deal of work from 
patients who were already known to the medical genetics department, or whose 
clinicians had connections to Ferguson-Smith. As prenatal testing continued to expand, 
and it became possible to detect both chromosome anomalies and neural tube defects, 
the workload grew exponentially, with several thousand maternal serum samples 
needing processed each year. This increased caseload required more staff, and with 
more staff came the need for larger premises.  
 
Despite financial difficulties, expansion of facilities was eventually achieved with the 
building of the Duncan Guthrie Institute of Medical Genetics. As outlined in chapter 
two, the Institute was one of the first of its kind in the United Kingdom, and was 
responsible for bringing together a number of individuals working on various aspects of 
prenatal testing, including clinicians, scientists and technicians. The founding of the 
Duncan Guthrie Institute and an analysis of its services again illustrates the importance 
of local case studies; it was possible to examine working relationships between staff, 
weekly routines, and specific details of testing programmes to gain a detailed insight 
into how the creation of such a facility impacted service availability. Although 
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Ferguson-Smith moved to Cambridge in 1987, the Duncan Guthrie Institute continued 
to provide prenatal services for several decades after this relocation, highlighting the 
demand for the services that were being provided. 
 
The detection of chromosome anomalies formed a central part of the department’s 
workload, and as highlighted in chapter one, was the cornerstone on which prenatal 
diagnosis was founded. Chapter three therefore focused on the development, 
implementation and uptake of testing for chromosome anomalies, both within the West 
of Scotland and further afield. Prior to the discoveries which enabled the analysis of the 
fetal karyotype, chromosome studies focused on patterns of heredity. It was hoped that 
it would be possible to predict the likelihood of a future pregnancy being affected by the 
condition being studied, but there was little thought towards preventing the birth of 
these future children through termination of affected pregnancies. It is argued in chapter 
three that the combination of the ability to culture and karyotype cells from the amniotic 
fluid, alongside the passing of more permissive abortion legislation in the form of the 
Abortion Act 1967, paved the way for the development of testing for chromosome 
anomalies. 
 
Beginning with amniotic fluid samples gathered from Rhesus-incompatibility 
pregnancies, the Glasgow group gained experience in developing these cell cultures, 
and a short time later were able to offer amniocentesis for the purposes of prenatal 
diagnosis. Other groups throughout the United Kingdom and further afield were also 
carrying out such work, and publications appeared in several prominent medical 
journals detailing their experiences. Although prenatal testing for chromosome 
conditions was shown to be relatively accurate, the testing faced a number of technical 
difficulties such as mosaicism, where a mixed chromosome constitution was 
discovered. As is argued in chapter three, these findings not only presented a challenge 
to the medical profession, but also to the pregnant women, who faced a choice of 
whether or not to terminate their pregnancies based on an uncertain prognosis. With 
problems surrounding the test results, and the link between amniocentesis and an 
increased miscarriage rate, it is perhaps unsurprising that many clinicians were wary of 
offering amniocentesis to all pregnant women. Instead, the association between 
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increased rates of chromosome anomalies and increasing maternal age was used to limit 
the testing to women who were seen to be at a higher chance of having a fetus with an 
anomaly. A great deal of debate existed within the scientific and medical community 
around what age should be used as a threshold for an offer of amniocentesis. Ferguson-
Smith was centrally involved in these debates, and advocated for an age of 35, which 
was a lower age than many of his colleagues and contemporaries opted for.  
 
Whilst debates were ongoing surrounding maternal age, it became apparent that uptake 
rates of prenatal testing programmes were lower than anticipated, with fewer women 
willing to undergo amniocentesis than expected. The number of fetuses with 
chromosome anomalies being detected was therefore small, which was deemed to be 
disappointing by some within the medical community. However, the advent of prenatal 
screening programmes extended the possibility of detecting fetal anomalies to the entire 
pregnant population. As decreased levels of alpha-fetoprotein in the maternal serum 
were associated with an increased likelihood of Down’s syndrome in the fetus, the 
possibility opened of detecting the condition in women who would not have typically 
been offered an amniocentesis, for example, if under the age of 35.  
 
As noted above, in the detection of neural tube defects, alpha-fetoprotein was also key, 
with elevated levels of the protein being associated with an increased likelihood of 
anencephaly or spina bifida. The rate of neural tube defects was particularly high in the 
West of Scotland, and was of significant medical concern. They therefore formed a 
major research focus for the group led by Ferguson-Smith. The development of testing 
and screening for neural tube conditions was described in chapter four. The screening 
programmes for Down’s syndrome and neural tube defects proved to be popular, with 
large numbers of women taking part. They have been developed over time, and are still 
in use today.  
 
There existed huge variations in the rates of neural tube defects amongst different 
geographical regions, and the detection rates using screening programmes varied greatly 
as a result. It was often found that screening programmes only played a useful role in 
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detection in areas where high rates of neural tube defects were prevalent. Indeed, one 
region cancelled their screening programme entirely, as they viewed their results as 
unsuccessful. What emerged was a situation in which access to such programmes was 
based on geographical location, a situation many were unhappy with. It did, however, 
become possible to circumvent these differences, when it was found that folic acid 
played a key role in preventing the formation of neural tube defects. Taking folic acid 
supplements decreased the recurrence rates of neural tube defects in future pregnancies 
of women who had previously had an affected child, therefore reducing the numbers of 
children born with these conditions. Despite the controversy surrounding the ethics of 
the clinical trials of folic acid, it was decided over time to recommend supplementation 
for all pregnant women. Thus, for the first time, it became possible to prevent the 
formation of a fetal condition, as opposed to terminating an affected pregnancy. This 
would be a far more acceptable outcome for many prospective parents. 
 
Whilst the first four chapters of this thesis examined the development of many of the 
technical and clinical aspects of the prenatal diagnosis field, these developments were 
happening amongst the changing social context of the decades in which they were 
situated. One of the key changes which occurred in the 1960s, was the passing of the 
Abortion Act 1967, which made access to abortion legal throughout Scotland, England, 
and Wales, with fetal anomaly forming a specific category within the legislation. The 
focus of chapter five was therefore the development of the Abortion Act 1967, and the 
various factors which influenced this, and the aftermath of the implementation of the 
legislation. 
 
Throughout this thesis it was argued that the passing of more liberal abortion legislation 
was essential for the prenatal field to expand in the manner in which it did. Without 
legal abortion, prenatal testing could have been used for information only. However, 
when confronted with a diagnosis of fetal anomaly, most women would choose to 
terminate their pregnancies. It is therefore unlikely that prenatal testing and screening 
programmes would have become such an established feature of antenatal care if 
providing information about the fetus without the option to terminate an affected 
pregnancy was its only use. One of the key arguments throughout chapter five is that 
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fetal anomaly played an important role in changing attitudes towards termination of 
pregnancy, with public opinion being broadly sympathetic towards women who wanted 
to abort their pregnancy for this reason. The importance of fetal anomaly for impacting 
abortion legislation was described in detail, and it was highlighted that many people 
viewed abortion after a diagnosis of a fetal condition as being ‘different’ to terminations 
for social reasons. It has been put forward by a number of commentators that the 
particular crises brought about by Thalidomide, and the rubella epidemic, in the 1960s, 
were influential in changing attitudes. This thesis presents evidence which supports 
these claims. 
 
An analysis was undertaken of the ways in which fetal anomaly was discussed within 
the abortion debates, with a key theme of uncertainty emerging. Concerns surrounded 
how sure a clinician could be in predicting a diagnosis, which was difficult prior to the 
advent of prenatal testing. Although there were worries over the termination of 
unaffected fetuses, many were still in favour of a fetal anomaly clause despite this 
uncertainty, including Steel himself. Attempts were made to alter the language within 
the fetal anomaly clause. However, these were defeated. By the time of Steel’s Bill, it 
was clear that there was widespread support for a fetal anomaly clause, although there 
were still some individuals who wanted the clause removed. It has been argued that 
those who opposed the fetal anomaly clause were those who were against abortion more 
broadly.  
 
Whilst fetal anomaly may have played a key role in changing views surrounding 
termination of pregnancy, it was relevant in only a small number of cases put forward 
for abortion requests, which could perhaps explain why it was viewed as different to 
some of the more controversial clauses. As was highlighted in the earlier discussion of 
chapter two, figures such as Ferguson-Smith also hoped that the advent of prenatal 
testing would actually lead to continuation of pregnancies which would have otherwise 
been terminated due to suspected fetal anomaly, without a confirmed diagnosis. By way 
of contrast, far more concern surrounded the idea of abortions taking place for ‘social’ 
reasons, under the provisions of the Abortion Act 1967. As the medical profession were 
going to be responsible for carrying out abortions, it is unsurprising that many of them 
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entered into debates surrounding the ethics of termination of pregnancy. The views of 
key medical professional bodies were considered in chapter five, with a key theme 
emerging that each of these organisations was acting in its own interests. As a whole, 
the medical profession was keen for clinicians to retain autonomy over the abortion 
decision making process, controlling access to abortion services. The specific views of 
two clinicians based in Scotland, Dugald Baird and Ian Donald, were examined in 
detail. As was emphasised throughout this section, these clinicians had a major impact 
on availability of, and access to, abortion services throughout their region. As Ian 
Donald was based in Glasgow, his story was of particular importance. As already noted, 
Donald’s view was that termination of pregnancy should be carried out only if the fetus 
had little prospect of spiritual development. Donald did carry out terminations of 
pregnancy on Ferguson-Smith’s patients whom he felt fitted into this category. This 
aspect of Donald’s views is not widely known, and a link with Ferguson-Smith has not 
been raised in the published literature. Donald’s refusal to carry out abortions for other 
reasons resulted in a problem with access to abortion services in Glasgow, illustrating 
the control that such senior medical figures exercised. The interesting case of Donald 
again emphasises the benefits of using a local area as a case study, in order to analyse 
these nuances in detail. 
 
Geographical inequality of access to abortion services, such as that which existed in 
Glasgow, became apparent in the years following the implementation of the Abortion 
Act. In response to this and other areas of concern, calls were made for an inquiry into 
how the legislation was working in practice. The Lane Committee was set up, and, in 
1974, published a detailed report of its findings. Although the Lane Report highlighted 
areas of concern, overall it unanimously supported the working of the Abortion Act. 
This chapter examines the Scottish response to the Report, from the perspective both of 
the medical profession and several religious organisations. Generally, the response of 
the medical profession was positive. One of the key areas of discussion, however, was 
the upper time limit at which abortions could take place, with many of the nursing and 
midwifery groups supporting a limit lower than the 24 weeks which the Lane 
Committee supported. The alternative of a 20-week limit was often suggested. 
However, an upper limit of 20 weeks could prove restrictive given the time necessary to 
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undergo prenatal testing, receive a diagnosis, and proceed with a termination of 
pregnancy. 
 
In addition to considering the medical profession’s views towards the Lane Committee 
report, several religious organisations were also considered. However, it became clear 
in the evidence presented within chapter five, that there was not such widespread 
support for the Lane Report amongst these groups, as there was by the medical groups. 
Several areas of concern were raised by religious organisations, including feeling that 
anti-abortion views were not represented within the composition of the Lane 
Committee. Whilst this section of chapter five briefly examined the opinions of several 
religious organisations, the views on abortion of two of the main religious 
denominations in the West of Scotland, the Church of Scotland and the Roman Catholic 
Church, were the focus of chapter six. Interestingly, it had been envisaged that the 
views of the Church of Scotland and the Roman Catholic Church to prenatal testing 
would be considered in detail for this thesis, but there was only sparse material available 
on the subject. Instead, the majority of the primary sources discussed attitudes towards 
abortion more generally. As the only options available after prenatal testing during the 
time of the study were either continuation or termination of the pregnancy, the views of 
both the Church of Scotland and the Catholic Church to abortion more generally were 
considered. 
 
It was shown throughout chapter six that the views of the Church of Scotland members 
to abortion were fluid, and changed a great deal over time. The Church of Scotland 
worked to influence the provisions of the Abortion Act 1967, and for almost two 
decades after the Act was passed, remained generally in favour of abortion being 
permissible in limited circumstances. However, the official views of the Church did 
change, albeit only temporarily, in the mid-eighties. By way of contrast, the views of 
the Catholic Church have remained fixed over time on the subject of abortion. They 
have declared that direct abortion is not permissible under any circumstances. Despite 
their stance, it is argued throughout chapter six that the Catholic Church did surprisingly 
little to prevent the development and implementation of the Abortion Act 1967. Very 
few campaigns took place, and it appears that the legislation took them by surprise. 
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However, the Catholic Church became one of the most vocal groups in the fight against 
abortion throughout the 1970s and 1980s. They were responsible for organising huge 
rallies, petitions, and sponsoring Bills in an attempt to restrict the circumstances under 
which abortion was available. Despite all of their efforts, the Abortion Act 1967 
remains in place, with many women making use of the legislation to legally end their 
pregnancies. 
 
It might therefore be expected that a conflict would exist between the Catholic Church 
and prenatal testing, due to the main clinical intervention following testing being a 
termination of pregnancy. However, interviews with medical professionals who worked 
in the West of Scotland reveal a much more complex story, whereby decision making 
did not seem to be directly linked to religious identification. Throughout the wider 
literature, it is apparent that women who identified as religious could still choose to 
undergo prenatal testing. It seemed to be religious adherence, as opposed to religious 
identification, which impacted such choices. Women who frequently attended religious 
services and who viewed their religion as being of central importance in their life, were 
found to be the least likely to undergo prenatal testing. For many others, whilst they 
identified as belonging to a religious group, their desire not to have a child affected by 
the conditions which could be tested for was more important than their religious faith. 
Thus, a complex system seemed to emerge, whereby prenatal decision making was 
determined by a number of factors, with religion one component which formed part of 
their consideration.  
 
III. Contribution to the Literature 
As was highlighted in the introduction of this thesis, there is a lack of published 
literature on the development of the prenatal testing field in the West of Scotland, and 
particularly the contributions made by Ferguson-Smith and the department he led. The 
few papers which do exist on Ferguson-Smith’s contribution have been celebratory in 
nature, or written by Ferguson-Smith himself. This lack of publications has led to a 
dearth of critical analysis. The detailed study of this particular region has enabled a 
comprehensive picture to be built up of the scientific and clinical research which was 
undertaken, and the impacts it had on service provision in the West of Scotland. By 
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utilising a wide range of sources throughout this project, a narrative has emerged which 
takes into account many regional differences, rather than considering the United 
Kingdom as a whole, in contrast to many previous studies. In their article examining the 
development of medical genetics as a specialty area in Manchester, Coventry and 
Pickstone highlighted the need for ‘comparative studies of other regional and national 
centres’ which they felt was ‘particularly true with regard to Scotland’.9 Whilst this 
thesis focuses on the West of Scotland, and not the country as a whole, it has 
highlighted some of the specific nuances of the developments which occurred in that 
region, which would differ from experiences elsewhere.  
 
Peter Harper, in his book A Short History of Medical Genetics, expressed the hope that 
professional historians of science and medicine would ‘open their eyes to the 
importance of the field as part of science and of medicine, and in particular to the 
richness of the material available to be analysed from a historical perspective, most of 
which has been barely used until now’.10 This thesis confirms Harper’s assertion that 
there is a ‘richness’ of research material available. If comparable studies were carried 
out in geographical regions throughout the United Kingdom, then a more 
comprehensive picture could be built up of the particular trajectories that prenatal 
testing went through as it became established as a discipline. 
 
From the literature review in the introduction of this thesis, it can be seen that there are 
several different texts available which cover various aspects of the development of the 
field of prenatal testing, and in some cases medical genetics more broadly. However, 
whilst all of these contain useful information, none focus specifically on the West of 
Scotland context, or on Ferguson-Smith’s contributions. There are texts which do have 
similarities, including Ilana Lӧwy’s Imperfect Pregnancies: A History of Birth Defects 
and Prenatal Diagnosis, and Malcolm Nicolson and John Fleming’s book Imaging and 
Imagining the Fetus: The Development of Obstetric Ultrasound. Both of these focus on 
the scientific and clinical developments which were occurring in prenatal testing and 
                                                          
9 Peter A. Coventry and John V. Pickstone, ‘From What and Why Did Genetics Emerge as a Medical 
Specialism in the 1970s in the UK? A Case-history of Research, Policy and Services in the Manchester 
Region of the NHS’, Social Science and Medicine, 49:9 (1999), p. 1236. 
10 Peter S. Harper, A Short History of Medical Genetics, (Oxford: Oxford University Press, 2008), p. 3. 
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ultrasound, respectively, and also look at the social context in which these were taking 
place. Lӧwy charts in detail the development of the field of prenatal testing as a whole, 
with only a brief mention of Glasgow or Ferguson-Smith. By way of contrast Imaging 
and Imagining is focused heavily on developments which happened in the Glasgow 
region. However, it deals specifically with the development of the ultrasound scanner. 
Therefore, the prenatal testing elements discussed are those which involved the direct 
application of ultrasound technology e.g. dating pregnancies and visualising physical 
anomalies. Thus, this thesis expands the scope of Lӧwy, and Nicolson and Fleming’s 
work into a different context, looking specifically at the wider developments occurring 
in the field of prenatal testing, but within a specific Glasgow context. 
 
Other texts discussed in the literature review which examined the social aspects of 
prenatal testing are The Captured Womb: A History of the Medical Care of Pregnant 
Women by Ann Oakley, Testing Women, Testing the Fetus: The Social Impact of 
Amniocentesis in America by Rayna Rapp, The Tentative Pregnancy: Amniocentesis 
and the Sexual Politics of Motherhood by Barbara Katz Rothman, and Heredity and 
Hope: The Case for Genetic Screening, by Ruth Schwartz Cowan. Whilst these texts are 
essential for gaining an understanding of the social context of the development of 
prenatal testing, and also consider some of the key scientific and clinical advances 
enabling these developments, none specifically consider the developments which took 
place in Scotland. As already argued, what this thesis adds is a more nuanced story of 
developments within a particular geographical region. This thesis is able to discuss, for 
example, specific cases where an incorrect diagnosis was made, and can also look at a 
broad variety of identified individuals who worked in prenatal testing. In addition, 
whilst some of the texts named above take a stance on whether prenatal testing is 
inherently right or wrong, this thesis does not take such an approach. The scientific and 
clinical developments are considered, alongside the social context in which they were 
occurring, from a neutral perspective.  
 
Within the literature review, the importance of Witness Seminars was also considered, 
with several of these being recognised as relevant to the development of the field of 
medical genetics more broadly, and in specific instances to prenatal testing too. Whilst 
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the advantages of these Witness Seminars were highlighted in the literature review, this 
thesis contributes to the literature in a different way. One of the key differences is that 
the oral history interviews carried out for this thesis took place individually in the 
homes or places chosen by the interviewees. Within such a setting, the interviewer has a 
greater freedom to lead and extend discussion on particular topics that may be of 
interest. The dynamic is also different within an individual interview, to that of a group 
discussion. Additionally, the selection of interviewees for this research was wider, 
involving many local technicians and other staff, thus representing a diverse group 
involved in prenatal testing in Glasgow. 
 
From the above discussion it can be seen that there are several texts available which 
consider a variety of aspects of the development of prenatal screening. However, none 
of these consider the issues from the same perspective as this thesis. Whilst some 
consider developments which were occurring in Scotland, others consider the scientific 
and clinical perspective from a larger geographical perspective, and others still are more 
focused on the social climate and connotations of the implementation of prenatal 
screening. What this thesis adds to the literature, therefore, is a nuanced, specific and 
technically informed discussion of the contribution of Ferguson-Smith and his 
colleagues. This can be placed against the wider developments which were occurring in 
the prenatal testing field, and the specific social climate of the West of Scotland can be 
examined.  
 
Whilst the above considers the contributions this thesis makes to the broader literature 
of prenatal testing, this thesis also examined the subject of abortion, due to its 
inextricable links to prenatal diagnosis. The importance of fetal anomaly in shaping 
abortion debates is considered by several scholars, but the work by Gleeson is perhaps 
the most in-depth. This thesis adds to the published literature on how fetal anomaly 
issues influenced legislative change. The ways in which fetal anomaly was discussed 
within abortion bills is examined, as is the role it played as an impetus of change. This 
thesis develops the idea of fetal anomaly being viewed as a separate category with 
regards to abortion, when considered alongside areas such as terminations for ‘social’ 
reasons. The original research carried out for this thesis highlights that much of the 
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concern initially surrounding a fetal anomaly clause was to do with the uncertainty of 
diagnosis. Interestingly, although for the most part prenatal testing had not become 
widely accessible prior to Steel’s Bill being presented, the fetal anomaly clause was 
subject to less debate than other clauses within the Bill.  
 
Within the literature review of this thesis it becomes clear that two of the most 
important scholars for consideration when examining Scotland are Gayle Davis and 
Roger Davidson. Davis and Davidson have written a great deal about the changing 
abortion legislation from a Scottish perspective, and their work is of key importance for 
chapter five. As Davis herself has commented, and as was previously highlighted, the 
lack of discussion focussing on Scotland in the published literature on abortion ‘is a 
particular shortcoming’.11 This thesis addresses this shortcoming, by considering many 
aspects of the abortion discussions from a Scottish perspective.  
 
As can be seen within this thesis, a key topic within Davis and Davidson’s work is the 
roles that Dugald Baird and Ian Donald played in impacting both abortion legislation, 
and the availability of abortion services within Scotland. This thesis pays particular 
attention to the case of Ian Donald, due to him being based in the Glasgow region. It 
examines the ideas put forward by Davis and Davidson that Donald was able to restrict 
access to abortion services, and provides a more nuanced analysis of Donald’s practice, 
by utilising primary sources such as archive material and oral history testimony to 
consider in more detail the situation which was occurring in the West of Scotland. 
Specifically, this thesis looks at the views of Donald towards termination of pregnancy 
for fetal anomaly, and links this to his working relationship with Ferguson-Smith. This 
builds on the work which was been carried out both by Davis and Davidson, and also by 
Nicolson and Fleming, on the importance of Ian Donald as a figure within the region, 
but goes further by considering the ways in which relationships within the region could 
also have impacted clinical practice. As has been emphasised, this link between Donald 
and Ferguson-Smith is not well known, and therefore by bringing this material forward 
                                                          
11 Gayle Davis, ‘The Medical Community and Abortion Law Reform: Scotland in National Context, c1960–
1980’, in Lawyers’ Medicine: The Legislature, the Courts and Medical Practice, 1760–2000, ed. by Imogen 
Goold and Catherine Kelly (Oxford: Hart Publishing, 2009), p. 144. 
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within this thesis, a new contribution to the literature surrounding Donald’s views on 
abortion is made. 
 
Davis and Davidson also examine key themes such as the role that medical 
professionals played in influencing abortion debates, and look at the ways in which the 
Lane Committee Report into the working of the Abortion Act 1967 was composed and 
received. Within this thesis, the Lane Committee Report is considered within chapter 
five, with an examination of the response to it from groups including those who were 
specifically based in Scotland. Where possible, the response to the Lane Report from 
groups who were based in the Glasgow region was considered, adding further 
contributions to the published literature on the responses of Scottish groups and 
organisations. It is hoped that such work helps to contribute to the work done by Davis 
and Davidson to highlight the specific situations and responses which were occurring in 
Scotland, which were often different from those which were happening in England. By 
examining Scottish responses, this thesis helps to add to the current literature on 
Scotland, which is important as the published literature which is available at present, 
aside from the work done by Davis and Davidson, often does not consider the nuances 
which existed in Scotland. 
 
In addition to contributing to the current literature available on the subject of abortion, 
another key area of consideration for this thesis are the views of religious organisations 
to prenatal testing, particularly the Roman Catholic Church and the Church of Scotland. 
One of the most substantial contributions of this thesis to the wider literature, is in the 
examination of the views of the Church of Scotland, both towards abortion more 
generally, and prenatal testing specifically. As is shown in the literature review of this 
thesis, very few texts exist which examine the viewpoint of the Church of Scotland to 
abortion, and there are no texts specifically considering their views on abortion as a 
result of prenatal testing. This is a significant gap in the literature, and the material 
presented within this thesis can act to fill this gap, due to the detailed analysis that was 
undertaken of the changing views of the Church of Scotland. Aside from published 
books such as Abortion An Ethical Discussion and Abortion in Debate, there is not a 
great wealth of information on the viewpoints of the Protestant faith to abortion. As is 
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seen in this thesis, this is of central importance, as the Church of Scotland viewpoint did 
not remain static on abortion issues, and was influenced by the views of its members.  
 
A similar statement could be made for the literature which exists on the Catholic 
Church viewpoint towards abortion. Whilst it was shown in the literature review that 
there are publications which discuss this viewpoint, most do not look specifically at 
prenatal testing. Indeed, even within the primary sources consulted for the research for 
this thesis, this material was difficult to locate. By instead examining the Catholic 
viewpoint to abortion more generally in the West of Scotland, this thesis contributes to 
the regional literature on the effect of Catholicism in the Glasgow area. This is of 
importance, as it provides a more detailed insight into the regional circumstances which 
existed within an area. For Glasgow, an area with a high population of Catholics, this is 
reflected in this thesis by highlighting that a great deal of work was going on to 
campaign against abortion legislation, which may not have been evident in other regions 
with a lower population of Catholics. 
 
IV. Reflection and Recommendations for Future Research 
This thesis set out to examine the history of prenatal diagnostic testing, utilising the case 
study of the West of Scotland. Specifically, key research questions included an analysis 
of the development of invasive and non-invasive prenatal technologies, and the role that 
Ferguson-Smith and his colleagues played in these developments, particularly for 
chromosome disorders and neural tube defects. It was argued in the introduction that the 
technical developments which occurred in the prenatal field were not stand-alone 
events, and were influenced and impacted by the social climate in which they were 
developing. By considering both the technical and social perspectives in detail, in a 
specific geographical region, the development of prenatal testing in Scotland can be 
placed amongst the broader history of prenatal diagnosis. This adds an important new 
perspective to the existing literature on the history of this antenatal development. 
 
To undertake this project, a variety of source materials were used, including the 
Malcolm Ferguson-Smith archive, oral history interviews, and published scientific and 
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clinical papers. In addition, to analyse the social context around which the prenatal 
testing field was developing, newspapers and magazines were also consulted. It is 
useful to reflect on the nature of these sources, particularly the Ferguson-Smith archive 
and the oral history interviews, to gain an insight into their overall contribution to this 
thesis.  
 
As mentioned previously, the Ferguson-Smith archive has been digitised as part of the 
Codebreakers: Makers of Modern Genetics programme, funded by the Wellcome Trust. 
This has resulted in the vast majority of the archive being available to access digitally, 
in PDF format. These documents were particularly useful to consult when constructing 
chapter two, as they gave a more personal insight into the developments which were 
occurring in the West of Scotland region than published scientific papers could. This 
was particularly true for the large correspondence section which contained 
communications to and from Ferguson-Smith spanning several decades. These letters 
helped to provide an insight into Ferguson-Smith’s personality, and his changing status 
within the medical genetics community as his career developed. It was possible to get a 
sense of the emotions Ferguson-Smith felt at various points in his career, including 
excitement when new developments were progressing, and disappointment when issues 
such as lack of funding had to be faced.  
 
However, as with all personal archives, there are limitations associated with using these 
sources. The documents housed in the archive are unlikely to be the full complement of 
all the written material that Ferguson-Smith gathered throughout his working career. It 
is likely that documents will have been discarded over time. Items that could be useful 
to a researcher may not have been deemed as of importance at the time they were 
created. It is also possible with any personal archive that decisions have been made not 
to include specific material, which the individual may not wish to have available to 
view by researchers or the wider public. This leads to the researcher not having access 
to documents which could provide a deeper insight into sensitive topics. It is also 
possible that the institution receiving the archived materials could make decisions as to 
which items were appropriate for inclusion in their holdings. This can also be reflected 
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in the way items are catalogued, which could result in items not being viewed in the 
same manner as when they were originally created.  
 
As with many personal archives, the Ferguson-Smith collection is made up mainly of 
written material, which can result in certain information being missed from the archival 
record. In the case of the Ferguson-Smith archive, this was particularly clear for his 
colleagues. As discussed in the introduction of this thesis, that this group are largely 
missing from the archival record is unsurprising – it is far more likely that colleagues 
would have been communicating in person, rather than writing letters to one another. 
That Ferguson-Smith’s colleagues were not represented in the written archival 
documents led to the decision to carry out oral history interviews, to try and gain a 
further insight into the inner workings of the department. Initial interviews were carried 
out with Malcolm and Marie Ferguson-Smith, and during these discussions the names 
of others who had worked in the department were given. Several colleagues who 
worked during the time period that this thesis is focusing on were traced and invited to 
interview, whilst others contacted me directly having heard details of this research 
project, and as discussed in the methodology section of the introduction, unstructured 
interviews were carried out with all of these individuals. By speaking to a variety of 
individuals who had held different roles within the department, it was possible to build 
up a more complex picture of how the department functioned, both in terms of scientific 
research and clinical practice, and also with regards to working relationships within the 
team. These oral history interviews gave many individuals who had been involved in 
the prenatal testing field in Glasgow an opportunity to tell their story, which for many 
was the first chance they had been given to do so. By hearing about some of the key 
work which had taken place, it gave the project a sense of direction in which to focus 
my research attentions, particularly for published scientific and clinical papers.  
 
Oral history interviews also have potential drawbacks. In the specific case of this 
research project, Malcolm Ferguson-Smith’s knowledge of and support for the project 
could have impacted the research material which was generated. He had the ability to 
choose what information was given during the interview process; his awareness of the 
potential legacy that this interview could leave behind could have impacted the stories 
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that he chose to share. As mentioned in the methodology section of the introduction, 
having previously taken part in other oral history interviews, it is also possible that 
Ferguson-Smith had already created a narrative of his career history, which would be 
more difficult to deviate from. That Ferguson-Smith gave his support for the project 
could have also impacted both the pool of interviewees who agreed to take part in the 
research process, and also the stories they might have shared. It would perhaps have 
been more difficult for interviewees to speak negatively about their time in the 
department, knowing that their past colleagues would have the opportunity to read their 
testimonies when they were deposited in the Ferguson-Smith archive. It is also 
potentially less likely that employees who did not enjoy working in the prenatal field, or 
perhaps did not enjoy working specifically in the department in Glasgow, would have 
become central figures within the team. If this was the case, then it is unlikely that these 
individuals would have been invited to interview, or would have approached myself 
directly having heard of the research project. However, not all interviewees were 
directly suggested by Ferguson-Smith, so it is hoped that a broader picture has been 
created. Despite this, the majority of interviewees had at some point worked with 
Ferguson-Smith, and this potential lack of diversity in the interviewee group could have 
impacted the material that the interviews generated.  
 
To triangulate these oral history testimonies, it could be useful in the future to hold a 
witness seminar to bring together former members of the department. Due to time and 
resource constraints this would not have been possible within the scope of this research 
project, but it could have played a useful role in helping to advance further the history 
of the medical genetics department. As can be seen in the Wellcome Trust Witness 
Seminars, having an open forum where individuals can recall their memories 
collectively plays an important role in untangling the unreliability of memory. If such a 
witness seminar was opened up to a broader constituency than just the medical genetics 
staff who worked under the leadership of Ferguson-Smith, perhaps to also include other 
research and clinical staff, it could perhaps go some way towards ensuring that the 
discussion of the development of the prenatal testing field in the West of Scotland was 
as balanced as possible.  
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In addition to widening the research focus within the West of Scotland, a particularly 
illuminating study which could be carried out in the future would be a comparison 
between the developments which occurred in the Glasgow and Edinburgh regions. This 
would help to further contribute to Coventry and Pickstone’s wish for more comparative 
studies, and could perhaps provide information on their theory that ‘The rapid 
institutionalisation of medical genetics in Edinburgh and Glasgow may well have 
stemmed from the historically closer ties between teaching hospitals and regional 
services in Scotland.’12 
 
Even using substantial archives in combination with extensive oral history interviews 
cannot provide a complete characterisation and contextualisation of the history of 
prenatal testing. However, in order to ensure that the developments which were 
occurring in Glasgow were being placed in a national and international framework, a 
wide range of published sources were also examined for this thesis. Examination of a 
variety of academic journals helped to develop a more detailed understanding of how 
the work of the Glasgow group fitted in amongst all of the other scientific and clinical 
work in the prenatal testing field. Published papers also often provided a high level of 
detail of the tests which were being carried out, and the laboratory procedures involved. 
What is missing from published papers is the story behind the work. However, it is 
hoped that the combination of the use of archive material alongside oral history 
interviews, in addition to published papers, provides a widely rounded view of the 
developments which were occurring in the prenatal field in Glasgow. This is also the 
case with placing this work in the relevant social context of the time period in which it 
was occurring – archive sources, interview material and published sources such as 
magazines and newspapers, all combined to provide this rounded view, with all of these 
sources subject to limitations similar to those already alluded to. 
 
A vast array of materials have been studied for the research for this thesis, but the 
voices of a few key groups are missing, namely, the women who underwent prenatal 
testing, and the religious figures who were active during the time period of the study. 
                                                          
12 Coventry and Pickstone, ‘From What and Why Did Genetics Emerge as a Medical Specialism in the 
1970s in the UK?’, p. 1236. 
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The tracking down of women who had underwent early prenatal diagnostic testing 
would be difficult, both in terms of access to the population, and also from an ethical 
standpoint. As was seen in discussions within this thesis, many women who underwent 
a termination after having a positive prenatal diagnosis struggled with this emotionally. 
Finding and approaching these women would therefore have to be done in a sensitive 
manner. This, however, should not preclude research taking place with the stories of 
these women as a central focus. Whilst the project was successful in locating a number 
of the scientists and clinicians who were active during the 1950s to late 1980s and 
beyond, it was not possible to find Catholic priests or Church of Scotland ministers who 
also fitted into this category. Interviews were carried out with two serving priests, and a 
midwife who strongly identifies as Catholic, but these individuals could not comment 
directly on many of the issues raised in the study. Of particular interest would be 
evidence relating to religious leaders who took an interest in the implications of prenatal 
testing.  
 
Moreover, this study does not contain the voices of those who live with the conditions 
for which the testing has been designed. Individuals with Down’s syndrome, for 
instance, could provide an important insight into how they feel the testing has impacted 
their lives. This would be particularly important and timely, given the discussions which 
currently surround the implementation of non-invasive prenatal testing (NIPT). As 
described in chapter three, NIPT involves analysing cell-free fetal DNA to determine 
the chromosome constitution of the fetus. The test is over 98% accurate in calculating 
the chance that the fetus has Down’s syndrome.13 NIPT is currently available from 
private providers at a cost of several hundred pounds. Talks are also underway to 
discuss its implementation by NHS Scotland. Concerns have already been raised that 
this programme will increase the numbers of terminations for Down’s syndrome. 
Groups such as the Don’t Screen Us Out campaign have been formed to protest against 
the implementation of the NIPT screening programmes.14 
 
                                                          
13 ‘NIPT for Down Syndrome A Guide For Patients and Healthcare Professionals’, The NHS Rapid Project 
<http://www.rapid.nhs.uk/guides-to-nipd-nipt/nipt-for-down-syndrome/> [accessed 24th July 2018].   
14 ‘Don’t Screen Us Out’, Don’t Screen Us Out <http://dontscreenusout.org/> [accessed 26th July 2018]. 
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Lӧwy has argued that prenatal diagnosis ‘did not acquire the fame of other medical feats 
of that period’, and that there was a lack of media discussion on the subject.15 She has 
remarked that ‘Recent developments in prenatal diagnosis seem to follow the trajectory 
of earlier innovations in this domain: a (mostly) incremental and (mainly) unexamined 
transformation of a new diagnostic method into a routine medical technology.’16 The 
implementation of NIPT programmes would therefore benefit from a closer scrutiny as 
they are implemented, and future research could focus on analysing these developments 
as they occur. Similar sources to those used throughout this thesis, such as monitoring 
the medical journals, alongside analysing the media response, would provide an 
important insight into current perspectives on such issues. Discussions with figures such 
as the medical professionals involved in the testing, alongside religious organisations, 
women taking part in such programmes, and the communities of individuals that the 
testing would greatly impact, such as individuals with Down’s syndrome and their 
families, would hopefully inform public discussion surrounding these issues. Whilst this 
thesis has analysed the historical development of prenatal testing, there is therefore a 
great deal of potential for the approaches used here to be implemented to analyse further 
developments.
                                                          
15 Ilana Lӧwy, Imperfect Pregnancies: A History of Birth Defects and Prenatal Diagnosis, (Baltimore: Johns 
Hopkins University Press, 2017), p. 3. 
16 Ilana Lӧwy, ‘Prenatal Diagnosis: The Irresistible Rise of the ‘visible fetus’’, Studies in History and 
Philosophy of Biological and Biomedical Sciences, 47 (2014), p. 291.p. 296. 
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Appendix 1: Participant Information Sheet Given to all Interviewees 
 
 
 Participant Information Sheet 
 
School of Social and Political Sciences 
The Genetics of Prenatal Diagnosis and Its Social Impact, c1950-c1990: the case of 
Malcolm Ferguson-Smith 
Researcher – Paula Blair, PhD student in History of Medicine 
Supervisors – Professor Malcolm Nicolson, Professor Kevin O’Dell and Professor 
Callum Brown 
  
You are being invited to take part in an interview for a research project. Before you 
decide it is important for you to understand why the research is being done and what it 
will involve. Please take time to read the following information carefully and discuss it 
with others if you wish. Ask us if there is anything that is not clear or if you would like 
more information. Take time to decide whether or not you wish to take part. 
Thank you for reading this.  
 
 
What is the purpose of the study? 
This study examines the development of genetics in the twentieth century, with a focus 
on the advances in prenatal diagnostics in the West of Scotland during this time. It will 
also consider the social impact of these advances, with a particular focus on the 
interaction between those working in the field and religious groups, who often had 
strong views about the testing for moral and ethical reasons. 
 
Why have I been chosen? 
You have been chosen due to the unique perspective you can provide on one or more 
of the following areas: the social, scientific and/or medical developments which 
occurred in prenatal testing during this time period. 
 
Do I have to take part? 
It is up to you to decide whether or not to take part. If you decide to take part you are 
still free to withdraw at any time and without giving a reason. 
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What will happen to me if I take part? 
Taking part will involve participating in one or more face to face interviews, and should 
not take more than a few hours of your time in total. The interviews will be audio 
recorded and transcribed. 
 
Will my taking part in this study be kept confidential? 
Due to the nature of the research project it will not be possible to keep your identity 
confidential. However you will have the opportunity to read the transcript before it is 
used for the research, and will be given a copy of the transcript to keep. 
 
Please note that assurances on confidentiality will be strictly adhered to unless 
evidence of wrongdoing or potential harm is uncovered. In such cases the 
University may be obliged to contact relevant statutory bodies/agencies. 
 
What will happen to the results of the research study? 
The results of the research study will be incorporated into a PhD which will be 
submitted in 2018. With your permission the transcript of this interview will be retained 
and housed in the Malcolm Ferguson-Smith archive at the University of Glasgow. 
 
Who is organising and funding the research? 
The research is through the University of Glasgow, but has been funded by the 
Economic and Social Research Council. 
 
Who has reviewed the study? 
The study has been reviewed by a number of Professors at the University of Glasgow, 
including Professor Malcolm Nicolson. It has also been reviewed by the College of 
Social Sciences Research Ethics Committee. 
 
Contact for Further Information  
If you have any questions regarding the study please contact me at 
p.blair.1@research.gla.ac.uk, or Professor Nicolson at Malcolm.Nicolson@gla.ac.uk 
If you have any concerns regarding the conduct of this research project, you can 
contact the College of Social Sciences Ethics Officer Dr Muir Houston, email: 
Muir.Houston@glasgow.ac.uk 
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Appendix 2: Consent Form Given to all Interviewees 
 
 
Consent Form 
 
Title of Project: The Genetics of Prenatal Diagnosis and Its Social Impact, c1950-c1990: 
the case of Malcolm Ferguson-Smith 
 
Name of Researcher: Paula Blair 
 
    
1. I confirm that I have read and understand the Plain Language Statement for the above 
study and have had the opportunity to ask questions. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at any time, 
without giving any reason. 
 
3. I consent to interviews being audio-taped and transcribed by the researcher. 
 
4.  I acknowledge that due to the small sample size anonymity will not be possible with this 
project, but that I will be given a copy of the transcript for verification. 
 
5.     I agree to the transcript of this interview being retained and housed in the Malcolm 
Ferguson-Smith archive at the University of Glasgow. 
 
5.    I agree / do not agree (delete as applicable) to take part in the above study.   
  
 
           
Name of Participant Date Signature 
 
 
Researcher Date Signature  
 
327 
 
Appendix 3: Details of Interviewees 
 
David Aitken and Jenny Crossley: 
David Aitken graduated with a BSc degree, and his initial role in the Department of 
Medical Genetics at the University of Glasgow was in the area of cytogenetics. He 
began studying for his PhD whilst based in the department, which involved examining 
the biochemical aspects of gene mapping. He spent time during his research working in 
Holland, learning about biochemical genetics, and would go on to lead the biochemical 
genetics team within the Duncan Guthrie Institute. He worked as a Consultant Clinical 
Scientist and spent time working on screening programmes for conditions such as 
neural tube defects and Down’s syndrome, and was centrally involved in the research 
aspect of the department. 
Jenny Crossley graduated with a degree in biochemistry from the University of 
Strathclyde. She initially worked in the Beatson hospital in Glasgow after graduating, 
and then took a career break. Upon returning to work, she took up a role in medical 
genetics in the Duncan Guthrie Institute in 1983, initially in the area of cytogenetics, 
before moving over to biochemistry in 1985. She worked as a Consultant Clinical 
Scientist, spending time on a variety of screening programmes and research projects 
throughout her time in the department.  
Both David and Jenny retired in 2011. 
 
Elizabeth Boyd and Anne Boyd: 
Elizabeth Boyd studied for a BSc degree at the University of Glasgow, which she 
graduated with in 1956. She then went on to study for her honour’s qualification in 
Botany, receiving this in 1958. This was followed by studying for a PhD in 
cytogenetics, under the supervision of Bernard Lennox. She moved over from working 
with Bernard Lennox to work with Malcolm Ferguson-Smith when he returned from the 
United States in 1961, and remained in the medical genetics department in Glasgow for 
the rest of her career. Worked in the diagnostics side of the department, working on 
blood and bone marrow samples. 
Anne Boyd did not work in medical genetics in any capacity, and was present at the 
interview only to support her sister. 
 
Mike Connor: 
Graduated with his medical degree from the University of Liverpool in 1975. Spent 
time working in Liverpool after qualifying, before moving to take up a post to work at 
Johns Hopkins University in Baltimore, in the department led by Victor McKusick. 
Returned to the UK and spent time working on an MD in Liverpool on a genetic-based 
project, before returning to Johns Hopkins once again. Moved to Glasgow in 1982, 
when he was appointed a consultant in medical genetics on an NHS post. Moved over to 
a senior lectureship post at the University of Glasgow in 1984. Was the first NHS 
consultant in Scotland in genetics. Succeeded Malcolm Ferguson-Smith as the Chair of 
Medical Genetics in 1987, when Ferguson-Smith moved to the University of 
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Cambridge. Acted as the Professor in Medical Genetics, and the Director of the West of 
Scotland Regional Genetics Service; was involved in both the clinical and research 
aspects of medical genetics in Glasgow.  
 
Alexander (Sandy) Cooke: 
Completed an undergraduate degree in molecular biology at the University of Glasgow, 
before going on to undertake a PhD at the University of Dundee, and a post-doctoral 
research post at the University of Aberdeen. He began working in the Department of 
Medical Genetics in Glasgow in December 1980, initially in cytogenetics, before 
moving over to biochemical genetics. Spent time working in flow cytometry in the 
department, and also carrying out some molecular genetics research. Retired in 2013. 
 
Malcolm Ferguson-Smith: 
Graduated with his medical degree from the University of Glasgow in 1955, and after 
completing his residencies, began a job in the pathology department of Western 
Infirmary in Glasgow in 1956. Remained in this role until he moved to Johns Hopkins 
University in Baltimore in early 1959, to begin working as a Research Fellow in the 
medical genetics laboratory which was being set up by Victor McKusick. Remained at 
Johns Hopkins until late 1961, when he returned to the University of Glasgow as the 
first Lecturer in Medical Genetics at the institution. He was promoted to the post of 
Senior Lecturer in 1965, and Reader in 1971, before going on to become a Professor in 
1973, the same year in which he was named the Burton Chair of Medical Genetics. He 
was responsible for the formation of the Duncan Guthrie Institute in Glasgow and 
remained working in the city as the key figure in medical genetics until 1987. He was 
involved in all aspects of medical genetics, including developing and implementing 
prenatal testing and screening programmes. He moved to take up the post of Professor 
of Pathology at the University of Cambridge in 1987 and went on to run their regional 
genetics service in East Anglia. He retired from his post in pathology in 1998 and went 
on to form the Cambridge Resource Centre for Comparative Genomics. 
 
Marie Ferguson-Smith: 
Began studying for a degree in history and economics in 1956, before becoming 
involved in genetics in 1958 through a part-time job working for Victor McKusick at 
Johns Hopkins University in Baltimore. She worked in medical genetics in Glasgow 
from its inception, initially working for the University of Glasgow, before moving over 
to an NHS contract in 1966/1967, where she would go on to lead the cytogenetics 
division of the prenatal testing section. She remained in Glasgow until she moved to 
Cambridge in 1987 with Malcolm Ferguson-Smith. Continued to work in medical 
genetics in Cambridge until her retirement from this field in 1993. 
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Fr. Fitzpatrick: 
Qualified as a medical doctor in 1990. Worked in medicine until 1995, before entering 
the seminary to study to become a Roman Catholic priest. Has an interest in medical 
ethics, and is still active as a Roman Catholic priest at the time of interview. 
 
Gordon Graham: 
Obtained his biology degree in 1979, and upon graduating began working in the 
biochemistry department in Gartnavel General Hospital in Glasgow for 18 months. 
Moved to the Department of Medical Genetics in Glasgow in 1981, to take up a post as 
a Medical Laboratory Scientific Officer. He remained in the department throughout the 
rest of his career, working in a variety of roles such as screening for neural tube defects, 
and also completed a PhD in the early 1990s, part of which involved looking at folate 
metabolism. Retired in 2016. 
 
Bill Hannay: 
Qualified as a medical doctor in 1966, began working in obstetrics and gynaecology in 
1967. Moved to Glasgow and started working with Ian Donald in 1974. Promoted to 
Senior Registrar in 1975, and Consultant in 1976, which resulted in a career move to 
work in the Lanarkshire hospitals. Retired in 2000. 
 
Stuart Imrie: 
Graduated with a degree in genetics in 1983, and began working as a Clinical Scientist 
in the medical genetics department in Glasgow the same year. Worked in various areas 
of the department initially including postnatal blood studies, before moving over to the 
prenatal section in 1985. Still working in the department at the time of interview. 
 
Jennifer Lambert: 
Graduated in 1976 with a degree in biochemistry. Worked in various research roles 
before moving to work as a Research Associate at the Duncan Guthrie Institute in 1984. 
Remained in medical genetics at Glasgow for the rest of her career, working in a variety 
of roles including a short period of time in the cytogenetics section, before moving over 
to the molecular genetics section. Retired in 2013. 
 
Catherine McConnell: 
Began working in the department of medical genetics in Glasgow in 1972, as a Junior 
Medical Laboratory Scientific Officer, based on her school qualifications. Studied 
various qualifications throughout her degree, and progressed on to become a Clinical 
Scientist. Spent time working in various areas of the department, including 
cytogenetics, assisting on a CSV research project, and working in molecular genetics. 
Retired in 2015. 
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Karen McIntosh: 
Trained as a nurse in 1978, before going on to study for her midwifery qualifications in 
1981. Began working in the medical genetics department in 1984, when they were 
looking for a midwife to be attached to the department. Heavily involved in direct 
patient care throughout her time in the department, and also worked on research 
projects. Remained in the department until she retired in 2014. Took up a role working 
with the charity Antenatal Results and Choices in the same year, as their Scottish Co-
Ordinator. 
 
Fr. Maguiness: 
Began studying to become a Roman Catholic priest in the 1980s. Has a special interest 
in moral theology, and wrote a PhD thesis on that subject. Still active as a Roman 
Catholic priest at the time of interview. 
 
Catholic Midwife: 
Began studying to become a nurse in 1975, and followed her nursing training with also 
gaining her midwifery qualifications. Worked abroad for many years, before returning 
to Scotland in 1987, and resuming work as a midwife in a Glasgow hospital in 1988. 
Remained working as a midwife in this Glasgow hospital until 2015. 
  
Sandy and Arlene Raeburn: 
Alexander (Sandy) Raeburn qualified with his degree in medicine from the University 
of Edinburgh in 1964. He worked in clinical roles in Edinburgh, before moving to take 
up a post as a lecturer in the Netherlands in the early 1970s. He remained in this post as 
a lecturer whilst also studying for his PhD, and continued this research when he moved 
back to Edinburgh in 1973 to take up a post as a senior lecturer in medical genetics. He 
remained in this role until 1990, when he moved to take up the role of Chair of Clinical 
Genetics at the University of Nottingham. During his employment in Edinburgh, he 
spent time on secondment to the Duncan Guthrie Institute in Glasgow. Throughout his 
career he specialised in the study of cystic fibrosis and Down’s syndrome, and after 
retiring in 2003 he was appointed a professor of genetics at the University of Oman, 
where he worked until 2008. He passed away in 2018.  
 
Arlene Raeburn qualified as a primary school teacher, and after a career break became 
involved in the Scottish playgroup association. She set up a playgroup for babies and 
children with Down’s syndrome in Edinburgh, which Sandy was also involved in. She 
returned to teaching full-time, and worked with children with a variety of disabilities in 
the school and college sectors, also in Edinburgh. She went on to pursue a qualification 
in counselling, and moved to Nottingham alongside Sandy, where she went on to take 
up a role as a counsellor at an IVF research unit. 
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Mary Shade: 
Graduated in 1972 with a degree in bacteriology and genetics. Began working in the 
Galton Laboratory at University College London after graduation, and spent four years 
there working in cytogenetics. Moved to Edinburgh from London, and took up a job 
working with the Medical Research Council, where she remained for four years. Moved 
over to a prenatal cytogenetics role at the Royal Hospital for Sick Children in 
Edinburgh in 1979, and aside from a three-month period, remained there for the rest of 
her career, until retiring in 2011.   
 
Margaretha van Mourik: 
Qualified as a nurse in the Netherlands, and also completed qualifications in midwifery. 
Worked in these areas and the public health field, before starting work at the Duncan 
Guthrie Institute in 1982, as a research assistant on the folic acid/neural tube defect link 
project. Remained in medical genetics in Glasgow for the rest of her career, spending 
time as a nursing officer in genetics, before going on to become qualified as a 
consultant genetic counsellor. Still working in the department at the time of interview. 
 
Douglas Wilcox: 
Graduated with his intercalated medical and science degree from the University of 
Glasgow in 1979. After two years of rotations in the medical wards, began working in 
the Department of Medical Genetics in 1982. He became an Honorary Consultant in the 
department, and was heavily involved in the teaching and organising of the medical 
genetics course at the University of Glasgow. He spent his entire career in the 
department and focused a great deal on muscular dystrophy throughout his working life. 
Retired in 2011. 
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